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Abstract 
Introduction: The studies reported in this thesis investigated a number of patient 
orientated aspects of its current diagnosis, management and treatment in Kuwait. A 
comprehensive literature survey is presented with a detailed critical analysis of the 
very limited number of published material relevant to type 2 diabetes in Kuwait is 
also provided. A concise list of aims and objectives is also provided. 
Methodology: The methodology used to derive knowledge of the present situation 
from the patient perspective, was a series of relevant questions, devised based on the 
internationally used diabetes Michigan questionnaire. Face to face interviews were 
used throughout for both patients and medical staff. Suitable data analysis was 
performed. 
Results: A pilot study consulted 10 Kuwaiti and 10 non-Kuwaiti patients, and after 
analysis of their data it was found to be reliable, appropriate and capable of being 
analysed and so was extended to a larger study of 109 diabetic patients. These 109 
diabetic patients were studied in thirteen clinics distributed throughout Kuwait. Two 
groups of patients were studied – Kuwaiti nationals and non-Kuwaitis both of whom 
were treated at these clinics during their residency in Kuwait. 38 questions were 
asked including demographics, medical treatment, monitoring of their disease, 
physiological consequences and dietary aspects. The major findings were that 
patients considered two major areas could be improved to enhance the treatment of 
their disease. The first was to improve the degree of empathy shown to them by the 
medical/nursing staff and secondly to provide simple practical advice on exercise, 
dietary considerations and renal aspects of their disease. More comprehensive 
findings are presented in the thesis but many of these were minor compared with 
these two major aspects. Also presented are interviews with the medical staff in 
Kuwait who treat diabetic patients and the problems they face when treating their 
disease. The opinions and views of selected ophthalmologists and renal specialists 
are also presented.  Medical views were also sought in the UK- Ascot Rehabilitation 
above their experiences treating diabetic patients from Kuwait. Another aspect of the 
study was to interview Kuwaiti nationals who had been sent to a clinic in Ascot, UK 
for the treatment of the serious consequences of their conditions. Many of these were 
had type 2 diabetes and their views and perspectives of their treatment in Kuwait 
were gathered as being representative of the long term treatment of this condition. 
Discussions and Conclusions: The thesis discusses in some detail all the results 
which were obtained and concludes with a series of recommendations which could 
be taken to improve the treatment of type 2 diabetes in Kuwait. 
Keywords: Diabetes type 2, Kuwait, diabetic patients, renal problems, patient 
experience of their disease.  
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Chapter 1 
1 Introduction - Type 2 diabetes and its occurrence in Kuwait. 
 
For a century diabetes mellitus has been an issue for global health care systems 
because of both the primary effects and secondary complications, which cause 
significant morbidity and mortality. To counter this disease, a variety of treatment 
options have been developed addressing the spectrum of diabetic patients’ needs. 
Naturally, the varying capabilities and capacities of nations health care system across 
the world, in combination with the accessibility of their services, have a critical 
influence on the way their diabetic citizens are able to continue their lives.  
The World Health Authority (WHO) recently issued an updated fact sheet, number 
312, (WHO, 2013) about the problem the world faces concerning type 2 diabetes. 
Central to this information was the global-based, comprehensive study produced by 
Danaei et al., (2011a) which used data from 370 country-years, which was calculated 
from 1980–2008 trends in mean fasting plasma glucose (FPG) and diabetes by sex, 
for 199 countries and 2·7 million participants. The concept of country-years, the 
same group had developed and published, earlier in 2011, when they considered 
global trends in systolic blood pressure. The method to calculate country-years used 
a Bayesian hierarchical model, and for those who require clarification, it is 
comprehensively explained in their 2011 paper (Danaei et al., 2011b). Essentially, 
this concept uses data obtained from a country, but where completed data sets were 
impossible to obtain the concept of country-years was invented as this allows the 
maximum amount of data to be examined even though not all countries have equal 
data sets. This ability to use unequal data sets is fundamental to Bayesian type 
analysis and their probability testing based on aprior assumptions of distributions 
(Bayes & Price, 1763). Interestingly, both the studies of Danaei et al., (2011a) were 
funded by the Bill and Melinda Gates Foundation and the WHO, emphasizing the 
worldwide interest in this topic. 
In the extensive diabetes study by Danaei et al., (2011a) they made the following 
data interpretation:-  
"Glycaemia and diabetes are rising globally, driven both by 
population growth and ageing and by increasing age-speciﬁc 
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prevalence. Elective preventive interventions are needed, and health 
systems should prepare to detect and manage diabetes and its 
sequelae" (Danaei et al., 2011a) 
The primary aim of the management of type 2 diabetes is that any strategy 
effectively produces for the patient a better quality of life and minimizes the 
secondary manifestations of the disease such as the pathological changes caused 
by microvascular changes in the eye and kidney. Traditionally this was done by 
directions from the physician which the patient had to implement which were 
initially based on trying to control the disease with diet, exercise and better life 
style choices e.g. elimination of smoking and if these changes  were 
unsuccessful then oral hypoglycemic drugs would be used. If this proved 
unsuccessful then insulin would be used. The effectiveness of all these 
measures was usually quantitatively assessed by determining blood sugar 
values or more recently by HbA1c measurements. This last measurement is 
now preferred since it gives an opportunity to assess glycemic control over a 
period of weeks rather than just a specific time point as the blood sugar 
measurement does. So to assess the effectiveness of any of the types of 
treatment the system of care has moved away from directions by the physician 
to what is known as patient centred care. 
This focuses on patient needs rather than ‘health care provision’.   
One recent study states: ‘There is current concern with patients’ experiences of 
health care system around the world and patients have their own views on what 
is best for them and their priorities in life. So health professionals require 
flexibility to meet patients’ needs. So, patients should work ‘hand to hand’ with 
health professionals to plan their care and their opinions must be considered and 
respected’  ( Royal College of Nursing, 2011).  
The World Health Organization (WHO) now has a global strategy on people-
centered and integrated health services, namely, ‘WHO global strategy on people-
centred and integrated health services’ (WHO, 2015), which requires a fundamental 
change in the quality of health services, management and delivery. This is needed to 
meet the challenges faced by global health care systems. These changes aim to 
decrease treatment cost of chronic diseases, enable the population to live longer due 
to an improved quality of care and be suitable for an individuals’ needs. Putting 
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people at the heart of the health care experience and integrating the services provided 
for them is still an urgent challenge faced by health care systems. 
People –centered health services should provide individual education and support, so 
families and communities can make decisions so participating in their own care in 
the partnership with the health professional. Self-management includes assessment 
and treatment plans, personalised care and patient satisfaction surveys (WHO, 2015). 
The benefits of this system are comprehensively reviewed in this WHO document. 
 
However this people-centred health care system requires more evaluation as to its 
effectiveness to ensure patients are diagnosed earlier, have an integrated health care 
plan formulated on an individual basis and which is adhered to throughout all their 
treatment for however long that takes. This personalized health care planning 
requires objective rather than subjective evidence. This thesis tries to establish the 
current situation in Kuwait for diabetic patients on the basis of such evidence. Once 
this is known then strategies to implement this patient-centred care might be possible 
to implement. Without this knowledge it would be impossible. If good glycemic 
control is obtained using such a method then reducing the disease consequences with 
far better outcomes for both patients and the health care system of Kuwait could be 
achieved. As suggested by Majeed et al., (2014) glycemic control is one of the three 
key areas which have to be addressed when treating diabetes. The other two, were 
hypertension and dyslipaemia both of which will be mentioned in this thesis. 
Majeed et al., (2014) also commented that the treatment of the disease should be 
carried out by multi-disciplinary teams of the primary care physicians, diabetes nurse 
specialists, podiatrists, pharmacists and other professional groups.  
 
It is now appropriate to consider type 2 diabetes in Kuwait. 
1.1 The Kuwait perspective of diabetes. 
According to WHO and the International Diabetes Federation (IDF), in Kuwait, diabetes 
has reached epidemic levels. Over 25% of the native Kuwaitis suffer from diabetes and its 
consequences (Diabetes UK, 2006). Both type 1 and type 2 can lead to progressive, 
irreversible changes and because of the numbers involved this has profound consequences 
for the Kuwaiti health care system. One major complication is renal failure, and this will 
form a significant sub-part part of this thesis. 
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Many people in Arabic countries are at risk of developing this condition (Al-Rubean, 
2005) and so Kuwait is not an unusual example to study.  
1.2 A brief overview of the types of diabetes and its symptoms. 
Diabetes is characterized by an increase in the fasting blood glucose concentration 
greater than 7.0 mmol/L known as hyperglycaemia, or a plasma glucose which is 
greater than10 mmol/L, two hours after a meal. Hyperglycaemia occurs because of 
uncontrolled hepatic glucose output and reduced uptake of glucose by skeletal 
muscle with reduced glycogen synthesis (Rang et al., 2012). Polyuria can also occur 
as the urinary glucose exceeds the threshold for re-absorption. An increased 
susceptibility to infection - both bacterial and fungal and constantly feeling hungry 
and thirsty due to the dehydration can also occur. Other symptoms include: weight 
loss, lethargy and fatigue and in some a ‘smelly breath’ due to the formation of 
ketone bodies (Walker & Rodgers, 2004). During ketosis there is an accelerated fat 
breakdown to acetyl CoA. In the absence of aerobic carbohydrate metabolism acetyl 
CoA is converted anaerobically to acetoacetate beta hydroxybutyrate and acetone - 
the classical ‘ketone bodies’ (Rang et al., 2012). More severe complications 
produced these ketone bodies induced by the state of hyperglycaemia can include 
diabetic ketoacidosis which if untreated, leads to coma which is a medical emergency 
as it can be fatal.  
The treatment of type 1 is usually dietary restrictions and insulin injections to replace 
that lost due to beta cells destruction. The different formulations of insulin: isophane, 
lispro and crystalline were developed to try and maintain a constant blood sugar 
level. In contrast, the treatments for type 2 are more diverse. In some people, 
although they produce insulin, due to insulin resistance it is less effective, and so 
drugs are given to increase glucose uptake in striated muscle, inhibit hepatic glucose 
output and intestinal glucose absorption – an example of which is metformin which 
does not require functioning beta cells. Another useful property of this drug is that 
does not stimulate the appetite and so is very useful in obese patients, which will be 
feature of particular interest in this thesis. In others patients, sulphonylureas, which 
stimulate insulin secretion, are given, but these individuals need to have functional 
pancreatic beta cells, adhere to a strict diet, do greater levels of exercise, regular 
monitoring of blood glucose levels and oral drug treatment (Walker & Rodgers, 
2004).   
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1.3 Causes and consequences of diabetes. 
The precise cause of type 1 diabetes is still the subject of much debate. Pancreatic 
islet beta cell destruction been documented for decades caused by the individuals’ 
immune system producing an absolute deficiency of insulin due to the autoimmune 
destruction of the beta cells. The precise way of immune system activation which 
targets the beta cells has three suggestions as to its mechanism. These are: a) genetic 
predisposition, greater than ten-fold in first degree relatives, of the individual due to 
autoantibodies to the HLA class II complex (Steck & Rewers, 2011, Coppieters et 
al., 2012) by viral damage due to Coxsackie or Echo virus (Filippi & Herrath, 2005) 
and/or c) complex environmental factors (Coppieters et al., 2012). Type 1 usually 
occurs in young children or adolescents who are not obese when they first develop 
symptoms. Consequently an individual can develop type 1diabetes in childhood, 
teenage years or adulthood. Diabetes UK (Diabetes UK, 2012) data  for 23 000 
people under the age of 17 stated that their diabetes started when they were: aged 0-4 
years, 4%,  5-9 years, 19.1%, 10-14 years,  42.5%, 15 years, 11.4%, 16 years, 12.2% 
and 17, years, 10.7%. The 2004 NICE guidelines (NICE, 2004) has an additional 
group, 18 years and over, as type 1 diabetes is not restricted to people below the age 
of 18 as it  can still occur in people in the age range of 20 -30 years.  
In contrast, type 2 diabetes typically occurs above the age of 40 with no immune 
system involvement. The primary problems include insulin resistance and impaired 
regulation of insulin secretion. Complications of the condition, as it progresses were 
well documented by Stevens & MacFadyen (1972) including the major secondary 
features, of retinopathy and neurogenic deafness. A more recent comprehensive 
study (Rizvi , 2004) of type 2 diabetes  consequences concluded the major diseases 
problems were: a) macrovascular disease - two to four fold increased risk of 
myocardial infarction and stroke, b) microvascular disease - retinopathy, 
nephropathy and neuropathy and c) other serious consequences of the disease - 
blindness, need for renal dialysis, lower extremity amputations and unresolved 
bacterial infections. A recent Mayo clinic publication (Mayo Clinic, 2013) expanded 
on the pathological consequences of the disease to a number of different body 
systems: atherosclerosis, neuropathy, kidney damage, eye damage, foot damage, skin 
and mouth infections, osteoporosis, hearing loss and Alzheimer's disease. 
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Potentially, many factors determine whether an individual develops type 2 diabetes: 
sex, race, age, history of diabetes with direct (first degree) relatives. Further 
complicating factors include smoking, frequency and types of physical exercise 
routines and dietary patterns. While clear relationships have not been established in 
terms of prevalence, development, and severity across all of these categories, Al-
Sultan & Al-Zanki (2005) have attempted to build on existing data and implications 
from the worldwide literature, relevant to the Arabic world, which will be used 
throughout the entirety of this introduction.  
Diet is important for type 2 diabetics, as it is for type 1 diabetes, as the patients are 
required to control their intake of calories/ dietary constituents, such as 
sugar/lipid/salt. This may be self-initiated or following professional dietary advice as 
to which types and how much food they should consume. Dietary adherence is 
considered beneficial, while excessive consumption due to poor eating habits, is 
generally thought to cause diabetic complications. Exercise, its intensity and 
frequency, are also beneficial in relation to diabetes especially if helped by a 
professional plan of exercise. Other contributory factors include a previous medical 
history of ischemic heart disease, hypertension and hyperlipidaemia.  
1.4 Diabetes and Kuwait 
One major aspect of type 2 diabetes in Kuwait is the problem of an increased body 
weight. Body proportionality, in terms of the body mass index (BMI), has been 
related to type 2 diabetes (Rang et al., 2012). A BMI alternative is the ratio of 
patients’ waist and hip circumference. While BMI and waist to hip ratios are used to 
define obesity some studies have varying definitions of what constitutes obesity. 
Critical abnormalities in body mass indexes and/or waist to hip circumference ratios 
are clearly defined by Al-Sultan & Al-Zanki (2005), in their study of factors relevant 
to diabetes in Kuwait. They defined a BMI value equal to or greater than 30 as 
‘obese’, while waist circumferences larger than 102 cm in men or 88 cm in women 
indicated obesity both of which were conducive to the prevalence, development, 
and/or severity of type 2 diabetes. The waist to hip ratios is considered above average 
if greater than 0.95 in men or 0.80 in women.  
Other ‘factors’ indicative of type 2 diabetes, include biochemical measurements such 
as glycated haemoglobin (HbA1c), plasma cholesterol and the levels of high-density 
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(HDL) or low-density lipoproteins (LDL) and  triglycerides. For example, a value for 
HbA1c less ≤7% is regarded as being optimal for glycaemic control as compared with 
a control range for HbA1c of less than 6%, or between 6% and less than but not equal 
to 7%. HbA1c levels 8 % or above are considered dangerous and therefore indicative 
that some form of additional action is required in the treatment of their diabetes 
(NCEP, 2003; American Diabetic Association, 2003). Similarly, net serum 
cholesterol, low density levels of cholesterol, and triglycerides, values (respectively) 
below 5.2 mmol/L, less than or equal to 2.6 mmol/L, and less than 1.7 mmol/L are 
considered healthy and not conducive to some aspect of type 2 diabetes. HDL levels 
are seen as a problem if they are under 1.1 mmol/L,  for men, or 1.3 mmol/L for 
women (NCEP, 2003; Al-Sultan & Al-Zanki, 2005). 
Similarly, hypertension is more common among patients with type 2 diabetes than 
aged matched patients who were non-diabetic, who can have abnormally high levels 
of both cholesterol and triglyceride and in Kuwait there is a positive association 
between lipids and diabetes (Al-Sultan & Al-Zanki, 2005). The found that 
abnormally low levels of HDL were common in type 2 diabetics, so increasing the 
risk of developing conditions such as atherosclerosis which may prove fatal for the 
patient. 
1.5 Treatment strategies for diabetes. 
  Before any pharmacological treatment of type 1 and 2 diabetes commences, 
lifestyle and dietary advice is usually given - on smoking, exercise and how to 
achieve an optimal body weight. Specific details are given on the selection of foods 
to reduce sugar/lipid intake. In terms of drugs the NICE guidelines (NICE, 2010) 
suggest the following. For type 1 diabetes the pharmacological treatment is to use 
insulin in a range of different formulations/doses to control the blood glucose. For 
type 2 it is more complicated. 
1.6 A brief overview of the pharmacological treatment of type 2 diabetes. 
A summary of the pharmacological treatments for type 2 diabetes is provided below.  
The first line drugs include metformin, insulin scretagogues and acarbose.  
Essentially, metformin, which decreases glucose neogenesis and also increases 
peripheral utilization of glucose acts in the presence of endogenous insulin so can be 
used in patients who are a) patients who have a residual pancreatic islet cells, b) of 
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the ‘accepted’ body weight and c) in overweight and obese patients where control 
has been impossible to achieve by using lifestyle and dietary changes. If these drugs 
fail then a secretagogue, such as a sulfonylurea, may be added to the treatment 
regimes. In patients of ‘accepted’ body weight the sulfonylureas, can also be used as 
first line drugs. Acarbose, an inhibitor of intestinal alpha glucosidases which delays 
the digestion and absorption of starch and sucrose is usually restricted to those 
patients who have not been able to use other oral glucose-lowering medications 
(NICE, 2010). 
Second line drugs are given when blood glucose control is inadequate. 
Dipeptidylpeptidase-4 (DPP-4) inhibitors which increase insulin secretion and lower 
glucagon secretion, include sitagliptin and vildagliptin. These are added to 
metformin therapy as a second line treatment instead of a sulphonylurea to achieve a 
better degree of blood glucose control. Other second line drugs include 
thiazolidinediones such as pioglitazone and rosiglitazone, which reduce peripheral 
glucose resistance, leading to a reduction of blood glucose concentration, but in light 
of the advice of the MHRA/CHM in 2011, because of their potential toxicity to the 
cardiovascular system and bone density, their future is uncertain. 
Third line drug treatments are used when blood glucose control proves to be very 
difficult and combines thiazolidinediones with metformin and sulfonylureas.  
Another third line drug is the glucagon-like peptide-1 receptor agonist (GLP-1) 
mimetic exenatide, given to obese patients with a BMI of over 35 kg/m
2
 or when 
insulin treatment is not practical for reasons of lifestyle. Finally, for severe, 
refractory patients, insulin can be used in combination with metformin and 
sulfonylureas and acarbose.  
1.7 The complication(s) of renal failure. 
The treatments associated with advanced levels of diabetes, ranging from complex 
oral hypoglycaemic medication regimes (see the NICE guidelines comments 
immediately above) to insulin injections, try and counter the potentially serious 
cardiovascular complications, metabolic syndrome and/ or renal failure occurring in 
diabetics. A recent study concluded that 43.8% of all renal failure cases were due to 
diabetes (National Kidney & Urologic Diseases Information Clearinghouse 
(NKUDIC), 2010). This data also shows that renal failure due to cardiovascular 
disease was 26.8% i.e. 61% of the diabetes number whereas renal problems due to 
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glomerulonephritis 17%, cystic disease 5% and urological diseases 4.5% led to the 
conclusion that diabetes causes more cases of renal failure than for any other cause 
seen in medicine (Figure 1). To avoid the occurrence of such a problem needs 
available resources and healthcare accessibility and in this regard Kuwait is no 
exception making a study of renal problems of diabetes worthy of investigation.  
 
Figure 1.1 Relationships between Diabetes and Renal Failure (source: NKUDIC, 
2010) 
The pathogenesis of kidney diabetic lesions is still a topic of great speculation. In a 
special article in the American Society of Nephrology (Cohen-Tervaert et al., 2010), 
they suggested that the mechanism could be due to intracellular changes within the 
kidney glomerulus and also cells lying outside this structure. For example, the 
mesangial cells in the renal glomerulus may expand causing changes to the adjacent 
glomerular basal cell membrane and this expansion compromises the ultrafiltrate 
production. Another possible mechanism could be angiopathic capillary changes in 
both the kidney glomerulus and the associated interstitial capillaries i.e. 
glomerulosclerosis and intercapillary glomerulonephritis, both of which will cause an 
adverse effect on renal function. 
Diabetic renal nephropathy, causes proteinuria, due to permanent changes in 
filtration and if left untreated, leads to end-stage renal failure. This serious 
complication requires either haemo- or peritoneal dialysis or even kidney 
transplantation. If the data shown in the 2010 NKUDIC study is similar to that of 
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Kuwait, then patient education about this condition, dietary advice and monitoring of 
their disease, central factors of patient centred care,  assume great importance to 
reduce the morbidity produced by this condition.  
1.8 The problem of microalbuminuria.  
A number of studies concerned with diabetes have focused on the relationship 
between microalbuminuria and type 2 diabetes (Lee et al., 1995). They studied the 
association between the rate of urinary albumin excretion with the glomerular 
filtration rate (GFR). In their analysis of 284 Korean diabetic patients, 64 were 
diagnosed with microalbuminuria and 71 with glomerular hyperfiltration. They 
concluded that the mean prevalence of GFR in microalbuminuric patients was not 
substantially different from that of normoalbuminuric patients (24% as compared 
with 28 %). One year later, Vedel et al., (1996) analysed patients below the age of 66 
years with microalbuminuria assessing the glomerular filtration rate over a four hour 
period. They concluded that patients who did not require antihypertensive treatment 
had a higher rate of glomerular filtration in microalbuminuria in comparison with 
normoalbuminuria. 
However, testing methods for microalbuminuria are complex and still evolving and 
their significance in diabetes is as yet not completely reliable. The tests for 
microalbuminuria include - immunoturbidometry, radioimmunoassay and 
immunophelometry (Clavant et al., 2007) but these tests have not been used in any of 
the reported Kuwait used below. 
1.9 Renal disease and treatment in type 2 diabetes 
Treatment options for type 2 diabetes induced renal disease depends upon various 
‘biochemical’ levels in blood and urine. Sometimes, examination of such 
‘biochemicals’ in a patient with existing renal disease may reveal the cause as either 
being diabetes or other factors. Consequently, the treatment options for renal disease 
in type 2 diabetes require a thorough biochemical assessment of renal function. Some 
studies recommend that urine albumin levels should done immediately following the 
diagnosis of type 2 diabetes, and once per year following diagnosis (McIntosh et al., 
2002). When increased levels of urinary albumin are found in a patient’s urine and 
also when retinopathy is also present, this is treated as renal disease. If however, 
retinopathy does not exist, patients and physicians should consider that alternative 
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possible causes exist than diabetes (McIntosh et al., 2002). The existence of 
increased urinary albumin or serum creatinine (or in some cases both may be raised) 
in a patient diagnosed with type 2 diabetes indicates a greater risk for premature 
cardiovascular complications and this may predict an increased chance of end-stage 
renal disease. If retinopathy is present, the chances that the patient will be diagnosed 
with diabetic renal disease are further increased.  
More specifically, the increased risks associated with high levels of urinary albumin 
are defined across two categories: microalbuminuria and proteinuria. In the instance 
of microalbuminuria, the creatinine ratio of 2.5 mg/mmol or greater in men or a 3.5 
mg/mmol in or greater in women can exist. In contrast, in proteinuria, the respective 
concentration ratios are 30 mg/mmol or more or otherwise and a concentration of 
albumin at 200 mg/l or higher (McIntosh et al., 2002). 
Microalbuminuria, or incipient nephropathy, is the earliest potential sign of diabetes 
causing renal disease. Studies have been reported that it is commonly predictive of 
cardiovascular morbidity, cardiovascular mortality and total mortality (Dineen & 
Gerstein, 1997). They used a variety of techniques for measuring urinary albumin 
levels and their results have enabled values for normal function and abnormal 
function to be established. Gathering a timed sample of urine was considered to be 
the most effective method for detecting microalbuminiuria. Winocour & Marshall 
(1998) reported that a range of 30-300 mg over 24 hours and other various ranges for 
different time frames was said to be typically indicative of abnormally high 
microalbuminuria.  
In contrast, proteinuria, also known as macroalbuminuria, is considered to be a more 
‘drastic’ rise in urinary albumin, usually associated with a greater progression of 
urine albumin excretion in comparison to microalbuminuria (McIntosh et al., 2002). 
Unlike microalbuminuria, however, there is no defined end value for albumin as an 
indicator, and there is also an overlap between the specific ranges of albumin used to 
define either microalbuminuria or the end values of the ranges for proteinuria as 
described in some areas of research (MacLeod et al., 1995).   Twenty-four years ago, 
studies indicated that proteinuria could be a precursor to cardiovascular morbidity or 
mortality, was established by an endpoint value of 300/mg per one day sample of 
urine, as well as a >200 mg/l value for a spot urine sample for analysis (Schmitz & 
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Vaeth, 1988; Gall et al., 1991) was significant. According to Dineen & Gerstein 
(1997), patients were capable of acquiring and moving beyond proteinuria to end 
stage renal failure. In Denmark, Fioretto et al., (1996) and Parving et al., (1992) 
conducted cross-sectional analyses of 363 Danish type 2 patients under the age of 66. 
Of these 363 patients, 50 of them were categorised as having persistent proteinuria, 
defined as having approximately 300 mg albumin in urine across a one-day period, 
and 36 of these 50 patients experienced diabetic glomerulopathies. Additionally, 
22% to 37% of glomerulopathy patients also suffered from proliferative or simple 
retinopathy, while none of the glomerulopathy patients without diabetes experience 
retinopathy (Parving et al., 1992). This suggests that arriving at a concensus about 
renal disease, microalbuminuria and proteinuria in relation to type 2 diabetes is very 
difficult. 
However, subsequent studies and observations have accumulated evidence to 
improve the analysis, treatments, definitions or renal problems in diabetes. Renal 
failure is of high importance because of its severity and ability to cause further 
complications. The stage of diabetes and renal disease should be continually 
analysed in detail for the purpose of developing guidelines for awareness, treatment, 
and prevention where possible. For example, if a patient’s level of serum creatinine 
is above 150μmol/l, the patient is referred to a specialist for nephrological evaluation, 
counselling, and preparation for end stage renal failure (McIntosh et al., 2002). 
Concerning prevalence, cross-sectional analyses have demonstrated that persistent 
microalbuminuria is present in roughly 20% of patients while proteinuria is evident 
in roughly 15% of patients. Furthermore, UK studies have found that diabetes is the 
primary cause for patients to seek a renal replacement programme, where most of 
these patients have type 2 diabetes. Fifteen percent of United Kingdom residents 
within the renal replacement therapy programme have been diagnosed with diabetes. 
In the UK the prevalence of diabetes patients scheduled to receive kidney transplants 
is nearly six times greater in the African and Asian ethnic groups than in Caucasians 
(McIntosh et al., 2002). 
The evidence for type 2 diabetes causing microalbuminuria and macroalbuminuria 
(proteinuria) has been compiled in some additional studies. Gupta et al., (1991) 
defined microalbuminuria as a stage within the development of diabetic nephropathy 
while being the forerunner of overt diabetic nephropathy. Meanwhile, 
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epidemiological research in microalbuminuria has created a variety of prevalence 
data, including the rates across categories. Variability has been observed in many 
cases, while this may be explained according to differences in the duration of the 
disorder as well as in the different techniques used in the initial urine collection 
assessment processes. Other factors, including physical exertion and even posture, 
have been further discovered to have a significant influence over the rates of albumin 
excretion (AER) (Gatling et al., 1988). Despite these findings, there is no general 
consensus among researchers, with each laboratory participating in these studies 
recording their own range, as to what it regarded as normal. These varying levels 
have caused difficulty in attempting to assess diabetic nephropathy. The broad 
quantitative range has ranged from the 8% as documented by Gatling et al., (1988) to 
32% as reported by Bruno et al., (1996). Such a large range might be the result of the 
varying techniques employed in task of the urine gathering and analysis, or it may 
also be the result of variation in the conduct of population sampling analyses. Only 
five of the analyses considered were actually based on a definite population, while 
the remainder of the studies obtained their values from clinical populations. As a 
result of such sampling, there may be a statistical bias of true prevalence. Many of 
the studies were within European populations, where six of the analyses revealed a 
prevalence of microalbuminuria to be near 25% (Gall et al., 1991, Mattock et al., 
1992, McIntosh et al., 2002). These studies also revealed a higher tendency for males 
to experience this health complication in comparison to females. Additionally, as 
previously mentioned, separate new studies have discovered new ways of measuring 
microalbuminuria and these include immunonephelomerty, immunoturbidimetry, and 
radioimmunassay (Clavant et al., 2007) which may change the baselines in the 
future.  
The prevalence, relevant relationships and other implications of macroalbuminuria of 
proteinuria in diabetes were as low as 5% (Standl & Stiegler, 1993) and as high as 19 
% as reported by Vijay et al., (1994). In the last study the range may be attributed to 
the variations in urine collection techniques. Meanwhile, the prevalence of 
proteinuria was typically less than for microalbuminuria where 75% of the relevant 
studies reported the prevalence rate to be near 15 % (Lee et al., 1995; Bruno et al., 
1996).  
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Naturally, assessing end stage renal failure is of great concern in assessing and 
treating type 2 diabetes. Renal disease in diabetes is the main cause of end stage 
renal failure (ESRF) and while a minority of diabetes patients opt for renal 
replacement therapy is still a considerable number. The inherent risk of nephropathy 
is equal across patients with either type 1 or type 2 diabetes. However the much 
greater prevalence (90%) of type 2 diabetes as compared to type 1 means that renal 
failure is commonly associated with type 2. The prevalence of end stage renal failure 
in type 2-diabetes is clearly evident in the studies of McIntosh et al., (2002) and 
Lippert et al., (1995). The latter observed that of 225 patients admitted for renal 
replacement therapy over an 18-month period in Germany, 38% of these suffered 
from type 2 in comparison to 4% who suffered type 1 diabetes. Researchers have 
long considered diabetic renal disease to be a primary cause of end stage renal 
failure, but the lack of data has made establishing clear distinctions between renal 
problems in type 2 and type 1 diabetes somewhat difficult (Roderick et al., 1994; 
McIntosh et al., 2002).  
Earlier, Gokal et al. (1987) found that 17% of all patients beginning long-term 
dialysis were diabetics. Seven years later, Roderick et al., (1994) discovered that 
many patients treated in the renal units across the Thames Region of the UK were 
diabetics as they number of diabetes who required dialysis treatment was 15%, and 
10% of diabetic patients were required to have kidney transplant treatment (Roderick 
et al., 1994). 
Twenty five years ago a collaborative study involving the Royal College of 
Physicians, The Renal Association, and the British Diabetic Association considered 
the number of diabetes patients that had yet to receive attention for their renal failure 
even though the exhibited levels of serum creatinine > 500 μmol/l. They discovered 
the number of diabetics who had suffered end stage renal failure was 10.3% across a 
single year (McIntosh et al., 2002). Today, thirteen years later, additional research is 
still needed for this specific statistic and the WHO (2006) reported that the exact 
relationship between renal disease and diabetes had generally relied on irregularly 
conducted, not periodic research, and so was not known. 
As previously mentioned, diabetes prevalence varies according to ethnicity, and 
some UK research revealed that the Asian community had a particularly high 
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prevalence of type 2 diabetes. One of the earliest studies, Mather and Keen (1985), 
found that Asians over the age of 30 were nearly 4 times as likely to become diabetic 
in comparison to Caucasians. In contrast, below the age of 30 this trend was not 
statistically significant. Three years later McKeigue et al., (1988) reported that in a 
local population of Bangladeshi origin aged between 35 and 69 years, they were 3 
times more likely to suffer diabetes than the local Caucasian population. A higher 
rate of type 2 diabetes in the Asian population was collected in the form of survey 
data revealing a greater rate of renal complications as a result of diabetes across this 
group. In Leicester, a study reported that the relative risk of renal replacement 
therapy occurring as a result of diabetic nephropathy in Asians in comparison to the 
Caucasian population was 13.6  (Burden et al., 1992). In the same study, all Asian 
patients undergoing renal replacement therapy as a result of diabetic nephropathy 
were suffering from type 2 diabetes (Burden et al.,1992; McIntosh et al., 2002). 
Roderick et al., (1994) had also studied trends in 6,000 patients who were receiving 
renal therapy and found that both Asians and Africans were nearly six times as likely 
as Caucasians to require renal replacement therapy once being diagnosed with 
diabetes as it progressed to end stage renal failure. 
 Researchers in the United States have assessed similar situations. Stephens et al., 
(1990) examined over 1,000 patients receiving treatment for diabetes and found that, 
aside from a 70.6% prevalence of diabetes, Africans were over 4 times more likely 
than Caucasians to have end stage renal failure stemming from either type of 
diabetes. Similarly, Cowie et al., (1989) assessed numerous United States patients 
between the years 1974 and 1983 found that African-Americans were more likely to 
suffer type 2 diabetes. Later, Pugh et al., (1995) assessed Hispanics, Africans, and 
Caucasians and discovered that of the 523 diabetic patients, 47% were of Hispanic 
origin, 32% were African, and 21% were Caucasian. These variations in prevalence 
rates are a recurring trend among studies which have considered different ethnic 
groups. Consequently, type 2 diabetics are at a considerable risk of developing end 
stage renal failure and if biochemical indicators suggest renal function is declining, 
physicians should refer them to a specialist who can provide counselling and 
preparation for the initial stages of a renal failure programme (McIntosh et al., 2002). 
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1.10 Prevalence and progression of renal disease in type 2 diabetes. 
 The speed of the progression of renal disease in these patients can vary greatly from 
patient to patient, based on: other medical conditions, general state of health, body 
chemistry and other diverse factors (McIntosh et al., 2002). Physicians’ guidelines 
recommend that urine albumin and serum creatinine levels should be measured 
immediately following diagnosis and then at a minimum, annually, in order to 
optimise the probability of a more positive outcome and improving their health. 
According to McIntosh et al., (2002) 25% of type 2 diabetics, will exhibit 
microalbuminuria at the time of their first diagnosis whilst patients measured as 
normal during diagnosis have a 15% chance of developing microalbuminuria and a 
5% chance of developing proteinuria within the following 5 years (McIntosh et al., 
2002).  It is estimated that 20 % of microalbuminuric patients capable of surviving 
for a decade will further develop proteinuria, while approximately 50% will continue 
with microalbuminuria, and the remaining 30% will be fortunate enough to return to 
a normal status. Meanwhile, patients who are treated at the onset of proteinuria and 
hypertension will progressively lose glomerular function at a rate of near 8 ml per 
minute per year. Some evidence suggests that this rate is also observable in type 1 
diabetics (McIntosh et al., 2002). In other analyses, patients having survived a 
decade or more of type 2-diabetes are at an 8% risk of renal failure. 
The specific stages of renal disease can be classified based on the rising levels of 
albumin in the urine, while those who do not experience a rising level are referred to 
as normoalbuminuric. Initially, the slow albumin excretion is usually referred to as 
microalbuminuria, as mentioned above. However as the condition develops 
proteinuria in some becomes substantially more rapid  whilst in others it can remain 
steady for a substantial period of time, or even revert to a more optimal state. 
According to Wirta et al., (1996a), out of 146 patients analysed over 6 years, 17 
patients died due to complications and from 109 patients from whom urine samples 
were fully assessed, 18% progressed from normal to microalbuminuria, 3 % 
developed proteinuria and the remainder maintained their status. In an earlier similar 
earlier study, Niskanen et al., (1993), studied 133 recently diagnosed type 2 patients 
and when examined over a five-year period,11 patients died and the remaining 108 
patients provided data which was further analysed which showed 43% of patients 
returned to normal excretion levels and 57% maintained their microalbuminuria. 
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Furthermore, this study found no significant differences across the groups in those 
maintaining or revert their stage of diabetes, with regard to age, sex, blood pressure 
or body mass index 
Another study by Mattock et al., (1998) examined 100 type 2 patients who exhibited 
normal rate of urine albumin excretion over a three to seven year period and found 
that 23 % of patients developed microalbuminuria, 6 % developed proteinuria and 
the remainder maintained a ‘normal’ state. Wirta et al., (1996b) made similar 
findings of the progression of patients with microalbuminuria, as 46% maintained 
their state and 19% progressed to proteinuria within six years. Similarly, Patrick et 
al. (1990) assessed 149 recently diagnosed type 2 patients in terms of their albumin 
excretion rate in direct comparison to creatinine levels (via early morning urinalysis). 
Over the following year, 68% were classified as normal, 16% had intermittent 
microalbuminuria, and 16% had persistent microalbuminuria. Within the persistent 
group, 86% exhibited increased levels of albumin to creatinine at the baseline, while 
the remaining 14% were classified as normal (Patrick et al., 1990; McIntosh et al., 
2002). 
Studying groups of ‘established type 2 diabetics’ has been particularly useful in 
regards to progression to various stages or reversion. An early study by Mogensen et 
al., in 1984 examined 232, type 2 patients across an entire decade. Their research 
was designed to discover whether in their patient group microalbuminuria was able 
to predict the probability of overt nephropathy (proteinuria) developing. They 
defined microalbuminuria as a concentration of albumin ranging between 30 and 140 
mg/l, while proteinuria was defined as an albumin concentration range above 140 
mg/l (Mogensen et al., 1984; McIntosh et al., 2002). They always used early 
morning urinalyses and had a ten-year follow-up assessment. 22% of the patients’ 
originally exhibiting microalbuminuria had progressed to proteinuria, as compared 
with 5% of the patients who were below the minimal level in the initial assessment. 
In a similar study, Beatty et al., (1995) assessed 94 patients with type 2 diabetes, of 
which 50% were diagnosed with microalbuminuria, and the other half had normal 
levels. Only 25 patients with microalbuminuria were still alive at the end of the 
eight-year assessment period. Of the remaining, 25 patients, 19 were further assessed 
for statistical follow-up and showed that 26% had developed proteinuria, 42% 
maintained their excretion level, and 32% reverted to normal (Beatty et al., 1995). 
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Due to the fact that there is no associated deterioration of blood pressure (or 
glycaemic control) in patients having persistent microalbuminuria in comparison 
with those whom had reverted to normoalbuminuria, experts have postulated that 
variations in albumin excretions accounted for the reversion. However, early 
morning sampling may have been "vulnerable" to measuring albumin excretion 
across samples in comparison to timed samples. 
1.11 Global scale of diabetes. 
  Diabetes is a global issue and the International Diabetes Federation (IDF) is an 
organisation which collects and publishes data obtained globally. Their stated 
purpose in their website: http://www.idf.org/who-we-are reads: 
“The Federation’s activities aim to influence policy, increase public 
awareness and encourage health improvement, promote the exchange of 
high-quality information about diabetes, and provide education for people 
with diabetes and their healthcare providers. IDF is associated with the 
Department of Public Information of the United Nations and is in official 
relations with the World Health Organization (WHO) and the Pan American 
Health Organization (PAHO).”(IDF, 2014). 
The organisation also explains from where it acquires its data. 
“The International Diabetes Federation (IDF) is an umbrella organization 
of over 230 national diabetes associations in 170 countries and territories. 
It represents the interests of the growing number of people with diabetes 
and those at risk. The Federation has been leading the global diabetes 
community since 1950”. : http://www.idf.org/who-we-are . 
 Consequently their data is both widely published and as up-to-date as is possible and 
it is taken in the subject area as an authoritative source. Their data was used to 
produce Table 1.1 showing USA and UK rates as compared with a number of Middle 
Eastern countries. Table 1.1 shows the prevalence of diabetes mellitus (DM), 
Impaired Glucose Tolerance (IGT) according to IDF data (IDF, 2013) 
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Table 1.1 The comparative prevalence in 2013 of diabetes mellitus and impaired 
glucose tolerance (IGT) according to the International Diabetes Federation 
(IDF) for the UK and USA as compared with countries from the Middle East 
[Source International Diabetes Federation (IDF, 2013 b) 
http://www.idf.org/atlasmap/atlasmap]. 
Country  Comparative prevalence of Comparative prevalence of  
   diabetes mellitus (%)              glucose tolerance (%) 
UK   4.92    6.6 
USA   9.21    12.4 
Baharin  21.8    16.4 
Egypt   16.8    7.4 
Kuwait  23.1    17.9 
United Arab Emirates 19.0    16.6 
Lebanon  15.0    7.5 
Qatar   22.9    17.1 
Saudi Arabia  24.0    1.3 
 
In 2011 the IDF found that globally, 366 million people were considered diabetic in 
both low and middle-income countries (IDF, 2011). In 2013 this figure increased to 
382 million and for 2035 the projected figure is 592 million. Based on these figures, 
the World Health Organization (WHO) considers diabetes an ‘epidemic’. The recent 
IDF report, sixth edition (IDF, 2013) suggests that diabetes, in the age group 20-79 
years, caused 8.4% of deaths (5.1 million people) for all-cause global mortality (IDF, 
2013). The Arabic countries are clearly part of this ‘epidemic’. 
1.12 Diabetes in Arabic Countries.  
In 2007, four out of the top five countries affected by diabetes were in the Arabic 
world (Farag & Singh, 2009) based on a study at the Harvard Medical School, (USA) 
in Boston and Dubai. They found in 2000, the Arabic world had 7,814,000 diabetics 
set to rise to 22,157,000 by 2030. Using 2007 data from different Arabic countries 
they produced rank order of adult diabetes. The highest was the United Arab 
Emirates (UAE) (19.5%), then Saudi Arabia (16.7%), Bahrain (15.2%) and Kuwait 
(14.4%) When using the 2000 and the 2030 projected values the data was: the UAE 
in 2000, was 350,000 and would rise to 684,000 by 2030; Saudi Arabia, 890,000 
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rising to 2,523,000; Bahrain 37,000 rising to 99,000 and Kuwait 104,000 rising to 
319,000. In three other Arabic countries a similar pattern emerged. Jordan had 
195,000 diabetics in 2000 rising to 680,000 in 2030; Libya had 88,000 rising to 
245,000 and Morocco, 427,000 rising to 1,138.000. This study also found that type 2 
diabetics were usually within the age range of 45-64 years and the elderly > 65 years 
Their analysis found that Jordan, Libya, Morocco and Oman had a diabetic 
prevalence of 3% before 1980, which on current trends may rise to 5% to 16% for 
their adult populations. An important finding was that in Jordan, the correlation 
between diabetes and end-stage renal disease (ESRD) was found to be 29.2% of its 
populace and in the UAE 23.3% of patients with ESRD had this condition due to 
diabetes (Farag & Singh, 2009).  
Another aspect of diabetes in the Arabic world is its financial implications. For 
example, in 2010, 2.5 million Saudis were diagnosed with diabetes, an increase of 
1.6 million (or 183%) over the previous 18 years (Alhowaish, 2013). This increase is 
estimated to have cost the Ministry of Health in Saudi Arabia (MOHSA) a 500% 
increase in expenditure over the last 18 years. The MOHSA considers diabetes and 
its consequences as an economic burden on the country and its healthcare system 
(Alhowaish, 2013). This reflects the costs of treating a diabetic patient as being ten 
times higher, at $3,686, than a non-diabetic patient, $380. In 2010, MOHSA total 
health expenditure was $9.4 billion of which 10% ($0.9 billion) was to treat diabetic 
patients. The diabetes economic burden in Saudi Arabia will be $2.4 billion in 2015 , 
an increase of $1.5 billion, or nearly three times the level in 2010 and may increase 
still further to $6.5 billion or 7 times higher than in 2010 (Alhowaish, 2013).  
Consequently, they have included diabetes-related education for both the disease and 
its complications in their health care programme, using community screening 
campaigns to detect diabetes early, concentrating diagnostic facilities in health 
centres and introducing diabetes management systems trying to diagnose patients at 
an early stage of their disease (Alhowaish, 2013).  The indirect costs of diabetes, 
including the ability of people to work due to disease-related disability / loss of 
production because of morbidity and mortality were also examined and they 
mentioned that Saudi has developed effective policies and strategies to address 
diabetes and its entailing complications to modify future public health spending 
(Alhowaish, 2013). 
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In a recent additional study about Kuwait (Badawi et al., 2015) studied five key care 
areas measures in primary health care in Kuwait City in three government clinics and 
one private clinic of the highest case load, to assess the quality of services and care 
that patients with diabetes should have such as: measuring - HbA1c test, blood 
cholesterol, kidney function test, blood pressure, and checking their smoking status. 
The study found that only 63% of the patients received one or more HbA1c tests in 
2012 compared to 30% of the patients in 2010. Around 34% received a lipid test in 
2012, as compared to 30% in 2010. In 2012 only 34% of the patients were tested 
specifically for LDL cholesterol a slight improvement as compared with 2010. In 
comparison with testing for lipids by countries such as Spain and Australia (50%), 
Abu Dhabi (58%) and Italy (70%), Kuwait recorded the lowest annual lipid test. 
 In 2012, 25% of the patients had a kidney function test as a part of their annual 
checkup while in 2010 only 8% had received such a test. The study reported that in 
2012 the blood pressure was not calculated but in 2010 it had been 45% which 
compares with baseline rates, for the UK and USA of 51% and 61% respectively.  
In Kuwait the annual smoking check averaged 81% compares favourably to the UK 
annual check average of 85%. However, annual checks the status of smoking among 
diabetic patients in 2012 was less than year 2010. The authors mentioned that 
intervention to keep the high level of the annual checks the status of smoking among 
people with diabetes should be maintained 
The study mentioned four limitations. Firstly, the results in other centers may be not 
similar, secondly, diabetes test performance was not comprehensive, thirdly clinical 
performances were not recorded. Their conclusion that there is no systematic factors 
affecting the rate of missing clinical data is of great interest since it re-enforces one 
of the major findings of this thesis. 
In a recent study about Gulf countries (Omar et al., 2016), which described  the 
status of the control of diabetes, its complications, and the quality of diabetes 
management in the Kingdom of Saudi Arabia, Kuwait, United Arab Emirates (UAE), 
an insight into the relationship between these factors. 17 diabetic clinics participating 
in this study from three countries from May 31, 2009, to January 18, 2010 was 
obtained. They studied  1290 diabetic  patients, with a mean age  of 49.4 ± 12.3 years 
and duration of diabetes of 8.7 ± 5.9 years .The data was based on the examination of 
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the medical records to determine patient demographics; HbA1c, blood lipids, blood 
pressure and diabetic complications. The HbA1c values, suggested poor blood sugar 
control mirrored perhaps by 34.9% having neuropathic complication of the disease, 
29.9% had retinopathy, 14.1% had cataract, more than 10% with cardiovascular 
complications and 34.4% of patients had microalbuminuria. This paper contains 
some interesting data about the drugs these patients were using. For example, 43.3% 
were taking oral hypoglycaemic agents and the 39.3% used both oral agents and 
insulin. Their conclusion that the standard of care for patients with diabetes was 
found to be sub-optimal. Better management of diabetes to prevent or delay the 
diabetes complications was required. 
 Another study about type 2 diabetes in Arabic speaking countries (Badran & Laher, 
2012) concluded that unhealthy food and low levels of exercise contributed to the 
prevalence of type 2 diabetes and its complications in Arabic speaking countries.  
Early education in the early stages of the disease and also about chronic disease, 
healthy food and exercise to prevent obesity which is the main reason for diabetes 
prevalence in Arabic speaking countries would be very useful. Healthy practices and 
good management of type 2 diabetes can be done in ways which do not affect the 
Arabian cultural norms. Programs to motivate patients to changes their lifestyle 
eating  healthy food and increasing their amount of exercise are both very important, 
enabling them to enhance self-care, and they should be started in all Gulf countries 
(Al-Rasheedi, 2015). 
In an extensive study about diabetes in the Middle-East and North Africa, Majeed et 
al., (2014), had the following data interpretation:-  
“… Enhanced research on the epidemiology of diabetes needs to be combined 
with more effective primary prevention of diabetes (particularly in areas such 
as diet, exercise and obesity); and the early detection and improved 
management of patients with established diabetes, including an increased focus 
on self-management by patients and carers, and management in primary care 
and community settings” Majeed et al., (2014). 
1.13 Experience of diabetes education in selected Arab countries. 
A 1997  Egyptian survey, studied the knowledge, skills, practices and attitudes of 
1600 young patients (adult and children) with type 1 diabetes and their parents ( 
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Assaad , 2005). The data was published as a book chapter entitled ‘Education and 
diabetes in the Arab region’ and their comments, included:  
Fewer than 2% of patients with diabetes or their parents had attended educational 
activity outside formal medical contacts   
Fewer than 12% of the patients had an educational experience for greater than 30 
minutes. 
His most surprising findings can be summarized in the following way:  
 82% of the patients thought their diabetes was temporary. 
 56% were not able to recognize or diagnose ketosis. 
 52% never change their insulin injection site. 
 52% stored insulin incorrectly. 
 56% failed to comprehend the importance of foot care. 
 80% of patients used only one daily dose of insulin. 
 98% suggested that diabetes kept them away from success. 
 46% considered that controlling diabetes deprived them of a good quality 
of life.  
Two examples, (using his own words) are: 
 “55% did not know how to deal with hypoglycemia” 
 “52% did not know how to adjust insulin dosage” (Assaad, 2005). 
 A similar study does not exist for Kuwait and one of the reason for this thesis was to 
collect such data.  
1.14 Overview of the literature of studies relevant to diabetes in Kuwait.  
Databases checking using suitable search terms for diabetes in Kuwait produced a 
very limited number of papers summarized below. 
 In 2009, Sajjad (2009) concluded that in Kuwait diabetes was a major health 
problem and summarized the situation as: ‘continues to have the highest rate of 
diabetes, per capita, in the world’. Two years later Alhyas et al., (2011) published 
data from The Co-operation Council for the Arab States of the Gulf (GCC) where 
they concluded  about the treatment of diabetes was: "We found the extent of control 
to be sub-optimal and relatively poor" (Alhyas et al., 2011). 
In 2010, Shaw et al., (2010) found that the diabetes rate in Kuwait was over 15% 
of the adult population and 22 for every 100,000 children under the age of 14 
years. Their projection was that if the lifestyle of both the young and adults 
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remained unchanged, then these diabetics would add to the global number of 
diabetics, which may exceed 300 million by 2025 ( Al-Adsani et al., 2009; Shaw 
et al., 2010 ; Danaei et al., 2011b). 
Previously, in 2007, when the data for Kuwait was calculated, it limited the age 
group to 20 - 65 years and the prevalence was 12.6% (El-Nesf et aI., 2008). 
However, without an age range, in 2011 the prevalence reached 21.2% as reported by 
Al-Taweel et al., in 2013.  According the IDF data shown in Table 1.1 the prevalence 
has almost doubled in the last 7 years, reaching 23.1% in 2013 (IDF, 2013). All these 
seemingly variable values may reflect the great inherent difficulties of carrying out 
such studies when only samples are taken rather than assessing the entire population. 
Al-Rubean (2005) summarised the difficulties and gave the following reasons to 
account for such variable data: 
 “different criteria used to diagnose both diabetes and IGT”. 
 “differences in sample size and study type”. 
 “most studies have focused on certain sex, age, or type of diabetes.”   
To help their diabetic patients, the Kuwaiti Ministry of Health developed a series of 
specialised clinics, diabetic care clinics (DCC), distributed in all the administrative 
regions, examples include: Salwa, Sabah al Salem and Salmeya. Figure 1.2 is a map 
of Kuwait showing the different regions mentioned above. For diabetic patients from 
their first screening they provide primary health care and follow up for three months 
For diabetic patients with complications : coronary artery disease, peripheral vascular 
disease, stroke, diabetic neuropathy, diabetic retinopathy and renal failure they are 
referred to specialized hospitals for tertiary care.  
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Figure 1.2 Map of Kuwait showing the different regions of Kuwait. [Source: 
http://www.kuwaitiah.net/kuwaitmapa.html] 
 Three studies, Al-Adsani et al., (2008), Awad et al., (2008), Al-Shaheen et al., 
(2011), provided data that there was poor adherence to guidelines and Kuwaiti 
diabetic patients lack of suitable dietary control/advice and failure to carry out 
glucose monitoring have resulted in an increase in disease morbidity. This may 
suggest more patient-centred care is needed. 
The consequences of poor adherence to guidelines, a lack of dietary control and 
failure to routinely measure blood glucose, may require more patient episodes of 
acute care, which could need intensive medical/nursing care to return their condition 
to a more stable state. This lack of self-care behaviour was considered earlier by Al-
Bustan et al., (1997) who ‘hoped’ that diabetic education and better co-ordinated 
services in Kuwait could be achieved, but unfortunately, the later studies of Adsani et 
al., (2008), Awad et al., (2008), Al-Shaheen et al., (2011), suggest this has not 
occurred.  
The use of international guidelines to promote positive collaborative actions to both 
maximise the use of financial resources and to help patients control their diabetic 
state are examples which could be taken. However, this requires accurate data 
documentation of patient’s experiences to modify service delivery and so help 
prevent, control and mitigate the impact of diabetes through effective programs of 
research, training, education, and treatments, which even as recently as 2013 is still 
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lacking (Al-Taweel et al., 2013). Evidence-based clinical practice has led to ‘tools’ 
being developed to measure prescribing adherence to national guidelines. These can 
both detect and measure inappropriate prescribing to specific patient groups by using 
quality standards extracted from evidence-based guidelines carried out by Kuwait 
physicians (Al-Taweel et al., 2013). Similarly, no published studies have been 
reported for Kuwait evaluating dietary factors, which could be compared with 
guidelines used elsewhere in the world. Furthermore, patients’ experiences of their 
diabetes treatments in Kuwait have never received a detailed study. 
In 2001 the KMOH produced a series of diabetes guidelines but no regular updates 
of such advice have been made (Al-Taweel et al., 2013). Additionally, studies 
considering the adherence of these guidelines in Kuwait cannot be found in the 
literature. Such information would form the necessary analysis to produce a quality 
assurance framework to ensure optimal patient care as suggested by Al-Taweel et al., 
(2013). These authors also stated that they found that International Guidelines, based 
on those used in the USA formulated by the American Diabetes Association, a 
summary of which can be found on their Website (Anon., 2013), were being used 
and an overall adherence to prescribing for diabetes according to such guidelines was 
78%. This suggested that International prescribing guidelines for diabetes were being 
closely followed. 
The KMOH is justifiably concerned that type 2 diabetes is a major health issue and 
related to abdominal obesity, hypertension, and atherogenic dyslipidemia which 
comprise severe metabolic complications (American Diabetes Association, 2003; Al-
Sultan & Zanki, 2005). Further, obesity in Kuwait, may increase the risk of a large 
range of serious medical conditions such as cancer, osteoarthritis, coronary heart 
disease, gall bladder disease, hypertension and many others diseases (Jackson et al., 
2001). Contributory factors include: specific dietary elements, behavioural traits, and 
even social and economic factors have all been established to play some part in the 
increasing prevalence of health complications (Al-Isa, 1999). In research studies in 
Kuwait and other Gulf States it has been found that obesity is becoming increasingly 
common and approximately one third of adult Kuwaitis are obese. Recently in 
Kuwaiti men their mean BMI was 31.8 (+/- 6.3) and 28.5 (+/- 5.1) (Al-Sultan & Al-
Zanki, 2005).  This rating used BMI values of 30 or above as being considered 
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obese. Some studies have found a role for ethnicity associated with the prevalence of 
diabetes and some have found relationships with sex as well. The highest end of the 
spectrum of body fat distribution was seen in obese women with diabetes (Emara et 
al., 1988). Some studies across the past decade have establishes an association 
between genetics/ heredity with the prevalence of both diabetes and hypertension 
(Abdella et al., 1998; Al-Sultan & Al-Zanki, 2005). 
In contrast, a limited number of studies conducted in Kuwait have revealed the 
severity of the diabetes problem and its ‘rippling effects’. Research in two hospitals, 
Mubarak and Farwania, found type 2 diabetes has become more common in women 
over the age of 40, as compared to the increases across sex and age groups (Al-
Sultan & Al-Zanki, 2005). Also, a positive relationship with family history/genetics 
has been found for 63% of patients Abdella et al., (1996). A study in the Hawalli 
region found hypertension in 40% of all assessed diabetes patients, obesity in 47% 
and hypercholesterolemia in 23%. 42% of patients, although not obese, were 
categorised as being generally overweight (Sorkhou et al., 2002).  
Additional studies in Kuwait showed that a high diastolic blood pressure and serum 
triglycerides are a risk factor for the onset and progression of type 2 diabetes. 
Meanwhile, the metabolic syndrome complications as described above is capable of 
further involvement to a variety of serious health complications such as "abdominal 
heaviness" leading to potentially severe obesity, insulin resistance, an increased 
fasting glucose level, hypertension, a drastically reduced HDL-cholesterol levels and 
increased levels of triglyceride resulting in dyslipidemia (Palaniappan et al., 2004, 
Al-Sultan & Al-Zanki, 2005). Some of the more recent progress improving the level 
of comprehension regarding the condition has occurred at the level of genetics, and 
the aforementioned metabolic syndrome. 
The "metabolic syndrome complications" associated with diabetes has only been 
defined in greater detail in last decade, when the USA the National Cholesterol 
Education Program (NCEP) provided the first formal medical definition of this 
syndrome within its national guidelines to accompany its Adult Treatment Panel III 
report (ATP III) (NCEP, 2003). At present, the ATP III guidelines are the most 
modern and commonly utilised organisation of data in this subject area. However, 
there have been other developments by other organisations which are commonly 
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referred to such as the World Health Organisation’s studies by Meigs (2002). The 
metabolic syndrome and associated issues as described by the ATP III guidelines 
‘demands’ the presence of any three of the abnormalities of abdominal obesity, 
dyslipidaemia, a low level of HDL cholesterol, or the presence of blood pressure 
medication. More specifically, the existence of these abnormalities must fall within 
the range of a waist circumference measurement greater than 102 cm for men or 88 
cm for women to constitute obesity, a serum triglyceride level greater than 150 
mg/dL (or 1.69 mmol/L) to constitute dyslipidemia, a level of high-density 
lipoprotein (HDL) less than 40 mg/dL (or 1.04 mmol/L) for men and less than 
50mg/dL (1.29 mmol/L) in women constitutes abnormally low levels of HDL. A 
blood pressure greater than 130/85 mmHg constitutes an abnormally high blood 
pressure or a fasting blood glucose level greater than 110mg/dL (or 6.1 mmol/L) thus 
needing medication (NCEP, 2003; Al-Sultan & Al-Zanki, 2005). Furthermore, ATP 
III emphasises the significance of treating diabetic patients and their metabolic 
syndrome complications in terms of preventing the more serious complications, such 
as cardiovascular disease or renal failure, which could be fatal. 
The significance of treating cardiovascular complications to prevent a worsening of 
the patients’ condition is emphasised in a number of studies, since these 
complications, which can be fatal even in non-diabetic patients, are frequently 
greater in diabetics (Isomaa et al., 2001, Meigs, 2002; Ford et al., 2002, Al-Sultan & 
Al-Zanki, 2005). In the USA, according to a national questionnaire assessment data, 
the prevalence of the metabolic syndrome is unusually high, as nearly 25%, suffer 
this condition. There is an increased occurrence in the elderly, especially in Mexican 
Americans (Marchesini et al., 2004; Al-Sultan & Al-Zanki, 2005). Those suffering 
this syndrome double their probability of developing some form of cardiovascular 
disease, and  in addition, are nearly four times as likely to develop type 2 diabetes in 
comparison with patients who that do not suffer metabolic syndrome. 
Some studies, suggest the syndrome might have a genetic basis, whilst others 
consider a role for environmental factors which are conducive to increasing the risk 
in the onset of the syndrome (Marchesini et al., 2004). Others have assessed the 
relationships between physiological anomalies, which are defined within the 
syndrome, and have concluded that the variables relevant to the metabolic syndrome 
are similar among the spectrum of ethnicities, unlike the prevalence of type 2 
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diabetes alone (Ford& Giles, 2003). Naturally, such a difference is of great interest to 
researchers and physicians, while this creates some immediate implications for areas 
such as prevention and preparedness in general (Ford& Giles, 2003). According to 
the United States’ Third National Health and Nutrition Examination Survey, this 
syndrome (adjusted for age) was nearly 24% using the ATP III definition and 25% 
when using the WHO description. In other analyses the metabolic syndrome across 
type 2 diabetic patients was found to be 81% and 78% using the descriptions 
developed by the WHO and the ATP (respectively) (Ford & Giles, 2003; Al-Sultan 
& Al-Zanki, 2005). 
Other factors relevant to type 2 diabetes and the metabolic syndrome provide a 
further insight into the prevalence of the condition. Isomaa et al. (2001) outlined that 
the metabolic syndrome had been increasing to 7 %, 43%, and 42% across the age 
groups of 20 to 29, 60 to 69 years, and less than or equal to 70 years (respectively). 
Isomaa et al. (2001) also discovered that the occurrence of this syndrome increased 
at a comparable rate for both sexes (24% rate of increase in men and a 23.4% rate of 
increase for women) while the metabolic syndrome was especially common among 
women of African-American ethnicity. Two years later Meigs et al. (2002) found 
that the metabolic syndrome affected 20 to 30% of middle-aged adults across the 
United States, and this was true across a variety of age groups, genders and ethnicity. 
This further supports the suggestion that while the ethnicity statistics with regards to 
diabetes prevalence may vary greatly, the occurrence of metabolic syndrome criteria 
as described by the ATP III and WHO criteria is a better index of the scale of the 
problem. 
With specific emphasis to Kuwaiti residents, a recent national study revealed that the 
metabolic syndrome criteria were found in 34% of patients suffering from 
hypertension. Males numbered 55% and females 45% in which 28% of patients were 
in range 40 to 55 years, and 42% of residents were over the age of 55 years (Sorkhou 
et al., 2002). In Oman Geographically near to Kuwait, research demonstrated 21% of 
the total population - 19.5% of men and 23% of women were affected by the 
metabolic syndrome. The same study, conducted by Al-Lawati (2003), severe 
abdominal obesity was much higher in women than men, 44 % as compared to 5%, 
respectively. 
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Returning to Kuwait, in 2005, Al-Sultan & Al-Zanki (2005) conducted another 
thorough and comprehensive study providing useful statistical information specific to 
type 2 diabetes and its prevalence in Kuwait. This study is extremely relevant for the 
purpose of this literature review. The Hawalli health centre served as the primary 
source of data collection, as it provides health care services to 160,000-180,000 
Kuwaiti residents. In 2005, the time of their study, the facility served exactly 162,116 
Kuwaiti residents. Today, due to population growth since 2005, the facility is 
currently attempting to serve an even greater number of residents, (Al-Sultan & Al-
Zanki, 2005). The Hawalli health centre provides extensive services to diabetes 
patients, and so is a prime location for research efforts attempting to discover 
relationships or compile statistics relevant to diabetes prevalence, treatment, or 
relationships with other health complication. 
Clearly, the complications associated with type 2 diabetes and with their range of 
severity, have not been fully researched in Kuwait. 
Al-Sultan & Al-Zanki’s (2005) assessment of select samples in Kuwait revealed 
some interesting trends and statistics. In terms of the fundamental data they 
collected, the basic prevalence of diabetes across an observed sample is as shown in 
Table 1.2. 
Table 1.2 Diabetes prevalence across the age groups and sex of Kuwaiti and 
non-Kuwaiti residents (source: Al-Sultan and Al-Zanki, 2005) 
Age group Men (n=142) 
n (%) 
Women  (n=114) 
 n (%) 
Total (n=256) 
n (%) 
Kuwaiti 28 (10.9) 53 (20.7)  81 (31.6) 
20 - 39 years 3 (1.2)  5 (2)  8 (3.1) 
40 - 59 years 16 (6.3) 25 (9.7) 41 (16) 
60 + years 9 (3.5)  23 (9) 32 (12.5) 
Non Kuwaiti  114 (44.5) 61 (23.8)  175 (68.4) 
20 - 39 years 17 (6.6) 53 (20.7) 24 (9.4) 
40 - 59 years 76 (29.7) 61 (23.8)  112 (43.8) 
60 + years 21 (8.2 ) 18 (7.3)  39 (15.2) 
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Table 1.2, shows the distribution of type 2 diabetes according to sex, age group in 
Kuwaiti and expatriate citizens i.e. non-Kuwaitis. For male Kuwaitis, the age range 
was between 36 and 71 years and for women between 33 and 73 years. Their median 
age was 48 years for men and 57 years for women. In contrast, the non-Kuwaitis had 
a wider age range as it was between 23 and 84 years for men and 29 to 84 years for 
women. Expressed as a median value this was 49 years for men and 53 years for 
women. The various ethnicities included as non- Kuwaiti’s were 70% ‘Arabian’ 
including people from Egypt, Syria, Oman, Iraq, Palestine, Jordan and Saudi Arabia 
and  30% were from Iran, India, Sri Lanka, Philippines, Bangladesh, and Pakistan. 
The non-Kuwaitis mean age was 51.7 years and their mean duration of diabetes was 
6.1 years (plus or minus 5 and a half years) with an overall range duration of zero to 
22 years (Al-Sultan & Al-Zanki, 2005). 
 
Numerous ‘factors’ relevant to health have been related to the onset, development, 
and severity of type 2-diabetes, and these are given in Table 1.3. 
 
Table 1.3 Personal ‘traits’ and relevant medical background of subjects used in 
a study of diabetes as abstracted from Al-Sultan and Al-Zanki (2005). 
 Kuwaiti 
men     
  n (%) 
Kuwaiti 
women 
n  (%) 
Non- Kuwaiti 
men 
n  (%) 
Non-Kuwaiti 
women 
n (%) 
p 
value* 
Family history 
of diabetes 
mellitus  
19 (67.9) 43 (81.1) 48 (42.1) 32 (52.5) 0.000 
Smoking  10 (35.7)  4 (7.5) 44 (38.6) 2 (3.3) 0.000 
Dieting 11 (39.3) 37 (68.8) 61 (53.5) 44 (72.1) 0.005 
Exercise   7 (25.0) 7 (13.2) 25 (21.9)  10 (16.4) 0.441 
Obesity 
(BMI >30) 
10 (35.7) 37 (71.2) 31 (27.2) 36 (59)  0.000 
Obesity 
WC > normal 
12 (44.4) 48 (96)  47 (41.2) 49 (87.5) 0.000 
Obesity 
WHR > normal 
 3 (60.0) 28 (82.4)  45 (64.3) 36 (73.5)  0.295 
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Hypertension  14 (50.0)  30 (56.6)  45 (39.5) 30 (49.2) 0.191 
IHD  3 (10.7)  14 (26.4) 5 (4.4) 11 (18) 0.001 
Hyperlipidemia 11 (39.3) 32 (61.5) 42 (36.8) 31 (50.8) 0.019 
 
Key* Please note - the authors did not describe whether this measure of evidence 
against the null hypothesis was in relation to one or both categories listed in the 
columns, they asserted that a value of p< 0 .05 for any category (in the rows) was 
deemed significant (Al-Sultan & Al-Zanki, 2005). 
Table 1.3 although it is published in the literature is rather misleading as it contains 
numerous calculations errors when absolute numbers are calculated as a percentage. 
Because this is a very important table to use for this thesis I have calculated the real 
percentage figures and inserted them in a new table shown below as Table 1.4. The 
corrected are shown in blue. 
Table  1.4  Personal ‘traits’ and relevant medical background of subjects used 
in a study of diabetes by Al-Sultan and Al-Zanki, 2005 with re-calculated 
percentage figures shown in blue. 
 Kuwaiti Men 
(n=28)     n 
(%) 
Kuwaiti 
Women 
(n=53)  n (%) 
Non-Kuwaiti 
(men=114)  
n(%) 
Non-Kuwaiti 
women 
(n=61) n(%) 
p 
value 
Family history 
of D.M. 
19 (67.9) 43 (81.1) 48 (42.1) 32 (52.5)  
0.000 
Smoking  10 (35.7)  4 (7.5) 44 (38.6)  2 (3.3)  
0.000 
Dieting 11 (39.3) 37 (69.8) 61 (53.5) 44 (72.1)  
0.005 
Exercise  7 (25.0)  7 (13.2) 25 (21.9)  10 (16.4)  
0.441 
Obesity 
(BMI >30) 
10 (35.7) 37 (69.8) 31 (27.2) 36 (59)  0.000 
Obesity 
WC > normal 
12 (44.4) 48 (96)  47 (41.2)  9 (80.3)  
0.000 
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Obesity 
WHR > normal 
 3 (10.7) 28 (32.8) 45 (39.5) 36 (39.0)  0.295 
Hypertension  14 (50)  30 (56.6)  45 (39.5) 30 (49.2)  
0.191 
IHD  3 (10.7)  14 (26.4) 5 (4.4) 11 (18) 0.001 
Hyperlipidemia 11 (39.3) 32 (60.4) 42 (36.8) 31 (50.8) 0.019 
 
Key* number of Kuwaiti men = 28 and number of Kuwait women = 53 number of 
non-Kuwaiti men = 114 number of non-Kuwaiti women = 61 .WC = waist - 
circumference, WHR= waist hip ratio, IHD = ischemic heart disease. 
As can be seen from Table 1.3, the corrected version of the data shown within Table 
1.4, for men, smoking is more common, and dieting less common, and exercise was 
only present in 25 % of the patients. Their family history and the role of genetics 
were also relevant in this recent analysis as Kuwait people proved to be more 
commonly affected (p< 0.000). Similarly, obesity, as according to the body mass 
index higher than or equal to 30, was found in 50% of the Kuwait patients but not the 
expatriates. The overweight, but not obese, patients were over 30 percent of the 
group so being overweight to some degree was found in nearly 80% of the patients 
(Al-Sultan & Al-Zanki, 2005). For the group, the female mean BMI value was 32.56 
kg/m
2
 (range 5.85 kg/m
2
) and 27.83 kg/m
2
 (range of 4.84 kg/m
2
) for men. The waist-
hip ratio or the general waist circumference found higher than normal values of waist 
circumference, greater than 102 cm in men and 88 cm in women in over 63 % of the 
observed population. The waist to hip ratios were greater than 0.95 for men or 
greater than 0.80 for women in over 71% of the patients. Patients in ethnicity and 
gender, obesity in terms of waist circumference in Kuwaitis by Al-Sultan & Al-Zanki  
(2005) who found it to be 93%, 41%, 78%, and 57% respectively across the female 
sex, the male sex, the Kuwaitis, and expatriates. They established a clear relationship 
between waist circumference, gender and nationality. Obesity in terms of the waist to 
hip ratio in type 2 diabetics in Kuwait was 77% for females, 65% for males and 80% 
across Kuwaitis, and 69% across non-Kuwaitis (Al-Sultan & Al-Zanki, 2005). 
Other relevant factors for type 2 diabetics in Kuwait were that 47% had a previous 
history of hypertension, 13% suffered hyperlipidaemia and 46% ischemic heart 
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disease. Such determinants were further related to gender and residency as listed in 
Table 1.3.  
In males, smoking has been closely linked with the prevalence of type 2-diabetes, 
and 39% of non-Kuwaitis and 36% of Kuwaitis currently smoke. For females, the 
most closely associated trait was a genetic predisposition,  in over 80% of the 
observed Kuwaitis, in 50% in the non-Kuwaitis and eating habits found in nearly 
70% of Kuwaiti and over 70% of non-Kuwaiti females. Women were more likely to 
exhibit multiple factors: obesity in terms of body mass index, waist circumference 
ratios, hypertension, hyperlipidemia, and ischemic heart disease (Al-Sultan & Al-
Zanki, 2005). Table 1.5 shows the biochemical characteristics they considered:  
Table 1.5 Summary of biochemical findings in type 2 Diabetics in Kuwait (Al-
Sultan and Al-Zanki, 2005). 
 n % 
HbA1c* 
Normal 10 4.5 
Goal 29 13.1 
Acceptable 35 15.8 
Unacceptable 148 66.7 
Total number of patients for which data 
was available 
222 86.7 
Total   Cholesterol  
Normal 123 52.3 
High 112 47.7 
Total 235 91.8 
Triglycerides   
Normal 172 72.9 
High 64 27.1 
Total 236 92.2 
HDLCholesterol in women 
Normal 41 39.8 
Abnormal 62 60.2 
Total 103 90.4 
HDLCholesterol in men 
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Normal 90 68.7 
Abnormal 41 31.3 
Total 131 92.3 
LDLCholesterol   
Normal 67 28.6 
High 167 71.4 
Total 234 91.4 
Key *Male and female values were added together for this part of the table.  
 
Data from recent Kuwait studies of type 2 diabetic patients provides much 'food for 
thought' for the present and future studies.  
Firstly, the result of Al-Sultan & Al-Zanki’s (2005) analysis indicate that a genetic 
predisposition and obesity are highly relevant components and major potential risk 
factors which are commonly found in the sample population agreeing with the results 
of Abdella et al., (1998), and Jackson et al., (2001). Meanwhile, Al-Sultan & Al-
Zanki’s (2005) reveals how hypertension, ischemic heart disease, and hyperlipidemia 
are more common in the female population of diabetic patients in direct comparison 
to their male counterparts. Much of this is supported by the work of American 
Diabetes Association (2003), as the stringent maintenance of blood pressure is 
strongly encouraged for any patient with diabetes. Obesity is common in the Kuwait 
population, as nearly half of the entire sample and considerably over half of the 
observed females were obese. Al-Sultan & Al-Zanki (2005) postulated that the 
prevalence of female obesity, as compared with their male counterparts, may be a 
direct result of their lifestyle differences. Kuwaiti females do less physical activity, 
the speed of modernisation, general affluence, rapid rates of food consumption, and 
elements of a sedentary lifestyle (Al-Isa, 1997; Abdella et al., 1998; Al-Sultan & Al-
Zanki, 2005) may all contribute. Other analyses have revealed comparable 
conclusions across the Kuwait population, while the study conducted by Al-
Muhailan et al., (1989) revealed that diabetic females were also more prone to being 
obese than males, and their numbers increased with age. Additionally, the tendency 
for Kuwaiti diabetics to be obese was higher than the averages of other nations 
assessed across the world (Al-Isa, 1997).  
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The Hawalli diabetic patients were formally assessed within the specific health care 
facilities (Al-Sultan & Al-Zanki, 2005). According to Abdella (1995), the mean age 
was 53±years and they had a mean duration of diabetes of 7.8 years, with a range 
between 2 and 28 years, comparable to the studies of Al-Sultan & Al-Zanki (2005). 
Both analyses showed a positive correlation between genetic predisposition and 
prevalence, with an immediate family relation was documented in over 66% at the 
time of Abdella’s (1995) analysis. Finally, he found that female Kuwaiti patients 
exhibited a BMI of 31.8 ± 6.3 kg/m2 and 28.5 ± 6.3 kg/m2 for men. The prevalence of 
hypertension in both male and female diabetic patients was found nearly 15%.  
Analyses using adjacent countries to compare with Kuwait show the prevalence of 
overweight or obese females is evident within all these nations, so this problem is not 
exclusive to Kuwait. It is not just an Arabic problem as in 2000, Chiu’s study of 
Taiwanese patients showed women had a greater BMI than males, and the prevalence 
of overweight/ obese patients was 30 % for males and over 40 % for females (Chiu, 
2000).  
Clearly, the recent findings in diabetic research enable physicians to maximise their 
awareness that the objectives of the treatment for diabetes should include not only 
the control of the inherent glucose complications and instability, but many other 
factors as well. Since obesity is a major factor for control in diabetes Sorkhou (2002) 
further recommended that appropriate action should be taken to inform the Kuwaiti 
people of all potential "precursors" of diabetes and how to control these ‘factors’. 
Cardiovascular disease, one of the most harmful effects of severe diabetes, is the 
leading cause of death in Kuwait, thus adding to the urgency for such awareness 
(Sorkhou, 2002). Finally, Al-Sultan & Al-Zanki (2005) reported that over 66% of his 
sample, had an unsafe level of glycated haemoglobin (HbA1c). The level was higher 
in the expatriate group than for the native Kuwaitis, especially in the males. 
Consequently, these researchers strongly recommended all health employees should 
realise the significance of diabetes awareness for all the Kuwaiti population through 
educators and educational programs. Additionally, physicians should be aware of the 
prevalence of all known existing risk factors of type 2 diabetes and cardiovascular 
disease, and should also understand that relationship to, and elements of, the 
development of the adverse metabolic syndrome needs addressing.  
 37 
 
 
Literature Review 
1.15 Published papers relevant to Kuwait – an in depth analysis. 
This analysis was designed to determine type 2 diabetes treatment within the overall 
health care system of Kuwait over the last two decades. The studies are considered in 
chronological order. 
 The first paper is by Al-Bustan et al., (1997) entitled ‘Socio-demographic features 
and knowledge of diabetes mellitus among diabetic patients in Kuwait’. 
Although the data was collected between1995-1996 and is now twenty years old it 
was still thought appropriate to review it since their data may still be of value and 
interest.  
This study was made on 760 patients, with approximately equal numbers of Kuwaiti 
and non-Kuwaiti patients. They studied demographics, physical and laboratory 
values analysed by both parametric and non-parametric tests using SPSS. They 
determined the ‘social demographic’ profile plus patients’ knowledge scores about 
their symptoms, nature of the disease, treatment(s), as well as possible diabetic 
complications. The study was a cross-sectional survey of 760 patients as they 
attended their diabetic clinics in 1995-96. Knowledge assessment was done indirectly 
through the capacity to correctly interpret and understands a questionnaire. The study 
identified little disparity of the Kuwaiti’s knowledge of diabetes as compared to the 
non-Kuwait residents. The ‘knowledge score’, for Kuwaitis was 66% and 64% for 
non-Kuwaitis. These scores were derived from questions about a) the type of disease 
that diabetes is considered to be, b) the symptoms of diabetes and c) hypoglycaemic 
symptoms. Their analysis used the then contemporary statistics where p values were 
expressed in terms of < 0.05, <0.01 and <0.001. Of the 35 questions about diabetic 
knowledge both Kuwaiti’s and non-Kuwaiti’s obtained identical scores of positive 
knowledge  (n=15)  on topics such as increased appetite, increased thirst, passing of 
large volumes of urine, frequency of urination and that poor control of the disease 
results in diabetic complications. For some questions (n=15) the Kuwaiti’s knew 
significantly more that the non-Kuwaitis about: the fatigue the diseases causes, the 
relative values of food such as potatoes and rice and that blood sugar increases in 
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uncontrolled diabetes. The non-Kuwaitis had a better knowledge score in three areas: 
the loss of body weight, avoidance of smoking and rice is a carbohydrate. 
From the socioeconomic and demographic data no gender differences in terms of 
duration of their diabetes (years) were found and the majority were on ‘drug only’ 
treatments. 17.2% of patients’ were using insulin with more Kuwaiti males (20.2%) 
using this therapy. No differences existed between the sexes, physical activity and 
BMI of the two groups. The finding that many patients lacked a basic knowledge of 
their disease positively correlated with their level of education (p < 0.001).  
If this study was to be repeated today perhaps more detail as to how the statistical 
tests were actually carried out and a statement made about a parametric or non-
parametric correlation test would be provided. The patients’ illiteracy was a point of 
interest and the authors devised a classification of four levels of education for the 
study: illiterate, primary, secondary and university. No verification in the study was 
made for the subjects to show their level of education by actually asking people to 
perform a task so allowing an assessment of their literacy. They simply took a 
patient’s educational background to assess literacy which is very difficult as simple 
educational attendance does not ensure literacy. It was concluded that Kuwaitis had a 
higher level of illiteracy than non-Kuwaitis and they recommended the establishment 
of a standard diabetes education system in Kuwait to produce desirable outcomes.  
Some areas of bias do exist but as compared to many of the other studies these are 
very limited. One area of comment is that patient selection was merely described as 
‘basically random’. This leads to uncertainty about how patients were actually 
selected which is the key to the success of any study. 
The second paper was by Al-Adsani et al., (2008) entitled ‘Evaluation of the 
impact of the Kuwait diabetes care program on the quality of diabetes care’ was 
a joint investigation between the Kuwait Ministry of Health and the Department of 
Medicine at the Al-Sabah hospital in Kuwait. The study assessed how a Diabetes 
Care Program introduced in September 1999 had progressed in the years 2001-2003.. 
Data from September 1999 acted as the comparative control data.  
Of great interest and relevance to the studies reported in this thesis was the ways in 
which the data was gathered. The data was solely based on the examination of 250 
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medical records - 50 from each of the chosen health regions of patients who had 
attended between October/September in each year studied. These were compared to 
the national guidelines for the care of diabetic patients. Over the five study periods 
the patients’ files had become more organised and structured from 60-100% (p< 
0.001). The prevalence of smoking assessment, eye and foot examination increased 
significantly from 2.8 to 27.2% (p<0.001), 2.4 to 31.6% (p<0.001) and 0.4 to 40.4% 
(p<0.001) respectively. For microalbuminuria the figures were 4.4% to 26.4% and 
for HbA1c levels the values were 10.4 to 60.8% (p<0.001). They concluded that the 
national diabetes educational programme had resulted in some successes but required 
continuous development to further improve diabetes care. 
These findings suggest that the policy to achieve better patient outcomes was 
working in 2008. The programme achieved some of its major objectives using 
medical records as the research tool. A comparison of the findings of the four cycles 
of audit in 1999, 2001, 2002, and 2003 in 21 centres, showed an improved 
organization from 60% to 100% in the structure of the patient files as more data was 
being recorded in the later files than in the earlier ones. Another improvement was 
the rise in rates of recording patient demographic/medical /treatment details - by 
improvements in the filing system, increased feedback to the physicians on the 
importance of documentation being always added to the records. This is shown by 
the rates of comprehensive data present in the files in 1999 was 38.6% and in 2003 it 
was 95.6%. Their data suggest that these interventions as part of the national diabetes 
programs were effective in developing a better standard of diabetes care for patients.  
The National Diabetes Programs (NDP) had been effective in increasing knowledge, 
so improving primary health care for diabetes patients in the country. The support by 
the authorities within the health care sector, provision of manpower  resources, the 
continuous monitoring process and evaluation as well as general awareness or 
education to the public were among other features identified as improving diabetes 
care within Kuwait. However, this study suffered critical shortcomings in that  
proper control groups were absent, random sampling of patients was not used, the 
questionnaire actually used was missing from the published paper and their 
electronic filing systems were not clearly described. Moreover, the study failed to 
study the impact of the diabetes care programme on the possible outcomes that 
would have resulted from a greater involvement of physicians, dieticians and 
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diabetes nurse educators in the NDP. The correlation of patients’ files and experience 
was therefore impossible and may have led to bias in the results. 
The study also considered some of the administrative care changes implemented to 
try and improve patients’ care. The number of patients using an appointments 
booklet, first mentioned in the 1999 baseline study did not change over the four year 
period used with no statistically significant differences being found over the four 
year study period as patient adherence to their appointments was 73% in the final 
year remaining unchanged since 1999.  
The study found marked improvements in the patients’ files in terms of their 
structure and organisation. In 1999 this was 60% adequate but in 2003 had 
significantly improved to 100%. Likewise for patients’ identification data, in 1999 it 
was 38.6% and in 2003, 95.6%. In 1999 laboratory sheets recording the values for 
clinical tests were only found in 28.9% of patient files whereas in 2003 this increased 
significantly to 91.2%. Finally and very interesting for my PhD thesis was the 
finding that in 1999 only 41% of prescriptions were located in the correct place 
whereas in 2003 it was 100%. This will mean that when I examine the files I will 
have confidence that the patient medication records will be complete.  
Paper number 3 written by Al Adsani et al., (2009) was entitled ‘The level and 
determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes’.  
This was carried out exclusively by native Arabic speakers based in Kuwait and was 
designed to determine diabetic patients’ knowledge of their disease. They studied 
5114 Kuwaiti patients, all over 30 years of age, using the widely accepted ‘tool’ and 
widely validated Michigan questionnaire. This is exactly the same method to be used 
in my thesis. Perhaps the most interesting finding was that only 29% of the patients 
performed glucose monitoring at home. Their average HbA1c level was 8.76 ±2.3% 
comparingly unfavourably with the international values for good control- below 7%, 
acceptable between 7-8% and poor above 8%. Consequently 25% of patients’ blood 
sugar control was poor but they found that 24.5% of the patients did have good 
glycaemic control with the other 50% had variable control.  
The overall level of knowledge, using the diabetic knowledge test (DKT), of the 
5114 patients who took part in the study was 58.9±22.1%. The DKT was divided, 
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into two subsections namely, a general knowledge subscale and an insulin 
knowledge subscale. They used 23 questions, 14 in the first and 9 in the second 
section. The first, the general knowledge section asked  questions about diabetes 
which the authors rated as being poor when the score for correct answers was less 
than 7, average 7-11 and good when greater than 11. In the second part related to 
insulin use the scoring system for this section- poor was less than 5, average was 5 to 
7, and good was greater than 7.  
The overall total knowledge score (TKS) was calculated out of 23. For males the 
mean score (±S.D) was 13.6 ±3.4 and for females 13.6±3.2. When this total 
numerical score is expressed as a percentage of the total possible correct answers 
(100%) the males score for correct answers out of 23 questions was 59.1% which 
curiously in the text is expressed as 58.9%. They then transformed the actual scores 
in each of the two sections into percentage values using 14 for the first subscale and 
9 for the second subscale and found the general knowledge subscale mean score was 
61.6% and for the insulin subscale was 54.7%. However when I attempted this 
calculation with their data shown in Table 3 the figures were 61.4% and 62.5%. 
These figures were made more complicated by the statement that only 9.7% scored 
“good” in the total test and 6.1% scored “good” in the tests about insulin knowledge. 
These values were very difficult to calculate from the data provided.  
The paper contains interesting data about the drugs these patients were using. For 
example, 58% were taking oral hypoglycaemic agents, 20% were only using insulin 
and the remaining 22% used both oral agents and insulin. Of special interest was the 
median duration of insulin therapy was four years, with the majority using insulin 
twice a day, injected either by themselves or 37% actually attended a clinic for their 
injections. The study found knowledge about diet and self-care lacking, which was 
age related, as the older patients knew less about their condition.  
The final aspect of the study was that the HbA1c values, suggested poor blood sugar 
control mirrored perhaps by 39% having a single complication of the disease, 12.8% 
having two complications and 4.4% having three or more complications. This poor 
degree of blood glucose control might have been expected to cause more 
complications than it actual did, as the evidence is available that precise control 
minimizes the complications of the disease. 
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The paper was a good summary of the level of diabetes education in Kuwait but the 
results fail to capture possible statistical differences between men and women since 
all the results were reported as a single group. The full questionnaire was not 
presented but only selected examples. Possible sources of bias included: not 
checking their data with the patients’ medical files, the lack of a random choice of 
patients, the use of five different laboratories for their HbA1c analyses and the lack of 
a statement about how samples were double or tripled checked for accuracy. The 
Michigan questionnaire clearly determined the knowledge, opinions, behavior and 
the practice of self-management of the diabetic condition in Kuwaitis.  
The fourth paper, by Awad et al., (2011) was entitled ‘Diabetic patients’ knowledge 
of therapeutic goals in Kuwait’ written by the Department of Pharmacy Practice 
,University of Kuwait in Jabriya in February to May 2008 but actually published in 
2011. The study analysed data from 247 diabetic patients in six Kuwait diabetic 
clinics.  
Data collection was made by face-to-face interviews using a pretested questionnaire 
of patients understanding of diabetes via open and closed questions. The validity of 
the questions was established in 15 diabetic patients and data analysis used simple 
cross-tabulations and logistic regression analysis (SPSS software, version 17). One 
researcher collected all the data using a face-to-face technique. Unfortunately, it was 
not stated how randomization was achieved and the actual question used were not 
shown.  A feature of the study is that non-Arabic speaking patients were also 
included in the study which necessitated the questionnaire being made available not 
only in Arabic but in English, fortunately the language it which had been originally 
written to develop their original ideas. The paper does not explain who these English 
speaking patients actually were and some data is expressed, for example family 
history of diabetes, collectively.  The majority of the patients were non-Kuwaiti, 
(n=174) as only 73 Kuwaitis took part.  A family history of diabetes, in 190 patients 
and for Education, Low/intermediate (n=147) and high (n=100). The majority, 58%, 
of patients were male. For analyses all the patients were grouped together which 
makes any sex-related differences between the populations impossible to determine. 
Consequently, comparisons with the earlier studies made purely on Kuwait nationals 
difficult to interpret. 
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They measured HbA1c, and also measured the low and high density lipoprotein levels 
as was done in the studies of of Al-Adsani (2008) and Alshaeen et al., (2011), the 
only other studies which made  these measurements. They also recorded drug 
histories, family history and patient knowledge of their disease. The last feature was 
of especial interest for the purposes of my planned study. 
Data analysis found that 160 out of 247 patients were on oral medications - 96 with 
monotherapy, 64 taking two or more drugs. Insulin was used as monotherapy in 29 
patients (12% of the patients) and 58 patients, 23% were receiving both oral 
medications and insulin. The authors expressed disappointment that even in 2008 
[when the study was actually carried out] many of the target goals had not been met. 
Only 5% of the patients knew about the target value of HbA1c and for lipoproteins 
levels only 2% understood its significance, contrasting with 43% who understood the 
relevance of blood pressure as a target goal in their treatment.   
In contrast, 60% understood the target goals for fasting and 47% understood post 
prandial blood glucose target levels. The study found that women aged 50 or above 
had a significantly poorer knowledge (p< 0.001) as compared to males. The poor 
knowledge about HbA1c and therapeutic goals led the authors to suggest  a change to 
current drug prescribing/education was necessary. 
Unfortunately, this data was not correlated by examining patients’ files and this may 
have led to bias in the results as some of the data required the patients to have 
knowledge of their clinical data such as being asked to describe their recent levels of 
LDL-C. If their notes had been examined verification of any values they suggested 
would have made the data more accurate.  
The fifth paper, Alshaheen et al., (2011) was entitled ‘Monitoring the standard of 
health care of diabetes mellitus type 2 in a primary health care setting’.  
This research at the Al-Yarmouk Health Centre, Kuwait combined researchers from 
the KMOH and the Faculty of Medicine, Alexandria University, Egypt. This makes 
the study rather unusual as it had direct KMOH involvement. 
Although the study did not specifically focus on patients’ experience of their 
treatment, dietary advice and exercise, it contained some unique findings about 
aspects of renal and ocular care of these diabetics.  
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The study followed 200 patients for a period of two years using the parameters of 
glycated haemoglobin (HbA1c), microalbuminuria, low density lipoproteins, regular 
eye examinations to assess their diabetic condition.  
A complicating factor of this study, similar to the other papers which had cited their 
analysis being made using both Kuwaiti and non-Kuwaiti nationals was that direct 
comparisons with the other studies, which had exclusively used Kuwaiti patients, 
was very difficult. However, they found, as had previous ones, that the majority of 
patients,46.5% were males and 53.5% females, had a mean age 51.2±8.8 years. 46.7 
% were below 50, 38% for the group 50-59 and 15.3% above 60 years. At the start of 
the study, 31% of the total group (n=62), both males and females, had an HbA1c 
value below 7%. Over the study period, 56.1% improved their HbA1c levels, 
microalbuminuria, fundus examination and LDL level only 2.3% had deteriorated. 
The study found clear benefit in providing patient education on their urinary output 
of microalbumin, suggesting an improvement in their renal complications of their 
disease. Only 2.3% of the group suffered a decline in their renal function as 
measured by this urinary value. The study found nationality, age, sex were associated 
with the levels of adherence. Non-Kuwait nationals were 56% of the respondents and 
over two years their adherence levels improved from 7.5% at the start to 24.6% at the 
end. Kuwait residents recorded higher levels of adherence as compared with non-
Kuwait residents.  
This study had some points of weakness as the patients were not randomly selected 
and all came from only one diabetic clinic in Kuwait and the experiences at one 
clinic may not be a fair representation of all the clinics in Kuwait. However, the 
overall findings suggest that the administration of standard care had the capacity to 
significantly (p<0.001) improve levels of adherence to eye examination, renal 
excretion of albumin and HbA1c levels in Kuwait.  
The next paper is by Al-Taweel et al., (2013) is entitled ‘Evaluation of adherence 
to international guidelines for treating patients with type 2 diabetes mellitus in 
Kuwait’,  
This was a retrospective study which analyzed 652 medical records of type 2 
diabetics, held in four secondary care centres (out of a total of five in the country)-80 
records being examined per centre, (n=320) and also in 8 primary care centres (total 
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number of records n=332). They used a validated 43-criterion medication assessment 
tool which they described as ‘MATKW’ later to be called MATKW, which studied the 
cardio-prevention and treatment of diabetic patients in the period January -June 
2010. They omitted to state who had actually obtained the data for this study which 
was analysed using SPSS (version 17) for the Mann Whitney U test showing their 
assumption of non-normally distributed data without actually doing a normality test.  
All the data was compared to graded standards by an independent panel of seven 
experienced consultant endocrinologists from primary and secondary care. 
 Data analysis found that 90.6% of patients in the primary care centres used 
metformin and in the secondary care centres it was 86.3%.  In contrast to metformin 
the thiazolidinediones were restricted to the secondary care units. Curiously, 
although the combination of insulin and oral therapy is mentioned in the text as being 
found in 41.6% (n=271) of the patients, this data is missing from their relevant table, 
Table 2 in the text. Perhaps this can be explained as the focus of the study was on the 
cardiovascular drugs the patients were taking rather than, to use their terminology, 
‘diabetes-control specific criteria’. Other criteria, which the study did not include 
data on individuals’ renal function, exercise and weight loss strategies, all of which 
would have been suitable for study about cardiovascular disease. The inclusion of a 
figure of 1.1% (n=7), again only found in the text, for the use of insulin for the 
treatment of type 2 diabetes is of interest for my thesis  as are the lack of renal 
values, weight loss strategies and exercise routines. 
The authors investigated the levels of adherence to the predefined clinical guidelines, 
for the treatment of type 2 diabetes, in primary and secondary levels of health care 
provision within Kuwait for Kuwaitis. The study used a specific, well-developed, 
validated research tool based on international standards at twelve diabetic clinics in 
four regions in Kuwait. The study focus was the number of times practitioners 
adhered to the predefined international guidelines while prescribing medication for 
diabetes. Among the respondents, 77.7% recorded a prompt adherence to the 
standard international guidelines. Disparities concerning the primary and secondary 
systems were found since higher adherence was found in the secondary level. Patient 
documentation and poor record keeping was suggested as being in need of urgent 
attention. The study recommended the adoption of better, improved, multifaceted and 
cost effective prescribing tools as well as in decision-making:  
 46 
 
…“Further qualitative studies to allow a comprehensive understanding of the 
factors  associated with the specific problems identified by this study, and cost 
effective multifaceted interventions are highly needed to secure the quality of 
diabetes management in the healthcare setting of Kuwait” … (Al-Taweel et 
al., 2013). 
The use of scientific designed tools for data collection and analysis showed strategic 
strengths but there were some weaknesses. For instance, the MATKW was used in 
collecting the information but in the event of a breakdown, then important 
information could be lost. Further, the use of MATKW and SPSS both require 
technical know-how and facilities so operators of the systems must be conversant 
with them before adopting them for routine use. Poor information and training in the 
use of this software may produce errors so being detrimental to any final decisions 
which had to be made.   
Finally, there were four potential points of bias in the study. Namely, a) they only 
examined patients’ medical records and did not attempt any sort of correlation with 
patients’ actual experience, b) the actual audit questions given in the text is 
incomplete, c) basing any analysis solely on medical records which they describe as 
having been revealed as ‘incomplete documentation of patients’ records’ may 
seriously bias the final analysis and d) patient selection was not random, and would 
have added great strength to the study. 
1.16 Overall conclusions from the available literature and studies to be 
addressed in this thesis. 
Diabetes is clearly a major medical problem in Kuwait and its current treatment 
should be study to determine if any potential enhancements could be made. The 
existing data is somewhat variable and further investigation is needed to clarify the 
exact current position. Also, one important aspects of type 2 diabetes data concerns 
renal problems and eventual renal failure and its problems and consequences which 
needs clarification by recent data, as only one 2005 study by El-Reshaid et al., 
(2005), reported a prospective study on chronic renal disease in Kuwait, where 24% 
of patients (n=271) with chronic renal failure had diabetes mellitus as the main 
aetiological factor.  
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This thesis proposes to using conversations/interviews with patients and physicians’ 
and the examination of patient notes to determine the experiences of diabetic 
patients’/physicians/medical notes, to establish the adherence to guidelines for 
treating type 2 diabetes mellitus. Further aspects of the renal disease brought about 
by diabetes and dietary advice as a resource to help them in their day to day 
nutritional support were also to be investigated. 
1.17 Research hypothesis. 
 
  The Oxford English dictionary defines a hypothesis as: 
‘A supposition or proposed explanation made on the basis of limited evidence as 
a starting point for further investigation’ (Oxford dictionary language matters, 
2016)   
Consequently, using this definition, the overall hypothesis on which this study was 
based is:, on the basis of limited evidence in the literature the supposition is that 
current quality of care of  type 2 diabetes in Kuwait may be capable of enhancement.  
 
This scientific hypothesis will represent the predicted relationship among the 
variables being investigated and the null hypothesis represents a statement of no 
relationship among the variables being investigated. To obtain support for the 
scientific hypothesis the evidence will be collected which enables the experimenter 
to reject the null hypothesis. So support for the scientific hypothesis is always 
obtained indirectly by rejecting the null hypothesis. So if the null hypothesis can be 
rejected by the evidence obtained there is evidence to support the scientific 
hypothesis (Christensen, 2004).  
To explore the hypothesis, three specific questions have been formulated:  
Research Question 1: “What do type 2 diabetic patients/ physicians currently 
experience in Kuwait in the diagnosis and treatment of the patient condition”. This 
should enable the abilities, capacity, effectiveness, and challenges posed to the 
nation’s facilities and professionals in their ability to treat diabetes to be determined. 
Research Question 2: “Can any of the issues described by diabetic patients and 
their physicians be better addressed in the future, and what specific areas should be 
the subject of further research?” 
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Research question 3: Do patient notes provide an accurate research tool for the 
analysis of treatment strategies of type 2 diabetes patients in Kuwait?  
 
This under-researched subject of diabetes in Kuwait, was considered to be worthy to 
be studied for a PhD for the following reasons: 
 
 It will generate new, up-to-date  data about the disease in Kuwait. 
 It will study the way the disease is currently both diagnosed and treated. 
 It will allow comparisons of treatment  to be made with International 
Guidelines 
 It will study renal problems caused by type 2 diabetes and their treatment 
in Kuwait. 
 
1.18 Aim and Objectives of this thesis. 
Aim. 
This study will examine the current treatment experience of type 2 diabetes in 
Kuwait, in patients/physicians attending diabetic clinics and hospitals, by 
determining their experiences, awareness and attitudes to their diabetic treatment in 
conjunction with their medical records. Additional considerations was to be given to 
diabetic patients with kidney disease. 
   
Objectives. 
  The objectives of this study were to:  
a)  find, study and critically assess the current literature relevant to diabetes with 
special reference to Kuwait 
b)  compare current type 2 diabetes treatments used in Kuwait, against international 
norms in developed nations 
c)  assess patient experiences of type 2 diabetes in Kuwait, enabling  any areas of 
strengths and weaknesses to be established 
d) examine the patients suggested improvements for the reduction of barriers, which 
complicate their treatment  
e) examine the complications of  renal problems in type 2 diabetics 
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f) formulate strategies to minimise  renal complications  in diabetic patients in 
Kuwait 
g) examine the opinions of physicians with regards to the standards of care currently 
in Kuwait. 
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Chapter 2 
2 Methods and study design. 
2.1 Overview. 
This research used a combination of both quantitative and qualitative methods 
following the advice of WHO that useful research in the health sciences can be both 
qualitative and/or quantitative in nature (WHO, 2001). This mixed method of 
analysis enables any study to obtain the strengths and offset the weakness, found in 
both qualitative and quantitative methods (Tashakkori &Teddlie, 2008; Cresswell et 
al., 2011). This research can be qualified as exploratory, rather than confirmatory, in 
view of the very limited number of previous studies specifically made in Kuwait. 
This approach is both inductive and deductive, involving certain measures of 
expectations requiring deduction from theoretical premises tested with the collected 
data. 
One technique is to use the process of triangulation, in which the researchers can use 
two methods to offset the weaknesses of single method and strength the study 
outcome." By combining multiple observers, theories, methods, and empirical 
materials, researchers can hope to overcome the weakness or intrinsic biases and the 
problems that come from single-method, single-observer, and single-theory studies. 
Often the purpose of triangulation in specific contexts is to obtain confirmation of 
findings through convergence of different perspectives. The point at which the 
perspectives converge is seen to represent reality." (Alexander, 2001). 
A more recent definition of this technique is provided by Yeasmin & Rahman 
(2012), "Triangulation is used to combine the advantages of both the qualitative and 
the quantitative approach. Each method offers specific advantages as well as 
disadvantages. Recent developments in the philosophy of science have argued that 
the two traditions should not have a separate-but-equal status, and should instead 
interact. Triangulation is not aimed merely at validation but at deepening and 
widening one's understanding, and tends to support interdisciplinary research rather 
than a strongly bounded discipline of sociology or anthropology."  
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This study will use triangulation between the patient, the physician and their medical 
records – some of which are quantitative and some qualitative to ensure the 
maximum reliable information is obtained in the study.  
2.2 Questionnaires design and their use. 
Once the diabetes literature on previous research relevant to Kuwait had been 
collected, read and studied in great detail it was used to devise a strategy for a 
combination of suitable questionnaires, to address two issues in type 2 diabetes: a) 
patient diagnosis and their treatment and b) the details recorded in patients’ notes.  
The questionnaire was based on the extensive protocol of the Michigan Diabetes 
Research and Training Centre (2011) which contains extensively validated questions 
to assess patients over a wide range of topics. 
In their own words they describe their system as: 
… “The Michigan Diabetes Research Center (MDRC) is multidisciplinary unit of the 
University of Michigan funded by the National Institute of Diabetes and Digestive 
and Kidney disease/National Institute of Health …The goal of MDRC is to establish, 
promote, and enhance multidisciplinary and collaborative basic biomedical and 
clinical research among member investigators studying diabetes, it is complications, 
and related endocrine and metabolic disorder. The missions of the MDRC are to 
create an environment that supports important and innovative research; raise 
awareness and interest in fundamental and clinical diabetes research; enhance 
diabetes research education and training opportunities for patients, students, 
scientists ,and clinicians …” (University of Michigan Health System, 2016). 
 This questionnaire has been used in many studies, in many countries, for many 
years. The most recent include: 
Country (Author)                                                              year 
Kuwait (Al –Adsani et al.,)                                                2009 
UK (Collins et al.,)                                                              2010 
Malaysia (Al-Qazaz et al.,)                                                 2010                                                       
Nigeria (Odili et al.,)                                                           2011 
USA (Myra et al.,)                                                               2011 
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India (Sindhu)                                                                      2012 
Jordan (Al-Sarihin et al.,)                                                   2012 
Arab Emirates (Al-Maskari et al.,)                                    2013 
Saudi Arabia (Al-Odayani et al.,)                                       2013 
Palestine (Sweileh et al.,)                                                      2014 
Greece (Digkliou et al.,)                                                       2016                                                 
Saudi Arabia (Al-Aboudi et al.,)                                        2016                                                       
 
These validated questionnaires, were designed to discover patient demographics, 
their diagnosis, medication(s), diagnostic experiences, their symptoms experienced 
before diagnosis and throughout the treatment of their diabetic condition. 
2.3 Questionnaire usage. 
 All answers were manually recorded for each patient at the time they were given and 
the language of the structured format was Kuwaiti Arabic, to ensure clarity about 
what was being asked so ensuring accurate data was collected as the patient could 
ask for clarification at any point should that be felt necessary. 
Where appropriate specific details of renal dialysis, kidney transplants in the event of 
renal failure, testing and its frequency for renal problems, advice on diet and exercise 
was also investigated.  
The choice of the Michigan questionnaire enabled the data from Kuwait to be 
compared to data obtained using the same questions, anywhere else in the world. The 
results intended to contribute to and inform best practice in relation to type 2 diabetic 
treatments in Kuwait, which may have positive future impact.  They were to be 
submitted to the Kuwaiti Ministry of Health for their consideration. 
2.4 Patients’ general medical and medication records. 
Aspects of patient diabetic history which they may have forgotten was to be verified 
from their medical records with help of the nurse who attends to these patients. This 
should increase the reliability of the data enabling appropriate analysis since if any 
terms were not understood, data could not be read, or unfamiliar abbreviations used 
then they could be checked with the nurse, who had been specifically allocated to 
these patients during their interview.  Data about treatment procedures/protocols used 
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in Kuwaiti clinics and hospitals were to be examined in detail, and the relevant 
material abstract to complement the patient acquired data. The files were provided by 
the central registry and examined in a secure location, confidentiality was ensured by 
the presence of a nurse at all times.  No data was ever copied, by any means 
whatsoever, so complying with the KMOH. All abstracted data was entered on a 
‘score sheet’ displaying only the unique number.  
In the thirteen clinics in which this study it was anticipated that the medical records 
would be the traditional paper record rather than in an electronic format. This would 
make access to them easier and selective manually copying some of the details on the 
written records would comply with the KMOH.  If electronic records were found the 
relevant data would be abstracted as for the paper type.  
2.5 Structured interviews with physicians. 
Nephrologists and ophthalmologists who volunteered were interviewed to obtain 
their views on current patient treatments of type 2 diabetes exploring the barriers, 
effectiveness and possible improvements in achieving better control of type 2 
diabetes, with emphasis on the renal and ocular aspects. The physicians’ answers 
were designed to discover their views and knowledge of the regulations, barriers and 
other relevant issues of diabetes treatment in Kuwait. These structured interviews 
were also to establish the ‘medical’ techniques used on patients including: eye and 
renal test, and the routinely applied diagnostic techniques.  
This data were to be compared to worldwide standards and to determine any 
differences, their causes, restrictions, potential solutions, other relevant issues, some 
of which may provide additional areas for further research. This enabled a 
corroboration  of findings from patients and their physicians, providing a well-
rounded perspective while further reducing the potential for bias, so enhancing the 
reliability of the data. 
Only five questions were asked, on the insistence of the Ministry of Health, so as not 
to overload the consultants. Notes were taken as tape recordings were not allowed 
2.6 Ethical considerations and research governance. 
Ethical approval was obtained both from the University of Bradford (number 
E437and E336), the Human Ethics Committee Kuwait, Ministry Of Health (Appendix 
9) and Ascot Rehab Centre. All the participants were coded and their names never 
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used in the research. The questionnaire results were only used for this research. The 
ethical issues in this study lies predominantly in the areas of confidentiality. 
  
 
Limitation 
A major research limitation was that none of the medical records could be copied by 
any means. To avoid the criticism of undue pressures, the researcher ensured 
freedom to cease participation up to one month following the collection of data. This 
was achieved by giving each participant a unique number to which all the data 
collected was and if the subject requested that their data be removed, this would be 
excluded from the study whilst still preserving anonymity of the individual. 
Under the auspices of the Ministry of health of Kuwait, who gave their official 
permission of this study to be carried out, they suggested that the physician would be 
the person who would make the request to their patients asking them to take part in 
this study. Consequently, the researcher had no way to influence their selection and it 
may be considered that this may have caused some bias because the researcher was 
not the one who selected patients to ask to take part in the study. Rather it was the 
physicians who asked patients if they would like to participate in this study  and so 
some  patients may have accepted to participate due to power of the ‘white coat 
effect’ of the physician. But an equal opportunity was given to each patient the 
physician saw. Of course if during the procedure they felt they had undertaken 
something they did not want to do they could always stop the process and have their 
responses removed from the record.  Since the investigator did not select which 
patients to ask, the process may not be considered to provide a random choice of 
patients but it was within the constraints insisted upon by the medical authorities. 
The conclusions reached will be considered with this caveat. 
2.7 Pilot patient study questionnaire/interviews.  
To determine the suitability of the questions a pilot study using a structured interview 
on 20 type 2 randomly chosen diabetic patients, 10 Kuwaiti and 10 non-Kuwaiti, in 
six different diabetics clinics was used (Appendix 1) The questions asked about their 
disease, diagnostic experiences and treatment in the Kuwaiti system and also to 
determine a deep understanding of patient experiences, needs and feelings. The 
answers were to determine the feasibility and practicality of the questionnaire design 
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(Saunders et al., 2009) so as to allow its extension to a greater number of diabetics in 
Kuwait.  
The questionnaire was designed to critically analysed prevalence factors of the 
disease, provided an insight into patient experiences of their treatment, their 
knowledge and awareness of and suggestions for quality improvement based on their 
needs and concerns, regarding their diabetes treatment.  
Patient data was to be corroborated using patient note analysis plus interviews with 
their physicians. The results were used to determine if it was necessary to alter the 
design of the questionnaire for future studies where over 100 patients would be 
studied. 
2.8 Reliability.  
A major factor to ensure the reliability of the study was the questions asked were in 
Kuwaiti Arabic. For non-Kuwaitis of Indian origin the questions were asked in 
English. For both groups of patients, they were able to query any question at any 
stage of the interview so improving the accuracy of the data obtained. 
2.9 Selection of patients.   
For both the pilot study (n=20) and expanded study (n>100) the following inclusion 
and exclusion criteria were applied.  
2.10 Inclusion criteria. 
1. All patients will be required to have been suffering from type 2 diabetes for at 
least 1 year.  
2. Expected to have experience of all the topics covered in the questionnaires.  
3. If a patient ‘achieves’ these conditions, they will be recruited based on these 
eligibility requirements plus the convenience of location, accessibility, and 
willingness to participate. 
4. Provide their written consent to be involved in such a study. 
2.11 Exclusion criteria. 
1. a patient who finds the questions ‘impracticable’ will be excluded from the 
study. 
2. patients suffering type 2 diabetes for less than one year  
3. patients who did not receive their diagnoses and treatment in Kuwait 
facilities. 
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4. children under 18 years of age 
5. people with learning disabilities 
6. people with a terminal illness 
7. people with mental health problems 
8. people with dementia 
9. asylum seekers 
10. those with any form of dependent relationship with the researcher. 
2.12 The selection of patients for the study. 
Following a scheduled, routine diabetic appointment, their physician asked them if 
they would like to take part in a study using a questionnaire/interview about diabetes 
being conducted by a University Postgraduate student. If they agreed, they were 
shown into an adjacent room where the investigator (Eman Buhajeeh) was sitting 
behind a table and after introducing themselves, and putting the patient at their ease, 
the purpose of the study was explained. If they agreed to voluntarily take part, all 
their answers would be written down, anonymously so no answer could be traced to 
an individual. The patient was then again asked if they still wanted to take part and if 
they agreed, their verbal and written agreement to take part in the study as stipulated 
by the Kuwaiti Ministry of Health was obtained. The questions were then asked. 
  It was always stressed that they could withdraw from the questions should they 
decide to do so. All patients were give a unique study number and all answers were 
written down at the time of the interview on numbered recording sheets. It was 
stressed to them that when they returned home they could ask for their data to be 
removed from the study by quoting their unique study number.  
2.13 Methods and study design. – Study groups. 
Pilot study: The pilot study was carried out on 20 randomly self-selected, type 2-
diabetics:  10 Kuwaiti and 10 non-Kuwaiti. 
Full Diabetic patients study: The questionnaires were answered by 109, randomly 
self-selected, type 2 diabetic patients who volunteered to take part in the study. There 
were 62 Kuwaitis (male 24 & female 38) and 47 non-Kuwaitis (male 23 & female 
24) from the diabetic clinics in the three regions of Kuwait namely Hawalli, Al 
Farwaniyah and Al Asimah. 
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Diabetic patients with kidney disease: The questionnaires were answered by 79 
patients, randomly self-selected, type 2-diabetic patients with kidney disease who 
volunteered to take part in the study. There were 55 Kuwaitis (male 27, female 28) 
and 24 non-Kuwaitis (male 14, female 10) from the Mubarak and Hamed Al Essa 
hospitals: (Appendix 3) 
Kuwaiti physicians: Seven consultants - four nephrologists and three 
ophthalmologists agreed, to participate in this supplementary study, providing 
evidence regarding the interactions between patients and physicians. (Appendix 4) 
2.14 Results of the pilot study in Kuwait. 
 
Pilot, patient study questionnaire/interviews. 
The pilot study used questionnaires (Appendix1) in randomly selected type 2 diabetic 
patients in a structured interview format (n=20, 10 = Kuwaiti and 10 = non-Kuwaiti) 
to determine the suitability of the questions, their diagnostic experiences and 
treatment of diabetes. Some data was corroborated and substantiated using analysis 
of patient notes and physician interviews. The questionnaire, measured the feasibility 
and/or practicality of the questionnaire design (Saunders et al., 2009) which analysed 
across the factors most prevalent in the disease, and also providing an insight into the 
quality of their care. The data was designed to be corroborated and substantiated by 
using patient note analysis and also physician interviews. The results could also be 
used to determine if it was necessary to alter the design of the questionnaire for 
future studies. The questionnaire was designed to determine a deep understanding of 
patient experiences, needs and feelings and the feasibility and practicality of the 
questions to achieve these objectives.  
Interviews with patients at diabetic clinics in Kuwait. 
The pilot study questionnaire was carried out in July-September, 2014 in the diabetic 
clinics specified in section 2 of the Methods.  The results generated a format to be 
used for the presentation of the larger study which was to be carried out (n>100).  
Sampling procedure. 
The questionnaire generated reliable data, despite the number of questions being 
limited by the Kuwaiti Ministry of Health (KMOH). Since no audio records were 
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allowed, all data was transcribed from the completed questionnaires immediately 
after it took place. This study served two purposes, a) to determine if the questions 
gave answers which could reliable quantify the prevalence and severity and 
symptoms of diabetes, and b) to determine an understanding of patient perspectives 
regarding quality, appropriateness and effectiveness of their treatment(s).  
 
Questionnaire results. 
The data collected the "prevalence" of a finding in both men / women, Kuwaiti and 
non- Kuwaiti, the groups to be used in the final study. The mean weight, height, and 
age enabled calculation of the BMI. The data allowed statistical tests and 
graphical/tabular representation to be used.  
General information from the questionnaires. 
The demographic data was: nationality, gender, current age, age of first diagnosis , 
height and body weight (Table 2.1) Comments for each ‘factor’ are appended below. 
Nationality. The KMOH diabetic clinics treated only type 2 diabetic patients, both 
Kuwaiti nationals and non-Kuwaitis (Table 2.1), 10 were Kuwaiti and 10 were non-
Kuwaiti. It should be stressed the data was from KMOH operated clinics and not 
privately funded clinics found in the ‘private sector’, sponsored for employees of 
specific companies e.g. Kuwait Oil Corporation [KOC] and other State departments 
e.g the military hospitals, because access to which could not be granted by KMOH.  
Sex/Gender.  
The WHO definition of sex and gender was used - "Sex" as the biological and 
physiological characteristics that define men and women. "Gender" refers to the 
socially constructed roles, behaviors, activities, and attributes that a given society 
considers appropriate for men and women, viz "male" and "female" are sex 
categories, while "masculine" and "feminine" are gender categories (WHO, 2016). 
Since both male and female patients’ took part both male and female experiences of 
diabetes were assessed.  The sample was three males and seven female Kuwaitis and 
six male and four female non-Kuwaitis (Table 2.1).   
Age and its distribution. 
The patients’ age distribution is shown in both Table 2.1 and Figure 2.1. The 
distribution shows : 20% below the age of 44, for the range 45-54 was 40% and 10 % 
in the group 55-59 years. Those aged over 60, including people of up to 70 years of 
age, were 30% reflecting perhaps their success at coping with their diabetes. So, 
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these clinics treated an age range of type 2 diabetic patients not just those recently 
diagnosed, indicating that ‘continued care’ existed for all ages groups in the 
KMOH clinics in Kuwait. 
 
Conclusion. After analysis of the pilot results the design of the questionnaire was 
ultimately left unchanged, as the data and the comments which were made by the 
participants revealed that the questionnaires’ structure was unambiguous, feasible, 
practical and capable of being analysed.  
 
 
Figure 2.1. Age (grouped by age range in years) distribution of the patients who took 
part in the pilot study. 
Table 2.1. Demographics of the patients, Kuwaiti and non-Kuwaiti taking part 
in the pilot study. 
Demographic Categories  n Percent 
Nationality 
Kuwaiti 10 50% 
Non-Kuwaiti 10 50% 
 Total 20 100% 
Sex 
Male 9 45% 
Female 11 55% 
 Total 20 100% 
Nationality/Sex  
Kuwaiti/Male 3 30% 
Kuwaiti/Female 7 70% 
Total 10 100% 
Non-Kuwaiti/Male 6 60% 
Non-
Kuwaiti/Female 
4 40% 
 Total 10 100% 
Current Age 
35-39 2 10% 
40-44 2 10% 
45-49 3 15% 
50-54 5 25% 
55-59 2 10% 
60+ 6 30% 
 Total 20 100% 
Age at original diabetes 
diagnosis 
Less than 20 Years 1 5% 
25-29 Years 1 5% 
0%
5%
10%
15%
20%
25%
30%
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10% 10% 
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30-34 Years 2 10% 
35-39 Years 6 30% 
40-44 Years 5 25% 
45-49 Years 3 15% 
50-54 Years 1 5% 
60+ Years 1 5% 
 Total 20 100% 
Height, weight and BMI 
140-149 cm 2 10% 
150-159 cm 6 30% 
160-169 cm 9 45% 
170-179 cm 2 10% 
180+ cm 1 5% 
      Total                  20                     100% 
2.15    The Ascot study. 
Kuwaiti patients in Ascot: The questionnaires were answered by 14 diabetic 
patients:  9 male & 5 female .All questions asked were in Arabic but an English 
contextual translation is provided in Appendix 2. The results of this part of the study 
are shown in Appendix 2A as they are not exactly the same as those asked in Kuwait 
and the severity of the patients was greater perhaps making direct like-with-like 
comparisons very difficult, hence, the study may produce great biased.   
 
The Ascot consultants: Five consultant physicians from Ascot Rehab, volunteered 
to participate in this supplementary study, providing evidence regarding the 
interactions between patients and physicians (Appendices5&5A).  
2.16    Quantitative/Qualitative Methods  
Quantitative analysis 
Both quantitative and qualitative methods were used in this thesis. The quantitative 
aspects of the study, the accuracy, reliability and relative freedom from bias are 
critical criteria for judging the quality of findings (Ulin et al., 2005) enabling valid 
hypothesis testing (Polgar & Thomas, 2013). Quantification was achieved by 
numerical procedures – measurement of variables such as HbA1c, estimations i.e. 
population parameters, with subsequent statistical testing of hypotheses (WHO, 
2001). For this thesis the quantitative data included: age, height and weight (enabling 
the calculation of the BMI) and their age at first diagnosis, enabled the calculation of 
their disease duration. Other quantitative values were the frequency of hyper/ 
hypoglycemia episodes and the doses of oral hypoglycemic drugs or insulin taken by 
patients. 
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Qualitative analysis. 
The qualitative aspects focused on patient and physicians perceptions and 
experiences using a number of open questions. Qualitative studies relate to an 
understanding of the personal meanings/interpretations concerning specified issues 
(Polgar & Thomas, 2013). Frequently, it builds theories and moves from 
observations or open questions to develop general conclusions, which are relative to 
an inductive process (Ulin et al., 2005). Furthermore, qualitative research does not 
usually test hypotheses (Polgar & Thomas, 2013) and predominantly uses methods 
which produce ‘text’ rather than numbers, i.e. transcripts of interviews, free to 
comment statements, observation notes, entries in medical/ nursing records (Avis, 
2005).   
2.17    Power analysis. 
The choice of >100 patients to be used in the studies outlined above would increase 
the power and so reduce the chance of making a type 2 error. In statistical analysis 
the concept of power is related to making a type 2 error. The usual symbol given for 
this rate of making this type of error is beta (β) the power of this is then expressed as 
1-β. For complex mathematical reasons it is generally accepted that 80% power (ie. 
Beta =20%) is acceptable in experimental design and is the minimal value for good 
power (SPSS power analysis http://www.ats.ucla.edu/stat/seminars/Intro_power/). 
This does however mean that even with this rate, there needs to be a big difference 
between the measured variable variations between the groups. Smaller differences 
are less likely to be found because of this type of error. The topic is complicated 
because some of the information on which the power could be based is simply not 
known before an experiment is actually carried out. Some say it is an educated guess 
based on experience, which for someone beginning a PhD is quite difficult to 
‘guess’. So a combination of an intelligent guess and an intelligent experimental 
design helped to maximize the power of the experiment. 
2.18    Data Analysis. 
All the data obtained were prepared in a form suitable for export to the Statistical 
Package for the Social Sciences (SPSS, version 21) for suitable analyses. Where 
appropriate, mean/median and standard deviation/interquartile ranges are presented 
in terms of the prevalence both for men and women, Kuwaiti and non-Kuwaiti. 
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Quantitative data such as body weight (kg), height (cm) and age (years) are 
expressed in conventional ways to show the homogeneity/heterogeneity of the 
groups. Further appropriate analyses using statistics and relationships were 
performed – a normality test, Student’s T test, Mann Whitney U test, correlation 
coefficients and thematic analysis of comments.  P values of less than 0.05 will be 
considered significant. Where suitable, graphical representations of suitable data will 
be constructed, ensuring clarity of data presentation.  
 
All the data gathered will be assessed in terms of a) ‘effectiveness of present 
treatment’, b) areas for future improvement, c) comparison to best practices, and d) 
perceived barrier to optimal diabetic care. This will enable the objectives of a) to 
examine the current patient care of Type 2 diabetes treatment in Kuwait; b) to locate 
potential barriers to development of treatment with emphasis to renal problems and 
c) to compare the treatment procedures and outcomes of diabetes in Kuwait, with 
those recently reported from the UK which used a very similar questionnaire – in 
terms of the questions asked to that used in this investigation making direct 
comparisons possible.  
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Chapter 3 
3. Questionnaire Results from 109 diabetic patients in Kuwait. 
109 questionnaires were completed by type 2 diabetic patients. There were 62 
Kuwaitis and 47 non-Kuwaitis from diabetic clinics in the three regions of Kuwait 
namely Hawli -Salmiya, Sabah Al- Salem, Rumaithiya, Al Farwaniya -  Jleeb Al-
Shuyoukh,Al- Farwaniya , Khaitan, Al-Ardiya , Abdullah Al-Mubarak , AL-Asimah 
- Qurtoba, Al Mansorea, Al-Rawda, Al Adelia and Kaifan . The collected data is 
presented in terms of the "prevalence" of a finding in both men and women, both 
Kuwaiti nationals and non-Kuwaitis. The mean weight, height, and age enabled the 
BMI to be calculated. Statistical tests were used where applicable and suitable 
graphical representations of some of the data are provided to ensure clarity in data 
presentation. 
3.1 General information from the questionnaires. 
Personal demographic characteristics of patients attending their regular appointments 
in diabetic clinics in Kuwait were obtained. Their nationality, gender, current age, 
age at which diabetes was first diagnosed and their height, weight and BMI are 
summarised in Table 3.1.  
Nationality of the participants. 
The diabetic clinics listed above, all funded by the Kuwaiti Ministry of Health 
treated both Kuwaiti nationals and non-Kuwaiti patients (Table 3.1). It should be 
stressed that these clinics treat only type 2-diabetics. In this random sample included 
62 Kuwaiti patients and 47 non-Kuwaiti patients. It should be stressed that this data 
was from the Ministry of Health operated clinics and not clinics in the ‘private 
sector’ which are privately funded, sponsored for employees of specific companies 
[e.g. Kuwait Oil Corporation (KOC)] and other departments of the State, such as the 
military hospitals. 
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Sex 
The numbers of male and female patients in this random sample was 24 males and 38 
females Kuwaitis and 23 male and 24 female non-Kuwaitis taking part in the study 
(Table 3.1). 
 
Table 3.1 Demographics of the patients, Kuwaiti and non-Kuwaiti taking part 
in the study. 
Demographic Categories  n Percent 
Nationality 
Kuwaiti 62 56.9 
Non-Kuwaiti 47 43.1 
 Total 109 100% 
Sex 
Male 47 43.1 
Female 62 56.9 
 Total 109 100% 
Nationality/Sex  
Kuwaiti/Male 24 38.7% 
Kuwaiti/Female 38 61.3% 
Total 62 100% 
Non-Kuwaiti/Male 23 48.9% 
Non-Kuwaiti/Female 24 51.1% 
 Total 47 100% 
Current Age 
30-34 1 0.9% 
35-39 6 5.5% 
40-44 12 11.0% 
45-49 14 12.8% 
50-54 32 29.4% 
55-59 10 9.2% 
60+ 34 31.2% 
 Total 109 100% 
Age at original diabetes 
diagnosis 
Less than 20 Years 1 0.9% 
20-24 Years 1 0.9% 
25-29 Years 5 4.6% 
30-34 Years 14 12.8% 
35-39 Years 20 18.3% 
40-44 Years 28 25.7% 
45-49 Years 23 21.1% 
50-54 Years 9 8.3% 
55-59 Years 3 2.8% 
60+ Years 5 4.6% 
 Total 109 100% 
Height 
140-149 cm 7 6.4% 
150-159 cm 41 37.6% 
160-169 cm 39 35.8% 
170-179 cm 18 16.5% 
180+ cm 4 3.7% 
 Total 109 100% 
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Age distribution in the patient sample 
The age distribution of all the patients in the study group (n=109) is shown in Figure 
3.1. The mode was found to be 60 years plus. 
 
 
Figure 3.1 .The distribution of the age ranges (years) of the diabetic patients in 
this study.  
The age distribution shows 17.4% were below the age of 45 years. In the next 
decade, 45-54 years it was 42.2% and 9.2 % in the age group 55-59 years. Those 
aged over 60, which included people over 70 years of age, was 31.2% of the total 
number, indicating that many were successfully coping with their diabetic condition 
which had potentially existed for several decades. Consequently, the clinics were 
‘seeing’ type 2 diabetic patients across an age range and not just those recently 
diagnosed, indicating perhaps that ‘continued care’ existed for all ages of diabetics in 
the KMOH clinics. The mode for their age at original diagnosis was 40-44 years. 
Table 3.2. Summary data of the height, body weight, and BMI of 109 diabetic 
patients.  
Variables 
Mean ± S. D. 
Height (cm) 161.9 9.8 
Current Weight (kg) 81.3 15.4 
First diagnosis Weight (kg)  84.6 18.4 
BMI (current in kg/m
2
) 31.1 5.4 
BMI (First Diagnosis in kg/m
2
) 32.3 6.2 
 
Table 3.2 shows the mean current weight was 81.3 kg, with a S.D. of ±15.4 kg, 
compared with a mean weight at first diagnosis of 84.6 Kg ±18.4 kg. Although the 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
30-34 35-39 40-44 45-49 50-54 55-59 60+
0.9% 
5.5% 
11.0% 
12.8% 
29.4% 
9.2% 
31.2% 
 66 
 
body weights and BMI at first diagnosis were greater than the current weight/BMI, 
on analysis there was no significant difference. 
Duration of diabetes and its treatment in the respondents.  
To enable a simplification of this data the age at which they were formally 
diagnosed with type 2-diabetes was placed into a series of five-year periods, the 
results are shown in Figure 3.2. The mode was found between 40-44 years, 25.7% 
the figure of 21.1% was found in the age range 45-49 years indicating that 84.3% had 
been diagnosed before the age of 49 years. If it is generally accepted that prior to 
correct diagnosis the disease may have been in process for a number of years, then 
this suggests that: a) in Kuwait diabetes is more quickly diagnosed than elsewhere, b) 
the disease actually has an earlier onset than in other countries or, c) that patients are 
referred to the specialist clinics more quickly. 
 
 
 
Figure 3.2. The distribution of the age ranges at which type 2 diabetes had first 
been diagnosed in the study group patients. 
 
Table 3.3 shows that the majority of the patients who took part in the study were 
‘established’ diabetics. The Kuwaiti patients had suffered the disease for a mean 
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duration of 14 years and for non-Kuwaitis 9 years. When the ages were statistically 
compared using Student’s t test, there was no significant difference (P>0.05) in terms 
of age of onset between Kuwaitis and non-Kuwaitis (Table 3.3). 
 
Table 3.3. Mean (± S.D.) of the patients current age (years) and their age at the 
time of original diabetes diagnosis for both Kuwaitis and non-Kuwaitis. 
Nationality 
Current Age 
(years) 
Age at the time of original diabetes 
diagnosis (years) 
Kuwaiti (n=62) Mean ± S.D. 55.2 3± 8.978 41.52 ± 9.042 
Non-Kuwaiti 
(n=47) 
Mean ± S.D. 51.13 ± 8.381 41.94 ± 8.050 
 
Measurements of and distribution of height, weight, and BMI for the Study 
Group. 
Height - A bar chart of the distribution of body height (cm) of the patients is shown 
in Figure 3.4 and the mode was 150-159 cm (i.e. 5 feet – 5.25 feet) 
 
 
Figure 3.4. Height (cm) distribution of all the patients in this study group. 
 
Body weight. Figure 3.5 shows their mean body weight at first diagnosis body was 
84.6 ± 18.4 kg (n=109) and at the time of the study, 81.3 ± 15.4 kg. (Figure 3.5) 
Using a paired Students t test a statistical difference (p <0.05) was found between the 
patients’ weight at first diagnosis compared to that at the time of the study. The 
paired t test had by virtue of its pairing effectively removed the influence of 
variability of the body weight differences between the groups.  
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Figure 3.5 .Bar chart of the mean values for the current body weight of patients 
in the study as compared with their body weight at their first diagnosis. 
 
Analysis of data distribution.  
At this stage of the analysis it was appropriate to verify the type of distribution of 
data the questionnaires had generated and so a test for normality of data was carried 
out on the quantitative data. 
Tests of distribution normality of the data for the body weight of patients in this 
study. 
Table 3.4 shows the results of the Kolmogorov-Smirnov and Shapiro-Wilk test for 
body weight at the time of the survey and body weight at first diagnosis. The results 
showed that the data were normally distributed, as their distribution was not 
significantly different (p > 0.05). Therefore, we can conclude that the data is 
normally distributed.  This validates the use of Student’s paired t-test for these two 
variables in the previous and later tests. 
 
Table 3.4. Tests of data normality obtained for the body weight part of the 
survey.  
Variables 
Kolmogorov-Smirnov  Shapiro-Wilk 
Statistic d.f. p Statistic d.f. P 
Body weight at the time of the 
survey  (Kg) 
0.059 109 0.20 0.982 109 0.136 
Body weight at first diagnosis 
(Kg) 
0.094 109 0.20 0.900 109 0.000 
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Table 3.5. Paired Samples Correlations. 
Paired Samples Correlations 
 n R P 
Kuwaiti 
Body weight (kg) at the time of the study and body 
weight (kg) at this time of first diagnosis. 
62 0.715 0.000 
Non-Kuwaiti 
Body weight (kg) at the time of the study and body 
weight (kg) at this time of first diagnosis. 
47 0.842 0.000 
 
Table 3.6.Paired Samples Test 
 
Paired Differences 
t d.f. p. 
Mean S.D. S.E. 
Kuwaiti       
Body weight (kg) at the time of the study - 
body weight(kg) at time of first diagnosis  
-4.5 14.1 1.79 -2.5 61 0.014 
Non-Kuwaiti       
Body weight (kg) at the time of the study - 
body weight(kg) at time of first diagnosis 
-1.7 8.8 1.28 -1.3 46 0.196 
 
Within the Kuwaiti group, there was a significant correlation between the current 
body weight and body weight at the time of first diagnosis (r= 0.72 and p value = 
0.000). Consequently, there has been a significant weight loss between the two time 
periods (p< 0.014). 
Among the non-Kuwaiti Sample, the body weight at the time of the study and at the 
time of first diagnosis were not significantly different between these two variables 
(p> 0.196. 
 
Body Mass Index (BMI). 
The BMI values ± S.D. were calculated and compared for the Kuwaiti group, using 
the paired Student’s t test, they were 33.3 kg/m2± 6.7 kg/m2 at first diagnosis and at 
the time of the study were 31.6 kg/m
2
± 5.6 (Table 4.7) . We have strong evidence 
against the null hypothesis, therefore, we can say a highly significant difference was 
found (p<0.01). For the other group (i.e. Non- Kuwaiti) the BMI values were 31.1 
kg/m
2
± 5.2 kg/m
2
 at first diagnosis and at the time of the study were 30.3 kg/m
2
± 5.1. 
Although the first value in the table appears to be less than the second is, due to the 
numerical range no statistical significant difference was found (p>0.05).  
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Table 3.7.  Mean (±S.D.) of BMI values before and after diagnosis of type 2 
diabetes according to nationality for both Kuwaiti & non-Kuwaitis. 
Nationality BMI - today BMI - before 
Kuwaiti (n=62) Mean ± S.D. 31.6± 5.6 33.3± 6.7 
Non-Kuwaiti (n=47) Mean± S.D. 30.3± 5.1 31.1± 5.2 
 
The data shown in Table 3.7 is also shown in Figure 3.6, given as an alternative way 
of data presentation but perhaps the table more clearly expresses the variability of the 
data whereas the bar chart does not do so. 
 
Figure 3.6. Mean Body Mass Index of male and female patients, Kuwaiti and 
non-Kuwaiti who took part in the study. [Key: Before = on diagnosis, today= the 
present value]. 
 
BMI and sex. 
When the BMI of the patients who took part in the study was calculated and 
expressed for both males and females, both Kuwaiti and non-Kuwaiti, the data is 
shown in Table 3. 8. Figure 3.6 also shows the data plotted in the form of a bar chart. 
Tables 3.8 to Figure 3.10 show further analysis of the data. 
Table 3.8. Mean ± S.D. of BMI ‘today’ and at their first diagnosis, according to 
gender. 
Gender BMI 
‘today’ 
BMI-first 
diagnosis  
Male (n=47) Mean ± S.D. 29.5± 5.33 31.2± 6.97 
Female (n=62) Mean ± S.D. 32.3± 5.19 33.2± 5.47 
Total (n=109) Mean ± S.D. 31.1± 5.41 32.3± 6.21 
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Figure 3.7.  The distribution of the current BMI of the patients who took part in 
the study 
Table 3.9. The distribution of the prior BMI of the patients who took part in the 
study.  
Category of BMI Frequency Percent 
Below Normal (<20) 2 1.8% 
Normal (20.0-24.9) 9 8.3% 
Over Weight (25.0-29.9) 25 22.9% 
Moderately Obese (30.0-34.9) 43 39.4% 
Severe Obese (above 35.0) 30 27.5% 
Total 109 100% 
 
 
Figure 3.8. The distribution of the prior BMI of the patients who took part in 
the study.  
 
 
 
 
 
12.8% 
31.2% 
36.7% 
19.3% 
Normal Over Weight
Moderate Obese Sever Obese
1.8% 8.3% 
22.9% 
39.4% 
27.5% 
Below Normal Normal Over Weight
Moderate Obese Sever Obese
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Table 3.10. The cross tabulation between current BMI of the patients and 
nationality. 
Nationality 
Current BMI  
Total 
Normal  Over weight Moderately obese 
Severely 
obese 
Kuwaiti n 8 (12.9%) 18 (29%) 22 (35.5%) 14 (22.6%) 62 
Non-
Kuwaiti 
n 6 (12.8%) 16 (34%) 18 (38.3%) 7 (14.9%) 47 
Total n/% 
14 
(12.8%) 
34 (31.2% 40 (36.7%) 21(19.3%) 
109 
(100
%) 
 
 
Figure 3.9. The cross tabulation between current BMI of the patients and 
nationality. 
Table 3.11. The cross tabulation between prior BMI of the patients and 
nationality. 
Nationality 
Current BMI  
Total Below  
Normal 
Normal 
Over  
 Weight 
Moderately 
Obese 
Severe 
Obese 
Kuwaiti n 1 (1.6%) 6 (9.7%) 11 (17.7%) 24 (38.7%) 20 (32.3%) 62 
Non-Kuwaiti n 1 (2.1%) 3 (6.4%) 14 (29.8%) 19 (40.4%) 10 (21.3%) 47 
Total n/% 2 (1.8%) 9 (8.3%) 
25 
(22.9%) 
43 (39.4%) 30 (27.5%) 
109 
(100
%) 
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Figure 3.10. The cross tabulation between prior BMI of the patients and 
nationality.  
3.2 Treatment & Medication Use. 
This question requested respondents to provide a statement as to what course of 
action was recommended for the treatment of their disease at the time of their 
original diagnosis. From the data shown in Table 3.12, the majority, n=83, of both 
Kuwaiti and non-Kuwaiti patients received tablet medication for their type 2 
diabetes. The next most common course of action was Insulin (n=10), and this 
represented 9.2% of the total number of patients.  A final group, had been prescribed 
oral medication in combination with exercise (n=5). 
Table 3.12. Cross tabulation between nationality and recommended course of 
action  
Nationality * what course of action was recommended when you were first 
diagnosed? 
Natio
nality 
What course of action was recommended when you were first diagnosed? 
Total 
Tablets 
medicati
on 
Dietary  
change 
Insulin 
Tablet 
Medicati
on, 
Dietary 
Change 
& 
Exercise 
Tablet  
Medication 
& Dietary 
Change 
Tablet  
& 
Exercise 
Dietary 
& 
Exercis
e 
Kuwaiti n 
45 
(72.6%
) 
5 
(8.1%) 
4 (6.5%) 1 (1.6%) 4 (6.5%) 2 (3.2%) 
1 
(1.6%) 
62 
Non-
Kuwaiti 
n 
38 
(80.9%
) 
0 
6 
(12.8%) 
0 0 3 (6.4%) 0 47 
Total 
n
/
% 
83 
(76.1%
) 
5 
(4.6%) 
10 
(9.2%) 
1 (0.9%) 4 (3.7%) 5 (4.6%)  
1 
(1.6%) 
109(10
0%) 
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Treatments and medication with regard to the sex of the patients. 
From Figure 3.11, the majority of patients received for their first line treatment 
‘tablet medication’. In contrast, 14.9% of the male respondents received insulin as 
their first line treatment and 8.5% tablets and exercise, respectively. Whereas, for 
females, 4.8% received insulin and 1.6% tablets and exercise. From Figure 3.12 and 
Table 3.13, 19.7% of the respondents (i.e. 14.9% male and 4.8% female), their first 
recommendation was to use insulin. 
 
Figure 3.12. Distribution between the sexes of recommended courses of action to 
help control their diabetes.  
Table 3.13. Summary table for both males and females of the recommended 
courses of action for the control of their diabetes.  
Nationality/Sex 
What course of action was recommended when you were 
first diagnosed? 
Total Tablets  
medicatio
n 
Dietary  
change 
Insulin 
Tablet  
medicatio
n, dietary 
change 
&exercise 
Tablet  
& 
exercis
e 
Dieta
ry  & 
exerci
se 
Kuw
aiti 
Male n 16 (66.7%) 
1 
(4.2%) 
3 (13%) 2 (8.3%) 
2 
(8.3%) 
0 24 
Femal
e 
n 29 (76.3%) 
4(10.5
%) 
1 
(2.6%) 
3 (7.9%) 0 
1(2.6
%) 
38 
Total n 
45 
(72.6%) 
5 
(8.1%) 
4 
(6.5%) 
5 (8.1%) 
2 
(3.2%) 
1 
(1.6%
) 
62 
(100
%) 
Non
-
Male n 17 (73.9%) 0 4 (17%) 0 
2 
(8.7%) 
0 23 
0.0%
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20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
tablets
medication
dietary
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Insulin tablet
medication
,diatery
change
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tablet
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&dietery
change
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excercise
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exercise
70.2% 
2.1% 
14.9% 
2.1% 2.1% 
8.5% 
0.0% 
80.6% 
6.5% 4.8% 0.0% 4.8% 1.6% 1.6% 
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Kuw
aiti 
Femal
e 
n 21(87.5%) 0 
2 
(8.3%) 
0 1(4.2%) 0 24 
Total 
n/
% 
38 (81%) 0 
6 
(13%) 
0 3 (6%) 0 
47 
(100
%) 
 
Dietary advice given to type 2 diabetes patients. 
This question asked if respondents were ever able to control their diabetes through 
diet alone. From the data shown in Table 3.14, the percentage of Kuwaitis who 
controlled diabetes with diet alone (8%) is greater than the percentage of non-
Kuwaitis none of whom had been able to control their diabetes through diet alone. 
From Table 3.14., we can see that females had a higher ability to control diabetes 
than males (10.5% and 4.2%) respectively. Only four Kuwaiti females reported being 
able to do this, and the disease was controlled only for six months. In one of the 
female patients she did not remember what actual dietary advice had been 
recommended for her to do. 
Table 3.14. Cross tabulation between Nationality and sex and ability to control 
diabetes with diet alone in both Kuwaiti and non-Kuwaiti. 
Nationality/ Sex 
Were you ever able to 
control your diabetes 
through diet alone? 
Total 
Yes No 
Kuwaiti 
Male n 1 (4.2%) 23 (95.8%) 24 
Female n 4 (10.5%) 34 (89.5%) 38 
Total n/% 5 (8.1%) 57 (91.9%) 
62 
(100%) 
Non-Kuwaiti 
Male n 0 23 (100%) 23 
Female n 0 24 (100%) 24 
Total n/% 0 47 (100%) 
47 
(100%) 
 
Controlling diabetes with tablets medication. 
This question enquired whether or not the patients were ever able to control their 
diabetes with "pill medication" for any length of time (Table 3.15). Kuwaiti patients 
were found to have a higher ability to control diabetes with tablets medication than 
Non-Kuwaiti patients do (96.8% and 95.7%) respectively.  
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Table 3.15. Cross tabulation between Nationality and their ability to control 
diabetes with ‘tablets medication’ i.e. oral hypoglycemic. 
Nationality/ Sex 
Were you ever able to 
control your diabetes with 
tablets medication? 
Total 
Yes No 
Kuwaiti n 60 (96.8%) 2 (3.2%) 62 
Non-Kuwaiti n 45 (95.7%) 2 (4.3%) 47 
Total n/% 105 (96.3%) 4 (3.7%) 109 (100%) 
 
Table 3.16. Cross tabulation between nationality and their current medications. 
Currently Taking Medications 
Nationality 
n 
Kuwaiti 
Non-
Kuwaiti 
Glyburide  n 4 (57.1%) 3 (42.9%) 7 
Glimepiride  n 3 (60%) 2 (40%) 5 
Metformin  n 
20 
(57.1%) 
15 (42.9%) 35 
Tablet medication replaced 
by Insulin 
n 6 (46.2%) 7 (53.8%) 13 
Gliclazide n 8 (88.9%) 1 (11.1%) 9 
Glucovance  n 1 (100%) 0 1 
I don’t remember the name 
of the tablet 
n 2 (100%) 0 2 
Glyburide & Metformin n 0 4 (100%) 4 
Glimepiride  & Metformin n 5 (62.5%) 3 (37.5%) 8 
Metformin & Gliclazide n 8 (47.1%) 9 (52.9%) 17 
Total n/% 
57 
(56.4%) 
44 (43.6%) 
101 
(100%) 
 
The medications taken by Kuwaiti and non-Kuwait diabetics were variable (Table 
3.16). The commonest monotherapy drug for both groups was metformin, Kuwaiti 
(n=20) and non-Kuwaiti (n=15). Glyburide was used by Kuwaitis and non-Kuwaitis 
alone (n=7), but only non- Kuwaitis used glyburide in combination with metformin 
(n=4). 
Table 3.17. Cross tabulation between nationality, sex and current taking 
medications. 
Sex Currently Taking Medications 
Nationality 
Total 
Kuwaiti 
Non-
Kuwait
i 
Male 
Glyburide  n 3  2  5 
Glimepiride  n 2  2  4 
Metformin  n 9  6  15 
Tablet Medication replaced by Insulin n 0 3  3 
Gliclazide n 2  1  3 
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I don't remember the name of the tablet n 1  0 1 
Glyburide & Metformin n 0 1  1 
Glimepiride & Metformin n 3  2  5 
Metformin & Gliclazide n 1 4  5 
Total 
n/
% 
21 (50%) 
21 
(50%) 
42 
(100%) 
Female 
glyburide n 1 1  2 
glimepiride n 1 0 1 
metformin n 11 9 20 
Tablet medication replaced by Insulin n 6 4 10 
Gliclazide n 6 0 6 
Glucovance n 1  0 1 
I don’t remember the name of the 
Tablet 
n 1 0 1 
Glyburide & Metformin n 0 3  3 
Glimepiride & Metformin n 2  1 3 
Metformin  & Gliclazide n 7  5 12 
Total 
n/
% 
36 (61%) 
23 
(39%) 
59 
(100%) 
 
We can see from Table 3.17, the percentage of non-Kuwaiti females who were 
currently taking glyburide and metformin was greater than that for non-Kuwaiti 
males (3 and 1 respectively). There was no association between sex and the types of 
medications taken currently according to nationality, Chi-Square Test p-values were 
0.421 and 0.280 for male and female respectively. 
 
Insulin usage in type 2 diabetes 
Table 3.18. Cross tabulation between nationality, sex, and controlling diabetes-
using insulin. 
Nationality/Sex 
Have you ever used insulin to 
control your diabetes? Total 
Yes No 
Kuwaiti 
Male n  9 (37.5%) 15 (62.5%) 24 
Female n 20 (52.6%) 18 (47.4%) 38 
            
Total 
n/% 29 (46.8%) 33 (53.2%) 62 (100%) 
Non-
Kuwaiti 
Male n 13 (56.5%) 10 (43.5%) 23 
Female n 13 (54.2%) 11 (45.8%) 24 
            
Total 
n/% 26 (55.3%) 21 (44.7%) 47 (100%) 
 
From Table 3.18, the percentage of Kuwaiti females who had occasion to control 
their diabetes using insulin is very similar to the percentage of non-Kuwaiti females 
using insulin (52.6% versus 54.2%). For males, 37.5% of the Kuwaiti males and 
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56.5% of non-Kuwaiti males had had occasion to control their diabetes using insulin. 
Statistical comparisons found no association between nationality and controlling 
diabetes using insulin according to sex, Chi-Square Test, p-values of 0.245 and 0.871 
for Kuwaiti and Non-Kuwaiti respectively. 
Using insulin to control your diabetes:  
Table 3.19. Cross tabulation between nationality and controlling diabetes-using 
insulin. 
Nationality 
Have you ever used insulin to 
control your diabetes? Total 
Yes No 
Kuwaiti n 29 (46.8%) 33 (53.2%) 62 
Non-Kuwaiti n 26 (55.3%) 21(44.7%) 47 
Total n/% 55 (50.5%) 54 (49.5%) 109 (100%) 
 
From Table 3.19 the percentage of Kuwaitis who used insulin to control diabetes is 
less than that for Non-Kuwaiti (46.8% versus 55.3%). Using the Chi-Square Test 
there was difference (p = 0.377) between these variables. 
Table 3.20. Cross tabulation between sex and controlling diabetes using insulin 
Sex 
Have you ever used insulin to 
control your diabetes? Total 
Yes No 
Male n 22 (46.8%) 25 (53.2%) 47 
Female n 33 (53.2%) 29 (46.8%) 62 
Total n/% 55 (50.5%) 54 (49.5% 109 (100%) 
 
From Table 3.20 the percentage of males who controlled their diabetes-using insulin 
was less than that for females (46.8% versus 53.2%).  But these were not 
significantly different (p value was 0.507). 
 
Table 3.21. Cross tabulation between nationality and sex and length of time 
(months/years) using insulin. 
Nationality/ length of time using Insulin 
Sex 
Total 
Male Female 
Kuwaiti 
If yes, please 
write the 
length of time 
you took 
Insulin 
Less than one 
month 
n 1 3  4 
1-2 months n 0 1 1 
3-4 months n 1  1  2 
5-6 months n 0 2  2 
7-12 months n 1 2  3 
1-2 years n 2  0 2 
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above 2 years n 4  11  15 
Total 
n 9 20 29 
%  31% 68% 100% 
Non-
Kuwaiti 
If yes, please 
write the 
length of time 
you took 
Insulin 
Less than one 
month 
n 2  2  4 
1-2 months n 1 3  4 
3-4 months n 1 1 23 
5-6 months n 2 0 2 
7-12 months n 1  1 2 
1-2 years n 1 0 1 
above 2 years n 5  6  11 
Total 
n 13 13 26 
%  50% 50% 100% 
 
 
Generally, both sexes among Kuwaiti and non-Kuwaitis tended to use insulin for 
different length of times. This will be considered in more detail in the discussion. 
 
The third part of the question was to establish if they were still using insulin and the 
result are as shown below in Table 3.22. 
 
Table 3.22. Cross tabulation between nationality and sex and still taking insulin 
for diabetes 
Nationality/Sex 
Are you still taking insulin for 
your diabetes? Total 
Yes No 
Kuwaiti 
Male n   8 (88.9%) 1 (11.1%)  9 
Female  n 18 (90%) 2 (10%) 20 
Total n/% 26 (89.7%) 3 (10.3%) 29 (100%) 
Non-Kuwaiti 
Male n 10 (76.9%) 3 (23.1%) 13 
Female n   9 (69.2%) 4 (30.8%) 13 
Total n/% 19 (73.1) 7 (26.9%) 26 (100%) 
 
Table 3.22 shows the percentages of Kuwaitis still taking insulin for diabetes were 
virtually the same for males and females (88.9% for males and 90% for females). For 
non-Kuwaiti members the percentage of males still taking insulin for diabetes was 
greater than that for females (76.9% and 69.2% respectively). 
 
Three patient experiences are worth specific comments. 
Patient one, mentioned that the diabetic physician prescribed insulin for her for a 
week and she suffered from severe hypoglycemia and after that she spoke with her 
physician and he changed it again to tablets.  
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Patient two, said that following sleeve gastrectomy surgery he stopped taking 
insulin and now he only takes tablets. 
Patient three, his blood glucose increase to 144 mg/dl (8 mmol) and his diabetic 
physician prescribed for him insulin. He took it for 3 days and he felt tiredness and 
he went to another physician and he told him that his blood glucose is not high. After 
that, he stopped insulin and he took tablets.   
3.3 Resource use (diagnoses and management) 
Table 3.23. Cross tabulation between nationality and sex and examining blood 
sugar using a primary method 
Nationality/ Sex 
What is your primary method for personally 
examining your blood-sugar level? 
Total 
Blood or 
urine test 
(at the 
doctor’s 
office 
only*) 
Blood 
glucose 
test strips 
read by 
eye at 
home 
Urine 
glucose 
test strips 
at home 
Blood 
glucose 
read by 
strips and 
meter** 
Non 
Kuwaiti 
Male n 11(45.8%)  0 
13 
(54.2%)  
0 24 
Female n 19 (50%)  3 (7.9%) 
14 
(36.8%) 
2 
(5.3%) 
38 
Total 
n 30  3 27 2 62 
% 48.4%  4.8% 43.5% 3.2% 100% 
Non-
Kuwaiti 
Male n 12 (52.2%) 1(4.3%) 0 9 (39.1%) 
1 
(4.3%) 
23 
Female n 10 (41.7%) 0 0 
14 
(58.3%) 
0 24 
Total 
n 22 1 0 23 1 47 
% 46.8% 2.1%  48.9% 2.1% 100% 
Key  *= these test are carried out at approximately two, three or four months apart. 
**= these tests were found to be carried out at variable timings such as: two 
to six times per week and some were carried out on a daily basis. 
Table 3.23 shows that 45.8% of Kuwaiti males used blood or urine tests at the 
doctor’s office only. In contrast, 52.2% of non-Kuwaiti males were using that 
method. In addition, 54.2% of Kuwaiti males used blood glucose strips and a meter, 
whereas 39.1% of non-Kuwaiti males used that method. There was no significant 
difference between nationalities and examining blood sugar using a primary method  
(p-value 0.421). On analysis, 55.3% of Kuwaiti females had never examined blood 
sugar level in the past month, while 45.8% of Kuwait males had never examined 
their blood sugar level in the past month. Moreover, 54.2% of non-Kuwaiti females 
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had never examined blood sugar level in the past month and 56.5% of the males had 
done the same (see Table 3.24). 
 
Table 3.24. Cross tabulation between nationality and sex and how often 
examined blood sugar level in the past month. 
Nationality/Sex 
How often have you examined your blood sugar level in 
the past month? 
Total 
Never 
Once a 
week or 
less 
Roughly 
2-6 
times 
per 
week 
Daily 
Twice a 
day or 
more 
Three  
times or 
more 
Kuwaiti 
Male n 11(45.8%) 6 (25%) 
4 
(16.7%) 
2 
(8.3%) 
0 1(4.2%) 24 
Female n 21(55.3%) 
7 
(18.4%) 
6 
(15.8%) 
1(2.6%) 
3 
(7.9%) 
0 38 
Total 
n 32 13 10 3 3 1 62 
% 51.6% 21.0% 16.1% 4.8% 4.8% 1.6% 100% 
Non-
Kuwaiti 
Male n 
13 
(56.5%) 
5 
(21.7%) 
4 
(17.4%) 
1(4.3%) 0 0 23 
Female n 
13 
(54.2%) 
6(25%) 
4 
(16.7%) 
1(4.2%) 0 0 24 
Total 
n 26 11 8 2 0 0 47 
% 55.3% 23.4% 17.0% 4.3% 0% 0% 100% 
 
Analysis of this data showed no association between nationalities and number of 
times of blood examination for blood sugar level in the past month, attributed to sex, 
(p 0.814 and 0.678). 
 
The eighth question asked patients if they have ever discussed the possibility of 
amputation as a result of their diabetes. Only one (14.3%) Kuwaiti females had had 
problems serious enough for amputation to be necessary.  
 
Routine visits to the doctor 
45.8% of Kuwaiti males visited their doctors for diabetes, five or more times a year, 
and 45.8% for 3 to 4 times a year, whereas 31.6% of Kuwaiti females visited their 
doctors for diabetes five or more times a year, and 63.2% for 3 to 4 times a year 
(Table 3.25). Among non-Kuwaiti males, 56.5% of them visited their doctors five or 
more times a year, and 43.5% for 3 to 4 times a year. In contrast, 75% of non-
Kuwaiti females visited their doctors for diabetes for 3 to 4 times a year. All sample 
members reported that they only visited a diabetes specialist. 
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Table 3.25. Cross tabulation between nationality and sex and visits to their 
doctor, approximately, do you routinely visit your doctor for diabetes 
Nationality/Sex 
How often, approximately, do you routinely 
visit your doctor for diabetes? 
Total 
5 or more times 
a year 
3 to 4 times a 
year 
1 or 2 
times a 
year 
Kuwaiti 
Male n 11 (45.8%) 11 (45.8%) 2 (8.3%) 24 
Female n 12 (31.6%) 24 (63.2%) 2 (5.3%) 38 
Total n/% 23 (37.1%) 35 (56.5%) 4 (6.5%) 
62 
(100
%) 
Non-
Kuwaiti 
Male n 13 (56.5%) 10 (43.5%)  0 23 
Female n   6 (25%) 18 (75%)  0 24 
Total n/% 19 (40.4%) 28 (59.6%) 
 0 47 
(100
%) 
 
On analysis there was an association between nationalities and making routine visits 
to the doctor, (p-value is 0.028), in favor of non-Kuwaiti, subject to sex. 
 
Foot examination. 
The feet of only 13.2% of Kuwaiti females and 8.3% of males were examined by a 
diabetes specialist. Among non-Kuwaitis 13.0% of males and 0% of females had had 
their feet examined (Table 3.26).  
Table 3.26. Cross tabulation between nationality and sex and examined feet by 
the doctor.  
 
 
 
 
 
Diet/weight management 
Statistical analysis of this data proved impossible because the majority of the patients 
used the “do not know” category. They did not know the number of calories that they 
should consume on a daily basis to maintain a healthy and optimal body weight. Also 
Nationality/Sex 
During the past year, has your doctor 
examined your feet? Total 
Yes No 
Kuwaiti 
Male n 2 (8.3%) 22 (91.7%) 24 
Female n 5 (13.2%) 33 (86.8%) 38 
Total 
n 7 55 62 
%  11.3% 88.7% 100% 
Non-Kuwaiti 
Male n 3 (13%) 20 (87%) 23 
Female n 0 24 (100%) 24 
Total 
n 3 44 47 
%  6.4% 93.6% 100% 
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only 4.2% and 2.6% of Kuwaiti males and females had been placed on a weight 
management program from a hospital dietitian. For non-Kuwaiti males and females 
0% were on weight management program from a hospital dietitian (see Table 3.27). 
Table 3.27. Cross tabulation between nationality and sex and weight 
management program from a hospital dietician 
Nationality/Sex 
Please state whether you are on a 
weight management program from 
a hospital dietician 
Total 
Yes No 
Kuwaiti 
Male n 1 (4.2%) 23 (95.8%) 24 
Female n 1 (2.6%) 37 (97.4%) 38 
Total n/% 2 (3.2%) 60 (96.8%) 
62 
(100%) 
Non-Kuwaiti 
Male n 0 23 (100%) 23 
Female n 0 24 (100%) 24 
Total n/% 
0 
47 (100%) 
47 
(100%) 
 
Exercise. 
37.5% and 28.9% of Kuwaiti males and females were walking for 10-30 minutes 
every day, while 43.5% and 25% of non-Kuwaiti males and females were walking 
for 10-30 minutes every day (Table 3.28). In addition, 37.5% and 39.5% of Kuwaiti 
males and females were walking twice or 3 times a week for 10-30 minutes, while 
39.1% and 45.8% of non-Kuwaiti males and females were walking twice or 3 times a 
week for 10-30 minutes (Table 3.28). 
Table 3.28. Cross tabulation between nationality and sex and types of exercise. 
Nationality 
Please fill in the appropriate box if you carry out any 
of the following type of exercise 
Tot
al 
Walking 
for  
10-30 
minutes 
every 
day 
Walking 
twice or 
three 
times a 
week for  
10-30 
minutes 
Attendi
ng a 
gym for 
a 
session 
of up to 
30 
minutes
. a week 
Swim
ming 
twice 
or 
more 
a week 
for 10-
30 
minut
es. 
Other/ 
Eikidu
e 
No 
exercis
e 
Kuwai
ti 
Male n 9(37.5%) 9(37.5%) 0 
1(4.2%
) 
1(4.2
%) 
4(16.7
%) 
24 
Fema
le 
n 
11(28.9%
) 
15(39.5%
) 
0 
2(5.3%
) 
0 
10 
(26.3%
) 
38 
Total n 20 24 0 3 1 14 62 
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% 32.3% 38.7% 0% 4.8% 1.6% 22.6% 
100
% 
Non-
Kuwai
ti 
Male n 
10(43.5%
) 
9(39.1%) 1(4.3%)  
1((4.3
%) 
2 
(8.7%) 
23 
Fema
le 
n 6 (25%) 
11(45.8%
) 
1(4.2%)  0 
6 
(25%) 
24 
Total 
n 16 20 2  1 8 47 
% 34.0% 42.6% 4.3%  2.1% 17.0% 
100
% 
 
The Chi-Square Test found no association between nationalities and types of exercise 
followed by the study members attributed to sex, since the p-values were 0.631 and 
0.382. 
3.4    Diabetes complications. 
Only 8.3% of Kuwaiti males had a high awareness of diabetes complications, and 
50.0% of Kuwaiti females a medium awareness, while only 4.3% of non-Kuwaiti 
males had a high awareness, and 41.7% of non-Kuwaiti females had a medium 
awareness (Table 3.29). The awareness value was calculated as follows: If a patient 
was aware of 5 or more of the complications this indicates a "high awareness", 3 to 4 
complications meant the patient had a "medium awareness" and 2 or less they had a 
"low awareness”.  
Table 3.29. Cross tabulation between Nationality and Sex and Awareness of 
Diabetes Complications 
Nationality/Sex 
Awareness of Diabetes Complications 
Total High 
Awareness 
Medium 
Awareness 
Low 
Awareness 
Kuwaiti 
Male n 2 (8.3%) 10 (41.7%) 12 (50%) 24 
Female n 0 19 (50%) 19 (50%) 38 
Total n/% 2 (3.2%) 29 (46.8%) 31 (50%) 62 100%) 
Non-
Kuwaiti 
Male n 1 (4.3%) 10 (43.5%) 12 (52.2%) 23 
Female n 0 10 (41.7%) 14 (58.3%) 24 
Total n/% 1 (2.1%) 20 (42.6%) 26 (55.3%) 
47 
(100%) 
 
On analysis there was no association between nationality and awareness of diabetes 
complications attributed to sex among the two groups (Kuwaiti and non-Kuwaiti) 
since p-values were 0.184 and 0.567 respectively (Chi-Square Test). 
 
After an analysis of the overall awareness answers to specific question was then 
carried out. 
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Kidney problems  
Table 3.30 shows that 83.3% of Kuwaiti males were aware of kidney complication 
and for Kuwaiti females it was 73.7%. In contrast, the non-Kuwaiti males, their 
awareness of kidney complication was 73.9% and for the non-Kuwaiti females’ the 
percentage was 66.7%. 
Table 3.30. Cross tabulation between nationality and sex and kidney 
complication(s).  
Nationality/Sex 
Kidney Complications 
Total 
No Yes 
Kuwaiti 
Male n 4 (16.7%) 20 (83.3%) 24 
Female n 10 (26.3%) 28 (73.7%) 38 
Total n/% 14 (22.6%) 48 (77.4%) 62 (100%) 
Non-Kuwaiti 
Male n 6 (26.1%) 17 (73.9%) 23 
Female n 8 (33.3%) 16 (66.7%) 24 
Total n/% 14 (29.8%) 33 (70.2%) 47 (100%) 
 
Feet problems 
Table 3.31 shows that the percentage of Kuwaiti males who knew about feet 
complication was 58.3% while for Kuwaiti females it was 55.3%. On other hand, the 
percentage of both non-Kuwaiti males and females who know about feet 
complication were 52.2% and 54.2% respectively. 
Table 3.31. Cross tabulation between Nationality and Sex and Feet 
Complication.  
Nationality/Sex 
Foot Complication 
Total 
No Yes 
Kuwaiti 
Male n 10 (41.7%) 14 (58.3%) 24 
Female n 17 (44.7%) 21 (55.3%) 38 
Total n/% 27 (43.5%) 35 (56.5%) 62 (100%) 
Non-
Kuwaiti 
Male n 11 (47.8%) 12 (52.2%) 23 
Female n 11 (45.8%) 13 (54.2%) 24 
Total n/% 22 (46.8%) 25 (53.2%) 47 (100%) 
 
Nerve problems. 
Table 3.32 shows that 29.2% of Kuwaiti males were aware of nerve complication(s) 
while the Kuwaiti for females it was 10.5%. For the non-Kuwaiti males, 13% were 
aware of nerve complication and for the non-Kuwaiti females the percentage was 
16.7%. 
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Table 3.32. Cross tabulation between nationality and sex and nerve 
complication(s). 
Nationality/ Sex 
Nerve Complication 
Total 
No Yes 
Kuwaiti 
Male n 17 (70.8%) 7(29.2%) 24 
Female n 34 (89.5%) 4(10.5%) 38 
Total n/% 51 (82.3%) 11 (17.7%) 62 (100%) 
Non-Kuwaiti 
Male n 20 (87%) 3(13%) 23 
Female n 20 (83.3%) 4(16.7%) 24 
Total n/% 40 (85.1%) 7 (14.9%) 47 (100%) 
 
Eye problems. 
From the percentage distribution in the above table (Table 3.33) all Kuwaitis had 
knowledge about eye complications, while above 95% of the non-Kuwaiti group had 
knowledge about eye complication 
Table 3.33. Cross tabulation between nationality and sex and eye complications.  
Nationality/Sex 
Eye Complication 
Total 
No Yes 
Kuwaiti 
Male n 0 24 (100%) 24 
Female n 0 38 (100%) 38 
Total n/% 0 62 (100%) 62 (100%) 
Non-Kuwaiti 
Male n 1 (4.3%) 22 (95.7%) 23 
Female n 1 (4.2%) 23 (95.8%) 24 
Total n/% 2 (4.3%) 45 (95.7%) 47 (100%) 
 
Digestive problems. 
Table 3.34 shows that the percentage of Kuwaiti males who knew of digestive 
complication was 8.3% while for Kuwaiti females it was 0%. On other hand, the 
non-Kuwaiti males, who knew about digestive complication was 8.7% while for the 
non-Kuwaiti females the percentage was 0%. 
 
Table 3.34. Cross tabulation between nationality and sex and digestive 
complication(s).  
 
 
 
Nationality/Sex 
Digestive  Complication 
Total 
No Yes 
Kuwaiti 
Male n 22 (91.7%) 2 (8.3%) 24 
Female n 38 (100%) 0 38 
Total n/% 60 (96.8%) 2 (3.2%) 62 (100%) 
Non-
Kuwaiti 
Male n 21(91.3%) 2 (8.7%) 23 
Female n 24 (100%) 0 24 
Total n/% 45 (95.7%) 2 (4.3%) 47 (100%) 
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Other Complications 
Table 3.35 shows that the percentage of Kuwaiti males and females who knew about 
other complications was 0% and 2.6%, while for the non-Kuwaiti males and females 
the percentages were 8.7% and 0%. 
 
Table 3.35. Cross tabulation between nationality and sex and other 
complication(s).  
Nationality/Sex 
other Complications 
Total 
No Yes 
Kuwaiti 
Male n 24 (100%) 0 24 
Female n 37 (97.4%) 1 (2.6%) 38 
Total n/% 61 (98.4%) 1 (1.6%) 62 (100%) 
Non-Kuwaiti 
Male n 21(91.3%) 2 (8.7%) 23 
Female n 24 (100%) 0 24 
Total n/% 45 (95.7%) 2 (4.3%) 47 (100%) 
 
Patient experience of symptoms& complication of the type 2-diabetes.  
Hypoglycemia 
Table 3.36 shows that non-Kuwaiti females and males who had experienced low 
blood sugar the figures were 57.9% and 54.2% respectively. This contrasts with non-
Kuwaiti female and males of 41.7% and 60.9% respectively who had experienced 
low blood sugar. The Chi squared test analysis indicated no association between the 
variables of gender and low blood sugar at the level of significance 5%, since p-
values were 0.773 and 0.188.  
Table 3.36.Cross tabulation between nationality and sex and low blood sugar. 
Nationality/ Sex 
Have you ever had a low blood sugar 
Total 
Yes No 
Kuwaiti 
Male n 13 (54.2%) 11(45.8%) 24 
Female n 22 (57.9%) 16 (42.1%) 38 
Total n/% 35 (56.5%) 27 (43.5%) 62 (10%) 
Non-
Kuwaiti 
Male n 14 (60.9%) 9 (39.1%) 23 
Female n 10 (41.7%) 14 (58.3%) 24 
Total n/% 24 (51.1%) 23 (48.9%) 47 (100%) 
 
The part of the questionnaire which asked for measured values concerning low blood 
sugar provided some interesting results. For example, 31% of Kuwaiti males decided 
that the level of blood sugar was low when it reached 60mg/dL contrasting with 14% 
of Kuwaiti females.  On other hand, the level of low blood sugar for non-Kuwaiti 
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males was considered to be 54 mg/dL (Table 3.37) although in many of the 
questionnaires ‘other’ was given. Moreover, Table 3.38 shows that 38% of Kuwaiti 
males thought that the level of blood sugar was low when it reached 40mg/dL while 
70% of Kuwaiti females thought that the level of blood sugar was low when it 
reached 36mg/dL. On other hand, the level of low blood sugar for non-Kuwaiti males 
was considered to be 40 mg/dL by 46% of them. 
Table 3.37. Cross tabulation between nationality and sex and value for low 
blood sugar which patients thought was too low. 
Nationality/Sex 
If yes how low does your blood sugar 
drop prior to noticing 
Total 
60 
mg/dL 
54 
mg/dL 
50 
mg/dL 
Other* 
Kuwait
i 
Male n 4 (31%) 1(8%) 0 8 (62%) 13 
Femal
e 
n 3 (14%) 6 (29%) 2 (10%) 10 (48%) 21 
Total 
n/
% 
7 (21%) 7 (21%) 2 (6%) 18 (53%) 
34 
(100%) 
Non-
Kuwait
i 
Male n 0 1(7%) 0 13 (93%) 14 
Femal
e 
n 3 (50%) 1(17%) 0 2 (33%) 6 
Total 
n/
% 
3 (15%) 2 (10%) 0 15 (75%) 
20 
(100%) 
 
*This group is further clarified in Table 3.38 below. 
The Chi squared test found no association between sex and low blood sugar (p value 
= 0.246) for both Kuwaiti males and females. 
 
Table 3.38. Cross tabulation between nationality and sex and other values for 
low blood sugar which patients thought was too low. 
Nationality 
Other hypoglycemia 
Total 
36mg/dL 
30mg/d
L 
45mg/dL 40mg/dL 
Kuwaiti 
Male n 2 (25%) 2 (25%) 1(13%) 3 (38%) 8 
Female n 7 (70%) 0 1(10%) 2 (20%) 10 
Total n/% 9 (50%) 2 (11%) 2 (11%) 
5 (28%5 )
( 
18 (100%) 
Non-Kuwaiti 
Male n 5 (38%) 1(8%) 1(8%) 6 (46%) 13 
Female n 1(50%) 1(50%) 0 0 2 
Total n/% 6 (40%) 2 (13%) 1 (7%) 6 (40)%  15 
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Warning signs 
The results obtaining from the analysis indicated that 54.2% and 57.9% of Kuwaiti 
males and females had warning signals; while 60.9% of non-Kuwaiti males and 
41.7% of non-Kuwaiti females had had warning signals (see Table 3.39). 
Table 3.39. Cross tabulation between nationality and sex and warning signals. 
Nationality/Sex 
Were there warning 
signals? Total 
Yes No 
Kuwaiti 
Male n 13 (54.2%) 11 (45.8%) 24 
Female n 22 (57.9%) 16 (42.1%) 38 
Total n/% 35 (56.5%) 27 (43.5%) 62 (100%) 
Non-Kuwaiti 
Male n 14 (60.9%) 9 (39.1%) 23 
Female n 10 (41.7%) 14 (58.3%) 24 
Total n/% 24 (51.1%) 23 (48.9%) 47 (100%) 
 
The percentage of females who had had warning signals was less than for males, 
51.6% and 57.4% respectively (Table 3.40). 
Table 3.40. Cross tabulation between sex and warning signals between both 
groups of patients.  
Sex 
Were there warning 
signals? Total 
Yes No 
Male n 27 (57.4%) 20 (42.6%) 47 
Female n 32 (51.6%) 30 (48.4%) 62 
Total n/ 59 (54.1%) 50 (45.9%) 109 (100%) 
 
Nausea 
Table 3.41 shows that 8.3% of Kuwaiti males had suffered nausea, compared with 
34.2% of Kuwaiti females. In contrast, 17.4% of non-Kuwaiti males had suffered 
nausea, compared with 25% of non-Kuwait females who had suffered this condition. 
Table 3.41. Cross tabulation between nationality and sex and suffering nausea. 
Nationality/Sex 
      Nausea 
Total 
No  Yes  
Kuwaiti 
Male n 22 (91.7%) 2 (8.3%) 24 
Female n 25 (65.8%) 13 (34.2%) 38 
Total n/% 47 (75.8%) 15 (24.2%) 62 (100%) 
Non-Kuwaiti 
Male n 19 (82.6%) 4 (17.4%) 23 
Female n 18 (75 %) 6 (25%) 24 
Total n/% 37 (78.7%) 10 (21.3%) 47 (100%) 
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Numbness 
Table 3.42 shows that both Kuwaiti males and females had suffered numbness, 
12.5% and 34.2% respectively, while the non-Kuwaiti males and females the figures 
were 30.4% and 25% respectively. 
Table 3.42. Cross tabulation between nationality and sex and suffering 
numbness. 
Nationality/Sex 
Numbness 
Total 
No Yes 
Kuwaiti 
Male n 21(87.5%) 3 (12.5%) 24 
Female n 25 (65.8%) 13 (34.2%) 38 
Total n/% 46 (74.2%) 16 (25.8%) 62 (100%) 
Non-Kuwaiti 
Male n 16 (69.6%) 7 (30.4%) 23 
Female n 18 (75%) 6(25%) 24 
Total n/% 34 (72.3) 13 (27.7%) 47 (100%) 
Anxiety 
Table 3.43 shows that the percentage of Kuwaiti males who had experienced anxiety 
was greater than for Kuwaiti females, 8.3% versus 5.3%. No patients from the non-
Kuwaiti group had suffered anxiety. 
Table 3.43. Cross tabulation between nationality and sex and suffering anxiety. 
 
 
 
 
 
 
 
Dizziness 
From Table 3.44 we can see that 33.3% of male Kuwaiti and 42.1% for Kuwaiti 
females had suffered dizziness. The percentage of non-Kuwaiti males who 
experienced dizziness was more than for non-Kuwaiti females, 43.5% versus 20.8%. 
Table 3.44 . Cross tabulation between nationality and sex and dizziness signal 
Nationality/Sex 
Dizziness  
Total 
No  Yes  
Kuwaiti 
 
Male n 16 (66.7%) 8 (33.3%) 24 
Female n 22 (57.9%) 16 (42.1%) 38 
Total n/% 38 (61.3%) 24 (38.7%) 62 (100%) 
Non-Kuwaiti 
 
Male n 13 (56.5%) 10 (43.5%) 23 
Female n 19 (79.2%) 5 (20.8%) 24 
Total n/% 32 (68.1%) 15 (31.9%) 47 (100%) 
 
Nationality/Sex 
Anxiety  
Total 
No  Yes  
Kuwaiti 
Male n 22 (91.7%) 2 (8.3%) 24 
Female n 36 (94.7%) 2 (5.3%) 38 
Total n/% 58 (93.5%) 4 (6.5%) 62 (100%) 
Non-Kuwaiti 
Male n 23 (100%) 0 23 
Female n 24 (100%) 0 24 
Total n/% 47 (100%) 0 47 (100%) 
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Headache 
None of the Kuwaiti males suffered headaches whilst 23.7% of females had 
experienced headaches (Table 3.45). For the non-Kuwaiti sample, 30.4% of the 
males experienced headache contrasting with 16.7% of the females. 
Table 3.45. Cross tabulation between nationality and sex and headache.  
Nationality/Sex 
Headache 
Total 
No Yes 
Kuwaiti 
Male n 24 (100%) 0 24 
Female n 29 (76.3%) 9 (23.7%) 38 
Total n/% 53 (85.5%) 9 (14.5%) 62 (100%) 
Non-Kuwaiti 
Male n 16 (69.6%) 7 (30.4%) 23 
Female n 20 (83.3%) 4 (16.7%) 24 
Total n 36 (76.6%) 11(23.4%) 47 (100%) 
 
Other “signals” of diabetes.  
41.7% of Kuwaiti males experienced other pain(s) in the body and blurred vision, 
while the figure was 34.2% for Kuwaiti females. For the non-Kuwaiti sample, 43.5% 
and 29.2% of males and females experienced other pain(s) in the body and blurred 
vision, respectively. 
Hypoglycemia 
Table 3.46. Cross tabulation between nationality and sex and hypoglycemia. 
Nationality/ Sex 
Hypoglycemia 
Total 
No  Yes  
Kuwaiti 
Male n 14 (58.3%) 10 (41.7%) 24 
Female n 25 (65.8%) 13 (34.2%) 38 
Total n/% 39 (62.9%) 23 (37.1%) 62 (100%) 
Non-
Kuwaiti 
Male n 13 (56.5%) 10 (43.5%) 23 
Female n 17 (70.8%) 7 (29.2%) 24 
Total n/% 30 (63.8%) 17 (36.2%) 47 (100%) 
 
Table 3.47 shows that 77% of Kuwaiti males reported that the duration of suffering 
from symptoms was 1 to 2 years or 2 to 3 years comparing with 63.7% of Kuwaiti 
females. Within the non - Kuwaiti sample, 93% of males and 70% of females 
reported that the duration of suffering from Symptoms was 1 to 2 years or 2 to 3 
years. 
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Table 3.47. Cross tabulation between nationality and sex and duration of 
suffering from symptoms of hypoglycemia. 
 
Using the Chi-Square Test there was no association between nationality and the 
duration of suffering from symptoms of hypoglycemia according to sex, since the p 
values were 0.702 and 0.428.  
Table 3.48 shows that 69.2% of Kuwaiti males reported that hypoglycemia affected 
their lifestyle, while this percentage was higher, 86.4% for Kuwaiti females. For non-
Kuwaitis members 100% of the females and 85.7% of the males commented that it 
affected their lifestyle. 
Table 3.48. Cross tabulation between nationality and sex and effecting of 
hypoglycemia on lifestyle. 
Nationality/ Sex 
Does hypoglycemia affect 
your lifestyle Total 
Yes No 
Kuwaiti 
Male n 9 (69.2%) 4(30.8%) 13 
Female n 19 (86.4%) 3 (13.6%) 22 
Total n/% 28 (80%) 7 (20%) 35 (100%) 
Non-Kuwaiti 
Male n 12 (85.7%) 2 (14.3%) 14 
Female n 10 (100%) 0 10 
Total n/% 22 (91.7%) 2 (8.3%) 24 (100%) 
 
Table 3.49 shows that 8.3% of Kuwaiti males reported that they had had severe 
hypoglycemic spells in the past 5 years while this percentage was slightly higher, 
13.2%, for Kuwaiti females. For non-Kuwaiti males, 34.8% of them reported that 
they had had severe hypoglycemic spells in the past 5 years, while this figure for 
non-Kuwaiti females was 12.5%. 
Nationality/Sex 
For how many years you have been suffering any of 
these symptoms 
Total 
1-2 Years 2-3  Years 3-4  Years 
4-5  
Years 
5  Years 
or more 
Kuwaiti 
Male n 6(46.2%) 4(30.8%) 2(15.4%) 0 1(7.7%) 13 
Female n 8(36.4%) 6(27.3%) 2(9.1%) 
1(4.5
%) 
5 
(22.7%) 
22 
Total 
n 14 10 4 1 6 35 
%  40.0% 28.6% 11.4% 2.9% 17.1% 100% 
Non-
Kuwaiti 
Male n 9(64.3%) 4(28.6%) 0 0 1(7.1%) 14 
Female n 6 (60%) 1(10%) 1(10%) 
1(10
%) 
1(10%) 10 
Total 
n 15 5 1 1 2 24 
%  62.5% 20.8% 4.2% 4.2% 8.3% 100% 
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Table 3.49. Cross tabulation between nationality and sex and severe 
hypoglycemic spells in the past 5 years. 
Nationality/Sex 
Have you had severe hypoglycemic 
spells in the past 5 years Total 
Yes No 
Kuwaiti 
Male n 2 (8.3%) 22 (91.7%) 24 
Female n 5 (13.2%) 33 (86.8%) 38 
Total n/% 7 (11.3%) 55 (88.7%) 62 (100%) 
Non-Kuwaiti 
Male n 8 (34.8%) 15 (65.2%) 23 
Female n 3 (12.5%) 21 (87.5%) 24 
Total n/% 11 (23.4%) 36 (76.6%) 47 (100%) 
 
Convulsions and Coma.  
From the data the incident of convulsions was very rare. Only 1 Kuwaiti male and 2 
females had suffered such an effect. Additionally, one non- Kuwaiti male reported 
that he had suffered from convulsions whereas none of the females had experienced 
this problem. 
For coma the figures were: One Kuwaiti male and female and for the non-Kuwaitis, 
just one female. Those affected as described in Table 3.50. 
 
Table 3.50. Cross tabulation between Nationality and Sex and type of severe 
diabetic problems namely convulsions and coma. 
Nationality/ Sex 
If Yes, which of the following 
Total 
C
o
n
v
u
ls
io
n
s 
C
o
m
a
 
Convulsions, 
heart 
problem and 
low 
temperature 
Unconsci
ous & 
low body 
temperat
ure 
Heart problem 
& low body 
temperature 
Kuwaiti 
M
al
e 
n 1(50%) 1(50%) 0 0 0 2 
F
em
al
e 
n 2(40%) 1(20%) 2(40%) 0 0 5 
T
o
ta
l n 3  2 2   7 
% 43% 29% 28%   100% 
Non-
Kuwaiti M
al
e 
n 1(13%) 0 5 (62%) 1(12.5%) 1(12.5%) 8 
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F
em
al
e 
n 0 1(33%) 2 (66.7%) 0 0 3 
T
o
ta
l n 1 1 7 1 1 11 
% 9.1% 9.1% 63.6% 9.1% 9.1% 100% 
 
Duration of symptoms of these conditions.  
Table 3.51 shows that 40% of Kuwaiti females who answered the question reported 
that the duration of severe was 3 to 4 times or greater over the last five years. 66.7% 
of non-Kuwaiti females who reported such events experienced them 1 to 2 times over 
the last five years.  
Table 3.51. Cross tabulation between nationality and sex and number of events 
over the last five years   
Nationality/Sex 
Please indicate number of events over the last five 
years 
Total 
1-2 Times 
2 -3 
Times 
3-4 
Times 
4-5 
Times 
More  
than 5 
Times 
Kuwait
i 
M
al
e 
n 1 (50%) 
 0 
0 1(50%) 0 2 
F
em
al
e 
n 1(20%) 
 0 
2(40%) 1(20%) 1(20%) 5 
T
o
t
a
l n 2  0 2 2 1 7 
% 28.6%  0  28.6% 28.6% 14.3% 100% 
Non-
Kuwait
i 
M
al
e 
n 4 (50%) 1(12.5%) 2(25%) 1(12.5%) 
0 
8 
F
em
al
e 
n 2 (66.7%) 0 1(33.3%) 0 
0 
3 
T
o
t
a
l n 6 1 3 1 0 11 
% 54.5% 9.1% 27.3% 9.1%  100% 
 
In addition, some of the sample patients verbally reported that when they go into a 
coma, they cannot move, suffer drowsiness, are always tired, cannot do anything, 
always feel sleepy, fatigued, weakness, suffering nervousness and are angry, as they 
cannot check on their children and their homes, and have to take sick leave from 
their work as they cannot walk. 
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Hyperglycemia 
Table 3.52 shows that 33.3% of Kuwaiti males did not test their urine for ketones, 
and 54.2% of them did not know what ketones actually were or indicated, and while 
26.3% of Kuwaiti females tested their urine for ketones, 47.4% of them did not know 
what ketones actually were or indicated. For non-Kuwaiti patients, 34.8% of males 
tested for urine for ketones, and 52.2% of them did not know what ketones were. 
Additionally, 79.2% of the non-Kuwaiti females did not know what ketones were.  
Table 3.52. Cross tabulation between nationality and test for urine for ketones. 
Nationality/ Sex 
Do you test for urine for ketones 
Total 
Yes No 
Don’t know 
what 
ketones are 
Kuwaiti 
Male n 3 (12.5%) 8 (33.3%) 13 (54.2%) 24 
Female n 
10 
(26.3%) 
10(26.3%) 18 (47.4%) 38 
Total 
n 13 18 31 62 
% 21.0% 29.0% 50.0% 100% 
Non-
Kuwaiti 
Male n 8 (34.8%) 3(13%) 12 (52.2%) 23 
Female n 3 (12.5%) 2 (8.3%) 19 (79.2%) 24 
Total 
n 11 5 31 47 
% 23.4% 10.6% 66.0% 100% 
 
On analysis of the data shown in table 50 there was no association between 
nationality and making test for urine for ketones according to sex, since the p-values 
were 0.422 and 0.133 (Chi-Square Test). 
 
Ketoacidosis 
Table 3.53 shows that 6 Kuwaiti females had ketoacidosis 1-2 times a year, while a 
further 1 had ketoacidosis for more than 5 times a year. Three Kuwaiti males and 
females had ketoacidosis 1-2 times a year.  
Table 3.53. Cross tabulation between nationality and sex and having 
ketoacidosis 
Nationality/Sex 
If Yes, please indicate how often you have ‘been 
in’ ketoacidosis 
Total 
1-2 times a 
year 
2-3 
times 
a year 
3-4 
times a 
year 
4-5 
times 
a year 
more 
than 5 
times a 
year 
Kuwaiti 
Male n 0 0 
1(33.3%
) 
0 2 (66.7%) 3 
Femal
e 
n 6 (60%) 0 2 (20%) 
1 
(10%) 
1 (10%) 10 
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Total 
n 6 0 3 1 3 13 
% 46.2%  23.1% 7.7% 23.1% 
100
% 
Non-
Kuwaiti 
Male n 3 (37.5%) 
2(25%
) 
1(12.5%
) 
0 2(25%) 8 
Femal
e 
n 3(100%) 0 0  0 3 
Total 
n 6 2 1  2 11 
% 54.5% 18.2% 9.1%  18.2% 
100
% 
 
Table 3.54 shows that above 90% of the patients in the study reported that they had 
had warning signals due to hyperglycemia. 
Table 3.54. Cross tabulation between nationality and sex warning signals due to 
hyperglycemia 
Nationality/ Sex 
Were there warning signals due 
to hyperglycemia? Total 
Yes No 
Kuwaiti 
Male n 22 (91.7%) 2(8.3%) 24 
Female n 36 (94.7%) 2 (5.3%) 38 
Total 
n 58 4 62 
%  93.5% 6.5% 100% 
Non-
Kuwaiti 
Male n 22 (95.7%) 1(4.3%) 23 
Female n 22 (91.7%) 2 (8.3%) 24 
Total 
n 44 3 47 
%  93.6% 6.4% 100% 
 
Describe what happened: 
In response to this open question a number of answers were given. These are 
summarized as: blurred vision, dizzy, drowsiness, dry mouth, fatigue, headache, 
hunger and frequent urination, increase of thirst, nausea, shivering, sweating, the 
body temperature increases, the blood glucose becomes 300mg/dl or more than 
180mg/dl (about 252) or up to 300mg, the blood sugar is more than 100mg/dl, the 
heart beats increase. The answers reported by the sample were a single or in 
combination with others (see Appendix 11)   
Table 3.55 shows that 27.3% of Kuwaiti males reported hyperglycemia occurring for 
1 to 2 years, and 22.7% reported hyperglycemia occurring for five or more years. For 
Kuwaiti females 30.6% reported 1-2 years, 5.6% reported 3 to 4 years, and 36.1% for 
more than five years. For non-Kuwaitis the position was the similar to the Kuwaiti 
group especially in the first category (1-2 years). Generally, for both non-Kuwaitis 
males and females the range was greater than that for Kuwaitis. 
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Table  3.55. Cross tabulation between nationality and sex and duration of 
occurring hyperglycemia 
 
Nationality/Sex 
How many years has hyperglycemia been occurring 
Total 1-2 
Years 
2-3 Years 
3-4 
Years 
4-5 
Years 
5 and 
Years 
Kuwai
ti 
Male n 6(27.3%) 4(18.2%) 5(22.7%) 2(9.1%) 5(22.7%) 22 
Female n 
11(30.6
%) 
8(22.2%) 2(5.6%) 2(5.6%) 
13(36.1%
) 
36 
Total 
n 17 12 7 4 18 58 
%
  
29.3% 20.7% 12.1% 6.9% 31.0% 
100
% 
Non-
Kuwai
ti 
Male n 6(27.3%) 7(31.8%) 4(18.2%) 1(4.5%) 4(18.2%) 22 
Female n 8(36.4%) 4(18.2%) 4(18.2%) 
3(13.6
%) 
3(13.6%) 22 
Total 
n 14 11 8 4 7 44 
%
  
31.8% 25.0% 18.2% 9.1% 15.9% 
100
% 
 
Using the Chi-Square Test there was no association between nationality and length 
of occurring hyperglycemia attributed to sex, since the p-values were 0.339 and 
0.690. 
 
Kidney 
This question highlighted a very interesting point about renal function when taken 
together with the next question. Essentially, question 23- suggesting they had no 
renal problems, contrasted with the result of question 24, when they reported protein 
in their urine. This suggested a mismatch between renal function and their 
knowledge of protein in urine.  
Table 3.56 shows the percentage of patients knowing they had kidney problems. 
Among Kuwaiti group 12.5% and 13.2% of males and females knowing they had 
kidney problems, while the results indicated that 21.7% and 16.7% of non-Kuwaiti 
males and females knowing they had kidney problems.  
 
Table  3.56. Cross tabulation between nationality and sex and knowing they had 
a kidney problem.  
Nationality/ Sex 
Have you ever been told by your doctor you 
have a kidney problem Total 
Yes No I Don’t know 
Kuwaiti 
Male n 3(12.5%) 21(87.5%) 0 24 
Female n 5(13.2%) 32(84.2%) 1(2.6%) 38 
Total 
n 8 53 1 62 
% 12.9% 85.5% 1.6% 100% 
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Non-
Kuwaiti 
Male n 5 (21.7%) 17(73.9%) 1(4.3%) 23 
Female 
n 4(16.7%) 19(79.2%) 1(4.2%) 24 
% 16.7% 79.2% 4.2% 100% 
Total 
n 9 36 2 47 
% 19.1% 76.6% 4.3% 100% 
There was no association between nationality and knowing they had kidney problems 
attributed to sex; (p 0.721 and 0.904 Chi-Square Test). 
Table 3.57 shows that only 3 males and 5 females from group one (Kuwaiti) added to 
5 males and 4 females from group two (non-Kuwaiti) answered this question. About 
33% of Kuwaiti females stated that the time since diagnosis was about 3 years, while 
60% of non-Kuwaiti males stated that the time since diagnosis was about 1 year. 
Table 3.57. Cross tabulation between nationality and sex and length of 
diagnosis. 
Nationality/ Sex 
if so, please indicate the time since diagnosis 
Total 
1 Year 2 Years 3 Years 4 Years Other  
Kuwaiti 
Male n 
1 
(33.3%) 
0 1(33.3%) 1(33.3%) 0 3 
Female n 1(20%) 0 2(40%) 1(20%) 1(20%) 5 
Total 
n 2  3 2 1 8 
% 25.0%  37.5% 25.0% 12.5% 100% 
Non-
Kuwaiti 
Male n 3(60.0%) 1(20%) 1(20.0%) 0 0 5 
Female n 0 3(75%) 1(25%) 0 0 4 
Total 
n 3 4 2 0 0 9 
% 33.3% 44.4% 22.2% 0 0 100% 
 
Protein in the urine.  
Table 3.58 shows that 67.7% of Kuwaitis and 63.8% non-Kuwaitis stated they had 
no protein in their urine. Additionally, 9.7% of Kuwaitis and 14.9% of non-Kuwaitis 
stated they did not know whether they had been diagnosed as having protein in their 
urine or not. Finally, 22.6% of Kuwaitis and 21.3% of non-Kuwaitis stated they had 
protein in the urine.  
Table 3.58. Cross tabulation between nationality and sex and having protein in 
your urine 
Nationality/Sex 
Have you been diagnosed as having 
protein in your urine? Total 
Yes No I don’t know 
Kuwaiti 
Male n 7(29.2%) 17(70.8%) 0 24 
Female n 7(18.4%) 25(65.8%) 6(15.8%) 38 
Total 
n 14 42 6 62 
% 22.6% 67.7% 9.7% 100% 
Non-Kuwaiti 
Male n 5(21.7%) 13(56.5%) 5 (21.7%) 23 
Female n 5(20.8%) 17 (70.8%) 2 (8.3%) 24 
Total 
n 10 30 7 47 
% 21.3% 63.8% 14.9% 100% 
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Patients concern about renal problems  
This generated the lowest answer rate of any the questions asked. 
Extension of the data from the above table (Table 3.58), 2 Kuwaiti patients (one male 
and one female), and one non-Kuwaiti patient (female) reported that they were 
transferred from their diabetic physician to a nephrologist. This is only three out of 
109 in the study. Despite the non-Kuwaiti female saying she had ‘no renal problems’ 
she had sufficient protein in her urine to be transferred to a nephrologist. Despite 
this, she stated that she did not have any problem with her kidneys. Therefore, she 
knew there was protein in her urine but she did associate this with her kidneys. The 
other two patients, both Kuwaitis, who knew they had a kidney problem, were not 
actually transferred to a nephrologist.  
 
Renal dialysis and renal transplants 
Only three Kuwaiti patients, one male two females and only one non- Kuwaiti 
female patient reported that they required dialysis. All these patients (n=4) stated that 
their dialysis schedule was 3 visits per week. In addition, only 2 Kuwaiti had 
received a kidney transplant, one male and one female. Table 3.59 shows that 69.4% 
of Kuwaitis and 61.7% of non-Kuwaiti had high blood pressure. Moreover, the 
percentage of female among the two groups who had high blood pressure was greater 
than the percentage of male among the two groups who had this problem.  
Table 3.59. Cross tabulation between nationality and sex and having high blood 
pressure. 
Nationality/ Sex 
Do you have high blood 
pressure? Total 
Yes No 
Kuwaiti 
Male n 12 (50%) 12 (50%) 24 
Female n 31(81.6%) 7(18.4%) 38 
Total 
n 43 19 62 
% 69.4% 30.6% 100% 
Non-Kuwaiti 
Male n 14(60.9%) 9(39.1%) 23 
Female n 15(62.5%) 9(37.5%) 24 
Total 
n 29 18 47 
% 61.7% 38.3% 100% 
 
Within the study patient groups those who had a high blood pressure, 99% of these 
patients reported that they were taking medication due to high blood pressure and a 
further one although hypertensive was not taking any medication. 
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When asked to provide the names of their medication, 87% of the sample members 
reported that they took: Zestril 10, Diovan, Norvasak, Twynsta or Diovan (valsartan) 
and Norvasc (Amlodipine) instead, Nifedipine, Tenormin 100mg(Atenolol), Zestril 
(Lisinopril), Capoten (Captopril) Lasix (Furosemide) - Zestoretic -
(Hydrochlorothiazide), while the 13% of them  reported that they didn’t remember 
the medication that they took. Generally, For Non-Kuwaitis prescribing of drugs was 
slightly different from Kuwaitis because if expensive drugs were required the patient 
would have to pay for them themselves rather than receiving them from the Kuwaiti 
system. With this caveat - their prescribed drugs are shown in both generic and 
proprietary names to avoid the complications of just using proprietary names as these 
can vary from country to country. See Appendix 10 for a full list of drugs. 
 
Eye – Table 3.60 shows that 66.7% of Kuwaiti males 71.1% of Kuwaiti females had 
their retinas examined. For non-Kuwaitis the figures were: 56.5% of the males and 
41.7% of the females had had their retinas examined. 
Table 3.60. Cross tabulation between nationality and sex and examined the 
retina  
Nationality/ Sex 
Have you ever had the back of 
your eyes (the retina) 
examined 
Total 
Yes No 
Kuwaiti 
Male n 16(66.7%) 8(33.3%) 24 
Female n 27(71.1%) 11(28.9%) 38 
Total 
n 43 19 62 
% 69.4% 30.6% 100% 
Non-
Kuwaiti 
Male n 13(56.5%) 10 (43.5%) 23 
Female n 10(41.7%) 14(58.3%) 24 
Total 
n 23 24 47 
% 48.9% 51.1% 100% 
 
The Chi-Square Test indicated there was no association between nationality and 
examination of the retina attributed to sex since p-values were 0.715 and 0.308.  
From table 3.61 we can see 31.2% of Kuwaiti males indicated that the specialist who 
conducted their eye examination was a diabetes specialist, while 68.8% indicated that 
the specialist who conducted the eye examination was an eye specialist. 46.2% of 
non-Kuwaiti males indicate that specialist who conducted the eye examination was a 
diabetes specialist, while 53.8% indicated just an eye specialist. Moreover, 48.1% of 
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Kuwaiti females and 50% non-Kuwaiti females respectively indicated that their eye 
examination was by a diabetes specialist.  
 
Table  3.61. Cross tabulation between nationality and sex and type of specialist 
who conducted the eye examination. 
Nationality/ Sex 
If yes who conducted the eye 
examination 
Total 
A diabetes 
specialist 
An eye 
specialist 
Kuwaiti 
Male n 5(31.2%) 11(68.8%) 16 
Female n 13 (48.1%) 14(51.9%) 27 
Total 
n 18 25 43 
% 41.9% 58.1% 100% 
Non-Kuwaiti 
Male n 6 (46.2%) 7(53.8%) 13 
Female n 5 (50%) 5 (50%) 10 
Total 
n 11 12 23 
% 47.8% 52.2% 100% 
 
There was no significant association between nationality and type of specialist who 
conducted the eye examination attributed to sex ( p-values , 0.278 and 0.855).  
 
The result from Table 3.62 found that routine eye examination for patients in the 
diabetic clinics does not occur for 45.2% of Kuwaiti and for 66% of non-Kuwaitis 
patients.  
Table 3.62. Cross tabulation between nationality and sex and frequency of 
visiting eye doctor  
Nationality/ Sex 
How many times do you see eye doctor 
Total 1  Per 
month 
1-2 Per 
year 
2-3 
Per 
year 
other Never 
Kuwaiti 
Male n 0 
5 
(20.8%) 
1(4.2%
) 
7(29.2%) 11(45.8%) 24 
Female n 2(5.3%) 2(5.3%) 0 17(44.7%) 17(44.7%) 38 
Total 
n 2 7 1 24 28 62 
%  3.2% 11.3% 1.6% 38.7% 45.2% 100% 
Non-Kuwaiti 
Male n 0 
4(17.4%
) 
1(4.3%
) 
4(17.4%) 14(60.9%) 23 
Female n 1(4.2%) 1(4.2%) 
1(4.2%
) 
4(16.7%) 17(70.8%) 24 
Total 
n 1 5 2 8 31 47 
% 2.1% 10.6% 4.3% 17.0% 66.0% 100% 
 
No significant association between nationality and frequency of visiting eye doctor 
was attributed to sex since p-values were 0.140 and 0.546. 
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The results shows in Table 3.63 indicate that diabetes blurred vision is a problem in 
88.7% of Kuwaiti patients and 87.2% of the Non- Kuwaiti patients. 
Table 3.63. Cross tabulation between nationality and sex and having diabetic 
blurred vision 
Nationality/ Sex 
Do you have diabetic blurred 
vision as a result of you 
diabetes? 
Total 
Yes No 
Kuwaiti 
Male n 20(83.3%) 4(16.7%) 24 
Female n 35(92.1%) 3 (7.9%) 38 
Total 
n 55 7 62 
% 88.7% 11.3% 100% 
Non-Kuwaiti 
Male n 19 (82.6%) 4(17.4%) 23 
Female n 22(91.7%) 2(8.3%) 24 
Total 
n 41 6 47 
% 87.2% 12.8% 100% 
 
The results shows in Table  3.64 indicate that decreased in clearness of vision is a 
problem in 88.7% of Kuwaiti patients and 80.9% of the Non- Kuwaiti patients. 
Table 3.64. Cross tabulation between nationality and sex and diagnosed with a 
decreased in clearness of vision. 
Nationality/ Sex 
Have you been diagnosed 
with a decreased in clearness 
of vision? 
Total 
Yes No 
Kuwaiti 
Male n 20(83.3%) 4(16.7%) 24 
Female n 35(92.1%) 3(7.9%) 38 
Total 
n 55 7 62 
% 88.7% 11.3% 100% 
Non-Kuwaiti 
Male n 19(82.6%) 4(17.4%) 23 
Female n 19(79.2%) 5(20.8%) 24 
Total 
n 38 9 47 
% 80.9% 19.1% 100% 
 
No significant association between nationality and being diagnosed with a decreased 
in clearness of vision attributed to sex ( p-values, 0.288 and 0.764).  
Table 3.65. Cross tabulation between nationality and sex and foot problem 
Nationality/ Sex 
Have you ever had foot 
problem Total 
Yes No 
Kuwaiti 
Male n 17(70.8%) 7(29.2%) 24 
Female n 26(68.4%) 12(31.6%) 38 
Total n/% 43 (69.4%) 19 (30.6%) 62 (100%) 
Non-Kuwaiti 
Male n 10(43.5%) 13(56.5%) 23 
Female n 20(83.3%) 4(16.7%) 24 
Total n/% 30 (63.8%) 17 (36.2%) 47 (100%) 
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There was no significant association between nationality (Kuwaiti) and having a foot 
problem attributed to sex since p-value was 0.841, but there was a highly significant 
association between nationality (non-Kuwaiti) and having foot problem attributed to 
sex (p = 0.004).  
 
Numbness 
The data for this is shown in Table 3.66 and there was no significant association 
between nationality (Kuwaiti) and suffering from numbness attributed to sex under 
the 5% level of significance; since p-value was 0.245, but there is a high significance 
association between nationality (non-Kuwaiti) and suffering from numbness 
attributed to sex under the 5% level of significance; since the p-value was 0.013.  
Table 3.66. Cross tabulation between nationality and sex and suffering from 
numbness 
Nationality/ Sex 
Suffer from numbness 
Total 
Yes No 
Kuwaiti 
Male n 15(62.5%) 9(37.5%) 24 
Female n 18(47.4%) 20(52.6%) 38 
Total n/% 33 (53.2% 29 (46.8%) 62 (100%) 
Non-Kuwaiti 
Male n 9(39.1%) 14(60.9%) 23 
Female n 18(75%) 6(25%) 24 
Total n/% 27 (57.4%) 20 (42.6%) 47 (100%) 
‘Burning’ 
The data is shown in Table 3.67 and after analysis we can conclude that there is no 
significant association between nationalities and suffering from problem burning 
attributed to sex under 5% level of significance; since p-values were 0.213 and 
0.110. 
Table 3.67. Cross tabulation between nationality and sex and suffering from 
problem of ‘burning’. 
Nationality/ Sex 
Suffer from  Burning 
Total 
Yes No 
Kuwaiti 
Male n 14(58.3%) 10(41.7%) 24 
Female n 16(42.1%) 22(57.9%) 38 
Total n/% 30 (48.4%) 32 (51.6%) 62 (100%) 
Non-Kuwaiti 
Male n 10(43.5%) 13(56.5%) 23 
Female n 16(66.7%) 8(33.3%) 24 
Total n/% 26 (55.3%) 21 (44.7%) 47 (100%) 
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Foot ulcers - In this group of patients (n=109) only four had foot ulcers (Table 3.68), 
three of them were Kuwaiti patients, two men and one women, and the fourth one 
was a non- Kuwaiti woman. 
 Table 3.68. Cross tabulation between nationality and sex and suffering from 
foot ulcers. 
Nationality/ Sex 
Suffer from _Foot ulcer 
Total 
Yes No 
Kuwaiti 
Male n 2 (8.3%) 22 (91.7%) 24 
Female n 1 (2.6%) 37 (97.4%) 38 
Total n/% 3 (4.8%) 59 (95.2% 62(100%) 
Non-Kuwaiti 
Male n 0 23 (100%) 23 
Female n 1 (4.2%) 23 (95.8%) 24 
Total n/% 1 (2.1%) 46 (97.9%) 47 (100%) 
There was no significant association between nationality (Kuwaiti) and suffering 
from foot ulcers attributed to sex at a 5% level of significance, since the p-value was 
0.456. 
 
Other problems 
The results shown in Table 3.69 indicate that 14.5% Kuwaiti patients and only 2.1% 
of non-Kuwaiti patients suffered from ‘other problems’. Females who were suffering 
from other problems described their problems in the following way. After walking 
for either short or long distances, they described the pain in their feet as ‘like needles 
being inserted into the foot’. One of them, described the consequences of having half 
both feet being amputated because her diabetes. This made walking impossible and 
so compromising her mobility. This woman also had ulcerated and infected areas on 
her upper, lower leg, which were fortunately treated by therapy in Thailand. In 
addition, one of them commented that she had severing itching in both feet, which 
disturbed her ability to sleep and walking. 
Table 3.69. Cross tabulation between nationality and sex and suffering from 
other problems 
Nationality/ Sex 
Suffer from Other 
problems Total 
Yes No 
Kuwaiti 
Male n 2 (8.3%) 22 (91.7%) 24 
Female n 7 (18.4%) 31(81.6%) 38 
Total n/% 9 (14.5%) 53 (85.5%) 62 (100%) 
Non-Kuwaiti 
Male n 0 23 (100%) 23 
Female n 1 (4.2%) 23 (95.8%) 24 
Total n/% 1 (2.1%) 46 (97.9%) 47 (100%) 
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After analysis there was no significant association between nationality and suffering 
from other problems attributed to sex under 5% level of significance; since p-values 
were 0.272 and 0.322.  
 
Circulation 
The results shows in Table 3.70 were those generated by question 34 and contained a 
perhaps expected finding. 35.5% of the sample who had cardiac problems were 
Kuwaiti, while 21.3% were non-Kuwaiti. The Kuwaiti patients who had cardiac 
problems were seven males and 15 were females, in contrast to the literature where 
the majority of heart problems would be male. The type of cardiac problems 
experienced by the Kuwaiti patients was that of chest pain. Among non-Kuwaitis, 
five males and five females had cardiac problems. 
Table 3.70 Cross tabulation between nationality and sex and suffering from 
heart problems.  
Nationality/ Sex 
Have you ever had heart 
problems Total 
Yes No 
Kuwaiti 
Male n 7 (29.2%) 17 (70.8%) 24 
Female n 15 (39.5%) 23 (60.5%) 38 
Total n/% 22 (35.5%) 40 (64.5%) 62 (100%) 
Non-Kuwaiti 
Male n 5 (21.7%) 18 (78.3%) 23 
Female n 5 (20.8%) 19 (79.2%) 24 
Total n/% 10 (21.3%) 37 (78.7%) 47 (100%) 
 
No significant association between nationality and heart problems attributed to sex, 
p-value were 0.409 and 0.940. 
Lipids - Both groups of patients took anti-cholesterol drug with more (n=37) 
Kuwaiti than Non-Kuwaiti (n=30) using such medications. 
Table  3.71. Cross tabulation between nationality and sex and taking 
medications for high cholesterol. 
Nationality/ Sex 
Do you take any medication for high 
cholesterol? 
Total 
Yes No 
I Don’t 
know 
Kuwaiti 
Male n 11(45.8%) 13 (54.2%) 0 24 
Female n 26 (68.4%) 10 (26.3%) 2(5.3%) 38 
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Total n/% 37 (59.7%) 23 (37.1%) 2 (3.2%) 62 (100%) 
Non-
Kuwaiti 
Male n 14 (60.9%) 9 (39.1%) 0 23 
Female n 16 (66.7%) 8 (33.3%) 0 24 
Total n/% 30 (63.8%) 17 (36.2%) 0 47 (100%) 
 
After analysis there was no significant association between nationality and taking 
any medication for high cholesterol attributed to sex under 5% level of significance; 
since the p-values were 0.061 and 0.679.  
 
Duration of medication for high cholesterol. 
Only six Kuwaiti males were receiving such treatment and this had been in taken for 
4 years. For Kuwaiti women the “picture” was more complicated as shown in Table 
3.72 eight patients had received such treatment for 10 years or more, and five for six 
years, three for four years and finally six for one year. For Non-Kuwaitis, four males 
(out of 14) had received the therapy for two years and three for four years, and four 
women in this group (out of 16) had taken the medication for one year and three of 
them for two years. 
 
Table 3.72.Cross tabulation between nationality and sex and length of time 
taking any medication for high cholesterol 
Nationality
/ Sex 
if  yes,  how long have you taken it 
Total 
1
 y
rs
. 
2
 y
rs
. 
3
 y
rs
. 
4
 y
rs
. 
5
 y
rs
. 
6
 y
rs
. 
8
 y
rs
. 
1
0
 y
rs
. 
>
 1
0
 y
rs
. 
K
u
w
ai
ti
 
M
al
e 
N 0 1 0 6 2 2   0 0 11 
% 0% 9% 0% 55% 18% 18%   0% 0 100% 
F
em
al
e 
N 6 2 3 3 0 5   5 3 27 
% 22% 7% 11% 11% 0% 19%   
19
% 
11
% 
100% 
T
o
ta
l 
N 6 3 3 9 2 7   5 3 38 
% 16% 8% 8% 24% 5% 18%   
13
% 
8% 100% 
N o n - K u w ai ti
 
M al e N 1 4 2 3 1 1 0 0 2 14 
 107 
 
% 7% 29% 14% 21% 7% 7% 0% 0% 
14
% 
100% 
F
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al
e 
N 4 3 3 2 1 0 1 1 1 16 
% 25% 19% 19% 13% 6% 0% 6% 6% 6% 100% 
T
o
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l 
N 5 7 5 5 2 1 1 1 3 30 
% 17% 23% 17% 17% 7% 3% 3% 3% 
10
% 
100% 
 
When this data was compared using the Chi-Square Test there was no significant 
association between nationality (non-Kuwaiti) and length of taking any medication 
for high cholesterol attributed to sex (p 0.696), but there is a significance association 
(p 0.034) between nationality (Kuwaiti) and length of taking any medication for high 
cholesterol attributed to sex. 
3.5     Behavioral measures- lifestyle 
Smoking habits (Table 3.73) found that 62.5% of Kuwaiti males were smokers, while 
only 2.6% of Kuwaiti females were smokers. Among the non-Kuwaiti group, 39.1% 
of males were smokers, and 8.3% of females were smokers. We can see that the 
incidence is for men to smoke more than the women in both groups of patients. 
Table 3.73. Cross tabulation between nationality and sex and smoking: 
Nationality/Sex 
Have you ever smoked 
cigarettes? Total 
Yes No 
Kuwaiti 
Male n 15(62.5%) 9 (37.5%) 24 
Female n 1(2.6%) 37 (97.4%) 38 
Total n/% 16 (25.8%) 46 (74.2%) 62 (100%) 
Non-Kuwaiti 
Male n 9 (39.1%) 14 (60.9%) 23 
Female n 2 (8.3%) 22 (91.7%) 24 
Total n/% 11 (23.4%) 36 (76.6%) 47 (100%) 
 
 
There was a highly significant association between sex and smoking under 1% level 
of significance, since the p-values were 0.0000 male versus female. 
 
Smokers in the Kuwaiti group (n=16) all of the men (n=15) and one woman had 
smoked for 5 years or more, and for the males in non-Kuwaiti group 88.9% of them 
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had smoked for 5 years or more. One non-Kuwaiti female had smoked for 4 years, 
and one non-Kuwaiti female had smoked for 5 years or more (Table 3.74). 
 
Table 3.74. Cross tabulation between nationality, sex and length of practicing 
smoking: 
Nationality/ Sex 
If yes, when did you start smoking 
Total 
2 Years 4 Years 5 Years or more 
Kuwaiti 
Male n  0  0 15(100%) 15 
Female n  0  0 1 (100%) 1 
Total n/%  0   0 16 (100%) 16 
Non-Kuwaiti 
Male n 1 (11.1%) 0 8(88.9%) 9 
Female n 0 1(50%) 1(50%) 2 
Total n/% 1 (9.1%) 1 (9.1%) 9 (81.8%) 1(100%) 
 
Using the Chi-Square Test there was a significant association between sex and length 
of practicing smoking, since the p-values was 0.015. 
Alcohol intake 
Since only two Kuwaiti’s reported drinking alcohol and only three non- Kuwaiti 
reported that, it was only possible to carry out the analysis shown in Table 3.75. 
Table 3.75 . Relationship between nationality and sex and drinking alcohol: 
Nationality/ Sex 
Do you drink alcohol 
Total 
Yes No 
Kuwaiti 
Male n 2(8.3%) 22(91.7% 24 
Female n 0 38(100%) 38 
Total n 2 (3.2 %) 60 (96.8%) 62 (100%) 
Non-Kuwaiti 
Male n 2(8.7%) 21(91.3%) 23 
Female n 1(4.2%) 23(95.8%) 24 
Total n 3 (6.4%) 44 (93.6%) 47 (100%) 
 
Four patients (two Kuwaiti males and two non-Kuwaiti males) out of five who drink 
alcohol indicate that they have consumed it for 5 years or more, while the 5th patient 
(Non- Kuwaiti female) report that she had consumed it for one year. In addition, 
three of the patients (n= 5) who drink alcohol indicated that their normal beverage is 
beer only, while the others indicated that their normal beverage was beer, wine and 
spirit (see Table 3.76). 
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Table 3.76. Relationship between nationality, sex and length of drinking alcohol 
(years): in Non-Kuwaitis 
Nationality/ Sex 
If yes, how long have you taken 
it? Total 
1 Year 5 Years or more 
Kuwaiti 
Male n  0 2 2 
Total n  0  2 2 
Non-Kuwaiti 
Male n 0 2 2 
Female n 1 0 1 
Total n 1 2 3 
 
Additional tables: 
Table 3.77.Sex * Body weight at this time of first diagnosis (Kg) * what course of 
action was recommended when you were first diagnosed? Cross tabulation 
What course of action was 
recommended when you were 
first diagnosed? 
Body weight at this time of first diagnosis (Kg) 
Total 
50-59 60-69 70-79 80-89 90-99 100+ 
Tablets  
medication 
Male 
n 1 4 8 6 6 8 33 
% 3% 12% 24% 18% 18% 24% 100% 
Female 
n 4 6 13 8 13 6 50 
% 8.0% 12% 26.0% 16.0% 26.0% 12.0% 100% 
Total 
n 5 10 21 14 19 14 83 
% 6% 12% 25% 17% 23% 17% 100% 
Dietary  
change 
Male 
n 0 0 0 0 0 1 1 
% 0% 0% 0% 0% 0% 100% 100% 
Female 
n 0 1 0 1 2 0 4 
% 0% 25% 0% 25.0% 50.0% 0% 100% 
Total 
n 0 1 0 1 2 1 5 
% 0% 20% 0% 20% 40.0% 20.0% 100% 
Insulin 
Male 
n 0 2 4 1 0 0 7 
% 0% 29% 57% 14% 0% 0.0% 100% 
Female 
n 0 0 1 1 0 1 3 
% 0% 0% 33.3% 33.3% 0% 33.3% 100% 
Total 
n 0 2 5 2 0 1 10 
% 0% 20% 50% 20% 0% 10% 100% 
Tablet  
medication, 
dietary 
change & 
exercise 
Male 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
Total 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
Tablet  
medication 
& dietary 
change 
Male 
n 0 0 0 0 1 0 1 
% 0% 0% 0% 0% 100% 0% 100% 
Female 
n 0 0 1 1 1 0 3 
% 0% 0% 33.3% 33.3% 33.3% 0% 100% 
Total 
n 0 0 1 1 2 0 4 
% 0% 0% 25% 25% 50% 0% 100% 
Tablet  & 
exercise 
Male 
n 0 1 1 0 0 2 4 
% 0% 25% 25% 0% 0% 50% 100% 
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Female 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
Total 
n 0 1 2 0 0 2 5 
% 0% 20% 40% 0% 0% 40% 100% 
Dietary & 
exercise 
Female 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
Total 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
 
Table 3.78 . Sex * Body weight today (Kg) * what course of action was 
recommended when you were first diagnosed? Cross tabulation 
What course of action was 
recommended when you were 
first diagnosed? 
Body weight today (Kg) 
Total 
50-59 60-69 70-79 80-89 90-99 100+ 
Tablets  
medication 
Male 
n 0 6 8 7 5 7 33 
%  0% 18% 24% 21% 15% 21% 100% 
Female 
n 3 11 10 14 8 4 50 
%  6% 22% 20% 28% 16% 8% 100% 
Total 
n 3 17 18 21 13 11 83 
%  4% 21% 22% 25% 16% 13% 100% 
Dietary  
change 
Male 
n 0 0 0 1 0 0 1 
%  0% 0% 0% 100% 0% 0% 100% 
Female 
n 1 0 1 0 0 2 4 
%  25% 0% 25% 0% 0% 50% 100% 
Total 
n 1 0 1 1 0 2 5 
%  20% 0% 20% 20% 0% 40% 100% 
Insulin 
Male 
n 0 1 2 3 1 0 7 
%  0% 14% 29% 43% 14% 0% 100% 
Female 
n 0 0 2 0 0 1 3 
%  0% 0% 67% 0% 0% 33% 100% 
Total 
n 0 1 4 3 1 1 10 
%  0% 10% 40% 30% 10% 10% 100% 
Tablet  
medication 
dietary 
change 
&exercise 
Male 
n 0 0 0 1 0 0 1 
%  0% 0% 0% 100% 0% 0% 100% 
Total 
n 0 0 0 1 0 0 1 
%  0% 0% 0% 100% 0% 0% 100% 
Tablet  
medication 
&dietary 
change 
Male 
n 0 0 0 1 0 0 1 
%  0% 0% 0% 100% 0% 0% 100% 
Female 
n 0 0 0 2 1 0 3 
%  0% 0% 0% 67% 33% 0% 100% 
Total 
n 0 0 0 3 1 0 4 
%  0% 0% 0% 75% 25% 0% 100% 
Tablet  & 
exercise 
Male 
n 2 0 0 0 0 2 4 
%  50% 0% 0% 0% 0% 50% 100% 
Female 
n 0 0 1 0 0 0 1 
%  0% 0% 100% 0% 0% 0% 100% 
Total 
n 2 0 1 0 0 2 5 
%  40% 0% 20% 0% 0% 40% 100% 
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Dietary & 
exercise 
Female 
n 0 1 0 0 0 0 1 
%  0% 100% 0% 0% 0% 0% 100% 
Total 
n 0 1 0 0 0 0 1 
%  0% 100% 0% 0% 0% 0% 100% 
 
Referring to Table 3.77 above, proportion of males with 100 or above kg weight who 
took tablets medication was 24% (n=8), followed by 24% of males with (70 to 79) kg 
weight took the same medication. Regarding females, 26% (n=13) of them with (70 
to 79) kg weight took tablets medication, followed by 26% (n=13) of them with (90 
to 99) kg weight took the same medication. 
 
By cross-tabulating body weight today with sex regarding course of action was 
recommended at first diagnosed (Table 3.78), we observed that 24% of males (n=8) 
with (70 to 79) kg weight took tablets  medication, while 21% of them who were 100 
kg weight or above took that medication. It is clear from the second table that 28% of 
females (n=14) with (80-89) kg weight took the tablets medication followed by 22% 
of them who were between 60 to 69 kg weight took the same tablet. 
 
Table 3.79 .Original Age * Do you have high blood pressure * Current Age * 
Gender  
Gender 
Current 
Age 
Original Age 
Do you have high 
blood pressure Total 
Yes No 
Male 
30-34 
30-39 
n 1 0 1 
% 100% 0 100% 
Total 
n 1 0 1 
% 100% 0 100% 
35-39 
30-39 
n 0 1 1 
% 0 100% 100% 
Total 
n 0 1 1 
% 0 100% 100% 
40-44 
20-29 
n 0 2 2 
% 0.0% 100% 100% 
30-39 
n 2 3 5 
% 40.0% 60.0% 100% 
40-49 
n 0 1 1 
% 0.0% 100% 100% 
Total 
n 2 6 8 
% 25.0% 75.0% 100% 
45-49 
20-29 
n 2 0 2 
% 100% 0.0% 100% 
30-39 
n 2 3 5 
% 40.0% 60.0% 100% 
40-49 
n 3 1 4 
% 75.0% 25.0% 100% 
Total 
n 7 4 11 
% 63.6% 36.4% 100% 
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50-54 
30-39 
n 2 0 2 
% 100% 0.0% 100% 
40-49 
n 6 5 11 
% 50.0% 50.0% 100% 
50-59 
n 0 1 1 
% 0.0% 100% 100% 
Total 
n 8 6 14 
% 53.3% 46.7% 100% 
55-59 
20-29 
n 1 0 1 
% 100% 0 100% 
40-49 
n 2 0 2 
% 100% 0 100% 
Total 
n 3 0 3 
% 100% 0 100% 
60+ 
40-49 
n 3 1 4 
% 66.7% 33.3% 100% 
50-59 
n 2 0 2 
% 100% 0.0% 100% 
60+ 
n 1 3 4 
% 33.3% 66.7% 100% 
Total 
n 6 4 10 
% 62.5% 37.5% 100% 
 
Continuing:  
Sex 
Current 
Age 
Original Age 
Do you have high 
blood pressure Total 
Yes No 
Female 
35-39 
less than 
20 
n 0 1 1 
% 0.0% 100% 100% 
30-39 
n 2 2 4 
% 50.0% 50.0% 100% 
Total 
n 2 3 5 
% 40.0% 60.0% 100% 
40-44 
30-39 
n 2 2 4 
% 50.0% 50.0% 100% 
Total 
n 2 2 4 
% 50.0% 50.0% 100% 
45-49 
30-39 
n 1 0 1 
% 100% 0 100% 
40-49 
n 2 0 2 
% 100% 0 100% 
Total 
n 3 0 3 
% 100% 0 100% 
50-54 
20-29 
n 1 0 1 
% 100% 0.0% 100% 
30-39 
n 1 1 2 
% 50.0% 50.0% 100% 
40-49 
n 8 5 13 
% 61.5% 38.5% 100% 
50-59 
n 1 0 1 
% 100% 0.0% 100% 
Total 
n 11 6 17 
% 64.7% 35.3% 100% 
55-59 30-39 
n 2 0 2 
% 100% 0.0% 100% 
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40-49 
n 3 0 3 
% 100% 0.0% 100% 
50-59 
n 1 1 2 
% 50.0% 50.0% 100% 
Total 
n 6 1 7 
% 85.7% 14.3% 100% 
60+ 
30-39 
n 7 0 7 
% 100% 0.0% 100% 
n 
n 9 2 11 
% 81.8% 18.2% 100% 
50-59 
n 4 2 6 
% 66.7% 33.3% 100% 
60+ 
n 2 0 2 
% 100% 0.0% 100% 
Total 
n 22 4 26 
% 84.6% 15.4% 100% 
 
Among the group of males, 11 patients who were 40-49 years old at the time of 
original diabetes diagnosis shifted to the next age group 50-54 which indicated that 
they had suffered  diabetes for more than 10 years, and 50% of them (n=6) have high 
blood pressure. While among the group of females 13 patients who were 40-49 years 
old at the time of original diabetes diagnosis shifted to the next age group 50-54 
which indicated that the diabetes stay with them for more than 10 years, and 61.5% 
of them (n=8) have high blood pressure. T-test indicated that no significant 
differences in percentages attributed to gender when studying the changing in age 
and having a high blood pressure. 
3.6     Qualitative analysis of the full study. 
Now I will focus on the Closing Remarks and Comments section on the questionnaire 
given to patients. The question asked was, "Do you have any comments to make 
regarding your condition, so that it may be used in medical research?" 
Their results revealed detailed information regarding the trends of diabetes patients 
in Kuwait. The questionnaire provided room, albeit limited, for patients to make 
general spontaneous comments about their disease and treatment. Since the answers 
to this question were open, no distinct classification group(s) was made in the results 
table. All the answers were translated from the patients comments made in colloquial 
Kuwaiti /or non-Kuwaiti Arabic into English. The Tables 3.80 (Non Kuwaiti 
patients) & 3.81 (Kuwaiti patients) given below, show the classification areas in 
which the patients commented upon. I have also included some additional interesting 
comments, which I felt were relevant to the topic in which they are listed. 
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Thematic analysis Due to the diversity of the comments made for the purpose of 
this thesis and to form part of the qualitative analysis of real patient comments a 
number of themes was devised, which are shown in the tables shown, which were 
gathered from their comments. The themes are given in the heading for the different 
columns. 
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Patients comments 
Table 3.80. Non- Kuwaiti  patients 
P
a
ti
en
t 
N
o
 1 2 3 4 5 
 
6 
 
7 8 9 10 11 12 13 14 
1               
2               
3 No comments   
4               
5 No comments  
6 No comments 
7               
8               
9               
10               
11               
12 No comments 
13               
14               
15               
16               
17               
18               
19               
20               
21               
22               
23               
24               
25               
26               
27               
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28               
29               
30               
31 No comment 
32 No comment 
33               
34
A 
              
35               
36               
37               
38               
39               
40               
41 No comment 
42 No comment 
43 No comment 
44               
45
A 
              
46               
47               
 
Patients 34, 45 (34, 45A), they did not transfer to a dietitian. 
From this complex table two major areas of concern were found for non-Kuwaiti 
patients. 
1. Lack of empathy (Dr/Nurses, /education or skill – this was highlighted by 27 out 
of the 47 as being their major area of concern. 
2. Eyes Examination by fundus camera/appointment – this was highlighted in 18 out 
of the 47.
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Table 3.81.  Kuwaiti patients 
 P
a
ti
en
t 
N
o
 1 2  3 4 5 
 
6 
 
 
7 8 9 10 11  12  13 14 
1               
2               
3
A 
              
4               
5                
6
B
               
7
C 
              
8               
9
D
               
10               
11 No comment 
12               
13E               
14 No comment 
15               
16               
17 No comment 
18               
19               
20               
21               
22 No comment 
23F               
24 No comment 
25 No comment 
26               
27               
28               
29               
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30G               
31E               
32               
33               
34G No comment 
35               
36               
37               
38E               
39               
40               
41               
42               
43               
44               
45 No comment 
46G               
47               
48               
49E               
50               
51               
52E               
53               
54 No comment 
55               
56               
57               
58               
59H               
 119 
 
60               
61               
62               
 120 
 
Key for column headings 
1= HbA1c 2=eye examination 3=Blood 4=digestive 5=pain
 (S*stomach  B^ body) 6 = foot 
7=medication   8=lack of empathy 9=treatment 10 = patient knowledge 11 
renal problems 
12= procedure transfer patient to the hospital  13 = pharmacist input 14 = 
private physicians and KOC 
From this complex table two major areas of concern were found for non-Kuwaiti 
patients. 
1. Lack of empathy (Dr/Nurses, /education or skill – this was highlighted by 47 out 
of the 62 as being their major area of concern. 
2. Eyes Examination by fundus camera/appointment – this was highlighted in 28 out 
of the 62.  
For the sake of comprehensiveness and clarity the tables above could not include 
some of the data the patients provided. Consequently, the additional comments they 
made are marked with a letter next to each patient number in the table above. An 
explanation of each of these letters now follows.  
Patient number 3 (3A). commented upon the changes in relation to the diabetic 
physician. For example, in Ramadan there is only one physician for all the patients in 
the clinic.  
Patient number 6 (6B). commented upon the ketones in urine. When the colour of 
her urine changed and she didn't know if that was normal or dangerous. Gyms are 
very expensive in Kuwait. 
Patient number 7 (7C). commented upon the Physician prescribing hypolipidemic 
drugs medication for no reason. The other comment mentioned by this patient was 
that the physician prescribed medication which caused an allergy such as (Exforge)    
Patient number 9 (9D). mentioned a concern about inflammation in their gums 
patient and interestingly, patient 13 had the same problem. The patient took herbs 
(Costus) to treat diabetes and patient 56 took the same herb to treat his diabetes. The 
patient asked the physician to prescribe for him vitamin B complex and physician 
also prescribed hypolipidemic drug without a reason. 
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Patients number 13,31,38,49,52 (13,31,38,49,52E), they did not transfer to 
dietitian. 
Patient number 23(23F), His mother and father and uncles are all diabetic type 2 
and his cousins all are diabetic too. One of his cousins is diabetic and he got his foot 
cut and he had kidney failure and he was blind after that he died, his mother got blind 
specialist she always had an headache and she told the diabetic physician he only 
gave her Panadol then she went to an eye doctor and he told her she came late and 
she got blind. The eye specialist said if she had come earlier she would not been 
blind. 
Patients numbers: 30, 34, 46 (30, 34, 46G), suffered from hypertension before 
diabetes. 
Patient number 59(59H), in her big toe then it ‘falls off’ she went to the UK for 
treatment and she used morrha to treat the infections in her legs. The doctor in the 
UK suggested the morrha because it dries the wound and prevents gangrene. She has 
been using the morrha for 7 years. 
Table 3.80 shows that only 38 from 47 (80%) non Kuwaiti patients give their 
comments, whereas in Table 4.78 reveal that only 53 from 62 (83%) from the 
Kuwaiti patients gave their comments 
 According to patient comments, the major areas for concern are shown below in 
italics.  
 The first area for concern of 47 Kuwaiti patients and 27 non Kuwaiti was that 
the majority of the clinical workers did not have sufficiently developed skills 
or empathy. Doctors and Nurse were commonly accused of not providing 
sufficient attention to patient problems, 
 The second area for concern in 28 Kuwaiti patients and 18 non Kuwaiti was 
that the diabetic physicians in the diabetic clinics did not know how to check 
the eye with the fundus camera, and were not transferred to an 
ophthalmologist and was not checked by the diabetic physicians. In another 
patient he had bleeding in his eye and for this reason he went to private 
hospital. Another mentioned that he had a problem in his eyes and he could 
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not see and the diabetic physician prescribed for him an eye drop but did not 
refer him to an ophthalmologist. The patient himself was so concerned that 
he had not been told what the eye drops were for that he went to a private 
ophthalmologist and after diagnosis the ophthalmologist mentioned he had 
retinal problem due to diabetes.   
 The third area of concern for 20 Kuwaiti patients and 5 non-Kuwaiti diabetic 
patients was that the effectiveness of their treatment as they considered it was 
either inadequate in terms of meeting patient desires, or even inadequate in 
terms of healthcare standards and principles.  
 The fourth area for concern of 20 Kuwaiti and 3 non Kuwaiti diabetic 
patients was that the private hospitals physicians were stated to care more 
about the patients and for this reason some of them went to the MOH diabetic 
clinic just to takes their medication and then went to the KOC ( Kuwait Oil 
Company) clinic  or private hospitals to check with a diabetic physician  due 
to the carelessness from the physician in the MOH clinic. One patient who 
had heart problems and another patient who had eye bleeding were 
diagnosed by the private hospitals, not the MOH diabetic clinic or hospital. 
In fact, one patient mentioned that the private hospitals were bad because 
they prescribed medications according the requirement of the patients, but 
the private hospital physicians are much better than the ones in the Ministry 
of Health because they listen to the patients’ problems. 
 The fifth area of concern of 11 Kuwaiti and 8 non Kuwaiti patients mentioned 
that the diabetic physicians just give the patients medications without telling 
them the reasons for it. For example one non Kuwaiti mentioned she did not 
know that she had a high cholesterol until the pharmacist mentioned to her 
the use of the drug she had been prescribed. Others Kuwaiti and non-Kuwaiti   
patients mentioned that diabetic physicians repeat the same medication even 
if it wasn’t good for the patient. In one non Kuwaiti patient lisinopril caused 
both breathing difficulties and cough and when she spoke with her physician 
about this side effect he told her there is alternative medicine but it is only 
prescribed for Kuwaiti patients. Another patient mentioned she is very weak 
and the diabetic physician prescribed for her vitamin D, without even 
checking if she had a deficiency or not. She said there is no care from the 
physician about the patients’ health medication may even be unsuitable for 
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administration such as the medications which they got from a company in the 
Emirates. Another example one Kuwaiti patient mentioned that the KOC 
clinic prescribed (Exforge) and blood pressure medication caused an allergy 
to him. In some patients they commented that even when medications were 
prescribed the choice was very limited and in some cases did not actually 
work because that is all that was available. 
 The sixth area for concern of 11 Kuwaiti and 5 non Kuwaiti patients that the 
diabetic physicians did not measure the levels of HbA1C, the HbA1C is not 
done without the requirement of the patient and only some of Kuwait and 
non-Kuwaiti patients mentioned that the last time a blood test to check the 
HbA1c was done some time ago. Also 13 Kuwaiti and 8 non Kuwaiti 
mentioned for the question about ‘blood analysis’  that no blood analysis was 
done. One of them mentioned that the last blood analysis had been done was 
more than 5 years ago  to check if there was any diabetic complications  
  The seventh area of concern of 5 Kuwaiti and 10 non Kuwaiti patients severe 
from either pain in there stomach and ‘toughness’ digesting the food  or 
constipation . 
  The eighth area of concern of 3 Kuwaiti and 2 non Kuwaiti was that one 
Kuwaiti mentioned that the nephrologist didn’t mention for him that he had 
kidney failure the nephrologists mentioned for him that both his kidneys work 
50% he didn’t feel well and travelled to Jordan and they mentioned for him 
he had kidney failure. Another Kuwaiti patient mentioned that she feel 
drowsiness and the diabetic physician didn’t know what was wrong with her 
she went to the hospital and they told her she had kidney disease. A third 
patient mentioned that he has a small stone in his kidney. Another non 
Kuwaiti mentioned that his blood pressure was not stable and he went to the 
diabetic physician and he didn't know the reason. After that he went to the 
hospital they made some blood tests and they told him he had problems in the 
kidney. The patient was surprised that the diabetic physician didn’t send him 
to a kidney specialist, before he checked his file and he told him he had 
protein in the kidney and the patient didn’t know if that was dangerous or 
not.  
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There are various concerns with a few patients. These will be discussed 
separately for Kuwaiti and Non Kuwaiti patients below. 
 
For non-Kuwaiti Patients 
 One patient mentioned she has severe body pain and she is always ‘in stress’. 
For Kuwaiti Patients 
  One patient mentioned that the reason for cutting her foot is because of 
the carelessness of the diabetic doctor -she felt burning and numbness in 
the foot but the doctor did not check her foot and she did not know the 
reasons and she always goes to the doctor and he continues writing the 
a medication only with no checkups. In Kuwait they were going to cut off 
the whole leg so she went to Thailand and got treated and they said that 
there is no need to cut off the whole leg. 
The area related to diabetic patient knowledge was that only 7 Kuwaiti 
patients give comments about their Knowledge as to how they treat their 
disease. One lady mentioned that she took medicines without asking her 
physician, such as pain killers for headache and foot pain example (Ponstan, 
Norgesic). Sometimes she does not take care of her food ‘routine’ as she 
eats everything even dessert, Secondly, she  mentioned  she checked her 
blood glucose every day only when she felt unwell. Another patient 
mentioned took some   herbs, Costus, barley for their disease 
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Summary of the key findings: 
1. The BMI values ± S.D. were calculated and compared for the Kuwaiti group, 
using the paired Student’s t test, they were 33.3 kg/m2± 6.7 kg/m2 at first diagnosis 
and at the time of the study were 31.6 kg/m
2
± 5.6. The highly significant difference 
which was found (p<0.01) provides strong evidence against the null hypothesis. For 
the other group (i.e. Non- Kuwaiti) the BMI values were not significant different 
(p>0.05), 31.1 kg/m
2
± 5.2 kg/m
2
 at first diagnosis and at the time of the study were 
30.3 kg/m
2
± 5.1.   
 
2. The majority of patients received for their first line treatment ‘tablet medication’. 
In contrast, 14.9% of the male respondents received insulin as their first line 
treatment and 8.5% tablets and exercise, respectively. Whereas, for females, 4.8% 
received insulin and 1.6% tablets and exercise. Most interestingly 19.7% of the 
respondents (i.e. 14.9% male and 4.8% female), their first recommendation was to 
use insulin. 
 
3. On analysis there was no association between nationality and controlling diabetes 
using insulin according to sex, since p-values were 0.245 and 0.871 for Kuwaiti and 
Non-Kuwaiti respectively. 
4. On analysis, 55.3% of Kuwaiti females had never had their blood sugar level 
measured in the past month, while for male Kuwaitis it was 45.8%. For non-Kuwaiti 
females, 54.2% and 56.5% of the males had never had their blood sugar level 
examined in the past month. 
5. Using the Chi-Square Test we can conclude that there is no association between 
nationalities and number of times of blood examination for blood sugar level in the 
past month, attributed to sex, since the p-values were 0.814 and 0.678. 
 
6. The feet of only 13.2% of Kuwaiti females and 8.3% of males were examined by a 
primary care doctor. Among non-Kuwaitis 13.0% of males and 0% of females had 
had their feet examined. 
 
7. Patients did not know the number of calories that they should consume on a daily 
basis to maintain a healthy and optimal body weight as only 4.2% and 2.6% of 
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Kuwaiti males and females had been placed on a weight management program from 
a hospital dietitian. For non-Kuwaiti males and females 0% were on weight 
management program from a hospital dietitian. 
  
8. 37.5% and 28.9% of Kuwaiti males and females undertook walking for 10-30 
minutes every day, while 43.5% and 25% of non-Kuwaiti males and females were 
walking for 10-30 minutes every day. In addition, 37.5% and 39.5% of Kuwaiti 
males and females were walking twice or 3 times a week for 10-30 minutes, while 
39.1% and 45.8% of non-Kuwaiti males and females were walking twice or 3 times a 
week for 10-30 minutes.  The Chi-Square Test found no association between 
nationalities and types of exercise followed by the study members attributed to sex, 
since the p-values were 0.631 and 0.382. 
 
9. An awareness value when calculated as follows: If a patient was aware of 5 or 
more of the complications this indicates a "high awareness", 3 to 4 complications 
meant the patient had a "medium awareness" and 2 or less they had a "low 
awareness” found that only 8.3% of Kuwaiti males had a high awareness of diabetes 
complications, 50.0% of Kuwaiti females a medium awareness. For non-Kuwaitis 
only 4.3% of the males had a high awareness, and 41.7% of non-Kuwaiti females 
had a medium awareness. Using the Chi-Square Test there was no association 
between nationality and awareness of diabetes complications attributed to sex among 
the two groups (Kuwaiti and non-Kuwaiti) since p-values were 0.184 and 0.567 
respectively 
 
10. The percentage of patients knowing they had kidney problems for the  Kuwaiti 
group was 12.5% and 13.2% of males and females whereas for the non-Kuwaitis it 
was  21.7% and 16.7% for males and females respectively.  Using the Chi-Square 
Test the result indicated that there is no association between nationality and knowing 
having kidney problem attributed to sex; since p-values were 0.721 and 0.904. 
 
11.  Only three Kuwaiti patients, one male two female and only one non-Kuwaiti 
patient reported that they require dialysis.   
 
 12. Only 2 Kuwaitis had received a kidney transplant, one male and one female.        
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13. 50% of Kuwaiti males and 60.9% of non-Kuwaiti males had hypertension, while 
81.6% of Kuwaiti females and 62.5% of non-Kuwaiti females had hypertension.  
 
14. No association between nationality and having hypertension attributed to sex 
since p-values were  0.490 and 0.260.  
 
15. Within the study patient groups who had hypertension, 99% of these patients 
reported that they were taking medication due to hypertension and a further one 
although hypertensive was not taking any medication. 
 
16. 66.7% of Kuwaiti males 71.1% of Kuwaiti females had their retinas examined. 
For non-Kuwaitis the figures were: 56.5% of the males and 41.7% of the females.  
 The Chi-Square Test indicated there was no association between nationality and 
examination of the retina attributed to sex since p-values were 0.715 and 0.308. 
 
17. 31.2% of Kuwaiti males indicated that the physician who conducted their eye 
examination was a primary care doctor, while 68.8% indicated that their eye had 
been examined by an eye specialist. 46.2% of non-Kuwaiti males indicate that 
physician who conducted the eye examination was a primary care doctor , while 
53.8% indicated an eye specialist. Moreover, 48.1% of Kuwaiti females and 50% 
non-Kuwaiti females respectively indicated that their eye examination was by a 
primary care doctor. The Chi-Square Test the results indicated no significant 
association between nationality and type of specialist who conducted the eye 
examination attributed to sex under 5% level of significance, since the p-values were 
0.278 and 0.855.  
 
18.  The results indicate that diabetes blurred vision is a problem in 88.7% of 
Kuwaiti patients and 87.2% of the Non- Kuwaiti patients. 
 
19. The results indicate that decreased in clarity of vision is a problem in 88.7% of 
Kuwaiti patients and 80.9% of the Non- Kuwaiti patients. The Chi-Square Test, 
found no significant association between nationality and diagnosed with a decreased 
in clarity of vision attributed to sex since the p-values were 0.288 and 0.764.  
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20.  There was no significant association between nationality (Kuwaiti) and having a 
foot problem attributed to sex since p-value was 0.841, but there is a highly 
significance association between nationality (non-Kuwaiti) and having foot problem 
attributed to sex under 5% level of significance; since p-value is 0.004.  
 
21. 35.5% of the sample who had cardiac problems were Kuwaiti, compared with 
21.3% were non-Kuwaiti. The number of  Kuwaiti patients who had cardiac 
problems was seven  males and 15 females. 
 
22. There was no significant association between nationality and heart problems 
attributed to sex under 5% level of significance, since the p-value were 0.409 and 
0.940. 
 
23. 62.5% of Kuwaiti males were smokers, while only 2.6% of Kuwaiti females were 
smokers. Among the non-Kuwaiti group, 39.1% of males were smokers, while only 
8.3% of females were smokers. So men smoke more than the women in both groups. 
 
24 Only two Kuwaiti’s reported drinking alcohol and only three non- Kuwaiti 
reported that. 
 
25. From the open question - the major area for concern of 47 Kuwaiti patients and 
27 non Kuwaiti was that the majority of the clinical workers did not have sufficiently 
developed skills or empathy. Doctors and Nurse were commonly accused of not 
providing sufficient attention to patient problems. 
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Chapter 4 
4. Results from 79 diabetic patients in Kuwait with kidney disease. 
 
This chapter use as a marker in term of poor quality of care of diabetes in Kuwait 
which causes severe complication such as kidney disease and that could have been 
avoided through managing patient’s condition better.  
 
Throughout the world renal complications as a result of diabetes is well 
documented. The exact reasons for this progression are somewhat debatable. The 
study of Ueda et al., (2003), suggested that insulin therapy, serum albumin, mean 
blood pressure and haemoglobin were independent predictors of renal failure.  
However a more recent by Hall (2006) has other suggestions: 
 
“The fact that most types 1 and 2 diabetics do not develop diabetic nephropathy 
(DN) suggests that other factors may be involved. Genetic factors clearly play a role 
in the predisposition to diabetic nephropathy in family members who have DN, and 
linkage to specific areas on the human genome is evolving. The theory of a reduction 
in nephron number at birth indicates that individuals born with a reduced number of 
glomeruli may be predisposed to subsequent renal injury and progressive 
nephropathy. This has been shown in animal studies in which the mother was 
exposed to hyperglycemia at the time of pregnancy. If this linkage is true in humans, 
that would have important implications concerning the role of maternal factors in the 
eventual development of kidney disease”. 
Some of these factors are considered in the study below.
 
4.1    General information from the questionnaire.  
Table 4.1. Demographics of the patients, Kuwaiti and non-Kuwaiti taking part 
in the study. 
Demographic Categories  n Percent 
Nationality 
Kuwaiti 55 70% 
Non-Kuwaiti 24 30% 
 Total 79 100% 
Sex 
Male 41 52% 
Female 38 48% 
 Total 79 100% 
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Nationality/Sex  
Kuwaiti/Male 27 49% 
Kuwaiti/Female 28 51% 
Total 55 100% 
Non-Kuwaiti/Male 14 58% 
Non-Kuwaiti/Female 10 42% 
 Total 24 100% 
Current Age 
30-34 Years 1 1% 
35-39 Years 4 5% 
40-44 Years 5 6% 
45-49 Years 8 10% 
50-54 Years 17 22% 
55-59 Years 6 8% 
60+ Years 38 48% 
 Total 79 100% 
Age at original diabetes 
diagnosis 
Less than 20 Years 3 4% 
20-24 Years 12 15% 
25-29 Years 12 15% 
30-34 Years 15 19% 
35-39 Years 8 10% 
40-44 Years 10 13% 
45-49 Years 4 5% 
50-54 Years 5 6% 
55-59 Years 6 8% 
60+ Years 4 5% 
 Total 79 100% 
Height 
150-159 cm 18 23% 
160-169 cm 34 43% 
170-179 cm 20 25% 
180+ cm 7 9% 
 Total 79 100% 
  
 
Table 4.2 shows that the mean (±SD) current weight was 86.2 ±17.8kg, , while the 
mean(±SD) of weight at first diagnosis was 85.4 kg ±20.7 kg. We can conclude that 
the body weight at first diagnosis was less than the current weight, with a SD and 
range of weights at first diagnosis greater than their current values. 
 
Table 4.2 .Measurements of location and dispersion for height, weight, and BMI 
for study sample: 
 
Variables 
Measurements 
Mean ± SD Range 
Height (cm) 166.3 9.0 40 
Weight (current in Kg) 86.2 17.8 102 
Weight (first diagnosis in Kg) 85.4 20.7 115 
BMI (current in Kg/h
2
) 31.2 6.5 36.2 
BMI (First Diagnosis in Kg/h
2
) 30.8 7.0 39.7 
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Age distribution.  
 
Figure 4.1. Current patient age distribution of the patients in this study. 
Duration of diabetes and its treatment in the respondents  
To enable a careful study of this data, the age at which they were formally diagnosed 
was placed into a series of five-year periods; the results are shown in Figure 4.2. The 
mode of 19% was found between 30-34 years. The median age being in the range 30-
34 years indicates that 50% had been diagnosed before the age of 35 years.  
 
Figure 4.2.  The distribution of the age ranges at which type 2 diabetes had first 
been diagnosed in the patients of the study group. 
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The data when expressed in tabular form, Table 4.3, shows that the majority of the 
patients who volunteered for the study were ‘established’ diabetics.  The Kuwaiti 
patients had suffered the disease for a mean duration of 21 years and 18 years for 
non-Kuwaitis. When the ages were statistically compared using Student’s t test, there 
was no significant difference in terms of age of onset between Kuwaitis and non-
Kuwaitis (p-values were 0.392 and 0.082 respectively) (Table 4.3).  
 
Table 4.3 .Mean (± S.D.) of the patients current age (years) and their age at the 
time of original diabetes diagnosis for both Kuwaitis and non-Kuwaitis. 
Nationality 
Current Age 
(years) 
Age at the time of original diabetes 
diagnosis (years) 
Kuwaiti (n=55) Mean ± S.D. 55.84 ± 11.23                    34.22 ± 12.4 
Non-Kuwaiti 
(n=24) 
Mean± S.D. 58.13 ± 9.98                    39.54 ± 12.18 
 
When the data for age of their original diagnosis and their current age according to 
the gender of the patients is plotted in a histogram the results are as shown in Figure 
4.3.  
 
Figure 4.3. The current age of the patients in their gender groups as compared 
with their age at their first formal diagnosis.  
 
Measurements of location and dispersion for height, weight, and BMI for study 
sample. 
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Height - A bar chart of body heights (cm) versus its distribution for the patients in 
the study group is shown in Figure 44. The mode was found to be 160-169 cm (i.e. 
5.2 feet – 5.5 feet) 
 
Figure 4.4. Height (cm) distribution of all the patients in the study. 
 
Body weight 
At their first diagnosis, the mean patient body weight was 85.4 kg (S.D. ± 20.7 kg) 
and at the time of the study, it was 86.2 kg (S.D. ± 17.4 kg) (Figure 4.5). Using a 
paired Students t test, there was no a statistical difference (p >0.05) between their 
original weight as compared to that at the time of the study.  
 
 
Figure 4.5.  Bar chart of the mean values for the current body weight of patients 
[kg] (vertical axis) in the study as compared with their body weight at their first 
diagnosis. 
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Analysis of data distribution.  
At this stage of the analysis it was appropriate to verify the type of distribution of 
data the questionnaires had generated and so a test for normality of data was carried 
out. 
 
Tests of distribution normality of the data for the body weight of patients in this 
study. 
Table 4.4 shows the results of the Kolmogorov-Smirnov and Shapiro-Wilk test 
statistics using SPSS for both variables-body weight at the time of the survey and 
body weight at first diagnosis. The results showed that the data were normally 
distributed, as their distribution was not significantly different (p > 0.05).  Therefore, 
we can conclude that the data follows a normal distribution, and this validates the use 
of Student’s paired t- test for these two variables in the previous and later tests. 
Table 4.4 .Tests of normality of the data obtained for body weight according to 
nationality. 
 
Variables  Nationality 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic df p Statistic df p 
Body weight today 
Kuwaiti 0.086 55 0.200 0.945 55 0.014 
Non-Kuwaiti 0.120 24 0.200 0.986 24 0.977 
Body weight at the time of 
first diagnosis 
Kuwaiti 0.111 55 0.090 0.957 55 0.047 
Non- 
Kuwaiti 
0.099 24 0.200 0.976 24 0.822 
 
 
Table 4.5. Paired Samples Correlations. 
Paired Samples Correlations 
 n R p 
Kuwaiti 
Body weight (kg) at the time of the study and 
body weight (kg) at this time of first diagnosis. 
55 0.53 0.000 
Non-Kuwaiti 
Body weight (kg) at the time of the study and 
body weight (kg) at this time of first diagnosis. 
24 0.333 0.112 
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Table 4.6.Paired Samples Test 
 
 
Paired Differences 
t d.f. p. 
Mean S.D. S.E. 
Kuwaiti       
Body weight (kg) at the time of the study - 
body weight(kg) at time of first diagnosis  
3.2 18.8 2.54 1.26 54 0.212 
Non-Kuwaiti       
Body weight (kg) at the time of the study - 
body weight(kg) at time of first diagnosis 
-4.8 20.7 4.23 -1.12 23 0.273 
 
Within the Kuwaiti group, there was a degree of correlation between the current 
body weight and body weight at the time of first diagnosis (r= 0.53 and p value = 
0.000). Consequently, we can state that there has been a significant weight loss 
between the two time periods. In addition from Tables 4 .5 and 4.6 there is no a 
significant difference between these two variables, since the p-value is 0.212. Among 
the non-Kuwaiti Sample, there is a poor correlation between the pairs of data of body 
weight at the time of the study and body weight at the time of first diagnosis (r= 0.33 
with a p-value = 0.112). In addition, from Table 4.6 there is no significant difference 
between these two variables, since the p-value is 0.273, therefore, we can conclude 
that there is no statistically difference between the two means. 
 
Body Mass Index (BMI). 
The BMI values were calculated and compared using Student’s t test. For the 
Kuwaiti group, it was 29.9 kg/m
2
 (S.D. ± 7.1 kg/m
2
) at first diagnosis and at the time 
of the study it was 31.1 kg/m
2 
(S.D. ± 7.0 kg/m
2
). We have no evidence against the 
null hypothesis, therefore, so no significant difference was found (p>0.05). For the 
non-Kuwaiti group, the BMI values were 33.0 kg/m
2
 (S.D. ± 6.1 kg/m
2
) at first 
diagnosis and at the time of the study were 31.5 kg/m
2 
(S.D. ± 5.2 kg/m
2
). Although 
the first value in the table appears to be greater than the second, due to the numerical 
range no statistical significant difference was found (p>0.05). This use of BMI 
instead of body weight perhaps was therefore not a useful comparison to make. 
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Table 4.7.  Mean (S.D.) of the BMI values at first diagnosis and after diagnosis 
of type 2 diabetes according to nationality (Kuwaiti & non-Kuwaiti).           
Nationality BMI-today BMI-first 
diagnosis 
Kuwaiti (n=55) 
Mean ± S.D. 31.1±7.0 29.9±7.1 
 
Non-Kuwaiti (n=24) 
Mean ± S.D. 31.5±5.2 33.0± 6.1 
 
 
BMI and Gender. 
When the BMI of the type 2 diabetes study patients was calculated for both males 
and females, both Kuwaiti and non-Kuwaiti the data is shown in Figure 4.6 the data 
being plotted in the form of a bar chart. 
 
 
Figure 4.6. Mean Body Mass Index of male and female patients, Kuwaiti and 
non-Kuwaiti who took part in the study. Before= first diagnosis, today= the 
present value. 
Table 4.8. The distribution of the current BMI of the patients who took part in 
the study.  
Category (BMI range kg/m
2
) Frequency Percent 
Normal (20.0-24.99) 10 12.7% 
Overweight (25.0-29.99) 30 38.0% 
Moderately obese (30.0-34.99) 22 27.8% 
Severely obese (above 35.0) 17 21.5% 
Total 79 100% 
 
From Table 4.8 the mode (38% of the patients) were overweight as their current BMI 
was between 25.0 - 29.99, followed by 27.8% of them who were moderately obese 
(i.e. the current BMI was between 30.0-34.99). Expressed as a pie chart the data is as 
shown in Figure 4.7. 
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Figure 4.7. The distribution of the current BMI of the patients who took 
part in the study 
Table 4.9 .The distribution of the prior BMI of the patients who took part 
in the study.  
Category  Frequency Percent 
Below Normal (<20) 1 1.3% 
Normal (20.0-24.99) 16 20.3% 
Over weight (25.0-29.99) 23 29.1% 
Moderately obese (30.0-34.99) 15 19.0% 
Severely obese (above 35.0) 24 30.4% 
Total 79 100% 
 
From Table 4.9 30% of the patients were severely obese as the prior BMI was above 
35.0, followed by 29.1% who were overweight as their prior BMI was between 25.0-
29.99. Expressed as a pie chart the data is shown in Figure 4.8. 
 
 
Figure 4.8. The distribution of the prior patient BMI in this study.  
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Table 4.10. Cross tabulation between current patient BMI and Nationality. 
Nationality 
Current BMI  
Total 
Normal  
Over  
 Weight 
Moderate 
Obese 
Severe Obese 
Kuwaiti n 7 (12.7%) 23 (41.8%) 14 (25.5%) 11 (20%) 55 
Non-Kuwaiti n 3 (12.5%) 7 (29.2%) 8 (33.3%) 6 (25%) 24 
Total 
n 
% 
10 (12.7%) 30 (38%) 22 (27.8%) 17 (21.5%) 79 (100%) 
 
From Table 4.10 the percentage of Kuwaiti patients who were overweight was 
greater than that for Non-Kuwaiti (41.8% versus 29.2%), while the percentage of 
Non-Kuwaiti patients who were moderately obese was greater than that for Kuwaiti 
(33.3% versus 25.5%). Expressed as a bar chart the same data is shown in Figure 4.9. 
 
Figure 4.9. The Percentage distribution of current BMI of the patients 
according to body weight. 
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Figure 4.10. The Percentage distribution of Prior BMI of the patients 
according to nationality. 
Figure 4.9 and 4.10 show that the percentage of Kuwaiti patients who were normal 
weight was so much greater than that for Non-Kuwaiti (25.5% versus 8.3%), while 
the percentage of Non-Kuwaiti patients who were severely obese was greater than 
that for Kuwaiti (41.7% versus 25.5%). 
4.2    Medications used for the treatment of type 2 diabetes 
Table 4.11. Cross tabulation between Nationality and controlling diabetes with 
tablets according to sex 
Nationality/ Sex 
Were you ever able to control 
your diabetes with tablets 
medication Total 
Yes No 
Kuwaiti 
Male n 19 (70.4%) 8 (29.6%) 27 
Female n 19 (67.9%) 9 (32.1%) 28 
Total n (%) 38 (69.1%) 17 (30.9%) 55 (100%) 
Non Kuwaiti 
Male n 14 (100%) 0 14 
Female n 10 (100%) 0 10 
Total n (%) 24 (100%) 0 24 (100%) 
Total 
Male n 33 (80.5%) 8 (19.5%) 41 
Female n 29(76.3%) 9 (23.7%) 38 
Total n (%) 62 (78.5%) 17 (21.5%) 79 (100%) 
 
Within the Kuwaiti group, 70.4% of males (n=19) and 67.9% females (n=19) were 
able to control their diabetes with tablets medication (Table 4.11). For the Non-
Kuwaiti group, 100% of males (n= 14) and 100% females (n= 10) were able to 
control their diabetes with tablets medication. The percentage of Kuwaiti patient who 
were able to control their diabetes with tablets medication was less than that for Non-
Kuwaiti (69.1% and 100%) respectively. 
Table 4.12. Cross tabulation between Nationality and the name(s) of tablet 
medication that the patients took 
 
Nationality 
Total 
Kuwaiti 
Non  
Kuwaiti 
If yes 
please 
specify the 
name(s) of 
tablet 
Glibenclamide  n 1 (33.3%) 2 (66.7%) 3 
Gliclazide n 1 (100%) 0 1 
Glimepiride & 
Glibenclamide 
n 0 1 (100%) 1 
Metformin n 15 (53.6%) 13 (46.4%) 28 
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medication 
you took 
Metformin & Glibenclamide n 1 (100%) 0 1 
Metformin & Gliclazide n 2 (40%) 3 (60%) 5 
Metformin & Sitagliptin n 2 (100%) 0 2 
Don’t know n 16 (76.2%) 5 (23.8%) 21 
Total n(%) 
38 
(61.3%) 
24 (38.7%) 
62 
(100
%) 
 
The medications taken by Kuwaiti and non-Kuwait diabetics who attended the 
clinics were variable (Table 4.12). The commonest individual drug for both groups 
was metformin Kuwaiti (n=15) and non-Kuwaiti (n=13). Glibenclamide was used 
alone by Kuwaitis and non-Kuwaitis, one Kuwaiti used glibenclamide in 
combination with metformin (n=1), and one non-Kuwaiti used glibenclamide in 
combination with glimepiride (n=1).  
Table 4.13. Cross tabulation between nationality, sex, and the name(s) of 
tablet medication that the patients took 
 
If yes please specify the name(s) of tablet 
medication you took 
Nationality 
Total 
Kuwaiti Non Kuwaiti 
Male 
Glibenclamide n 1 (33.3%) 2 (66.7%) 3 
Gliclazide n 1 (100%) 0 1 
Glimepiride  & 
Glibenclamide 
n 0 1 (100%) 1 
Metformin n 9 (56.3%) 7 (43.8%) 16 
Metformin & 
Glibenclamide 
n 1 (100%) 0 1 
Metformin & 
Gliclazide 
n 1 (33.3%) 2 (66.7%) 3 
Don’t know n 6 (75%) 2 (25%) 8 
Total n (%) 19 (57.6%) 14 (42.4%) 
33 
(100
%) 
Female 
Metformin n 6 (50%) 6 (50%) 12 
Metformin & 
Gliclazide 
n 1 (50%) 1 (50%) 2 
Metformin & 
Sitagliptin 
n 2 (100%) 0 2 
Don’t know n 10 (76.9%) 3 (23.1%) 
13 
(100%
) 
Total n (%) 19 (65.5%) 10 (34.5%) 
29 
(100
%) 
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We can see from Table 4.13, the percentage of non-Kuwaiti males who were 
currently taking Gliclazide and metformin was greater than that for Kuwaiti males 
(66.7% and 33.3% respectively). When this data was compared using Pearson Chi-
Square Test there was no association between sex and the types of medications taken 
currently according to nationality, p-values are 0.421 and 0.280 for male and female 
respectively 
Table 4.14. Cross tabulation between nationality and sex and length of time 
(days) using tablets medication. 
How many years did you take it?  
Sex 
Total 
Male Female 
Kuwaiti 
less than 1 year n 1 (50%) 1 (50%) 2 
1-3 years n 1 (50%) 1 (50%) 2 
3-5 years n 1 (100%) 0 1 
More than 5 years n 16 (48.5%) 17 (51.5%) 33 
Total n (%) 19 (50%) 19 (50%) 38 (100%) 
Non-
Kuwaiti 
1-3 years n 1 (100%) 0 1 
3-5 years n 2 (100%) 0 2 
More than 5 years n 11 (52.4%) 10 (47.6%) 21 
Total n 14 (58.3%) 10 (41.7%) 24 (100%) 
 
 
The majority of Kuwaiti males and females reported that they stopped taking tablet 
medication for their diabetes (89% and 83%) respectively, while within Non- 
Kuwaiti patients it is clear that 93% of males and 80 % of females indicated that they 
do not take the medicine now (Table 4.15). 
 
Table 4.15.Cross tabulation between sex and currently taking tablet medication 
for the diabetes according to nationality.  
Nationality/ Sex 
Are you still taking tablet 
medication for your diabetes? Total 
Yes No 
Kuwaiti 
Male n 2 (10.5%) 17 (89.5%) 19 
Female n 3 (16.7%) 16 (83.3%) 19 
Total n (%) 5 (13.5%) 33 (86.5%) 38 
Non- 
Kuwaiti 
Male n 1 (7.1%) 13 (92.9%) 14 
Female n 2 (20%) 8 (80%) 10 
Total n (%) 3 (12.5%) 21 (87.5%) 24 (100%) 
Total 
Male n 3 (9.1%) 30 (90.9%) 33 
Female n 5 (17.9%) 24 (82.1%) 29 
Total n (%) 8 (13.1%) 54 (86.9%) 62 (100%) 
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Insulin usage in type 2 diabetes 
Although patients had taken oral medications for their type 2 diabetes in the past a 
large number were now receiving insulin as their primary treatment for their disease. 
In some cases they stopped both oral and insulin medications during renal dialysis. 
The data is shown below and for both sexes, Kuwaiti and non-Kuwaitis tended to use 
insulin for different length of times. 
 
Table 4.16. Cross tabulation between nationality, sex, and controlling diabetes-
using insulin. 
Nationality/Sex 
Have you ever used insulin to 
control your diabetes? Total 
Yes No 
Kuwaiti 
Male n 25 (92.6%) 2 (7.4%) 27 
Female n 25 (89.3%) 3 (10.7%) 28 
            
Total 
n (%) 50 (90.9%) 5 (9.1%) 55 (100%) 
Non-Kuwaiti 
Male n 12 (85.7%) 2 (14.3%) 14 
Female n 8 (80%) 2 (20%) 10 
            
Total 
n (%) 20 (83.3%) 4 (16.7%) 24 (100%) 
Total 
Male n 37 (90.2%) 4 (9.8%) 41 
Female n 33 (86.8%) 5 (13.2%) 38 
Total n (%) 70 (88.6%) 9 (11.4%) 79 (100%) 
 
From Table 4.16, the percentage of non-Kuwaiti females who were controlling 
diabetes using insulin is less than the percentage of Kuwaiti females using insulin 
(80% versus 89.3%). For males, 92.6% of the Kuwaiti males and 85.7% of non-
Kuwaiti males were controlling their diabetes using insulin. On analysis the Chi-
Square Test found no association between nationality and controlling diabetes using 
insulin according to sex, since the p-values are 0.245 and 0.871 for Kuwaiti and 
Non-Kuwaiti respectively. 
Using insulin to control your diabetes.  
Table 4.17. Cross tabulation between nationality and controlling diabetes-using 
insulin. 
Nationality 
Have you ever used insulin to 
control your diabetes? Total 
Yes No 
Kuwaiti n 50 (90.9%) 5 (9.1%) 55 
Non-Kuwaiti n 20 (83.3%) 4 (16.7%) 24 
Total n (%) 70 (88.6%) 9 (11.4%) 79 (100%) 
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We can conclude that from Table 6.17 the percentage of Kuwaitis who have used 
insulin to control diabetes is greater than that for Non-Kuwaiti (90.9.8% versus 
83.3%).  
 
Table 4.18. Cross tabulation between sex and controlling diabetes using insulin 
Sex 
Have you ever used insulin to 
control your diabetes? Total 
Yes No 
Male n 37(90.2%) 4(9.8%) 41 
Female n 33(86.8%) 5(13.2%) 38 
Total n (%) 70 (88.6%) 9 (11.4%) 79 (100%) 
 
Table 4.18 shows that the percentage of males who were controlling diabetes-using 
Insulin is greater than that for females (90.2%, 86.8%).  When this data was 
compared using Pearson Chi-Square test the p value was 0.643, indicating no 
significant correlation  between sex and controlling diabetes-using insulin .  
 
Table  4.19. Cross tabulation between Nationality and Sex and length of time 
(days) using Insulin 
Nationality/ length of time using Insulin 
Sex 
Total 
Male Female 
Kuwaiti 
If yes, 
please 
write the 
length of 
time you 
took 
Insulin 
< one year n (%) 1 (50%) 1 (50%) 2 (100%) 
One year n (%) 0 1 (100%) 1 (100%) 
2-3 years n (%) 1 (25%) 3 (75%) 4 (100%) 
4-7 years n (%) 6 (54.5%) 5 (45.5%) 11 (100%) 
8-10 years n (%) 4 (50%) 4 (50%) 8 (100%) 
11-15 years n (%) 3 (37.5%) 5 (62.5%) 8 (100%) 
> 15years n (%) 10 (62.5%) 6 (37.5%) 16 (100%) 
Total n (%) 25 (50%) 25 (50%) 50 (100%) 
Non-
Kuwaiti 
If yes, 
please 
write the 
length of 
time you 
took 
Insulin 
< one year n (%) 0 1 (100%) 1 (100%) 
One year n (%) 1 (100%) 0 1 (100%) 
4-7 years n (%) 8 (61.5%) 5 (38.5) 13 (100%) 
8-10 years n (%) 2 (66.7%) 1 (33.3%) 3 (100%) 
11-15 years n (%) 0 1 (100%) 1 (100%) 
> 15years n (%) 1 (100%) 0 1 (100%) 
Total n (%) 12 (60%) 8 (40%) 20 (100%) 
 
Generally, both sexes among Kuwaiti and non-Kuwaitis tended to use insulin for 
different length of times. 
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Table 4.20. Cross tabulation between Nationality and Sex and still taking insulin 
for diabetes 
Nationality/Sex 
Are you still taking insulin for your 
diabetes? Total 
Yes No 
Kuwaiti 
Male n 23 (92%) 2(8%) 25 
Female  n 20 (80%) 5 (20%) 25 
Total n (%) 43 (86%) 7 (14%) 50 (100%) 
Non-
Kuwaiti 
Male n 11 (91.7%) 1 (8.3%) 12 
Female n 8 (100%) 0 8 
Total n (%) 19 (95%) 1 (5%) 20 (100%) 
 
We can see that from Table 4.20 the percentage of Kuwaitis males who were still 
taking insulin for diabetes was greater than that for females (92% versus 80%). For 
non-Kuwaiti patients the percentage of males who were still taking insulin for 
diabetes was less than that for females (91.7% versus 100%) respectively. 
4.3    Awareness of complications of their disease. 
Weight Management 
Table 4.21. Cross tabulation between nationality and sex and weight 
management program from a hospital dietician. 
Nationality/Sex 
Please state whether you are on 
program from a hospital dietitian Total 
Yes No 
Kuwaiti 
Male n 3 (11.1%) 24 (88.9%) 27 
Female n 1 (3.6%) 27 (96.4%) 28 
Total n (%) 4 (7.3%) 51 (92.7%) 55 (100%) 
Non-Kuwaiti 
Male n 2 (14.3%) 12 (85.7%) 14 
Female n 0 10 (100%) 10 
Total n (%) 2 (8.3%) 22 (91.7%) 24 (100%) 
Only 11.1% and 3.6% of Kuwaiti males and females had been placed on a program 
from a hospital dietitian. Similarly, 14.3% of non-Kuwaiti males and 0.0% females 
were on program from a hospital dietitian (Table 6.21). 
 
Examination of blood sugar.  
On analysis, 7.1% of Kuwaiti females (n=2) had never examined blood sugar level in 
the past month, while 40.7% of Kuwaiti males (n=11) had examined their blood 
sugar level in the past month for roughly 2-6 times per week. 10% of non-Kuwaiti 
females had never examined blood sugar level in the past month (Table 4.22). 
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Table 4.22. Cross tabulation between nationality and sex and how often 
examined blood sugar level in the past month 
Nationality/Sex 
How often have you examined your blood sugar level 
in the past month? 
Total 
Never 
Once a 
week or 
less 
Roughly 
2-6 
times 
per 
week 
Daily 
Twice a 
day or 
more 
Three  
times or 
more 
Kuwaiti 
Male 
n 1 1 11 9 3 2 27 
% 3.7% 3.7% 40.7% 33.3% 11.1% 7.4% 100% 
Female 
n 2 0 16 3 7 0 28 
% 7.1% 0.0% 57.1% 10.7% 25.0% 0.0% 100% 
Total 
n 3 1 27 12 10 2 55 
% 5.5% 1.8% 49.1% 21.8% 18.2% 3.6% 100% 
Non-
Kuwaiti 
Male 
n 1 0 7 4 1 1 14 
% 7.1% 0.0% 50.0% 28.6% 7.1% 7.1% 100% 
Female 
n 1 1 5 3 0 0 10 
% 10.0% 10.0% 50.0% 30.0% 0.0% 0.0% 100% 
Total 
n 2 1 12 7 1 1 24 
% 8.3% 4.2% 50.0% 29.2% 4.2% 4.2% 100% 
 
No significant difference was found between nationality and number of times of 
blood examination for blood sugar level in the past month, attributed to sex(p-values 
0.115 and 0.717). 
 
Low blood sugar levels. 
Table 4.23. Cross tabulation between nationality / sex and low blood sugar. 
Nationality/ Sex 
Have you ever had a low blood 
sugar Total 
Yes No 
Kuwaiti 
Male n 26 (96.3%) 1 (3.7%) 27 
Female n 28 (100%) 0 28 
Total n (%) 54 (98.2%) 1 (1.8%) 55 (100%) 
Non-
Kuwaiti 
Male n 11 (78.6%) 3 (21.4%) 14 
Female n 9 (90%) 1 (10%) 10 
Total n (%) 20 (83.3%) 4 (16.7%) 24 (100%) 
 
Table 4.23 shows that non-Kuwaiti females and males who had experienced low 
blood sugar the figures were 90% and 78.6% respectively. This contrasts with all 
male and female Kuwaitis as 96.3% and 100% had experienced low blood sugar.  
The analysis using the Pearson Chi squared test indicated that there was no 
association between the variables of gender and low blood sugar at the level of 
significance 5%, since p-values were 0.304 and 0.459.  
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Table 4.24. Cross tabulation between nationality / sex and high blood sugar 
Nationality/ Sex 
Have you ever had a high blood 
sugar? Total 
Yes No 
Kuwaiti 
Male n 26 (96.3%) 1(3.7%) 27 
Female n 27 (96.4%) 1 (3.6%) 28 
Total n (%) 53 (96.4) 2 (3.6%) 55 (100%) 
Non-
Kuwaiti 
Male n 13 (92.9%) 1 (7.1%) 14 
Female n 10 (100%) 0 10 
Total n (%) 23 (95.8%) 1 (4.2%) 24 (100%) 
 
Table 4.24 shows that non-Kuwaiti females and males who had experienced high 
blood sugar the figures were 100% and 92.9% respectively. This contrasts with all 
male and female Kuwaitis as 96.3% and 96.4% who had experienced high blood 
sugar.  The analysis using the Chi squared test no association between the variables 
of gender and high blood sugar at the level of significance 5%, since the p-values 
were 0.979 and 0.388.  
 
Urinary tests – Table 4.25 shows that 14.8% of Kuwaiti males did not  test their  
urine for ketones, and 81.5% of them did not know what ketones actually were, 
while 0.0% of Kuwaiti females tested  urine for ketones, and 89.3% of them did not 
know what ketones were. Within non-Kuwaiti patients, 14.3% of males tested for 
urine for ketones and 71.4% of them did not know what ketones were. Additionally, 
90% of the non-Kuwaiti females did not know what ketones were. 
  
Table  4.25. Cross tabulation between Nationality and Sex and test for urinary 
ketones 
Nationality/ Sex 
Do you test for urine for ketones 
Total 
Yes No 
Don’t know 
what ketones 
are 
Kuwaiti 
Male n 1(3.7%) 4 (14.8%) 22 (81.5%) 27 
Female n 0 3 (10.7%) 25 (89.3%) 28 
Total n (%) 1 (1.8%) 7 (12.7%) 47 (85.5%) 55 (100%) 
Non-
Kuwaiti 
Male n 2 (14.3%) 2 (14.3%) 10 (71.4%) 14 
Female n 1 (10%) 0 9 (90%) 10 
Total n (%) 3 (12.5%) 2 (8.3%) 19 (79.2%) 24 (100%) 
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When this data was compared, using the Chi-Square Test there was no association 
between nationality and making test for urine for ketones according to sex; since the 
p-values were 0.518 and 0.413. 
 
Ketoacidosis - This problem was found to occur very rarely (Table 4.26) 
Table 4.26. Cross tabulation between Nationality and Sex and having 
ketoacidosis 
 
Nationality/Sex 
If Yes, please indicate how often you have 
been in ketoacidosis 
Total 
1-2 times a 
year 
2-3 times a 
year 
3-4 times a 
year 
Kuwaiti Male n (%) 
0 0 1(100%) 1 
Non-
Kuwaiti 
Male n 0 1 (50%) 1 (50%) 2 
Femal
e 
n 
1 (100%) 0 0 1 
Total N (%) 1 (33.3%) 1 (33.3%) 1 (33.3%) 3 (100%) 
 
Table 4.26 shows that one Kuwaiti male had ketoacidosis 3-4 times a year, while 
three of none Kuwaiti males and females had ketoacidosis for different times a year. 
  
Hypertension. 
 Table 4.27. Cross tabulation between nationality and sex and having high blood 
pressure 
Nationality/ Sex 
Do you have high blood pressure? 
Total 
Yes No 
Kuwaiti 
Male n 24 (88.9%) 3 (11.1%) 27 
Female n 24 (85.7%) 4 (14.3%) 28 
Total n (%) 48 (87.3) 7 (12.7%) 55 (100%) 
Non-
Kuwaiti 
Male n 13 (92.9%) 1 (7.1%) 14 
Female n 9 (90%) 1 (10%) 10 
Total n (%) 22 (91.7%) 2 (8.3%) 24 (100%) 
 
 
Table 4.27 shows that 87.3% of Kuwaitis and 91.7%% of non-Kuwaiti had high 
blood pressure. Moreover, the percentage of male among the two groups who had 
high blood pressure was greater than the percentage of female among the two 
groups who had this problem.  
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Table 4.28. Cross tabulation between sex, nationality and if so, do you take 
medication for this reason  
Nationality/ Sex 
And if so, do you take 
medication for this reason Total 
Yes No 
Kuwaiti 
Male n 23 (95.8%) 1 (4.2%) 24 
Female n 24 (100%) 0 24 
Total n (%) 47 (97.9%) 1 (2.1%) 48 (100%) 
Non 
Kuwaiti 
Male n 13 (100%) 0 13 
Female n 8 (88.9%) 1 (11.1%) 9 
Total n (%) 21 (95.5%) 1 (4.5%) 22 (100%) 
  Total 
Male n 36 (97.3%) 1 (2.7%) 37 
Female n 32 (97.0%) 1 (3%) 33 
Total n (%) 68 (97.1%) 2 (2.9%) 70 (100%) 
 
Within the study group 97.1% of patients reported that they were taking medication 
due to high blood pressure and a further two, although hypertensive, were not taking 
any medication. 
 
When asked to provide the names of their medication, 51.5% of the sample members 
reported that they took: amilodipine (7.4%), atenolol (2.9%), atenolol & lisinopril 
(1.5%), captopril (1.5%), Concor (4.4%), Concor Andzestoretic (1.5%), hydralazine 
(4.4%), lisinopril (10.3%), nifedipine (7.3%), nifedipine & Concor & hydralazine, 
hydralazine (1.5%), valsartan (4.4%), verapamil (1.5%), verapamil & hydralazine 
(1.5%), while the 48.5% of them  reported that they did not remember the medication 
that they took. 
Table 4.29. Cross tabulation between sex, nationality and how often you check 
your blood pressure.  
Nationality/ Sex 
How often is your blood pressure 
checked Total 
Daily Weekly Monthly Annually 
Kuwaiti 
Male 
n 6 13 4 1 24 
% 25.0% 54.2% 16.7% 4.2% 100% 
Female 
n 4 16 4 1 25 
% 16.0% 64.0% 16.0% 4.0% 100% 
Total  
10 29 8 2 49 
% 20.4% 59.2% 16.3% 4.1% 100% 
Non -Kuwaiti 
Male 
n 5 5 2 1 13 
% 38.5% 38.5% 15.4% 7.7% 100% 
Female n 0 7 1 1 9 
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% 0.0% 77.8% 11.1% 11.1% 100% 
Total 
n 5 12 3 2 22 
% 22.7% 54.5% 13.6% 9.1% 100% 
 
 
From the table 4.29, it is clear that 54.2% and 64.0% of Kuwaiti males and females 
indicated that they checked blood pressure weekly. For the non-Kuwaiti patients, 
38.5% of males and 77.8% of females checked their blood pressure weekly. In 
general, 20.4% of Kuwaiti patients, versus 22.7% of non-Kuwaiti checked their 
blood pressure daily. 
 
Eye - Table 4.30. Cross tabulation between nationality and sex and 
examined the retina  
Nationality/ Sex 
Have you ever had the back of 
your eyes (the retina) examined? 
(not including examination by an 
option or optometrist just for 
glasses) 
Total 
Yes No 
Kuwaiti 
Male n 26 (96.3%) 1(3.7%) 27 
Female n 24 (85.7%) 4 (14.3%) 28 
Total n (%) 50 (90.9%) 5 (9.1%) 55 (100%) 
Non- 
Kuwaiti 
Male n 13 (92.9%) 1(7.1%) 14 
Female n 10 (100%) 0 10 
Total n (%) 23 (95.8%) 1 (4.2%) 24 (100%) 
Total 
Male n 39 (95.1%) 2 (4.9%) 41 
Female n 34 (89.5%) 4 (10.5%) 38 
Total n (%) 73 (92.4%) 6 (7.6%) 79 (100%) 
 
Table 4.30 shows that 96.3% of Kuwaiti males 85.7% of Kuwaiti females had their 
retinas examined, while for non-Kuwaitis the figures were 92.9% for males and 
100% for females respectively. When this data was compared using chi-square test 
there was no association between nationality and examination of the retina attributed 
to sex at the 5% level of significance, since the p-values were 0.172 and 0.388. 
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Table 4.31. Cross tabulation between Nationality and Sex and type of specialist 
who conducted the eye examination 
Nationality/ Sex 
If yes who conducted the eye 
examination 
Total 
A diabetes 
specialist 
An eye specialist 
Kuwaiti 
Male n 1 (3.8%) 25 (96.2%) 26 
Female n 0 24 (100%) 24 
Total n (%) 1 (2%) 49 (98%) 50 (100%) 
Non-
Kuwaiti 
Male n 0 13 (100%) 13 
Female n 1(10%) 9 (90%) 10 
Total n (%) 1 (4.3%) 22 (95.7%) 23 (100%) 
Total 
Male n 1 (2.6%) 38 (97.4%) 39 
Female n 1(2.9%) 33 (97.1%) 34 
Total n (%) 2 (2.7%) 71 (73.3%) 73 (100%) 
 
From Table 4.31 we can see only 3.8% of Kuwaiti males indicated that the specialist 
who conducted their eye examination was a diabetes specialist, while 96.2% 
indicated that the specialist who conducted their eye examination was a non-diabetes 
eye specialist. Additionally, 100% of non-Kuwaiti males (n=13) indicate that 
specialist who conducted the eye examination was a non-diabetes eye specialist. 
Moreover, none of Kuwaiti females and 10.0% of non-Kuwaiti females respectively 
indicate that the specialist who conducted the eye examination for them was a 
diabetes specialist.  
When this data was compared using Pearson chi-square test the results showed no 
significant association between nationality and the type of specialist who conducted 
the eye examination attributed to sex under 5% level of significance, since the p-
values were 0.332 and 0.244.  
Table 4.32. Cross tabulation between sex, nationality and * Have you had laser 
treatment for your eyes? 
Nationality/ Sex 
Have you had laser treatment for 
your eyes? Total 
Yes No 
Kuwaiti 
Male n 21 (77.8%) 6 (22.2%) 27 
Female n 19 (67.9%) 9 (32.1%) 28 
Total n (%) 40 (72.7) 15 (27.3) 55 (100%) 
Non-
Kuwaiti 
Male n 10 (71.4%) 4 (28.6%) 14 
Female n 6 (60%) 4 (40%) 10 
Total n (%) 16 (66.7%) 8 (33.3%) 24 (100%) 
Total 
Male n 31(75.6%) 10 (24.4%) 41 
Female n 25 (65.8%) 13 (34.2%) 38 
Total n (%) 56 (70.9%) 23 (29.1%) 79 (100%) 
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Table 4.32 shows that 77.8% and 67.9% of Kuwaiti males and females had recieved 
laser treatment for their eyes, while 71.4% and 60.0% of non-Kuwaiti males and 
females had had laser treatment for their eyes.  
Table 4.33. Cross tabulation between sex, nationality and have you ever had a 
foot problem?   
 
Nationality/ Sex 
Have you ever had a foot 
problem? Total 
Yes No 
Kuwaiti 
Male n 23 (85.2%) 4 (14.8%) 27 
Female n 23 (82.1%) 5 (17.9%) 28 
Total n (%) 46 (83.6%) 9 (16.4%) 55 (100%) 
Non-
Kuwaiti 
Male n 12 (85.7%) 2(14.3%) 14 
Female n 9 (90%) 1 (10%) 10 
Total n (%) 21 (87.5%) 3 (12.5%) 24 (100%) 
Total 
Male n 35 (85.4%) 6 (14.6%) 41 
Female n 32 (84.2%) 6 (15.8%) 38 
Total n (%) 67 (84.8%) 12 (15.2%) 79 (100%) 
 
Table 4.33 shows that 85.2% and 82.1% of Kuwaiti males and females indicated that 
they experienced a foot problem. Among the non- Kuwaiti group, 85.7% of males 
and 90% of females reported that they experienced a foot problem. In addition, 
26.1% of Kuwaiti males experienced numbness or tingling, and 47.8% of them 
experienced both numbness or tingling and burning or pain in feet, while 30.4% of 
Kuwaiti females suffered from burning or pain in feet. Compared to the other group, 
33.3% of males suffered from numbness or tingling, while 55.6% of females suffered 
from both numbness or tingling and burning or pain in feet. 
Table 4.34. Cross tabulation between nationality and sex and types of exercise 
Nationality 
Please fill in the appropriate box  if you 
carry out any of the following type of 
exercise 
Total 
Walking for  
10-30 minutes 
every day 
Attending a 
gym for a 
session of up to 
30 minutes a 
week 
No exercise 
Kuwaiti 
Male n 17 (63.0%) 1 (3.7%) 9 (33.3%) 27 
Female n 6 (21.4%) 0 22 (78.6%) 28 
Total n  (%) 23 (41.8%) 1 (1.8%) 31 (56.4%) 55 (100%) 
Non-
Kuwaiti 
Male n 10 (71.4%) 0 4 (28.6%) 14 
Female n 6 (60%) 0 4 (40%) 10 
Total n (%) 16 (66.7%) 0 8 (33.3%) 24 (100%) 
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From Table 4.34 we can see that 63.0% and 21.4% of Kuwaiti males and females 
were walking for 10-30 minutes every day, while 71.4% and 60.0% of non-Kuwaiti 
males and females were walking for 10-30 minutes every day. In addition, 33.3% 
and 78.6% of Kuwaiti males and females and 28.6% and 40.0% of non- Kuwaiti 
males and females did not follow any exercise. Using the Chi-Square Test there was 
a highly significant association between sex and types of exercise followed by the 
study members within Kuwaiti patients (p<0.01),   while there was no statistical 
association between sex and types of exercise followed by the study members within 
non-Kuwaiti patients since the p-value was 0.558.  
 
Circulation –Table 4.35 indicates that 58.2% of the sample who had cardiac 
problems were Kuwaiti, while 37.5% were non-Kuwaiti. For those Kuwaiti patients 
who had cardiac problems 18 were males and 14 female. For non-Kuwaiti ‘s there 
were 6 males and 3 were females. The sex difference is perhaps expected from 
global findings on cardiac problems. 
Table 4.35. Cross tabulation between nationality and sex and suffering from 
heart problems.  
[ 
Nationality/ Sex 
Have you ever had heart 
problems Total 
Yes No 
Kuwaiti 
Male n 18 (66.7%) 9 (33.3%) 27 
Female n 14 (50%) 14 (50%) 28 
Total n (%) 32(58.2%) 23(41.8%) 55 (100%) 
Non-Kuwaiti 
Male n 6 (42.9%) 8 (57.1%) 14 
Female n 3 (30%) 7 (70%) 10 
Total n (%) 9 (37.5%) 15 (62.5%) 24 (100%) 
 
On analysis there is no significant association between nationality and heart 
problems attributed to sex under 5% level of significance, since the p-values were 
0.210 and 0.521. 
Table 4.36. Cross tabulation between nationality, sex, and if yes is it.  
Nationality/ Sex 
If yes, is it 
Total 
Chest Pain Heart attack 
Kuwaiti 
Male n 5 (27.8%) 13 (72.2%) 18 
Female n 4 (28.6%) 10 (71.4%) 14 
Total n (%) 9 (28.1%) 23 (71.9%) 32 (100%) 
Non -Kuwaiti 
Male n 2 (33.3%) 4 (66.7%) 6 
Female n 2 (66.7%) 1 (33.3%) 3 
Total n (%) 4 (44.4%) 5 (55.6%) 9 (100%) 
Total Male n 7 (29.2%) 17 (70.8%) 24 
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Female n 6 (35.3%) 11 (64.7%) 17 
Total n (%) 13 (31.7%) 28 (68.3%) 41 (100%) 
 
The type of cardiac problems experienced by the Kuwaiti patients was that of chest 
pain, (28.1%) (n=9) and 71.9% had had a heart attack (n=23)(Table 4.36). Among 
non-Kuwaiti the proportions were (44.4%) and (55.6%) respectively. Generally, the 
proportion of the patients who had chest pain was 31.7% while 68.3% had a heart 
attack. 
 
Kidney - Table 4.37. Cross tabulation between sex, nationality * Have you ever 
been told by the diabetic physician you have kidney disease?  * Cross tabulation 
 
Nationality/ Sex 
Have you ever been told by the 
diabetic physician you have 
kidney disease? 
Total 
Yes No 
Kuwaiti 
Male n 11 (40.7%) 16 (59.3%) 27 
Female n 7 (25%) 21 (75%) 28 
Total n (%) 18 (32.7%) 37 (67.3%) 55 (100%) 
Non  - Kuwaiti 
Male n 2 (14.3%) 12 (85.7%) 14 
Female n 2 (20%) 8 (80%) 10 
Total n (%) 4 (16.7%) 20 (83.3%) 24 (100%) 
Total 
Male n 13 (31.7%) 28 (68.3%) 41 
Female n 9 (23.7%) 29 (76.3%) 38 
Total n (%) 22 (27.8%) 57 (72.2%) 79 (100%) 
 
From Table 4.37, 40.7% of Kuwaiti patients who had been told by the diabetic 
physician that they had kidney disease were males (n=11), with 25% were females 
(n=7). Among the non- Kuwaiti patients we can see that 14.3% of them were males 
(n=2) indicated that they had been told by the diabetic physician that they had kidney 
disease, while 20% of them were females (n=2). 
 
Table 4.38. Cross tabulation between nationality and sex and proteinuria.  
Nationality/Sex 
Have you been diagnosed by diabetic clinic as 
having protein in your urine? Total 
Yes No I don’t know 
Kuwaiti 
Male n 8 (29.6%) 15 (55.6%) 4 (14.8%) 27 
Female n 4 (14.3%) 21(75%) 3 (10.7%) 28 
Total n (%) 12 (21.8%) 36 (65.5%) 7 (12.7%) 55 (100%) 
Non-
Kuwaiti 
Male n 2 (14.3%) 12 (85.7%) 0 14 
Female n 1(10%) 8 (80%) 1 (10%) 10 
Total n (%) 3 (12.5%) 20 (83.3%) 1 (4.2%) 24 (100%) 
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Table 4.38 shows that 65.5% of Kuwaitis as compared with 83.3% of non-
Kuwaitis  stated they had no protein in their urine. Additionally, 12.7% of 
Kuwaitis and 4.2% of non-Kuwaitis stated they did not know whether they had 
been diagnosed as having protein in their urine or not. Finally, 21.8% of Kuwaitis 
and 12.5% non-Kuwaitis stated they had protein in the urine. Furthermore, 16 
Kuwaiti patients (11 males and 5 females), and three non-Kuwaiti patients (two 
males and one female) reported that they were transferred from diabetic physician to 
a nephrologist. In addition, all the patients (n=79) reported that they had been told 
what caused their kidney disease, and this is due to diabetes. 
 
Table 4.39. Cross tabulation between sex, nationality and what tests does the 
clinic carry out to diagnose that you have kidney disease on you whilst you were 
there?  
Nationality/ Sex 
What tests does the clinic carry out to diagnose 
that you have kidney disease on you whilst you 
were there? Total 
Blood test Nothing 
I don’t 
know 
Other 
Kuwaiti 
Male n 9 (33.3%) 16 (59.3%) 1 (3.7%) 1 (3.7%) 27 
Female n 6 (21.43%) 
21 
(78.57%) 
0 1 28 
Total 
n 
(%) 
15 
(27.3%) 
37 (69.1%) 1 (1.8%) 1 (1.8%) 
55 
(100
%) 
Non- 
Kuwaiti 
Male n 2 (21.4%) 11 (78.6%) 0 0 13 
Female n 1 (10%) 9 (90%) 0 1 11 
Total 
n 
(%) 
4 (16.7%) 20 (83.3%) 0 0 
24 
(100
%) 
Total 
Male n 11 (29.3%) 27 (65.9%) 1(2.49%) 1((2.49%) 40 
Female n 7 (18.4%) 30 (81.6%) 0 2 39 
Total 
n 
(%) 
18 
(24.1%) 
57 (73.3%) 1 (1.3%) 1 (1.3%) 79 
 
Table 4.39 shows that 27.3% of Kuwaiti patients (9 males and 6 females) indicated 
that they had a blood test in their clinic, to diagnose kidney disease while they were 
there, compared with 4 non- Kuwaiti patients (3 males and one female) respectively. 
In addition, 69.1% of Kuwaiti patients (n=38) and 83.3% of non-Kuwaiti patients 
(n=20) stated that the clinic, which they attended, did nothing for them to diagnose 
 155 
 
kidney disease while they were there and these patients found by “accident” they had 
kidney disease. 
Table 4.40. Cross tabulation between sex, nationality and how long has it 
been since you were first diagnosed with kidney disease? Circle one. 
Nationality/ Sex 
How long has it been since you were first 
diagnosed with kidney disease? )Circle 
one) Total 
1  
year 
1-3 
years 
3-5 
years 
5-10 
years 
others 
Kuwaiti 
Male 
n 2 5 6 11 3 27 
% 7.4% 18.5% 22.2% 40.7% 11.1% 100% 
Female 
n 3 9 10 5 1 28 
% 10.7% 32.1% 35.7% 17.9% 3.6% 100% 
Total 
n 5 14 16 16 4 55 
% 9.1% 25.5% 29.1% 29.1% 7.3% 100% 
non 
Kuwaiti 
Male 
n 3 3 2 5 1 14 
% 21.4% 21.4% 14.3% 35.7% 7.1% 100% 
Female 
n 2 2 2 2 2 10 
% 20.0% 20.0% 20.0% 20.0% 20.0% 100% 
Total 
n 5 5 4 7 3 24 
% 20.8% 20.8% 16.7% 29.2% 12.5% 100% 
Total 
Male 
n 5 8 8 16 4 41 
% 12.2% 19.5% 19.5% 39.0% 9.8% 100% 
Female 
n 5 11 12 7 3 38 
% 13.2% 28.9% 31.6% 18.4% 7.9% 100% 
Total 
n 10 19 20 23 7 79 
% 12.7% 24.1% 25.3% 29.1% 8.9% 100% 
 
Among the Kuwaiti patients, 29.1% of them (5 males and 9 females) indicated that 
the time since first diagnosis with kidney disease was 3-5 years, with more 29.1% 
stated that the length was 5-10 years. Compared to the non-Kuwaiti patients, the time 
distribution tends to be less concentrated. Interestingly, some of patients within the 
two groups indicated that they were first diagnosed with kidney disease 15 years 
previously. 
Table 4.41 Cross tabulation between sex, nationality and what type of kidney 
disease do you have? 
Nationality/sex 
What type of kidney disease do 
you have? Total 
Chronic I don’t know 
Kuwaiti 
Male n 23 (85.2%) 4 (14.8%) 27 
Female n 24 (85.7%) 4 (14.3%) 28 
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Total n (%) 47 (85.5%) 8 (14.5%) 55 (100%) 
Non -  
Kuwaiti 
Male n 11 (78.6%) 3 (21.4%) 14 
Female n 7 (70%) 3 (30%) 10 
Total n (%) 18 (75%) 6 (25%) 24 (100%) 
Total 
Male n 34 (82.9%) 7 (17.1%) 41 
Female n 31 (81.6%) 7 (18.4%) 38 
Total n (%) 65 (82.3%) 14 (17.7%) 79 (100%) 
 
Table 4.41 shows that 85.5% of Kuwaiti patients had chronic disease (23 males and 
24 females), while 75% of non-Kuwaiti patients had chronic disease (11 males and 7 
females). Additionally, 14.5% and 25% of Kuwaiti and non-Kuwaiti patients 
indicated that they didn’t know what type of kidney disease they had. 
 
Table 4.42. Cross tabulation between sex, nationality and ‘Do you know what is 
the stage of your kidney disease?’  
Nationality/ Sex 
Do you know what is the stage of 
your kidney disease? Total 
Yes No 
Kuwaiti 
Male n 24 (88.9%) 3 (11.1%) 27 
Female n 24 (85.7%) 4 (14.3%) 28 
Total N (%) 48 (87.3%) 7 (12.7%) 55 (100%) 
Non- Kuwaiti 
Male n 11 (78.6%) 3 (21.4%) 14 
Female n 7 (70%) 3 (30%) 10 
Total N (%) 18 (75%) 6 (25%) 24 (100%) 
Total 
Male n 35 (85.4%) 6 (14.6%) 41 
Female n 31 (81.6%) 7 (18.4%) 38 
Total N (%) 66 (83.5%) 13 (16.5%) 79 (100%) 
 
Among the Kuwaiti patients, 87.3% of them (24 males and 24 females) indicated that 
they knew what is the stage of their kidney disease, compared to 75% of non-
Kuwaiti patients. The proportions of Kuwaiti and non-Kuwaiti patients who did not 
know what the stage of their kidney disease were 12.7% and 25% respectively. It is 
worth mentioning here, the stage of kidney disease which the patients were left was 
the stage 5-kidney failure. The chi-squared test indicated no association between 
nationality and knowledge of the disease’s stage attributed to sex, since p values 
were 0.724 & 0.633 respectively (Table 4.42). 
 
Also from this table, the patients indicated that they had several symptoms due to 
kidney disease namely: swelling, skin rash/itching, coma, nausea and vomiting, 
shortness of breath, fatigue, alone or with combinations with each other. 
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Table 4.43. Cross tabulation between sex, nationality and does kidney disease 
affect your daily life?  
Nationality/ Sex 
Does kidney disease affect 
your daily life? Total 
Yes No 
Kuwaiti 
Male n 26 (96.3%) 1 (3.7%) 27 
Female n 26 (92.9%) 2 (7.1%) 28 
Total n (%) 52 (94.5%) 3 (5.5%) 55 (100%) 
Non- Kuwaiti 
Male n 13 (92.9%) 1 (7.1%) 14 
Female n 9 (90%) 1 (10%) 10 
Total n (%) 22 (91.7%) 2 (8.3%) 24 (100%) 
Total 
Male n 39 (95.1%) 2 (4.9%) 41 
Female n 35 (92.1%) 3 (7.9%) 38 
Total n (%) 74 (93.7%) 5 (6.3%) 79 (100%) 
 
For Kuwaiti patients, 94.5% of them (26 males and 26 females) indicated that kidney 
disease affected their daily life as compared to 91.7% of non-Kuwaiti patients (13 
males and 9 females). The kidney disease affected the diet exercised by patients 
(12.2%), and affected their work (14.9%), their social life (9.5%), and (63.5%) for 
these effects together. The chi-squared test indicated that there was no association 
between the nationality and the knowledge of the disease’s stage attributed to sex, 
since p-values were 0.574, 0.803 respectively. 
 
Table 4.44. Cross tabulation between sex, nationality and a family history of 
kidney disease?  
Nationality/ Sex 
Do you have a family history of 
kidney disease? Total 
Yes No 
Kuwaiti 
Male n 10 (37%) 17 (63%) 27 
Female n 5 (17.9%) 23 (82.1%) 28 
Total n (%) 15 (27.3%) 40 (72.7%) 55 (100%) 
Non- 
Kuwaiti 
Male n 2 (14.3%) 12 (85.7%) 14 
Female n 2 (20%) 8 (80%) 10 
Total n (%) 4 (16.7%) 20 (83.3%) 24 (100%) 
Total 
Male n 12 (29.3%) 29 (70.7%) 41 
Female n 7 (18.4%) 31 (81.6%) 38 
Total n (%) 19 (24.1%) 60 (75.9%) 79 (100%) 
 
 
Table 4.44 shows that 27.3% and 16.7% of Kuwaiti and non-Kuwaiti patients 
indicated that they had a family history of kidney disease. The family member who 
suffered the condition were father (26.3%), mother (36.8%), brother (26.3%), father 
and mother and brother (5.3%), and uncle (5.3%) The chi-squared test indicated that 
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there was no association between the nationality and the family history of kidney 
disease attributed to sex, since the p-values were 0.110, 0.711 respectively. 
 
Table 4.45. Cross tabulation between Sex, Nationality and do you know what 
food you should avoid if your kidneys are not behaving in a normal way?  
Nationality/ Sex 
Do you know what food you should 
avoid if your kidneys are not 
behaving in a normal way? 
Total 
Yes No 
Kuwaiti 
Male n 18 (66.7%) 9 (33.3%) 27 
Female n 22 (78.6%) 6 (21.4%) 28 
Total n (%) 40 (72.7%) 15 (27.3%) 55 (100%) 
Non- 
Kuwaiti 
Male n 13 (92.9%) 1 (7.1%) 14 
Female n 7 (70%) 3 (30%) 10 
Total n (%) 20 (83.3%) 4 (16.7%) 24 (100%) 
Total 
Male n 31 (75.6%) 10 (24.4%) 41 
Female n 29 (76.3%) 9 (23.7%) 38 
Total n (%) 60 (75.9%) 19 (24.1%) 79 (100%) 
 
Table 4.45 shows that 72.7% and 83.3% of Kuwaiti and non-Kuwaiti patients 
indicated that if their kidneys were not behaving in a normal way they should avoid 
some foods (high knowledge). These foods were as follows: Salt (13.3%), Potassium 
(18.3%) all the patients whom mentioned they have avoided meals containing 
potassium they stopped eating banana, orange and tomatoes only but not other food 
like chocolate, lettuce, cucumber and nuts , and protein (1.7%). The patients whom 
mentioned they stopped eating protein such as meat but not others food such as egg 
and milk, salt & potassium & protein (20%), salt & potassium (41.7%), and the 
remaining proportion (5%) for different combination of these foods. 
 
Dialysis 
 
It was found that 64 patients out of 79 indicated that they were having renal dialysis 
(46 were Kuwaiti (23 males, 23 females) and 18 non-Kuwaiti (11 males, 7 females). 
They reported that the risks from this type of treatment were hypotension (n=13, 
20.3%), anemia (n=6, 9.6%), cramps, nausea and headaches (n=3, 4.7%), infections 
(n=1, 1.6%), hypotension &other hypertension (n=1, 1.6%), while the remainder 
(n=40, 62.5%) were distributed in different groups of combinations of these types of 
renal dialysis. All the patients having renal dialysis (n=64) did so in a hospital. 
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Table 4.46. Cross tabulation between sex, nationality and how long does each 
dialysis take?  
Nationality/ Sex 
How long does each dialysis take? 
Total 
1-3 hours 4-6 hours other  
Kuwaiti 
Male n 2 (8.7%) 6 (26.1%) 15 (65.2%) 23 
Female n 3 (13%) 7 (30.4%) 13 (56.5%) 23 
Total n (%) 5 (10.9%) 13 (28.3%) 28 (60.9%) 46 (100%) 
Non- 
Kuwaiti 
Male n 3 (27.3%) 2 (18.2%) 6 (54.5%) 11 
Female n 1 (14.3%) 3 (42.9%) 3 (42.9%) 7 
Total n (%) 4 (22.2%) 5 (27.8%) 9 (50%) 18 (100%) 
Total 
Male n 5 (14.7%) 8 (23.5%) 21 (61.8%) 34 
Female n 4 (13.3%) 10 (33.3%) 16 (53.3%) 30 
Total n (%) 9 (14.1%) 18 (28.1%) 37 (57.8%) 64 (100%) 
 
Table 4.46 shows that, 10.9% of Kuwaiti patients took each dialysis for 1-3 hours, 
and 28.3% of them took it for 4-6 hours, while the majority of them (60.9%, n=28) 
took each dialysis for another length of time (3.5 hours). Compared with the non-
Kuwaiti patients, 22.2% of them (n= 4) indicated that they took each dialysis for 1-3 
hours, and 27.8% used 4-6 hours, while 50% stated that they took each dialysis for 
other length of time (3.5 hours). All of the patients (n=64) stated that their dialysis 
schedule was three visits per week. 
 
Kidney Transplant  
Table 4.47. Cross tabulation between sex, nationality and have you had a kidney 
transplant?   
Nationality/ Sex 
Have you had a kidney 
transplant? Total 
Yes No 
Kuwaiti 
Male n    6 (22.2%) 21 (77.8%) 27 
Female n 5 (17.9%) 23 (82.1%) 28 
Total n (%) 11 (20%) 44 (80%) 55 (100%) 
Non- 
Kuwaiti 
Male n 1 (7.1%) 13 (92.9%) 14 
Female n 2 (20%) 8 (80%) 10 
Total n (%) 3 (12.5%) 21 (87.5%) 24 (100%) 
Total 
Male n 7 (17.1%) 34 (82.9%) 41 
Female n 7 (18.4%) 31 (81.6%) 38 
Total n (%) 14 (17.7%) 65 (82.3%) 79 (100%) 
 
 
In addition, among patients who were having renal dialysis, 14 of them had a kidney 
transplant. They were 6 Kuwaiti males with 5 Kuwaiti females, and 3 non-Kuwaiti (1 
male and 2 females). The proportion of patients who had a kidney transplant was 
17.7%. The chi-squared test indicated that there was no association between the 
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nationality and having kidney transplant attributed to sex, since p-values were 0.686 
and 0.348 respectively. From Table 4.47, 42.5% of patients who had a kidney 
transplant indicated that this issue started before 2011, While 42.9% of them pointed 
out that their kidney transplant started in 2014.  
 
Table 4.48. Cross tabulation between Sex, Nationality and if yes is it …?  
Nationality/ Sex 
If yes,  is it 
Total Living related donors 
like  parents, children 
or siblings 
Altruistic 
donor 
Kuwaiti 
Male n  4 (66.7%) 2 (33.3%) 6 
Female n 2 (40%) 3 (60%) 5 
Total n/%  6 (54.5%) 5 (45.5%) 11 
Non- Kuwaiti 
Male n 1 (100%) 0 1 
Female n 2 (100%) 0 2 
Total n/% 3 (100%) 0 3 
Total 
Male n 5 (71.4%) 2 (28.6%) 7 
Female n 4 (57.1%) 3 (42.9%) 7 
Total n /% 9 (64.3% 5 (35.7%) 14 (100%) 
 
The 14 patients stated that they knew what the source of the transplant kidney was. 
Within Kuwaiti patients, 54.5% of them (4 males and 2 females) indicated that living 
related donors like parents, children or siblings was the source of the transplant; 
while 45.5% of them pointed out that an altruistic donor was the source. All the non-
Kuwaiti patients (n=3) indicated that living related donors, such as parents children 
or siblings was the source of the transplant kidney. Further to the Table 4.49, five 
Kuwaiti patients (3 males and 2 females) and two non-Kuwaiti patients (1 male and 1 
female) had developed hypertension following the transplant. While two male 
Kuwaiti patients and two non-Kuwaiti patients (1 male and 1 female) had suffered 
from other types of cardiovascular disease, and only one non-Kuwaiti patient (male) 
had blood in the urine. 
Table 4.49. Cross tabulation between Sex, Nationality and do you know what 
treatment(s) are currently prescribed for you?   
Nationality/ Sex 
Do you know what 
treatment(s) are currently 
prescribed for you? 
Total 
Yes No 
Kuwaiti 
Male n 6 (100%) 0 6 
Female n 4 (80%) 1(20%) 5 
Total n 10 (90.9%) 1 (9.1%) 11 
Non -Kuwaiti Male n 1 (100%) 0 1 
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Female n 2 (100%) 0 2 
Total n 3 (100%) 0 3 
Total 
Male n 7 (100%) 0 7 
Female n 6 (85.7%) 1(14.3%) 7 
Total 
n 13 1 14 
% 92.9% 7.1% 100% 
 
It is clear from the Table 4.49, 10 Kuwaiti patients out of 14 (6 males and 4 females) 
know what treatment(s) are currently prescribed for them, while 3 non- Kuwaiti 
patients know that. The treatment(s) were: cyclosporins (Neoral, Sandimmune, 
SangCya) and corticosteroids such as prednisolone (Deltasone, Orasone) (61.5%), 
tacrolimus (7.7%), while the remaining (30.8%) had combinations treatments. 
Table 4.50. Cross tabulation between sex, nationality and are there any side 
effect(s) due to the medication(s)?  
Nationality/ Sex 
Are there any side effect(s) due 
to the medication(s)? Total 
Yes No 
Kuwaiti 
Male n 5 (83.3%) 1 (16.7%) 6 
Female n 5 (100%) 0 5 
Total n (%) 10 (90.9%) 1 (9.1%) 11 (100%) 
Non- 
Kuwaiti 
Male n 1 (100%) 0 1 
Female n 2 (100%) 0 2 
Total n (%) 3 (100%) 0 3 (100%) 
Total 
Male n 6 (85.7%) 1 (14.3%) 7 
Female n 7 (100%) 0 7 
Total n (%) 13 (92.9%) 1 (7.1%) 14 (100%) 
 
 
Questioned about the side effect(s) due to their medication(s), 13 patients out of 14 
(92.9%) (10 Kuwaiti and 3 non-Kuwaiti) reported positively. These effects included: 
an increase in body weight, puffiness of face, high blood sugar, elevated blood 
pressure, facial hair, bone disease, skin changes, acne, stomach acidity, alone or in 
combinations with each other. 
 
Anemia - Table 4.51. Cross tabulation between sex, nationality and have you 
ever been told you were anemic?   
 
Nationality/ Sex 
Have you ever been told you were 
anemic? Total 
Yes No 
Kuwaiti 
Male n 11 (40.7%) 16 (59.3%) 27 
Female n 25 (89.3%) 3 (10.7%) 28 
Total n (%) 36 (65.5%) 19 (34.5%) 55 (100%) 
Non  -  Male n 6 (42.9%) 8 (57.1%) 14 
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Kuwaiti Female n 9 (100%) 0 9 
Total n (%) 15 (65.2%) 8 (34.8%) 23 (100%) 
Total 
Male n 17 (41.5%) 24 (58.5%) 41 
Female n 34 (91.9%) 3 (8.1%) 37 
Total n (%) 51 (65.4%) 27 (26.7%) 78 (100%) 
 
 
Table 4.51shows that, 65.5% and 65.2% of Kuwaiti and non-Kuwaiti patients 
respectively, reported they had been told they were anemic. According to sex, the 
proportion of females who were told they were anemic was greater than males. 
The chi-squared test indicated that there was a high statistical difference between the 
nationality and their knowledge of the presence of anemia attributed to sex, since the 
p values were 0.000 and 0.005 respectively. 
Table 4.52. Cross tabulation between sex, nationality how long ago were you 
first diagnosed with anemia. 
Nationality/ Sex 
If yes, how long ago were you first 
diagnosed? 
Total 
Less than 
1 year 
1-3 
years 
3-5 years 
More than 
5 years 
Kuwaiti 
Male 
n 2 4 4 1 11 
% 18.2% 36.4% 36.4% 9.1% 100% 
Female 
n 2 10 6 7 25 
% 8.0% 40.0% 24.0% 28.0% 100% 
Total 
n 4 14 10 8 36 
% 11.1% 38.9% 27.8% 22.2% 100% 
Non- 
Kuwaiti 
Male 
n 2 0 3 1 6 
% 33.3% 0.0% 50.0% 16.7% 100% 
Female 
n 2 1 2 4 9 
% 22.2% 11.1% 22.2% 44.4% 100% 
Total 
n 4 1 5 5 15 
% 26.7% 6.7% 33.3% 33.3% 100% 
Total 
Male 
n 4 4 7 2 17 
% 23.5% 23.5% 41.2% 11.8% 100% 
Female 
n 4 11 8 11 34 
% 11.8% 32.4% 23.5% 32.4% 100% 
Total 
n 8 15 15 13 51 
% 15.7% 29.4% 29.4% 25.5% 100% 
 
From the Table 4.52, 50% (n=18) and 66.6% (n=10) of Kuwaiti and non-Kuwaiti 
patients stated that the first diagnosis of anemia was before 3 years or more. In 
addition, 97.3% of Kuwaiti patients (n=36, 11 males and 24 females) indicated that 
they took medication to prevent anemia. The medications taken by the Kuwaiti 
patients were iron (94.4%), folic acid (2.8%) and ‘others’ (2.8%). All non-Kuwaiti 
patients (n= 15, 6 males and 9 females) pointed out that they took iron medication to 
prevent anemia.  
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Bone disease - Table 4.53. Cross tabulation between sex, nationality and have 
you ever been told you had weak bones?   
Nationality/ Sex 
Have you ever been told you had 
weak bones? Total 
Yes No 
Kuwaiti 
Male n 18 (66.7%) 9 (33.3%) 27 
Female n 20 (71.4%) 8 (28.6%) 28 
Total n(%) 38 (69.1%) 17 (30.9%) 55 (100%) 
Non- 
Kuwaiti 
Male n 8 (57.1%) 6 (42.9%) 14 
Female n 6 (60%) 4 (40%) 10 
Total n (%) 14 (58.3%) 10 (41.7%) 24 (100%) 
Total 
Male n 26 (63.4%) 15 (36.6%) 41 
Female n 26 (68.4%) 12 (31.6%) 38 
Total n (%) 52 (65.8%) 27 (34.2%) 79 (100%) 
 
Table 4.53 shows that, 69.1% and 58.3% of Kuwaiti and non-Kuwaiti patients 
respectively, pointed out that they were told that they had weak bones. According to 
sex, the proportion of females who had been told they had weak bones was greater 
than males. In addition, 60.5% (n=23) and 42.9% (n=6) of Kuwaiti and non-Kuwaiti 
patients stated that they had weak bones since 3 years or less. 
 
From this table, 90% of Kuwaiti patients (n=36, 17 males and 19 females) indicated 
that they took medication for their bones. The medications taken by the Kuwaiti 
patients were calcium (30.6%), vitamin D (5.6%), a combination of vitamin D and 
calcium (63.8%). All non-Kuwaiti patients (n= 14, 8 males and 6 females) mentioned 
that they took medication for their bones, namely, calcium (21.4%) and combination 
of vitamin D and calcium (78.6%). 
Additional Tables: 
Table 4.54. Sex * Body weight at this time of first diagnosis (Kg)* if yes 
please specify the name(s) of tablet medication you took Cross tabulation  
Name(s) of tablet medication you 
took 
Body weight at this time of first diagnosis (Kg) 
Total > 
50 
50-59 
60-
69 
70-
79 
80-
89 
90-
99 
100+ 
Don’t  Know 
Male 
n  0 0 1 0 3 1 3 8 
%  0% 0% 13% 0% 38% 13% 38% 100% 
Female 
n  0 3 1 3 0 3 4 14 
%  0% 21% 7% 21% 0% 21% 29% 100% 
Total 
n  0 3 2 3 3 4 7 22 
%  
0% 14% 9% 14% 
14
% 
18
% 32% 
100
% 
Glibenclamide  Male n 0 0 1 1 0 0 1 3 
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%  0% 0% 33% 33% 0% 0% 33% 100% 
Total 
n 0 0 1 1 0 0 1 3 
%  0% 0% 33% 33% 0% 0% 33% 
100
% 
Gliclazide  
Male 
n 0 0 0 1 0 0 0 1 
%  0% 0% 0% 
100
% 
0% 0% 0% 100% 
Total 
n 0 0 0 1 0 0 0 1 
%  0% 0% 0% 
100
% 
0% 0% 0% 
100
% 
Glimepiride    & 
Glibenclamide 
Male 
n 0 0 0 1 0 0 0 1 
%  0% 0% 0% 
100
% 
0% 0% 0% 100% 
Total 
n 0 0 0 1 0 0 0 1 
%  0% 0% 0% 
100
% 
0% 0% 0% 
100
% 
Metformin 
Male 
n 1 0 1 3 3 3 5 16 
%  6% 0% 6% 19% 19% 19% 31% 100% 
Female 
n 0 1 3 2 1 3 2 12 
%  0% 8% 25% 17% 8% 25% 17% 100% 
Total 
n 1 1 4 5 4 6 7 28 
% 4% 4% 14% 18% 
14
% 
21
% 
25% 
100
% 
Metformin & 
Glibenclamide 
Male 
n 0 0 0 0 0 0 1 1 
%  0% 0% 0% 0% 0% 0% 100% 100% 
Total 
n 0 0 0 0 0 0 1 1 
% 0% 0% 0% 0% 0% 0% 
100
% 
100
% 
Metformin & 
Gliclazide 
Male 
n 0 0 0 0 1 0 2 3 
%  0% 0% 0% 0% 33% 00% 67% 100% 
Female 
n 0 0 0 0 0 1 1 2 
%  0% 0% 0% 0% 0% 50% 50% 100% 
Total 
n 0 0 0 0 1 1 3 5 
% 0% 0% 0% 0% 
20
% 
20
% 
60% 
100
% 
Metformin & 
Sitagliptin 
Female 
n 0 0 2 0 0 0 0 2 
%  0% 0% 
100
% 
0% 0% 0% 0% 100% 
Total 
n 0 0 2 0 0 0 0 2 
% 0% 0% 
100
% 
0% 0% 0% 0% 
100
% 
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Table 4.55. Sex * Body weight today (Kg)* if yes please specify the name(s) 
of tablet medication you took Cross tabulation 
Name(s) of tablet medication you 
took 
Body weight today (Kg) 
Total 
50-59 60-69 70-79 80-89 90-99 100+ 
Don’t  Know 
Male 
n 0 0 3 1 3 3 10 
% 0% 0% 30% 10% 30% 30% 100% 
Female 
n 2 1 1 4 2 2 12 
% 17% 8% 8% 33% 17% 17% 100% 
Total 
n 2 1 4 5 5 5 22 
% 9% 5% 18% 23% 23% 23% 100% 
Glibenclamide  
Male 
n 0 2 0 0 0 1 3 
% 0% 67% 0% 0% 0% 33% 100% 
Total 
n 0 2 0 0 0 1 3 
% 0% 67% 0% 0% 0% 33% 100% 
Gliclazide  
Male 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
Total 
n 0 0 1 0 0 0 1 
% 0% 0% 100% 0% 0% 0% 100% 
Glimepiride  & 
Glibenclamide 
Male 
n 0 1 0 0 0 0 1 
% 0% 100% 0% 0% 0% 0% 100% 
Total 
n 0 1 0 0 0 0 1 
% 0% 100% 0% 0% 0% 0% 100% 
Metformin 
Male 
n 0 2 3 4 5 2 16 
% 0% 13% 19% 25% 31% 13% 100% 
Female 
n 0 1 3 3 1 4 12 
% 0% 8% 25% 25% 8% 33% 100% 
Total 
n 0 3 6 7 6 6 28 
% 0% 11% 21% 25% 21% 21% 100% 
Metformin & 
Glibenclamide 
Male 
n 0 0 0 1 0 0 1 
% 0% 0% 0% 100% 0% 0% 100% 
Total 
n 0 0 0 1 0 0 1 
% 0% 0% 0% 100% 0% 0% 100% 
Metformin & 
Gliclazide 
Male 
n 0 0 1 0 2 0 3 
% 0% 0% 33% 0% 67% 0% 100% 
Female 
n 0 0 0 0 1 1 2 
% 0% 0% 0% 0% 50% 50% 100% 
Total 
n 0 0 1 0 3 1 5 
% 0% 0% 20% 0% 60% 20% 100% 
Metformin & 
Sitagliptin 
Female 
n 0 2 0 0 0 0 2 
% 0% 100% 0% 0% 0% 0% 100% 
Total 
n 0 2 0 0 0 0 2 
% 0% 100% 0% 0% 0% 0% 100% 
 
Referring to the data related to patients with kidney disease presented in table 4.54, 
we can see that   31% of males (n=5) with 100 kg weight or above took metformin, 
followed by 19% of them distributed equally to three categories of weight namely 70 
to 79, 80 to 89, and 90 to 99 kg weight. 
 166 
 
With respect to females group, 25% (n= 3) of them who were between 60 to 69 kg 
weight took metformin, followed by 25% with 90 to 99 kg weight took the same 
medication. 
 
When reflecting the data obtained for body weight today (Table 4.55) with sex and 
medication took by the patients,  31% (n=5) of males with 90 to 99 kg weight took 
metformin, followed by 25% of them with 80 to 89 kg weight took the same 
medication. Regarding females group, 33% of them who were 100 kg weight or 
above took metformin, followed by 25% of them distributed equally to two 
categories of weight namely 70 to 79 kg and 80 to 89 kg weight took the same 
medication. 
 
Original Age * How long has it been since you were first diagnosed with kidney 
disease? Circle one) * Age Current * sex Cross tabulation 
Sex 
Curren
t 
Age 
Original Age 
How long has it been since you were first 
diagnosed with kidney disease? 
Total 
1  year 
1-3 
years 
3-5 
years 
5-10 
years 
other 
Male 
30-39 
Less than 
20 
n 0 0 0 1 0 1 
% 0% 0% 0% 100% 0% 100% 
20-29 
n 0 1 1 1 0 3 
% 0% 33.3% 33.3% 33.3% 0% 100% 
Total 
n 0 1 1 2 0 4 
% 0% 25.0% 25.0% 50.0% 0% 100% 
40-49 
20-29 
n 0 0 0 1 1 2 
% 0% 0% 0% 50.0% 50.0% 100% 
30-39 
n 0 1 0 0 0 1 
% 0% 100% 0% 0% 0% 100% 
Total 
n 0 1 0 1 1 3 
% 0% 33.3% 0% 33.3% 
33.3
% 
100% 
50-59 
20-29 
n 0 0 0 3 0 3 
% 0% 0% 0% 100% 0.0% 100% 
30-39 
n 0 1 0 0 0 1 
% 0% 50.0% 0% 12.5% 37.5% 100% 
40-49 
n 1 0 0 0 0 1 
% 100% 0% 0% 0% 0% 100% 
Total 
n 1 4 0 4 3 12 
% 8.3% 33.3% 0% 33.3% 
25.0
% 
100% 
60+ 
20-29 
n 0 0 2 2 0 4 
% 0.0% 0.0% 50.0% 50.0% 0% 100% 
30-39 
n 0 1 2 2 0 5 
% 0.0% 20.0% 40.0% 40.0% 0% 100% 
40-49 
n 0 0 1 2 0 3 
% 0.0% 0.0% 33.3% 66.7% 0% 100% 
50-59 
n 2 1 1 2 0 6 
% 33.3% 16.7% 16.7% 33.3% 0% 100% 
60+ n 2 0 1 1 0 4 
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% 50.0% 0.0% 25.0% 25.0% 0% 100% 
Total 
n 4 2 7 9 0 22 
% 18.2% 9.1% 31.8% 40.9% 0% 100% 
Femal
e 
30-39 
20-29 
n 0 0 0 1 0 1 
% 0% 0% 0% 100% 0% 100% 
Total 
n 0 0 0 1 0 1 
% 0% 0% 0% 100% 0% 100% 
40-49 
less than 
20 
n 0 1 0 0 0 1 
% 0.0% 100% 0.0% 0.0% 0% 100% 
20-29 
n 1 2 1 1 0 5 
% 20.0% 40.0% 20.0% 20.0% 0% 100% 
30-39 
n 1 0 1 1 0 3 
% 33.3% 0.0% 33.3% 33.3% 0% 100% 
 
Continuing: 
Sex 
Curre
nt 
Age 
Original Age 
How long has it been since you were first 
diagnosed with kidney disease? 
Total 
1  year 
1-3 
years 
3-5 
years 
5-10 
years 
other 
Female 
 
40-49 
n 2 3 2 3 0 10 
% 0.0% 0.0% 0.0% 100% 0% 100% 
Total 
n 2 3 2 3 0 10 
% 20.0% 30.0% 20.0% 30.0% 0% 100% 
50-59 
Less than 
20 
n 0 0 1 0 0 1 
% 0.0% 0.0% 100% 0.0% 0.0% 100% 
20-29 
n 0 0 2 2 0 4 
% 0.0% 0.0% 50.0% 50.0% 0.0% 100% 
30-39 
n 0 0 0 0 2 2 
% 0.0% 0.0% 0.0% 0.0% 100% 100% 
40-49 
n 2 1 0 0 1 4 
% 50.0% 25.0% 0.0% 0.0% 
25.0
% 
100% 
Total 
n 2 1 3 2 3 11 
% 18.2% 9.1% 27.3% 18.2% 
27.3
% 
100% 
60+ 
20-29 
n 0 1 1 0 0 2 
% 0.0% 50.0% 50.0% 0.0% 0% 100% 
30-39 
n 0 1 3 0 0 4 
% 0.0% 25.0% 75.0% 0.0% 0% 100% 
40-49 
n 1 3 1 0 0 5 
% 20.0% 60.0% 20.0% 0.0% 0% 100% 
50-59 
n 0 2 2 1 0 5 
% 0.0% 40.0% 40.0% 20.0% 0% 100% 
Total 
n 1 7 7 1 0 16 
% 6.3% 43.8% 43.8% 6.3% 0% 100% 
 
Among the group of males, the patient who reported that he was less than 20 years 
old at the time of original diabetes diagnosis shifted to the next age groups (30 to 39) 
which indicated that he suffered diabetes stay for more than 10 years. Between 5 to 
10 years passed since he was first diagnosed with kidney disease.  
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Among the group of females, one of the two patients who reported that they were 
less than 20 years old at the time of original diabetes diagnosis shifted to the next age 
groups (40-49), while the other woman became between 50-59 years old, which 
indicated that the diabetes stay with them for more than 10 years. The number of 
years passed since they were first diagnosed with kidney disease varied between 1 to 
5 years. 
We can observe that 9 of the males patients (41%) and 6 of the females patients 
(55%) who were between 20 to 39 years old at the time of original diabetes diagnosis 
has become 60 years and above, and they experienced 3 to 10 years with kidney 
disease . T-test indicated that no significant differences in percentages attributed to 
gender when studying changing in age and time since experienced kidney disease 
(Sig.>0.05). 
 
4.4     Qualitative analysis of patients’ comments about their renal disease. 
Now I will focus on the Closing Remarks and Comments section on the 
questionnaire given to patients. The question asked was, "Do you have any comments 
to make regarding your condition, so it may be used in medical research? 
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  From this complex table two major areas of concern were found for non-Kuwaiti 
patients, namely. 1. Bad treatment and diagnosis - this was highlighted by 21 out of 
the 24. 2. Lack of empathy (Doctors /Nurses) and education or skill - this was 
highlighted by 20 out of the 24. 
 
Table 4.55.  Kuwaiti patients 
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From this complex table two major areas of concern were found for non-Kuwaiti 
patients. 
1. Lack of empathy (Doctors /Nurses) and a lack of education or skill – this was 
highlighted by 46 out of the 55. 
2. Poor treatment and diagnosis –this was highlighted by 41 out of the 55. 
For the sake of comprehensiveness and clarity the tables above could not include 
some of the data the patients provided. Consequently, the additional comments they 
made are marked with a letter next to each patient’s number in the table above. An 
explanation of each of these letters now are the following; 
Patients 19
A 
and 20
B 
of non –Kuwaiti patients and 45A had received a kidney 
transplant.  
For patient 19 the kidney was rejected . 
For patient 20, who was a non-Kuwaiti, he suffered from “water in his lungs” 
(pulmonary oedema) and the creatinine has increased and he was worried that he will 
suffer again from kidney failure. He mentioned that due to the carelessness of the 
physician and bad treatment also due to lack of information about diet he suffered 
from these complications. 
 Patient 45
A 
had a kidney transplant
 
and the body
 
rejected it. He mentioned that the 
physician did not mention for him which type of food he should avoid when his body 
temperature increases. When he went to the hospital the physician mentioned to him 
that his kidney had failed and that's because he did not stop eating some type of food 
and he was very upset and blamed his physician.  
Table 4.54 shows that 21 of 24 (87%) non -Kuwaiti patients gave their 
comments, and Table 4.55 shows that 46 of 55 (83%)  Kuwaiti patients gave 
their comments. These high ‘completion rates’ enables major statements to be 
made and are grouped together as areas of concern. 
The first area for concern of both 46 Kuwaiti and 20 non Kuwaiti patients was that 
the majority of the clinical workers did not have sufficiently developed skills or 
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empathy. Doctors and Nurses were commonly accused of not providing sufficient 
attention and consideration to their problems. 
The second area - was that they considered the effectiveness of their treatment to be 
either inadequate in terms of meeting their desires, or even inadequate in terms of 
healthcare standards and principles. Although the diabetic physician were caring, and 
treated /diagnosed the diabetic patient properly the majority had discovered their 
kidney problem by accident. For example the majority had kidney pain, difficulty in 
breathing, vomiting, body pain, weakness, high body temperature and in some cases 
had suffered a coma. When they went to the hospital they mentioned to them that 
they had kidney disease, the severity of which required kidney dialysis. 
One patient mentioned that she has been suffering from breast cancer and when she 
had a blood and urine test they told her that she had kidney disease.  
Another patient broke his leg and the doctor in the Alrazi hospital (orthopedic 
Hospital) mentioned to him that he had kidney disease.  
Another patient had a heart attack then discovered he had kidney failure. 
Some patients discovered their kidney problem when they travelled to another 
country for a health check-up for example UK, Lebanon and Germany. 
In another case a patient suffered from great weakness, body pain and vomiting and 
so he went his physician, described his symptoms and the physician prescribed 
paracetamol and an anti-emetic. Despite this he still did not feel well and so went to a 
hospital casualty unit, in which gave him the same medicine. He continued to take 
this medication for more than one year without any improvement so he went to 
another hospital where they mentioned that he has kidney failure 
A female patient’s blood pressure was too high but her diabetic physician did know 
what was the reason for her condition. So she went to a private hospital where they 
mentioned to her that she had kidney disease. So she went to her diabetic physician 
and she asked her to transfer her to a nephrologist in the hospital but she was refused. 
After that she had suffered from severe headaches and pain in all her body so she 
went to the casualty unit in the hospital where they transferred her to a nephrologist.    
The third area - 17 Kuwaiti and 6 non-Kuwaiti patients were worried that no blood 
analysis had been done in the diabetic clinic and this had resulted in their kidney 
disease being undiagnosed. 
The fourth area - 15 Kuwaiti and 2 non-Kuwaiti patients considered the private 
hospitals physicians were more caring about them than those in the MOH clinics 
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because their kidney disease was only made known to them through private 
hospitals. The private hospital physicians, the patients thought were empathetic than 
those in the MOH diabetic clinics because they listened to their problems. 
The fifth area - 7 Kuwaiti and 3 non-Kuwaiti patients were concerned  that the 
system did not transfer them to a dietitian and they did not know what the best type 
of food should be eaten . One patient mentioned that his kidneys failed after renal 
transplantation because he thought he had eaten ‘inappropriate food’.  
The sixth area - 6 Kuwaiti patients and 2 non- Kuwaiti when they mentioned to their 
physicians that they had kidney pain or were suffering from nausea and/or vomiting 
had had prescribed an analgesic and anti-vomiting medications. In many these 
prescribed medications were ineffective and only later they found out that they had 
kidney disease  
The seventh area - 5 Kuwaiti patients and one non-Kuwaiti patient   
Were worried that diabetic physicians in their clinics did not know how to check 
their eyes with the fundus camera, and they were not transferred to an 
ophthalmologist. Some mentioned they had bleeding in their eye and for this reason 
they went to private hospital.  
The eighth area - 4 Kuwaiti patients were concerned that the diabetic physicians did 
not routinely measure their levels of HbA1C. Some mentioned that the last time a 
blood test to check the HbA1c was done “some time ago”. 
The ninth area - was expressed by just two Kuwaiti patients who did not know 
anything about their kidney problem or about their medications and surprisingly one 
of them thought that he did not suffer from kidney disease and he was in renal clinic 
just for routine check-up. 
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Summary of the findings: 
1. The Kuwaiti patients had suffered renal disease for a mean duration of 21 years 
and 18 years for non-Kuwaitis. When the ages were statistically compared using 
Student’s t test, there was no significant difference in terms of age of onset between 
Kuwaitis and non-Kuwaitis (p-values were 0.392 and 0.082 respectively). 
 
2. The mean current body weight was 86.2 kg (SD ±17.8 kg), and the mean of weight 
at first diagnosis was 85.4 kg (SD ±20.7 kg). No difference was found on analysis. 
 
3. The BMI values were calculated and compared using Student’s t test. For the 
Kuwaiti group, it was 29.9 kg/m
2
 (SD ± 7.1 kg/m
2
) at first diagnosis and at the time 
of the study it was 31.1 kg/m
2 
(SD ± 7.0 kg/m
2
). We have no evidence against the 
null hypothesis, therefore, there was no significant difference (p>0.05). For the non-
Kuwaiti group, the BMI values were 33.0 kg/m
2
 (SD ± 6.1 kg/m
2
) at first diagnosis 
and at the time of the study were 31.5 kg/m
2 
(SD ± 5.2 kg/m
2
). Although the first 
value in the table appears to be greater than the second, due to the numerical range 
no statistical significant difference was found (p>0.05). This use of BMI instead of 
body weight perhaps was therefore perhaps not a useful comparison to make. 
 
4. The majority of Kuwaiti males and females reported that they stopped taking 
tablet medication for their diabetes (89% and 83%) respectively, while within Non- 
Kuwaiti patients it is clear that 93% of males and 80 % of females indicated that they 
do not take the medicine now. 
 
5. Although all patients had taken oral medications for their type 2 diabetes in the 
past, a large number were now receiving insulin as their primary treatment for their 
disease. In some cases they stopped both oral and insulin medications during renal 
dialysis. Kuwaiti and non-Kuwaitis tended to use insulin for different length of 
times. 
 
6. 87.3% of Kuwaitis and 91.7%% of non-Kuwaiti had hypertension. Moreover, the 
percentage of males among the two groups who had hypertension was greater than 
the percentage of female among the two groups. 
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7. 3.8% of Kuwaiti males indicated that the physician who conducted their eye 
examination was a primary care doctor, while 96.2% indicated the physician  who 
conducted their eye examination was an eye specialist. Additionally, 100% of non-
Kuwaiti males (n=13) indicate that physician who conducted the eye examination 
was an eye specialist. Moreover, none of Kuwaiti females and 10.0% of non-Kuwaiti 
females respectively indicate that the physician who conducted their eye examination 
was a primary care doctor. When this data was compared using Pearson chi-square 
test the results showed no significant association between nationality and the type of 
specialist who conducted the eye examination attributed to sex under 5% level of 
significance, since the p-values were 0.332 and 0.244.  
 
8. 77.8% and 67.9% of Kuwaiti males and females had received laser treatment for 
their eyes, while 71.4% and 60.0% of non-Kuwaiti males and females had had laser 
treatment for their eyes. 
 
9. 85.2% and 82.1% of Kuwaiti males and females indicated that they experienced a 
foot problem. Among the non- Kuwaiti group, 85.7% of males and 90% of females 
reported that they experienced a foot problem. 
 
10. 58.2% of the sample who had cardiac problems were Kuwaiti, while 37.5% were 
non-Kuwaiti. For those Kuwaiti who had cardiac problems 18 were males and 14 
female. For non-Kuwaiti ‘s there were 6 males and 3 were females. On analysis there 
is no significant association between nationality and heart problems attributed to sex 
under 5% level of significance, since the p-values were 0.210 and 0.521. 
 
11. 40.7% of Kuwaiti patients who had been told by the primary care doctor that they 
had kidney disease were males (n=11), with 25% were females (n=7). Among the 
non- Kuwaiti patients 14.3% of them were males (n=2) and indicated that they had 
been told by the primary care doctor that they had kidney disease, while 20% of them 
were females (n=2). 
 
12. Among the Kuwaiti patients, 87.3% of them (24 males and 24 females) indicated 
that they knew what is the stage of their kidney disease, compared to 75% of non-
Kuwaiti patients . The proportions of Kuwaiti and non-Kuwaiti patients who did not 
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know what the stage of their kidney disease were 12.7% and 25% respectively. It is 
worth mentioning here; the stage of kidney disease which the patients were left was 
the stage 5-kidney failure. The chi-squared test indicated no association between 
nationality and knowledge of the disease’s stage attributed to sex, since p values 
were 0.724 & 0.633 respectively.  
 
13. 27.3% and 16.7% of Kuwaiti and non-Kuwaiti patients indicated that they had a 
family history of kidney disease. 
 
14. 64 patients out of 79 indicated that they were having renal dialysis (46 were 
Kuwaiti (23 males, 23 females) and 18 non-Kuwaiti (11 males, 7 females). 
 
15. 14 of them had a kidney transplant - 6 Kuwaiti males and 5 Kuwaiti females, and 
3 non-Kuwaitis (one male and 2 females). 
 
16. 65.5% and 65.2% of Kuwaiti and non-Kuwaiti patients respectively, reported 
they had been told they were anemic. 
 
17. 69.1% and 58.3% of Kuwaiti and non-Kuwaiti patients were told that they had 
‘weak bones’. The proportion of females who had been told they had ‘weak bones’ 
was greater than males. Moreover, 60.5% (n=23) and 42.9% (n=6) of Kuwaiti and 
non-Kuwaiti patients stated that they had ‘weak bones’ for 3 years or less. 
 
18. The major area for concern of both 46 Kuwaiti and 20 non Kuwaiti patients was 
that the majority of the clinical workers did not have sufficiently developed skills or 
empathy. Doctors and Nurses were commonly accused of not providing sufficient 
attention and consideration to their problems. 
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Chapter 5 
5. Results from the examination of medical files in Kuwait. 
 
Patient files were found to be of two types: written by hand and in an electronic 
format. Of the thirteen clinics used in this study 11 had the traditional paper records 
and 2 an electronic format.  Irrespective of the type of record, for each patient the 
data was checked and since no copy could be made key facts were abstracted and 
entered on an anonymous record sheet. A summary of some of the key findings for 
all 109 patients is recorded below.  
Surprisingly, the majority of patient files were incomplete from all the clinics which 
were used for this study. Ten examples will be given of this incompleteness. 
Example 1. As an example to illustrate this ‘incompleteness’ in one patient the 
records for his blood and urine tests  for example records existed for 2012 but not for 
either 2013 or 2014.   . 
Example 2. In another patient’s file the last record of blood and urine tests which 
were carried out was for 2010 and so this suggests that no tests were done in 2011, 
2012, 2013 and 2014. Their blood values were therefore at the time of this study four 
years out of date. 
Example 3. Although many files had poor records of blood and urine tests perhaps 
the most startlingly was that found for a patient in whose file the latest records were 
those of 2002 – this is not a mistake – 2002.  
Example 4. Many files contain very few recent records of blood and urinary levels.  
In some the most recent records are from  2009 and for many other patients there are 
actually no records of blood and urine tests.  
Example 5. In many cases the weight of the patient at the time of the first diagnosis, 
and the provision of body heights were in the minority. Patient BMI calculations 
were never found in any file. 
Example 6. Some records – a minority – included details of the dietary advice given 
to patients. However for the majority this data was simply lacking.  , 
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Example 7.  Comments about the examination of the feet was absent for the majority 
of files. 
Example 8. The levels of HbA1c were very rarely recorded  
Example 9. The examination of patients’ eye using the fundus camera to provide 
data for diagrams in the patients notes or an actual photograph were extremely 
limited. Example 10. The files made no mention of whether a patient smoked or 
drank alcohol. 
After these examples a more positive finding was made in example 11. 
Example 11. It is very interesting that it was found in the files that the name of  
diabetes medications which was prescribed for the diabetic patients and also the 
name of an eye drop and eye ointments. The prescribing of eye medications was 
somewhat surprising as it was made by the diabetic physician against a background 
of not using the diabetic fundus camera or transferring them to an ophthalomologist. 
This lack of detail in the files was not expected but perhaps not unsurprising 
considering what the patients had provided in their questionnaires.  
This finding supports Al-Taweel et al., 2013 which mention " this study revealed 
incomplete documentation of patients records at both primary and secondary care 
settings. In order to insure optimum continuity of care between health and situations 
and personals attentions to adequate documentation should be encouraged. "  
Surprisingly which was found in this study about patient file disagrees with  
Al-Adsani et al., 2008 which mention that over a five study period the patients’ files 
became more organized and structured from 60 – 100% (p< 0.001). The prevalence 
of smoking assessment, eye and foot examination increased significantly from 2.8 to 
27.2% (p<0.001), 2.4 to 31.6% (p<0.001) and  0.4 to 40.4% (p<0.001) respectively. 
For microalbuminuria the figures were 4.4% to 26.4% and for HbA1c levels the 
values were 10.4 to 60.8% (p<0.001) These findings although promising led to the 
suggestion that  national diabetes educational program's required continuous 
development to improve diabetes care. 
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 And also with Al Shaheen et al., 2011, which mentions the patients score for 
complying with their treatment started with an average value of 7.5% and after three 
years had a value of 24.6%. For HbA1c the values started at a 31% adherence and at 
the end was 46.5% adherence, a change which had a p value of <0.001. This suggests 
a significant improvement in their standard of care. This study also measured 
microalbuminuria, the limits of which was set at <20mg/L, and at the end of the 
study 85.2% of the subjects had achieved this value. The highest improvement was 
for the fundus examination which at the beginning of the study was 53.5% and the 
end was 76.6%. 
Summary and Implications 
 This finding is line with the preliminary hypothesis and answered the third question 
Do patient notes provide an accurate research tool for the analysis of treatment 
strategies of type 2 diabetes patients? 
The findings made for this thesis do not support to the hypothesis that the patient 
notes provided answers about a patient’s treatment since the majority of patients file 
were incomplete and provide little detail of patient treatments. 
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Chapter 6  
6. Results from the structured interviews of Kuwaiti and UK 
physicians. 
6.1     Kuwaiti’s physicians - Introductory comments.  
In addition to the previous patient questionnaires, some surveys were conducted with 
consultants in Kuwait for additional supplementary data collection and analysis, 
regarding topics relevant to diabetes and renal failure. 
Seven consultants, four nephrologists and three ophthalmologists agreed, to 
participate in this supplementary study, providing evidence regarding the interactions 
between patients and physicians. This thereby serves to establish any links the 
findings from patients and from these physicians, contributing to a well-rounded 
perspective while further reducing the potential for bias from any area and so this 
would enhance the reliability of the data. 
These questionnaires contained only four - five questions on the insistence of the 
Kuwaiti Ministry of Health so as not to overload the consultants with extensive 
questionnaires (see Appendix 4).  
6.2     Interview Results for Kuwaiti physicians.  
What, in your clinical experience, are the major causes of kidney disease? 
Nephrologists Nephrologists Comments 
1 Provided with a variety of answers: a) blood pressure, b) diabetes, 
c) the combination of blood pressure and diabetes, and d) family 
history of kidney failure. 
Comment.  This combination of factors is commonly 
acknowledged in the world literature; with the consultant pointing 
out that the combination of such factors along with genetics sets 
patients at an especially high predisposition to kidney disease. 
2 provided similarly meaningful results for the same questions asked 
above. 
3&4 The consultants were at great pains to emphasise that in their 
opinion, diabetes was the most common cause for this condition in 
Kuwait. 
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What are the most common kidney tests which should be done? 
Nephrologists Nephrologists Comments 
1 The consultant answered stating that the most common tests were 
urine tests for protein (urinary albumin test), and blood tests for 
creatinine. 
Comment. The results of these tests are primarily used to find 
protein loss from the kidney and the glomerular filtration rate (GFR) 
both of which assess kidney function. 
2 Stated the most common kidney tests include blood tests 
(measuring build up and waste for example urea), urine tests 
assessing the protein and electrolyte levels and abdominal 
ultrasound scan were also recommended. 
3&4 The consultants answered in a very similar way to consultant 
number 1. They stated that the most common urine tests were for 
protein (urinary albumin test), and blood tests for creatinine and 
urea. 
 
 
How often the patient should be tested? 
Nephrologists Nephrologists Comments 
1  
The response was, “every six months … but if there is, for example, 
micro albumin in his urine- [they] should be tested every three 
months until it returns to a stable value when six month tests are re-
instated.” Comment. Not required as the answer was very 
comprehensive. 
2 The frequency of the recommended patient testing was every 
six months if there were no problems and three months if there were 
obvious problems. 
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3&4 The response was again very similar to consultant number 1. In 
summary, of a very comprehensive answer, it reads very like 
consultant number 1. “every six months … but if there is, for 
example, micro albumin in his urine- [they] should be tested every 
three months until it returns to a stable value when six month tests 
are re-instated.” 
 
 
How does the patient know if they have poor renal function? 
Nephrologists Nephrologists Comments 
1 “Early kidney disease doesn’t have clear and precise 
symptoms, so testing is the only way to know how the kidneys are 
working. It is important that the patient gets tested for kidney 
disease if they have the key risk factors (diabetes, high blood 
pressure, family history of kidney failure and heart disease).” 
2 “In the beginning of kidney failure [patients may] not be 
producing any symptoms, but if the kidney function decreases, this 
may produce pain in some patient change in colour of urine, 
turbidity in urine, weakness, shortness of breath, and wastes product 
in blood [leading to] losing the appetite. This will progress to the 
point where the mental function will decrease and coma may 
occur.” 
 
3&4 That it was only by using suitable tests that the physician could 
establish that patient’s kidneys were working at a normal rate. 
 
Have you ever seen a diabetic patient with a final stage of a kidney disease due 
to not being referred at the onset of the renal problems?  
Nephrologists Nephrologists Comments 
1 Yes, if the physician controls the glucose and the blood 
pressure”. He further commented in general on the reduced risk of 
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kidney complication, stating that the presence of indicators (i.e. 
micro albumin) should result in the transfer to a kidney consultant. 
Such instances have led to increased awareness initiative, but have 
not completely resolved the problem, thereby being a considerable 
factor in the continued existence of cases representing a need for 
reform or improvement. 
Comment. Not required as the answer was very comprehensive. 
2 Yes, regarding untreated patients, this physician stated final 
stage renal disease is common when inadequate treatment has been 
used and is an area in need of significant development.  He stated, 
“many these [cases] are because the diabetic is not well controlled 
by the primary care doctor. For example, if he doesn’t do a blood 
test every 6 months and even if this test is carried out, some of them 
do not transfer their patients to the nephrologist from the beginning. 
In some cases, the patients come to the hospital and they thought 
they had asthma due to shortness of breath, and when we do a blood 
test for the patient, they find they have the end stage of kidney 
disease. Some of the patients are admitted to the hospital due to 
coma, and then we find they are undergoing kidney failure.” 
3&4 Yes, many and some of them they came to the hospital and they 
needed immediate dialysis because their condition was so critical. 
This problem is extremely sad because some of them were in the 
age from 20-30 years (especially type 1). This perhaps is primarily 
related to the problem of the primary care doctors not carrying out 
suitable tests due to their knowledge of both the patient and the 
physician. Clearly some education of both parties should be 
enhanced. 
 
 
General comment common to all the nephrologists interviewed. 
All the renal consultants who were interviewed expressed the view that primary care 
doctors require a more comprehensive knowledge of the renal problems in diabetes 
in order that their patients’ treatment could be improved. 
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Ophthalmologists 
How often do you think that the diabetic patients’ eyes should be checked? 
Ophthalmologists 
 
ophthalmologists comments 
1 Annually, when there were no obvious problems, and every six 
months when there were retinal changes, and every three 
months for any ‘moderate’ changes. 
2 Annually or every six month, when there were no obvious 
problems, and every 2 to 3 months when there were mild to 
moderate change retinal changes, and every month for any" 
saver" changes. 
3 This respondent provided similar comments as the previous 
consultant, emphasising the need at all times to support the 
patient. 
 
What do you think is the best strategy to ensure that the treatment reduces the 
value of proliferative retinopathy? 
Ophthalmologists 
 
Ophthalmologists comments 
1 “The primary care doctor should check the eye of the patient by 
fundus camera…if there's any change in the retina, he should 
not prescribe any medication for the patient, so he should 
transfer him to a specialist ophthalmologist.” (Note: the fundus 
camera is a specialized piece of equipment which photographs 
the interior surface and retina showing very accurately the 
distribution of the blood vessels and any extravascular deposits. 
 
2  “The primary care doctor should check the eye of the patient by 
fundus camera…if there's any change in the retina, he should 
transfer him to a specialist ophthalmologist.” 
3 This respondent provided similar comments as the previous 
consultant. 
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How long does it take for the first diagnosis of retinopathy to progress to 
blindness? 
Ophthalmologists 
 
ophthalmologists comments 
1 The ophthalmologist provided a detailed answer for this, stating 
“if the primary care doctor controlled the blood pressure and the 
diabetes well, and if he found any changes [with the] fundus of 
the eye, he should transfer him to an ophthalmologist; [this is] 
because the diabetic patient may get problems in his eye in the 
first 10 years from the diabetes, and changes may happen as 
they age. Up to 50% of changes may happen and as the patient 
grows, more changes occur; so if the patient was transferred 
from the beginning to a retinopathy consultant, the eye will 
perhaps stay stable, and no complication will occur.” Surgery 
was also mentioned, but only as a potential solution. 
2 “If the primary care doctor controlled the blood pressure and the 
diabetes well, and if he found any changes [with the] fundus of 
the eye, he should transfer him to an ophthalmologist; [this is] 
because the diabetic patient may get problems in his eye in the 
first 5 years from the diabetes, so if the patient was transferred 
from the beginning to, an ophthalmologist the eye will perhaps 
stay stable, and no complication will occur. If the patient is not 
treated very well during two years the patient will become 
blind. 
3 “If the primary care doctor controlled the blood pressure and the 
diabetes well”. He also added that, “The high blood pressure 
and diabetes should be controlled also control the HbA1C and 
give patients Lipanthyl to decrease the eye complications.  And 
if he found any changes [with the] fundus of the eye, he should 
transfer him to an ophthalmologist; [this is] because the diabetic 
patient may get problems in his eye in the first 5 years from the 
diabetes. So if the patient was transferred from the beginning to 
an ophthalmologist, the eye will perhaps stay stable, and no 
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complication will occur. If the patient is not treated very well 
during two years the patient will become blind” 
Have you ever seen a diabetic patient with a severe eye problem due to not being 
referred at the onset of the ocular problems? 
Ophthalmologists 
 
ophthalmologists comments 
1 Here, the respondent provided similar support as the previous 
nephrology consultant, again accounting for the reality and 
potential for severe cases of misdiagnosis, and need for 
improvements in both treatments and awareness. Their response 
was “yes, this reason is because the primary care doctors need 
more training, and they need to be more [informed] about 
diabetes. Diabetes is a very serious disease and will lead to very 
serious complications in the eye so the primary care doctors 
should be more aware about these complications, and any 
simple issue in the eye must be transferred to a consultant. If the 
physician was aware about these complications, this will let the 
patient be more aware about this disease, and they should give 
out booklets about eye complications due to diabetes. Perhaps 
more TV programs should be about these complications and 
also posters should be displayed in many locations. Without 
careful analysis of their patients condition physicians should not 
prescribe any medication for the patient.” 
2 Many patients, especially the younger ones, in the age from 20-
30 years become blind and this is due to the carelessness of 
primary care doctors. He mentioned if you “believe or not that 
some physicians don’t know that diabetes cause eye problems”. 
Also the AL Bahar hospital there is a zone until there turn 
comes. Many patients have severe eye problems and they came 
to the clinic alone without being transferred by the physician. 
This ophthalmologist said he is one of the doctors who taught 
the primary care doctors to use the fundus camera in Ministry of 
Health in Kuwait. He stated that “Unfortunately due to the 
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carelessness of the physician this can cause the progress of the 
eye problem”. The primary care doctors should know “that 
diabetes is a disease of blindness". Also the Ministry of Health 
should increase the amount of inspection in the diabetic clinics. 
Nowadays some diabetic patients are aware that diabetes cause 
blindness but also the Ministry of Health should encourage 
patients more to be aware. 
3 Is “yes, he saw many diabetic patients specially type 1 and their 
age is between 20-30 and they came to the clinic alone without 
the transfer from the physician and some of them are blind in 
only one eye and the rest are close to blindness are trying to 
treat it before they get blind. Some of the diabetic women are 
pregnant”. He also reported that” he had seen severe cases and 
when he checked their eyes he understood from their eye they 
have complication in their kidney and in their heart because the 
eye is the first step of this complication”.   He recommended 
“educating the primary care doctors and we need eye assistant 
in the diabetic clinic to check the eye of the patient and of there 
are any problem with the eye of  diabetic patient they should be 
transferred to the specialist”. 
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6.3     Summary of the analysis of comments by physicians in Kuwait. 
1. Comments of nephrologists about their current experiences in treatments of 
diabetic patients with renal disease due to diabetes. Each physician made a 
number of comments which have been listed below. 
Table 6.1 Comments made by the nephrologists in this study. 
 
 
 
 
 
Key: 1*diabetes /hypertension, 2* blood /urine test, 3* primary care doctor 
skill/education, 4*patients with final stage of renal diseases, 5* inadequate treatment, 
6* patients knowledge. 
From Table 6.1 column 1, the major areas of concern were found to be similar for all 
the nephrologists who took part in the study, namely: the major causes of kidney 
disease were a) blood pressure, b) diabetes this- was highlighted by all nephrologists. 
From Table 6.1 column 2, the most suitable kidney test which should be done for the 
diabetic patients were a urine test and a blood test. The physicians recommended 
patient testing was every six months if there were no problems and three months if 
there were obvious problems like micro albumin - was highlighted by all 
nephrologists. From the results obtained from the patients this may be very difficult 
to ensure since many of them did not understand the renal problems they had and 
would not see the relevance of any tests they had to undergo. It was of interest to 
note that when the medical files were checked concerning this point  for the majority 
of patients had no records of any tests being carried out.  Comment. These tests 
were not done for the majority of the patients 
From Table 6.1 column 3, regarding primary care doctor  skill/education which has 
led to many untreated patients. These physicians stated that in their opinion, final 
stage renal disease is common when inadequate treatment has been used and is an 
area in need of significant development.  Comment. Primary care doctor 
education needs to be improved, which is also the major comment of the 
patients and UK Physicians. 
Physicians 
number 
1* 2* 3* 4* 5* 6* 
1 + + + + +  
2 + + + + +  
3 + + + + + + 
4 + + + + + + 
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From Table 6.1 column 4 & 5.The physicians stated, “They saw many of patients 
with final stage renal disease because the patients’ diabetes is not well controlled by 
the primary care doctor. In some cases, the patients have come into the hospital 
because they thought they had asthma due to shortness of breath, but after doing a 
blood test for the patient, they found they had end stage of kidney disease. In a 
number of cases, some of the patients are admitted to the hospital due to coma, and 
then they find they are undergoing kidney failure. Comment: These physicians’ 
comments were fully supported by the comments of the patients.  
From Table 6.1 column 6. Education of patients should be carried out to prevent any 
complication - was highlight by two of the physicians. Comment: The patients 
frequently made the comment that they felt their knowledge of their condition 
was inadequate. This was also commented upon by the UK physicians 
(Appendix 5&5A)  
2. Comments of ophthalmologists about their current experiences in treatments 
of diabetic patients with eye disease due to diabetes. Each physician made a 
number of comments which have been listed below. 
Table 6.2 Comments made by the of ophthalmologists in this study. 
 
 
 
 
 
 
Key: 1* frequency of eye examinations, 2* fundus camera, 3* primary care doctor 
skill/education, 4* transfer to ophthalmologists, 5* inadequate treatment,  6* patients 
education  
From Table 6.2 column 1, the major areas of concern were found to be similar for all 
the ophthalmologists who took part in the study, namely: the frequency of eye 
examinations in diabetic patients, should be according to the consultants annually, 
when there were no obvious problems, and every six months when there were retinal 
changes, and every three months for any ‘moderate’ changes. Comment: This tests 
were not be done for the majority of the patients as  determined from patients’ 
file and patients’ comments. 
Physicians 
number 
1* 2* 3* 4* 5* 6* 
1 + + + + + + 
2 + + + + + + 
3 + + + + +  
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From Table 6.2 column 2, the primary care doctors should check the eye of the 
patients by fundus camera.Comment: This was not done for the majority of the 
patients as determined from both the patients’ file and patients’ comments. 
From Table 6.2 column 3, the primary care doctors need more training, and they 
need to be more [informed] about diabetes. Diabetes is a very serious disease and 
will lead to very serious complications in the eye so the primary care doctor should 
be more aware about these complications. Comment : The patients’ thought that 
they needed greater care and the fundus camera should be used. 
From Table 6.2 column 4. The concensus view was that if any problems arose with 
vision then any simple issue in the eye must be transferred to an ophthalmologists.  
Comment: For the majority of the patients they stated that this simply did not 
happen. Also the evidence from their files shows that referral was not carried 
out. 
From Table 6.2 column 5. Many patients, especially the younger ones, in the age 
from 20-30 years had become blind and this is due to the carelessness of the primary 
care doctor and the rest who are close to blindness are trying to treat it before they 
get blind. Some of the diabetic women are pregnant with eye complications. One 
ophthalmologist also reported that he had seen severe cases and when he checked 
their eyes he understood from their eye they have complication in their kidney and in 
their heart because the eye is the first stage of the development of this complication. 
From Table 6.2 column 6. Education of the patients’, one ophthalmologist said more 
TV programs should be made and broadcast about these complications and also 
posters should be displayed in many locations to inform patients about their 
condition. Comment . The patients also stated that they were not aware of the 
complications which could occur and they needed more information to be 
provided. 
Part of the study was designed to determine what the current treatment of diabetes 
was like in the UK.   In order to compare the two systems  both of which have 
guidelines to follow which are based on International norms.  This may be 
considered to be quite selective since the hospital used for this was the Ascot Rehab 
and not a general hospital. However the hospital treated a large number of diabetic 
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patients from Kuwait. And as such they thought could provide their experiences of 
the treatments in Kuwait as clearly as the patients who were interviewed in Kuwait. 
These physicians it should be stressed were also concurrently treating both Kuwaiti 
and UK patients in bigger teaching hospitals and so their experience of diabetes is 
much larger than simply this specialist unit. (See Appendix 5&5A).   
The full details of this part of the study is shown in the Appendix rather than the 
main body of the thesis but a few background details may be usefully presented in 
this part of the thesis.  
6.4     Summary and Implications.  
The results of the two  custom questionnaires answered by seven consultants in 
Kuwait and five  consultants  in UK serves to address the potential for the bias in 
analysis, when only one or two questionnaires are obtained in a study. This comment 
is in line with the preliminary hypothesis. The capacity and observation of best 
practices appears to be sufficient for consultants, but the primary questionnaires 
reveal that numerous patient problems have developed in response to misdiagnosis or 
ignorance. The consultants acknowledged these problems and recommend improved 
training and awareness initiatives at a minimum to help local facilities reduce the 
chances of continuing trends detrimental to patient health. 
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Chapter 7 
7. Discussion 
7.1    Part A. Discussion of the diabetic patients’ questionnaires in Kuwait 
Introductory comment. 
The increasing prevalence of type 2 diabetes in Kuwait is considered by authors of 
papers about diabetes in Kuwait ‘alarming’. Many people, including Kuwaitis and 
non-Kuwaitis are diagnosed with the condition every year (Al Khalaf et al.,2010). 
With proper careful management, both by the medical ‘systems’ and also by self-
management by the patient, the diabetic state can usually be successfully managed. 
However, why patients in Kuwait have problems treating their diabetes is the central 
topic that this thesis aimed to explore.  
Diabetes Management 
Although the usual presentation of diabetes mellitus (DM) are periods of acute 
elevated blood glucose levels (hyperglycemia) it is also a chronic condition of the 
endocrine disorder. Diabetes mellitus is characterized by defects in carbohydrate as 
well as protein and fat metabolism. This condition occurs due to impairment of 
insulin secretion that can be associated with or without insulin resistance (Mellitus, 
2005).  
According to a recent publication by Inzucchi et al., (2012), the central/essential aim 
of diabetes management is to avoid the complications of diabetes, which have been 
well documented almost since the disease was first described. Consequently, the 
inadequate or lack of appropriate management of diabetes can adversely affect the 
health of patients, for example eye complications, nerve complications, renal 
complications and cardiovascular complications in addition to the increasing cost of 
treatment.  
The management of the two types of diabetes, type 1 and type 2, essentially varies 
simply because they have different fundamental causes. Whereas individuals 
diagnosed with type 1 require treatment with insulin, in order to survive as soon as 
possible after diagnosis, the mainstay of treatment for type 2 diabetes mellitus should 
be dietary control (Jain and Saraf 2010). Insulin treatments aim to mimic the typical 
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physiological insulin secretion pattern, and this is achieved by using a variety of 
combinations be short-acting, intermediate-acting, long-acting or combination 
regimens. These combinations can be sometimes very complicated but are usually 
provided against a very clear educational background for the patient.  
Although dietary control and exercise should be given priority in the initial 
management of type 2 diabetes (NICE, 2010) there are exceptions, but these should 
be expectations. For example, in severe cases of hyperglycemia in type 2 diabetes, 
insulin regimens can be used but not as first line treatments in the average patient. 
The use of insulin in type 2 patients is generally when they are obese and require diet 
control, exercise, and oral hypoglycemic agents (OHAs) have failed to bring the 
blood sugar towards normal values. It should be stressed that with strict dietary 
controls and exercise leading to weight loss, the progression of diabetes can be 
delayed or in some cases prevented. In addition, type 2 does not usually require 
insulin regimens because it is less acute as the production of insulin decrease in 
either effectiveness - due to insulin resistance - or a decline in the levels of this 
hormone over time.  During this time period, insulin can still maintain glucose levels 
until about 50 % of the β islet cells are destroyed and lost their function. The function 
of these islet cells continues to decline with time irrespective of treatment leading to 
hyperglycemia. Consequently, after their disease has been active for many years and 
the decline of these cells assumes significant numbers there may be a need for 
regular insulin therapy. Through adequate and appropriate care, both hypo- and 
hyperglycaemia and impaired glucose tolerance (IGT) may be minimsed. 
Suitable diets for diabetic patients have been the subject of a considerable number of 
reviews, and several dietary changes are usually made as part of the effective control 
plan for a patient suffering from type 2 diabetes. The National Institute for Health 
and Clinical Excellence (NICE) recommends a diet that is the same for the general 
population for management of type 2 diabetes. It includes eating foods that have a 
high starchy fiber and low in fat content especially the saturated animal fat.  The 
patients should also eat at least five portions of fruit and vegetable per day, and cut 
down on sugar and sugary foods.  Drinking alcohol in moderation, and regularly 
exercising are highly recommended since exercise improves glucose utilization, thus 
lowering blood glucose.  
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Type 2 Diabetes Management in Kuwait and UK – arrangement of structures. 
In efforts to effectively control diabetes and prevent its complications, the World 
Health Organization (WHO) encourages nations to develop programs that would 
enable them address the challenge of diabetes (WHO, 1999). Kuwait like many other 
countries have so far developed specific programs for diabetes management. In 
addition, there are established international clinical guidelines for the treatment of 
the disease one of which is very clearly described by Ceriello and Colagiuri 
(2008).The Government of Kuwait through the Kuwait Ministry of Health provides 
the overall management for diabetes free of charge to both the Kuwaitis and non-
Kuwaitis, living in Kuwaiti, by funding specific diabetic clinics (Al-Adsani, 2008). 
The diabetes services are comprehensive as the services they offer and are at three 
levels of care, namely: the primary, secondary and tertiary levels.  
The primary care services do not treat type 1 diabetics because they are treated 
exclusive in the hospital level of medical care. Consequently, these clinics only treat 
type 2 diabetics and these are described colloquially as ‘mini-clinics’. It was at these 
centers where the questionnaire studies were carried out to ensure that all the patients 
seen were suffering from type 2 diabetes and not type 1, to ensure the homogeneity 
of the sample population. The Kuwait Diabetes Care Program (KDCP) was 
developed to improve the quality of care to the diabetic patients in the primary health 
care (PHC) setting throughout Kuwait. It ensures that diabetes care is provided at the 
primary care level via several mini-clinics diabetic patients in the country. 
If required due to complications of the disease these patients can be referred to the 
hospital service which is classed being the secondary level of care for these diabetic 
patients. It was at these centers where the part of the thesis involved with the renal 
complications was carried out. 
Another level of care, which can be classed as a third type, is different from that 
provided by the Ministry of Health since these clinics are sponsored for employees 
by the individual companies such as Kuwait Oil Corporation (KOC).  
This system is different to that found in the UK, which also the responsibility of the 
central government to provide adequate care to its citizens. It achieves this by 
providing universal access to care to all sections of the population in UK through the 
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National Health Service (NHS) (Mainous et al., 2006). In 2001, the Department of 
Health published the National Service Framework for Diabetes. It sets out minimum 
standards for proper diabetes care and treatment targets for management of blood 
sugar, blood pressure, and cholesterol so as to reduce the risk of developing diabetic 
complications (Department of Health, 2001). The standards include nine basics of 
care that allow early detection of complication signs such as blindness and kidney 
disease. The National Institute for Care and Excellence (NICE), an NHS 
organization, provides clinical guidelines for the management of chronic conditions 
such as diabetes. 
Comparative Treatment Guidelines and Treatment Studies 
Due to the potential complexity of the condition and its consequences if not treated 
correctly for both the individual and the health care services of any country, then the 
NICE guidelines have been devised to try and optimise care.  
It is true that treatment guidelines vary internationally and regionally, and can even 
vary within the nations, depending on the nature of treatment and facilities. For 
example, the same standards and procedures of care may be comprehensive in the 
UK for diagnostics, testing, and/or referrals. For surgery, if the latter this is necessary 
for severe complications such as gangrene, guidelines may be given but the precise 
nature of advice or preferences for specific types may vary. For medication(s) the 
advice tries to encompass a wide range of severities and so may vary between 
patients National Audit Office (NAO, 2012). However the guidelines still attempt to 
try and standardize medications even though this is dependent upon many patient 
factors which may be impossible to standardize such as duration, intensity and 
severity of the disease. All of these considerations have financial implications. For 
example, the NAO (2012) reported that the cost of diabetes treatments in the UK had 
risen from just under £1 billion in 2007 to over £1.3 billion in 2010. Although it 
should be stressed that these were only estimates and they suggested it was very 
likely that they were actually less than the real figures. Consequently, including the 
costs of medications, inpatient care and outpatient care, the NAO (2012) estimated 
the cost in 2010 was closer to £4 billion. The following figure presents percentages 
of registered patients treated throughout ‘care processes’ in the UK published in 
2012.  
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Figure 7.1. Trends in UK diabetic patient care (NAO, 2012) 
The data shown on this bar chart is very interesting. Not unexpectedly, 98% those 
registered patients received 1 ‘care process’. This figure only dropped to 90% when 
they received 6 ‘care processes’. The figures then slightly declined to 86% for 7 ‘care 
processes’, 76% for 8 ‘care processes’ and 49 % received 9 ‘care processes’. 
Consequently, this intensive number of ‘care processes’ which the diabetic patients 
have received is reflected in the cost of their treatment as mentioned above.  
 
The NAO report ( NAO,2012) also states that the greatest needs for improvement in 
the UK treatment are those which test for early signs of limb, eye, and kidney 
damage, while the costs incurred to address such damage are significant in the UK. 
The most common testing processes used to assess patient response to treatment 
were blood pressure tests and cholesterol tests, which were used in 94 percent of 
patients. These trends are similar in the United States, but comparative frequency of 
tests are not commonly discussed  in the developing nations; for example, testing is 
much less common in Africa, and considerable less common in Kuwait (IDF, 2012; 
NAO, 2012). The NAO (2012) reported “significant variation” in health care 
procedures across primary care facilities, and stated:,  
“the proportion of people with diabetes receiving all nine basic care 
processes ranged  from less than 10 percent in two primary care trusts up to no 
more than 69 percent in any  primary care trust”… (NAO, 2012) 
They then further commented that: 
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 Some areas of England will have significantly more patients at risk of 
diabetes than  others, but the Department cannot fully explain the variation of 
differences in local  populations, socio-economic factors or local spending on 
diabetes services … It is therefore likely that diabetes services are being affected by 
how local services are organised and managed, and their effectiveness” (NAO, 
2012).  
The report also had some very interesting findings which they presented using the 
following figure which shows some of the standards achieved for people with 
diabetes. 
 
 
Figure 7.2. Treatment standards in the UK (NAO, 2012) 
The data shown in Figure 9.2 is perhaps a little unexpected since only 16% of the 
patients had all the routine tests for HbA1c, Cholesterol and blood pressure. Even 
more unexpected perhaps was that only 14% were routinely checked for the HbA1c 
levels.  
 
Other earlier studies have shed light on the nature of treatment in the UK, implying it 
is comparable to universal treatment in other developed countries, with matching 
technological potential that exceeds the capacities in some other nations. Khunti et 
al., (2007) conducted an extensive review of studies of quality in UK diabetes care, 
using articles published between 1999 and 2006. The people involved in the selected 
studies (n = 83,098), with the researchers noting an inclination towards improving 
processes and positive outcome. Overall, the study found that the quality of care 
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established through developmental efforts was high, while there have been 
improvements in both outcome and process measures recorded in publications across 
the 21
st
 century. Three years later, Gale (2010) published a study about UK primary 
care, noting major increases in consultations between 1997 and 2007, while drug 
costs nearly doubled, from £391 millon to £740 million, during the same period. 
With this, however, the costs of glucose management were less than a third of the 
total cost. The author concluded “previous reports from primary care in the UK have 
been encouraging. The proportion of patients with a diagnosis of Type 2 diabetes and 
an HbA1c below 7.5%, for example, reportedly increased from 37.8% in 1997 to 
54.9% in 2007: 
'… the most likely explanation is that the reported improvement in glucose 
control is because of earlier detection and more aggressive management of those in 
the earlier states of Type 2 diabetes” (Gale, 2010).  
However, in those patients with advanced pancreatic beta cell failure who did have 
similar access to being monitored and treated  they were not therefore able to benefit 
in the same way that less advanced cases were able to do, which reflects on the 
improved benefits of the treatments over the  past decade by monitoring the HbA1c 
values. 
More recently, Dalton et al., (2011) studied relationships between practice traits, 
patients, and exclusions from quality indicators for diabetes; here, the authors 
focused on the impact of the Quality and Outcomes Framework established in the 
UK, examining the aforementioned relationships across their first three years of 
relevance in the operations. Here, the electronic medical records of diabetic patients 
from 23 practices were assessed, and exclusions and three outcome indicators were 
assessed in the care provided. The results lead the authors to conclude that patients 
excluded from ‘pay-per-performance’ programs were less likely to reach the goals of 
treatment, while they are also more commonly from ethnic or disadvantaged groups; 
with this, the authors also concluded that allowing physicians to exclude patients can 
exacerbate health complications.  
 
Education should now be considered to be an increasingly understood ‘factor’ in the 
treatment of diabetes ,as well as the challenges in implementing the necessary 
understanding and isolating the causes which make it difficult to help an individual 
with type 2 diabetes. For example, Lackdar and Gill (2005) described aspects of 
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diabetic complications that are important to be addressed by education which is 
worth quoting at length since it has some very interesting findings within it:  
“improvements in diabetes care and education for individuals with diabetes 
and their relatives in developing countries has reduced mortality rates from acute 
metabolic complications of diabetes to near Western standards. Examples include 
improved diabetes care in Soweto, South Africa, led to a reduction in mortality rates 
from hyperglycaemic emergencies from 25% to 10%. The mortality rate from 
diabetic ketoacidosis is reported as 2% in Libya, 3% in Tunisia, and 4% in Saudi 
Arabia whereas no deaths we recorded among 150 Kuwaiti children who presented 
with DKA” (Lackdar and Gill (2005).  
Meanwhile, education programs in schools and awareness initiatives established 
through medical facilities or other organisations continue to attempt to improve 
understanding, but the details and scope of these programs vary greatly; there is no 
standard, even at regional levels, for informing children of the potential that they 
may have diabetes. However, general nutrition and health education that facilitate 
reduced chances for diabetes commonly mention the potential for it to manifest as a 
consequence of bad diet. Parents are also increasingly targeted with this information, 
as well as symptom and prevalence information amid the epidemic (Lackdar and 
Gill, 2005; IDF, 2012).  
Studies in Medication 
Studies focusing on medication provide a background of the developmental attempts 
and achievements in this specific area of treatment, which have revealed 
improvements in some areas but ‘lingering barriers’ for treatment in others. 
Additionally, such studies have revealed trends in operations in the UK, shedding 
light on the nature of developmental trends, outcomes, and demands.  
A recent study by Currie et al., (2010) studied prescription behaviour in the UK from 
2000 to 2008, using open source data from four UK pricing agencies. Changes in 
dispensing were assessed for diabetic patients, showing a rise in costs from £290 
million to £591 million across the specified time span, i.e. 2000 - 2008. With their 
analysis, the authors found that all of the medication types used for reducing glucose 
levels (with the exception of alpha-glucoside inhibition and prandial regulations) 
exhibited a reduction in volume, while the cost of insulin alone rose from £128 
million to £286 million.  
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The greater use of insulin may reflect the findings from the NAO (2012) that only 
14% of patients had a routine check of their HbA1c levels and this low value may 
have resulted in more acute use of insulin to bring control back to acceptable levels.  
 
Overall, the increase in cost for diabetic patients is asserted to be 7 percent of the 
entire NHS budget, while the authors concluded that changes were likely to be 
induced by commercial influences rather than clinical ones. Currie et al., (2010) also 
concluded that dispensing patterns should also be better controlled to facilitate cost 
containment. In a related study, Hsia et al., (2009) examined the rises in diabetic 
medication for young people in the UK, noting that increases had been observed in 
the US without comparable data for the UK. Acknowledging rises in both type 1 and 
2 diabetes in the UK, but also acknowledging that more specific statistics are 
challenging to obtain (while the majority of statistics are only estimates anyhow), the 
authors aimed to estimate the rises in insulin and oral drugs between 1998 and 2005. 
This study found that medication use increases with patient age, considering a 
sample of 505,754 children, also concurring substantial and epidemic increases in 
both patient and medication quantities. Gale (2010) further concurred that medication 
costs have increased, with insulin prices rising 48.4 percent between 2000 and 2008; 
the author reported that opinions regarding routine use of the drug is needed in type 2 
cases, asserting the majority of analysts feel this is only necessary for those who have 
actually experienced hypoglycaemia (and multiple times). Overall, these studies have 
shown that the changes to the medical system have not reduced the onset of diabetes, 
have not changed much in terms of outcome despite changes in treatment, while drug 
expenses per patient and overall continue to increase in the UK.  
Complications of diabetes 
Diabetic complications exist and are variable in their onset and outcome, but further 
illustrate the significance of the ‘diabetes epidemic’, which is highly relevant to the 
UK, in spite of the advanced state of its medical facilities and programs. According 
to the NAO (2012),  
“People with diabetes are at significantly increased risk of serious health 
problems … the overall life expectancy for people with type 1 diabetes is reduced on 
average by around 20 years and approximately ten years for people with type 2 
diabetes. In January 2012, the Department of Health estimated that 24,000 of the 
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75,000 people that die each year with diabetes, die early from causes that could 
have been avoided through managing their condition better (I have added the bold 
characters)” (NAO, 2012)  
With this, it is known that diabetes can damage both blood vessels and nerve cells, 
leading to deteriorations of the cardiovascular systems, eyes, feet, kidneys, and can 
exacerbate other conditions. As a consequence of such changes occurring, diabetics 
are up to five times more prone to strokes and heart attacks (Figure 7.3), and diabetes 
is the leading cause of ‘end-stage’ kidney disease or failure. Roughly half of foot 
amputations in the UK are for diabetics, while diabetes is the most common cause of 
blindness outside of the senior age group (NAO, 2012). The following figure 
presents the nature of other complications resulting from the onset of the disorder.    
 
Figure 7.3: Diabetes complications in the UK (NAO, 2012) 
The NAO (2012) further reported: 
 “the rates of diabetes-related complications, such as kidney disease, 
amputation and eye disease, are used as a measure of the final outcomes of care. 
With the exception of diabetic ketoacidosis … the complications associated with 
diabetes can take a number of  years to develop, and therefore indicate the 
quality of long-term care. Diabetes-related complications can lead to complex and 
costly treatment and significantly impact on quality of life” (NAO, 2012). 
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 Meanwhile, ketoacidosis can cause potentially fatal complications, if not medically 
treated. In the UK, while the frequency of diabetes induced heart failure, eye disease, 
and amputation have been stable since 2004, the frequency of ketoacidosis and 
kidney failure have progressively increased. Recently, the American Diabetes 
Association (2012) reported statistics about complications increasing despite 
developed healthcare facilities for its treatments, reporting that 60 to 70 percent of 
patients have mild to severe forms of damage to their nervous systems.    
Treatment of the condition in both Kuwait and UK includes diet control, exercise and 
home-based glucose monitoring. Additionally, a person should change their lifestyle, 
diet, and monitor their weight when diagnosed with type 2 diabetes. However, oral 
medications with or without insulin are recommended in some cases and 40% of 
diabetic patients may require insulin treatment at some time. Since diabetes is a 
progressive degenerative condition, medicines are introduced at an appropriate stage 
and then have to be used long term (Diabetes UK, 2010). These treatments include 
tablets, insulin injection or combination of both. According to Peyrot et al. (2005), 
insulin is not recommended as a first line of treatment in managing type 2 diabetes as 
it can result in early insulin resistance. 
General information from the questionnaires. 
The findings of the studies reported in this thesis have leant support for the published 
findings in the literature which have shown that diabetes is an increasingly major 
health problem in Kuwait. This study has resulted in a range of other very interesting 
findings that are not immediately apparent from the literature. One such finding was 
that  some diabetic physicians in Kuwait still recommend insulin for initial treatment 
of type 2 diabetes. Furthermore, those patients who had been diagnosed with protein 
in the urine were not aware that they had renal problems because they were not 
informed what such findings actually meant. 
The study considered findings in relation to the nationality, gender, weight, height, 
body mass index, current age of the patient, age of diagnosis, and the complications 
of a large patient group in Kuwait. These patients because they were randomly 
chosen from the ‘mini clinics’ not unsurprisingly include both Kuwait citizens and 
non-Kuwait citizens, both groups of whom were treated at the centers. Out of the 
total volunteers, 62 were Kuwaitis whereas 47 were non-Kuwaitis. Regardless of 
their nationality, females form the largest group of those diagnosed with diabetes. 
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The significant number of the type 2 patients were diagnosed in the age range 40 - 44 
years accounting for 25.7% of those diagnosed. In this group, the average age at 
diagnosis was 41 for both citizens and non-citizens. This is the same as found by Al-
Sultan & Al-Zanki, (2005).  However, at the time of this study those over 60 years 
formed the largest number of diabetics (31.2%). This does agree with the findings of  
Al-Sultan & Al-Zanki, (2005), perhaps explainable by them using a different number 
of subjects between Kuwaiti and non-Kuwaiti. The findings of Abdella et al., (1998) 
similarly found that more patients were found across the age range 20-59 than in any 
other age groups. On average, the Kuwaitis had survived with the disease for about 
14 years from the time of diagnosis whereas for the non-Kuwaitis it was 9 years.  
With a mean age of diagnosis at 41 years old, three assumptions can be made. The 
disease started earlier, diabetes is diagnosed more quickly, and/or the onset is earlier 
in Kuwait than other countries or the patients are referred to specialist clinics more 
quickly. These will be considered later. 
Consideration of Body Mass Index values (BMI) 
The observation that the patients mean body weight and BMI had reduced from the 
time of diagnosis, with men losing more weight than women could be attributed to 
diet modifications as well as exercise that promotes use of excess calories or perhaps 
it is just an inherent feature of the disease. The results show that by the time of 
diagnosis with type 2 diabetes, the majority was moderately obese, overweight, and 
severely obese accounting for 39.4%, 22.9% and 27.5% of the diabetic patients 
respectively. Very few people with normal and below normal weight developed type 
2 diabetes (8.3% and 1.8% respectively). This finding suggests diabetes type 2 is 
directly linked to obesity and through appropriate lifestyle modifications it can be 
prevented (Klein et al. 2004) The prevalence of obesity in relation to diabetes in 
observed patients was in line with WHO (2006) BMI figures (Figure 7.4) For 
example in the results above the mean BMI for the group of the patients studied has 
for males29.5±5.33 kg/m
2
 and for females 32.3±5.19kg/m
2
. These results are very 
closely comparable to those of Al-Sultan & Al-Zanki, (2005) who found values of 
27.8±6.3 kg/m
2
 for men and 32.5±5.1 kg/m
2
 for females. Clearly for both males and 
females the mean were in the zones of the overweight and obese.  
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This findings of the patients who participated in the study being either overweight or 
obese may reflect the dietary pattern of the subjects since obesity in general has been 
found to be especially prevalent in Kuwait due to the culture being less conducive to 
exercise, very high ambient temperatures, common car usage even for short 
distances, walking is very difficult due to temperatures, and gyms are very expensive 
in Kuwait. On one occasion on a visit to one of the diabetic clinics there was 
displayed a poster encouraging people to do exercise. One of the suggestions for 
diabetic patients was that they should bicycle for a period of time to reduce their 
body weight. What was not clear on the poster is how this could be done at summer 
temperatures of more than 45
o
C or how this was to accommodate the cultural 
limitations of ladies in Kuwait (see Appendix 12). 
In addition, there is a practise to ingest large quantities of food with a high 
consumption of dates, afternoon naps, and even fast food eaten in the middle of the 
night. Furthermore high starch foodstuffs are staples of common meals for example 
rice, potatoes, bread and pasta many of which are often eaten in great quantities. A 
further complications, which is more likely in women than in men, is that the 
lifestyle of society expects that women will spend most of their time within their 
houses so decreasing their possible opportunities for physical activity is made even 
less likely by many families employing maids to carry out domestic duties.  
As described in the literature review (Chapter One), dieting is typically regarded as 
relevant to diabetes if the patient is intentionally controlling their consumption of 
calories, or if they are following professional instructions in some other way in how 
the food they consume should be eaten. Awareness and initiatives to the described 
conducive elements of culture could serve to curb some of the problem. Dieting in 
this manner is considered beneficial in relation to diabetes, while the opposite level 
of consumption (poor eating habits) is generally considered to be somewhat 
conducive to complications in diabetes. This is aside from the inherent sugar 
consumption, while other factors promote a deterioration of health and exacerbation 
of diabetes onset or development. The health and exercise expressed by patients 
reflected either a lack of specific awareness, or a lack of motivation to achieving 
better health (even with the potential consequences in their diabetes.)  
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Figure 7.4: Body Mass Index Chart WHO (2006) (Public Domain) 
Current state of type 2 diabetes management in Kuwait 
Despite the existing guidelines or standards of care for diabetic patients, some 
diabetic physicians in Kuwait still recommend insulin for the initial treatment of this 
condition. It is true there may be some severe states in which this is necessary to 
bring about a very rapid and careful reduction of the blood sugar levels. However 
this cannot really apply to the number of patients in the sample who underwent this 
form of therapy.  This non-adherence to standard guidelines does not only result in 
poor patient outcomes, can be potentially dangerous, induce a loss of insulin 
sensitivity and finally cause a greater loss of financial resources. It was most 
interesting to find that 9.2% (n=10) of the respondents had received insulin regimens 
as the first recommendation after their diagnosis. 
Kuwait is not alone in suffering the complications of diabetes and other countries, 
including the UK, have also experienced high rates of diabetic complications. 
Suggestions have been made in the UK that these problems are made worse by the 
patients’ lack of adequate education in managing their conditions, inadequate care 
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and support by the NHS professionals also contribute to this scenario (Hojat et al, 
2011). In the data gathered in Kuwait for this thesis many of these same factors 
which affect the quality of care received by the diabetic patients was present in both 
countries. 
Strategy for drug treatment in Type 2 Diabetes 
Apart from the occasions where insulin was recommended as a first line of treatment, 
the majority of the patients were initially prescribed oral therapy, 72.6% of Kuwaitis 
and 81% of non-Kuwaitis. However, in some individuals, if oral medication was not 
effectively controlling their symptoms they were given insulin. At the time of this 
study, some of the patients had used insulin for less than one month .Despite the fact, 
that apparently more females than males used insulin to control diabetes, on analysis 
no significant difference in insulin use according to sex and nationality was found . 
 Synopsis of patient experiences of using insulin for the correction of Type 2 
diabetes in Kuwait 
There are two types of insulin misuse which were found in Kuwait.  In this thesis, 
insulin was found to have been used as a first line of treatment for type 2 diabetic 
patients for 4 Kuwaiti and 6 non-Kuwaiti diabetic patients. One Kuwaiti patient 
mentioned that their physician prescribed insulin for her as a first line of treatment 
but she used it for 3 days only because she fainted as a result a severe low blood 
sugar.   
The other three patients, at the time of the study, were still using insulin and they had 
all suffered from severe hypoglycemic episodes. One of them mentioned that he had 
had episodes where he lost consciousness as he was driving a motor car, the 
seriousness of which can be very easily understood.  
One non- Kuwaiti patient, whose diabetes could not be in any way classified as being 
‘critical’  mentioned that her physician prescribed  insulin for her and was done for 
the convenience of once a day dosage. She used it for six months during which time 
she suffered convulsions due to her hypoglycemia, and after these episodes she spoke 
with her physician and he changed her medication to tablets.  Another patient was 
dispensed a prescription of insulin and he stopped using it after 3 days because he 
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went into a coma. Another two patients had insulin prescribed for them and they 
stopped it after 2 days because they he went into coma. Two other patients still used 
insulin but they frequently suffered from periods of severe hypoglycemia  
Surprisingly, all of these patients with this experience of insulin were not transferred 
from the physician to the dietician as would perhaps been expected.   
Secondly, the diabetic physician replaced tablet medication with insulin with no 
reason   
One of the examples is a Kuwaiti patient's physician prescribed for her insulin for a 
week and she suffered from severe hypoglycemia. After that she spoke with her 
physician and he changed it again to tablets. The original change to insulin had been 
done for the convenience of once a day dosage. 
A second example is for a Kuwaiti patient who was taking oral hypoglycaemic 
medication. He visited the physician and when checked his blood glucose had 
increased to 144 mg/dl (8.0 mmol/L). No measurements of HbA1c were made at the 
time. His diabetic physician then prescribed for him insulin and he took it for 3 days. 
During this time he felt tired and he went to another physician who he told him that 
his blood glucose was not high and he didn’t understand why the other physician 
prescribed insulin. 
A third example is for a non- Kuwaiti who was taking oral medication who was then 
placed on insulin. During the first week of this treatment he went into a coma. After 
that episode the tablets were reinstated.  
About   3.6% (n=3/109) of the respondents their primary care doctor had replaced 
tablet medication with insulin with no reasons provided to the patient. A further 
9.2% (n=10/109) were put on insulin regimens as the first recommendation after 
their diagnosis. The example from Poland and the other example above, gives a 
cumulative total of total 12.8% (n=14/109) they used insulin against the guidelines.  
In none of these cases were they ever referred to a dietician to aid in their insulin 
therapy. 
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 The cases above highlight the problems experienced by both Kuwaiti and non-
Kuwaiti patients who had been placed on insulin therapy. In the UK NICE has 
published guidelines on the correct use of this hormone which state: 
The National Institute for Care and Excellence (NICE), an NHS organization, 
provides clinical guidelines when the diabetic patient uses Insulin "When starting 
insulin therapy, use a structured programmed employing active insulin dose 
titration that encompasses: − structured education  
− continuing telephone support  
− frequent self-monitoring  
− dose titration to target  
− dietary understanding  
− management of hypoglycaemia  
− management of acute changes in plasma glucose control  
− support from an appropriately trained and experienced healthcare 
professional." (NICE, 2010) 
  Surprisingly, all these conditions were simply not met in Kuwait. In fact one patient 
gave the following example of his treatment using insulin. 
The patient was diagnosed as having a high blood sugar level. He was prescribed 
insulin, but not taught where or how to use it properly. He returned to the physician 
who when he checked the blood sugar and found it high stated that he was uncertain 
as to why the blood sugar even in the presence of insulin should be still too high. 
This patient only found out by accident how to properly use insulin when he visited 
Polish hospital and somebody took the time and trouble to show him exactly where 
and how to use it. As a consequence of him using the insulin incorrectly his blood 
sugar was brought down to acceptable levels. Quite simply, simply because of poor 
understanding of the necessary technique, his blood glucose always remained high 
due to faulty technique and so dosage.   
Insulin is a potent and effective way of controlling diabetes but special 
considerations need to be made. The standard insulin regimens must be tailored to 
individual patients and depend on:  lifestyle, willingness to achieve the best control 
and ability to cope with injecting insulin and subsequent careful blood glucose 
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monitoring. The two types of insulin regimens used to control diabetes include 
mealtime plus basal regimen and the twice daily regimens (Ashwell et al., 2006). 
The mealtime regimen is the best for managing type 1diabetes and mimics normal 
physiological insulin release more closely than other regimens. It requires meal time 
injection of insulin with fast-acting preparations preferably an analog (lispro/aspart) 
plus one or more injection of basal insulin (Ashwell et al., 2006). The advantage of 
this regimen is that it offers the most flexibility in dosing and eating habits and 
provides better blood glucose control. It also has its disadvantages. It requires 
multiple injections that may go up to 5 times during the day and requires regular 
blood glucose monitoring, which many patients might not be able to achieve thus 
reducing compliance (Home & Kurtzhals, 2006). 
In contrary, twice daily regimens are the alternative for those not able to manage 
meal time regimens.  It uses re-mixed insulin of short- or rapid-acting plus 
intermediate-acting insulin. Currently, regular human insulin mixes and analog mixes 
are available for diabetes management. The regular human insulin combinations 
should be given 30 minutes before breakfast and 30 minutes before evening meals. 
On the other hand, analog mixes should be given immediately before meals because 
the analogs have a faster onset of action than the regular human insulin. Human and 
analog insulin are only available for parenteral administration. As an alternative 
inhaled insulin was developed and made available. However in practice it was less 
than successful and withdrawn. So, the subcutaneous route is still the major route 
used, and the site of injection includes the abdominal wall, buttocks, thighs and arm 
because they are readily accessible.  The IV route of insulin can be used for special 
circumstances such as in the management of diabetic ketoacidosis, hyperosmolar 
states and patients who are due for surgery (De La Rosa et al., 2008). 
Treatment and Medication use 
At their first diagnosis, the majority of the patients were prescribed tablets and then 
some (9.2%) moved to insulin. Single or combined medication were given with the 
highest number receiving metformin alone (n=35) and on a percentage basis this is 
equivalent to 57.1% and 42.9% for Kuwaiti and Non-Kuwaiti respectively. 
Combined metformin and gliclazide (n=17) was in 47.1% and 52.9% for Kuwaiti and 
Non-Kuwaiti respectively. Metformin and glimepiride (n= 8) was 62.5% and 37.5% 
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for Kuwaiti and Non-Kuwaiti respectively. Other drugs and drug combinations were 
used less commonly for the management type 2 diabetes. It was also found that some 
Kuwaitis could control their condition with diet, whereas non-Kuwaitis could not. 
This is highlighted by the finding that out of the entire study group only 5 Kuwaiti 
patients, one male and four females were able to control their diabetes through diet 
alone.  
The majority of patients received for their first line treatment ‘tablet medication’ 
72.6% for Kuwaiti patients and 80.9% for non-Kuwaiti. In the group designated as 
the first line treatment of diet and exercise only, the figures were 1.6% Kuwaiti and 
0% and non-Kuwaiti patients respectively.  For diet alone the figures were 8.1% 
Kuwaiti and 0% non-Kuwaiti patients.   
Consequently, in those patients where dietary control cannot effectively control their 
diabetes, then tablet medication(s) is recommended. This can be a single drug or a 
combination of various classes of drugs. It is imperative to note that exercise and 
proper diet still plays a significant role in disease management and, therefore, should 
form part of the management process. It is imperative to note that exercise and 
proper diet still plays a significant role in disease management and, therefore, should 
form part of the management process to enhance ‘seamless care’ of patients 
condition. However, insulin injections can be used if the current treatment fails to 
manage the condition (NICE , 2010).  The NICE guidelines state very specifically 
the following criteria. 
"• Provide individualised and ongoing nutritional advice from a healthcare 
professional with specific expertise and competencies in nutrition. 
• When setting a target glycated haemoglobin (HbA1c): − involve the person in 
decisions about their individual HbA1c target level, which may be above that of 
6.5% set for people with type 2 diabetes in general  
− encourage the person to maintain their individual target unless the resulting 
side effects (including hypoglycaemia) or their efforts to achieve this impair 
their quality of life  
− offer therapy (lifestyle and medication) to help achieve and maintain the 
HbA1c target level " (NICE, 2010) 
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In the Arab world and in Kuwait particularly there are many cooking methods and 
spices which produce high calorie food as the diet has been influenced by other diets 
including Iranian, Indian, and more recently the American ‘diet’. The problem is 
complex as the gender and age of the diabetic person must be also taken into 
consideration when deciding on an adequate calorie intake. (Allawi, 1997)  
What Should a Diabetic Person Eat?  
A diabetic person living in the Arab world, and specifically in Kuwait, faces many 
challenges when it comes to choosing the correct diet. There are various food choices 
cooked by different methods and a diabetic has to make careful decisions about the 
type and quantity of food that is consumed. The organization of the meal quantities, 
types and timing are very important as are the age and the gender of the diabetic 
(Allawi ,1997).  
Three Important dietary factors to be considered by the diabetic: 
 1. Meal Timing. 
The type of meal suitable for a type 1 diabetic depends on their age and their 
working hours, and it is highly recommended that the meal is eaten 10-30 minutes 
after the insulin injection is taken. Patients that work at evening shifts get their main 
meal in the evening others that work from 8am -5pm get their main meal during the 
day.  
 In contrast, type 2 diabetic patients that use oral hypoglycaemics mainly focus on 
weight reduction and eating less food after 6 pm. The meals during this period focus 
more on vegetables and salads made with lemon and vinegar. Chicken, fish, or low 
fat meat can be eaten as also can eat fruits which is recommended due to their high 
fiber content which helps in digestion and contains high amounts of vitamins and 
other trace elements. (Allawi, 1997) 
2. Type of Nutrition. 
As discussed earlier there is no one, comprehensive specific diet for a diabetes 
patient as it depends on many factors such as the patient’s gender, age, weight and 
working hours. The diet also depends on the treatment method (insulin injections or 
oral hypoglycemic tablets). Diets for diabetic patients can be classified into eight 
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main groups, within each group examples of food that the diabetic person should stay 
away from and examples of the replacements are also given. (Allawi, 1997) [See 
Table 1 in Appendix 13] 
3. Quantity of food and fluid to be taken daily.  
Nutritional advice is centred around calorie and vitamin and mineral intake. For 
example:  
Proteins: (Animal and Plant) - each gram of proteins provides 4 calories 
Carbohydrates: (sugar and flour) - each gram of carbohydrates provides 4 calories, 
alcohol provides 7 calories per gram 
Fats:  (Animal and Plant) - each gram of fats provides 9 calories. 
Vitamins and Minerals - these are considered nutritional supplements that do not 
provide any calories, they are very important to the human body and misusing them 
leads to many health problems. (Allawi, 1997) 
The tables in the Appendix 13 show the number of calories provided by the Arabic 
diet, for common types of Arabic appetizers such as Kubbah and stuffed vegetables, 
and Arabic main courses such as rice specialties, soups and deserts.  A diabetic 
person living in the Arab world faces many dietary challenges as the majority of 
foods are cooked with either plant or animal fats. The majority of appetizers in 
Kuwait are either fried with oil or cooked with fats. Main courses include rice with 
chicken, meat or fish. Table 2 in Appendix 13 are important to consider by diabetes 
patients     
Patients’ knowledge of their diabetes, its management and complications. 
The understanding of the patient about the condition, medications use and 
therapeutic outcomes can significantly improve the quality of care 
 " … Offer structured education to every person and/or their 
carer at and around the time of diagnosis, with annual 
reinforcement and review. Inform people and their carers that 
structured education is an integral part of diabetes care. … 
"(NICE, 2010).                                                                                               
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However, the majority of the patients in this thesis had a medium or low awareness 
of diabetes complications, plus they failed to monitor their blood sugar regularly and 
some could not even remember their medications name. Only 3.2% and 2.1% of 
Kuwaitis and non-Kuwaitis respectively had a high awareness of the complications 
of diabetes whereas the rest had a low or medium awareness. This lack of knowledge 
about diabetes is probably reflected by the results in which poor management with 
subsequent acute and chronic conditions was found. This is exemplified by the eye 
and renal problems of which they are unaware.  According to Inzucchi et al., (2012), 
“hyperglycemia and hypertension are the two major controllable factors that 
influence development of diabetic complications, and they can be prevented if 
good management occurs from an early stage”. 
Diabetic emergencies can be either acute or long-term complications. The three acute 
emergencies of diabetes include hypoglycemia, diabetic ketoacidosis and 
hyperosmolar non-ketotic hyperglycemia. The chronic complications are broadly 
categorized into micro- and macrovascular depending on the blood vessels affected. 
Macrovascular complications are caused by damage due to atherosclerosis of the 
blood vessels that may lead to occlusion and /or platelet activation. The risks of 
macrovascular occlusion include cardiovascular disease(s) (CVDs) and peripheral 
vascular disease (PVD) (Deedwania & Srikanth, 2008). On the other hand, the 
microvascular complications include nephropathy, retinopathy, and neuropathy. 
In a comprehensive study by Deedwania & Srikanth (2008) they state that CVDs are 
the most common cause of death in cases of type 2 diabetes mellitus and the risk is 
increased further if nephropathy is also present. Two common types of 
cardiovascular diseases in diabetes are coronary artery disease (CAD) and 
cerebrovascular illnesses or even stroke with women reporting higher cases of 
cardiac problems than males (Deedwania & Srikanth, 2008). In a earlier paper by 
Soedamah-Muthu et al., (2006) they observed, that stroke caused a greater mortality 
and morbidity in diabetic patients as compared with the general population. 
Hypertension is also twice as common among diabetics as compared to the general 
population, and it affects over 80% of people with type 2 diabetes. Since 
hypertension is associated with macro and microvascular complications, its treatment 
target ranges are lower for diabetes (ACCORD Study Group, 2010). For people with 
type 2, hypertension is a feature of metabolic syndrome X, which is associated with 
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insulin resistance. However, for those with type 1, it is closely associated with 
retinopathy and renal disease (Alberti et al., 2005).  
Peripheral vascular diseases also affect the blood vessels of diabetics and affects the 
arteries of the legs and may give rise to a ‘clumping pain’ experienced in walking. 
This pain results from reversible skeletal muscle ischemia secondary to the 
atherosclerosis (Aulivola et al., 2005). Affected iliac vessels can cause pain and also 
erectile dysfunction. It is vital to note that peripheral vascular disease increases the 
risk of cardiovascular disease and it is also associated with diabetic foot problems. 
Thus, better management of peripheral vascular conditions can significantly reduce 
or prevent the progression of cardiovascular disease. 
Renal complications 
The study found that 77.4% of Kuwaitis and 70.2% of non-Kuwaitis were aware of 
kidney complications, though they did not know the significance of the presence of 
protein in the urine. Most of the kidney problems had developed 2-3 years after their 
initial diagnosis.  According the NICE guidelines the physician should discuss with 
patients about present of protein in the urine and he should mention for them about 
this complication, but in Kuwait this did not happen. The text of the NICE guidelines 
simple states: … "Discuss the significance of a finding of abnormal albumin 
excretion rate, and its trend over time, with the individual concerned" (NICE, 
2010). 
The renal complications or nephropathies are microvascular complication of diabetes 
mellitus causing a reduction in glomerular filtration rate (GFR) and a loss of protein 
into the urine. The presence of nephropathy is indicated by the presence of a small 
amount of albumin in the urine (microalbuminuria). In higher amounts, it is referred 
to as proteinuria. This may progress to end-stage renal disease and so require 
dialysis. In order to avoid these effects, early diagnosis of nephropathy by measuring 
GFR is essential (Gross et al., 2005). High blood pressure is a common risk of 
developing nephropathies, and in the study group, 69% of Kuwaitis and 61.7% of 
non-Kuwaitis had hypertension with females reporting a higher number of cases. 
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Drug usage 
 In addition to their anti-diabetic medications, 87% were aware of the 
antihypertensive drugs they were taking. The Kuwaitis could easily afford to treat 
their hypertension as they are covered by the comprehensive Kuwaiti health care 
system as opposed to non-Kuwaitis for whom cover is restricted to the drugs below a 
certain price and who could buy the necessary expensive medications if they wanted 
to, but due to their cost many did not do so. Tight control of both the glycemic levels 
and blood pressure significantly reduces the risk of developing nephropathy. In 
concurrent conditions of hypertension and nephropathy seen in type 2 diabetes, the 
treatment of choice is the angiotensin converting enzyme (ACE) inhibitors such as 
captopril or adrenergic blocking receptors (ABRs). They are the best medications 
because they have been shown to provide renal protective effect in addition to their 
antihypertensive effects (Rahman et al., 2005). 
Nerve complications 
Only 17.7% of Kuwaitis and 14.9% of non-Kuwaitis patients were aware of the 
nerve complications or neuropathies. This was a surprising finding since diabetic 
peripheral neuropathies can lead to a broad range of sensory, motor and autonomic 
symptoms. The most common type of nerve complication is that known as the distal 
sensory type that is particularly evident in the feet. It manifests first of all as a loss of 
sensation that can progresses to a complete loss of feeling. Painful diabetic 
neuropathy is another manifestation of sensation neuropathy which can be extremely 
disabling. Muscle pain is common and may require opiate analgesics (Mayo Clinic, 
2015). On the other hand, autonomic neuropathy may affect any part of the 
sympathetic or parasympathetic nervous system commonly shown in man as diabetic 
impotence (Freeman, 2007). The neuropathies of the gastrointestinal tract result in 
digestive complications such as diabetic diarrhea which is common and can be 
troublesome as it tends to occur at night (Freeman, 2007). Freeman also states that 
gastroparesis may cause vomiting, and delayed gastrointestinal transit and variable 
food absorption causing difficulty in the insulin-treated patients. Consequently some 
of the study patients described some of the conditions listed above, such as stomach 
pain, without actual realising that they were describing nerve complications of their 
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diabetes. Only 15% were aware of this complications suggesting that there are 
profound educational requirements of the sufferers of diabetes in Kuwait. 
Eye complications 
Another serious and irreversible microvascular complication of diabetes is 
retinopathy. Blurred vision is a common problem in diabetes, and over 95% of the 
patients in this thesis were aware of this problem and 88.7% of Kuwaiti patients and 
87.2% of the Non- Kuwaiti patients had this condition. Further, a decreased clarity of 
vision was a problem in 88.7% of Kuwaiti patients and 80.9% of the Non- Kuwaiti 
patients. From Table 4.61, 41.9% of Kuwaiti indicated that the specialist who 
conducted their eye examination was a diabetes specialist, while 58.1% indicated that 
the specialist who conducted their eye examination was a non-diabetes eye specialist. 
A value of 47.8% of non-Kuwaiti indicated that the specialist who conducted the eye 
examination was a diabetes specialist, while 52.2% indicated that the specialist who 
conducted the eye examination was a non-diabetes eye specialist. Most the eye 
specialists are in private hospitals. So most diabetic physicians did not examine 
patients’ eyes, which is against NICE guidelines:                                                   
…  " Arrange or perform eye screening at or around the time of 
diagnosis. Arrange repeat of structured eye surveillance 
annually. Explain the reasons for, and success of, eye 
surveillance systems to the individual and ensure attendance is 
not reduced by ignorance of need or fear of outcome." … (NICE, 
2010) 
This lack of eye examination is not due to a lack of suitable equipment or facilities 
since all the diabetic clinics in Kuwait contain a special room to check patients’ eyes 
using a fundus camera. Surprisingly, many of these rooms were found to be locked 
and not used by the large majority of diabetic physicians. That this was the case has 
been established by information from the patients’ files and also by what patients 
actual said had occurred. Furthermore, the ophthalmologists also said that this was 
the case.   
 
Diabetic retinopathy is the leading cause of blindness in people less than 60 years of 
age (Mohamed et al., 2007). It is symptomless until the disease is far advanced, and, 
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therefore, regular screening is required in diabetic patients for those found 
susceptible to this condition. ‘Tight’ glycemic control and blood pressure control 
reduce the risk of developing retinopathy. When it is detected early, the affected sites 
may be saved by laser photocoagulation. In advanced cases, more intensive types of 
surgery may be required (Chavala et al., 2009).  
 
Foot problems 
Foot problems are also another common complication of diabetes, which the 
majority of the patients were aware of. They are often associated with particular 
problems of having diabetes such as sensory and autonomic neuropathy, peripheral 
vascular disease (PVD), and hyperglycemia. Poor foot care and poorly controlled 
diabetes are also contributory factors.  Despite this well-known problem it was 
surprising that the feet of the majority of patients had not been examined on a regular 
basis. Fortunately, foot ulcers were 4.8% in Kuwaiti patients and 2.1% in non-
Kuwaiti patients.  
Female patients who had a foot problem did not know the reasons why, but one 
woman described the pain in her feet as ‘like needles being inserted into the foot’ 
especially after walking for either short or long distances. Another woman said that 
she had severing itching in both feet, which disturbed her ability to sleep and 
walking. In one far more severe case, a woman had had half of both feet amputated 
due to diabetes, thus making walking impossible so making her immobile. In 
addition, she also had ulcerated infected areas on her upper and lower legs which in 
Kuwait were going to be treated by amputation. However despite her difficulties the 
woman made her way Thailand where she was successfully treated without recourse 
to amputation. 
From these patient experiences, diabetic feet complications can be devastating and 
diabetic foot ulcers are prone to infection, with the pathogens mostly implicated 
being Staphylococci and Streptococci with anaerobic microorganisms commonly 
infecting wounds with an ischemic component (Al Benwan et al., 2012). These 
authors stated that infected diabetic foot ulcers account for the largest number of 
diabetes-related hospital stay and are the most common causes of non-trauma causes 
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of amputations. Proper patient education on foot care and management of wounds is 
essential to minimize the occurrence of diabetic foot ulcers. 
Hypoglycemia and hyperglycemia 
The patients also experienced acute complications such as hypoglycemia and 
hyperglycemia where 56.5% of Kuwaitis and 51% of non-Kuwaitis had experienced 
hypoglycemia with the warning signals of nausea, numbness, anxiety, dizziness and 
headache among others. It adversely affects the lifestyles of many patients, and if, 
not managed, it can be fatal. 
In diabetes, hypoglycemia is defined as a blood sugar level of 3.5mmol/L or less 
(Diabetes UK, 2010). It can occur both in insulin treatment and oral hypoglycaemic 
agents especially the longer-acting sulfonylureas such as glibenclamide. It is caused 
when the doses of insulin and/or insulin oral secretagogues are increased (NICE, 
2010) and with a reduced carbohydrate intake, increased exercise, and excessive 
alcohol consumption (Diabetes UK, 2010). Symptoms of hypoglycemia can be due 
to an effect on the autonomic system (caused by adrenaline) or neuroglycopenic 
effects that affect the brain Autonomic symptoms are sweating, tremors, tachycardia, 
pallor, and hunger. Neurologic symptoms, on the other hand, include loss of 
concentration, drowsiness, confusion and coma (Mellitus, 2005). 
Usually, the normal physiological response by the autonomic system to 
hypoglycemia is to alert the person to eat carbohydrates. Failure of an individual to 
act on these symptoms or if unaware may lead to further drop of blood glucose levels  
causing neuroglycopenic symptoms – which occurs when the brain is starved of 
glucose. At this time, the patient requires assistance to correct the hypoglycemia 
(Mellitus, 2005). In some cases, the patient loses the sensation to associate the 
symptoms produced by the autonomic nervous system and, therefore, is not ‘alerted’ 
so as to correct the hypoglycemia. This condition is known as hypoglycemia 
unawareness. It is a problem especially for those who are on insulin and may 
necessitate more frequent blood monitoring (Governor & Armstrong, 2015). The 
causes of hypoglycemia unawareness include long duration of diabetes, autonomic 
neuropathy, excessive alcohol consumption and other concurrent medications such as 
beta blockers.  These drugs cause loss of adrenergic warning signs with the exception 
of sweating (Governor & Armstrong, 2015). Even though, they are not 
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contraindicated in diabetes, alternatives such as verapamil and diltiazem should be 
used if hypoglycemic unawareness becomes a problem (Governor & Armstrong, 
2015). Hypoglycemia is treated by giving oral glucose to the patient who can 
swallow safely without the risk of aspiration. If this is not possible, parenteral 
treatment of either intravenous (IV) glucose or glucagon should be given.  
Ketoacidosis 
When asked about their knowledge of ketones and urine test for ketones, the majority 
of the patients did not know what these agents or the tests actually were. Fortunately, 
in this group of patients, ketoacidosis was rare. The reason for this is that diabetic 
ketoacidosis (DKA) is usually only a common occurrence of type 1 diabetes and is 
demonstrated by hyperglycemia and metabolic acidosis with the presence of ketones. 
In this condition the blood glucose level is usually more than 22 mmol/L. Since 
insulin is absent in type 1, the normal restraining effect on lipolysis is eliminated. As 
a result, the fatty acids are released into circulation for transport to the liver for the 
production of acetyl-CoA for production acetone, acetoacetate, and hydroxyglutarate. 
These compounds are then released into the circulation, and the patient’s breath may 
have a fruity odor of acetone (Cotter et al., 2013). 
The hyperglycemia associated with DKA lowers plasma volume due to osmotic 
diuresis resulting in postural hypotension causing dizziness and weakness (Nugent, 
2005). There is also an increased loss of potassium ions through urinary excretion 
causing further weakness. The produced ketones from the Krebs’ cycle irritate the 
vomiting center in the brain, thus responsible for vomiting in diabetes. In addition, 
ketoacidosis exacerbates dehydration and hyperosmolality by producing anorexia, 
nausea and vomiting (Nugent, 2005). The rise in plasma osmolality causes impaired 
consciousness with coma in approximately 10% of the cases. In an attempt to restore 
acidosis, the metabolic acidosis stimulates the respiratory center giving rise to deep 
and rapid breathing (Cotter et al., 2013). 
The trigger factors of ketoacidosis in type 1 diabetes include ‘omission’ of insulin 
dose, acute infection, trauma and myocardial infarction (American Diabetes 
Association, 2008). DKA can be treated by fluid replacement, usually 0.9% normal 
saline, and for the correction of hyperglycemia and presence of ketones by infusing 
soluble insulin and prevention of hypokalemia due to loss of potassium ions. Apart 
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from hyperglycemia and metabolic acidosis, other tests for determining the extent of 
ketoacidosis include urinary electrolytes, arterial paO2 and paCO2, arterial pH and 
bicarbonate ions (Nugent, 2005). 
Another common type of acute diabetic complication is the hyperosmolar non-
ketotic hyperglycemia (HONK) (American Diabetes Association, 2008). It occurs in 
type 2, especially in middle-aged and elderly people. In HONK there is no ketone 
production and, therefore, no severe acidosis. Hyperglycemia occurs gradually over 
time resulting in osmotic diuresis with subsequent dehydration. In severe cases, it 
leads to hyperosmolality that may increase blood viscosity and increase the risk of 
thromboembolism (Diabetes UK, 2010). The diagnostic features of HONK are 
hyperglycemia or glucose greater than 55.5 mmol/L, hyperosmolality, and mild 
metabolic acidosis. Successful treatment is fluid replacement to stabilize the blood 
pressure, which improves the circulation and urine output. Normal saline is given, 
and blood pressure is monitored. IV insulin is given but not ‘aggressively’ because 
fluid replacement is enough to lower plasma glucose level. Potassium may also be 
added if required (Jerreat, 2010) 
Warning signals 
The majority of the patients in this thesis had had warning signs of hyperglycemia: 
blurred vision, dizziness, drowsiness, dry mouth, fatigue, headache, hunger and 
frequent urination, increase of thirst, nausea, shivering, sweating, and increased body 
temperature. Additionally, the blood glucose level rises to 300mg/dl or more than 
180mg/dl and heart beats increases. 
These warning signals of hyperglycemia are due to the osmotic effects. Fatigue 
results from the inability of the cells to utilize glucose and produce energy (American 
Diabetes Association, 2008). As an alternative to energy source, proteins and fats are 
broken down resulting in weight loss. Blurred vision is a consequence of severe 
osmolality that may reduce intraocular pressure causing lenses deformity and visual 
disturbances (American Diabetes Association, 2008). Sometimes prodromal signs of 
a hyperglycemia crisis occur. A dry skin is also common, due to the dehydrating 
effect by osmotic diuresis (American Diabetes Association, 2008). 
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Glycosuria, the presence of glucose in urine, occurs when the blood glucose exceeds 
the renal threshold, and as a result, large quantities of glucose are excreted in the 
urine. Since glucose provides favorable growth medium for perianal microorganisms, 
diabetic patients are susceptible to the urinary tract infections (UTIs) (Geerlings, 
2008). 
Blood sugar monitoring 
Monitoring blood glucose levels is an effective way of evaluating the diabetic state to 
ensure it is being controlled. According to Diabetes UK (2010), understanding the 
ranges of blood glucose level is useful in diagnosis and self-management of diabetes. 
The average blood sugar level is about 4mmol/L and immediately, after a meal it can 
temporarily shoot up to 7.8mmol/L. However, the regulatory controls restores blood 
glucose levels to a range of 4.4-6.1mmol/L. In type 2 diabetes the normal range of 
glucose is 4 – 7mmol/L (Diabetes UK, 2010). Most of the patients in this thesis did 
not know their blood sugar levels and only realized a drop when it reaches below 
60mg or 3.3mmol/L – a potential risk for convulsions and comas. The study also 
found some patients had developed a diabetic coma and this had affected them to a 
significant extent. Some reported that they could not move, walk, do anything or 
even not check on their children and homes after going to a coma. In addition, they 
suffered drowsiness and nervousness; they always felt fatigued, weak, sleepy, angry, 
and more often, they had to take sick leave from their work. 
These problems of low blood sugar reflect the failure of the patients to regularly 
monitor their blood sugar. A major finding and one to seriously worry about is that 
the majority of the patients had never checked their blood sugar within the last 
month, despite the fact that it can be done accurately and simply at home. There are 
several ways of monitoring blood sugar. Blood or urine test can be used at the 
doctor’s office or home using test strips and meter. Even though, strips and meter can 
be used at home by the patients, most preferred visiting their doctors because they 
did not understand how to use them. Some patients had mentioned that they did not 
check their levels even though they all had meters because they were worried about 
what levels they would actually find in their blood.  A further complication was that 
HbA1c levels were rarely measured which would have provided useful information 
for both the patient and the physician to optimise an individual’s treatment. Clearly, 
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educational opportunities exist for the measurement and recording of blood glucose 
values. 
Treatment guidelines and other similar studies 
The international standards of diabetes management place a lot of emphasis on the 
provision of suitable patient advice on diet, exercise, weight loss and smoking 
cessation, if appropriate. However, the results of this study indicate that the majority 
of the patients were not in a weight management program, failed to do exercise as 
required and some were smokers as well as drinking alcohol. Only 3.2% of the 
Kuwaiti patients and none of the non-Kuwaitis were on a weight management 
program. In addition, there were many cases of preventable complications that 
increase the cost of the health care as well affecting the patient’s quality of life. 
Failure of the physicians to comply with the clinical guidelines and the lack of 
patient awareness among the diabetic patients can be largely being blamed for all 
these outcomes. Other studies have also been done in Kuwait to evaluate how these 
factors have adversely impacted on the diabetes management in Kuwait. 
Al-Adsani et al., (2009) found out that the majority of patients failed to monitor their 
blood glucose levels and in addition, were not aware of their dietary requirements 
and self-management. These factors were attributed to illiteracy, old age, low 
income, smoking and negative family history of diabetes. They recommended 
educational programs that would empower those with low income and individual 
with low educational level to effectively manage their condition. Two year later, 
Awad (2011) conducted a study to determine how diabetic patients’ knowledge 
influences the therapeutic goals and the factors associated with the correct 
knowledge. Their findings showed that lack of knowledge about the therapeutic 
goals, recent levels of blood pressure, low-density lipoprotein and glycated 
hemoglobin, (HbA1c) was a challenge to the better management of diabetes. Thus, 
they recommended for the need of a multi-disciplinary team to provide patient 
education and encourage patient education and self-care. 
The same year, Alshaheen et al., (2011) studied how adherence to standards of care 
could influence the diabetes management and found out that compliance with 
standard practice of care significantly improved patient management outcome. This 
provides valuable information useful to both the medical staff and the patients when 
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evaluating their efforts on glycemic control and its complications. The authors used 
four treatment indicators to determine the compliance rates to the standard of care by 
both Kuwaitis and non-Kuwaitis type 2 diabetics. They studied the glycated 
hemoglobin (HbA1c), low-density lipoprotein, microalbuminuria (MA), and fundus 
examination (FE). These indicators were measured at the beginning and the end of 
the study. They found that Kuwaitis had better control of their LDL than the non-
Kuwaitis and that increased compliance significantly improved the outcome of the 
identified indicators, with microalbuminuria having the best control and the least 
being HbA1c.  
Kuwait Diabetes Society 
Surprisingly, the data found in this thesis could not be reconciled with the aims and 
objectives of the Kuwait Diabetes Society. This organisation has a precise set of aims 
on its Web site but the evidence obtained from 109 patients these were never 
commented upon. They suggested that they provided many very useful facilities for 
the diabetic patients - low cost blood glucose meters and educational campaigns. 
Against this background none of the patients ever commented that they had used the 
services of this organisation, read their written material or used their screening 
capabilities for HbA1c or eye tests. The Society also stated they ran courses for 
physicians which if they could be persuaded to attend such courses may improve 
both their theoretical knowledge and empathy with their patients. Also they may 
stimulated to complete patient files so ensuring all their patients receive a continuity 
of care which at the moment because the rudimentary data in the files is impossible 
to achieve. 
Patient care 
Patient involvement is crucial for the successful management and minimizing 
diabetic complications. Successful education depends on the individual patients and 
the availability of local resources. Individual education should start soon after 
diagnosis. Later, group training can be effective, and many patients appreciate and 
find support in meeting others who have the same disease. Not only patients should 
be educated but the involvement of the patient’s family and caregivers is also 
essential. Patient education/ information should cover many areas of their condition 
including: the disease, its signs, symptoms, hyperglycemia and hypoglycemia (signs, 
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symptoms, and treatment). Knowledge and information about these topics would not 
only enable the patients to identify the complications but also manage them 
effectively whenever they arise. The need for exercise and its benefits and effect on 
blood glucose control should be stressed. Dietary advice should be of top priority 
highlighting foods rich in fats to avoid high cholesterol levels and the essential nature 
of dietary fiber. 
For patients taking one or more of the oral hypoglycemic agents they require 
knowledge of the time to take their medications so avoiding the complications 
arising from failing to take the drugs at the right time.  In addition, those on insulin 
therapy should be taught the correct injection techniques, how to store their insulin 
and to be aware of the onset and peak actions so enabling them to use insulin 
appropriately and monitor its effects. Home blood glucose testing is of significant 
importance when monitoring diabetes and patients should be made aware of the need 
for regular monitoring their blood sugar levels. Urine testing would help in 
identifying comorbidities such as kidney disease. 
Foot problems are common in diabetes so appropriate foot care is essential in 
preparing patients on  how to care for their foot such wearing appropriate foot ware 
and proper hygiene which could  significantly reduce foot problems necessitating 
amputations. 
They should be made aware of the cardiovascular risk factors such as smoking, 
hypertension and obesity. Avoiding smoking and controlling weight to prevent 
cardiovascular disease and the correct way to use their antihypertensive medications 
would be helpful. Regular medical and ophthalmological examinations is also critical 
to enable the doctor to identify any complications early enough to instigate the 
appropriate treatments so improving their prognosis. 
Discussion of the open question answered by diabetic patients. 
In the Closing Remarks and Comments section on the questionnaire was an open 
question to which the majority of the patients contributed some very useful ideas.  
As a way of an introduction to this section a few preliminary comments may be 
useful. 
The responses from the diabetic patients clearly show that they felt that there were 
significant ‘treatment deficiencies’ existing in the management of their type 2 
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diabetes in Kuwait. These’ treatment deficiencies’ included: a lack of enough 
knowledge about diabetes, its complications, and treatment by both the physicians 
and their patients. They thought this fundamental lack of knowledge adversely 
affected the nationwide management of their condition and in particular, the outcome 
to them, and the patients. It is upon their concerns that the following discussion 
focuses and on the challenges that affect diabetes treatment in Kuwait so as to be 
able to formulate a number of recommendations for the better management of type 2 
diabetes in Kuwait. 
 
The two major concerns of both the Kuwait and non-Kuwait patients were a) the lack 
of empathy among the caregivers and b) the inability of the physicians to use the 
fundus camera for an eye examination which are provided by the Ministry of Health 
in all the Diabetics Clinics. Both of these areas of concern the patients thought, 
showed a lack of crucial skills in the management of their diabetes.  A similar 
viewpoint was expressed in a study by Hojat et al., (2011), who strongly suggested 
that all physicians treating any disease including diabetes, should understand and 
share the patients' experiences as doctors’ empathy significantly improves the 
clinical outcomes of the diabetic patients. They wrote: 
  "Patients of physicians with high empathy scores were significantly more likely 
to have good control of hemoglobin A1c (56%) than were patients of physicians 
with low empathy scores (40%, P<.001). Similarly, the proportion of patients 
with good LDL-C control was significantly higher for physicians with high 
empathy scores (59%) than physicians with low scores (44%, P< .001)" (Hojat et 
al., 2011).  
So patients in the Kuwaiti diabetic clinics, had caregivers which did not provide the 
needed compassionate care which may result in a poor prognosis because as Hojat et 
al., (2011) have shown empathy significantly improves the clinical outcome of 
diabetic patients. This lack of empathy was more common in the Ministry of Health 
(MOH) clinics than in either the private hospitals or the Kuwait Oil Company (KOC) 
hospital.  
One reason to account for this difference between the Ministry of Health Clinics and 
the private facilities may simply be that the number of patients a physician has to see 
in MOH clinics in a given time is vastly more than in the private medical facilities. 
Furthermore in the MOH clinics there are a limited number of specialist diabetic 
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physicians and each doctor sees a great many patients and there is simply not enough 
time necessary for creating good physician-patient relationship. When I attended 
such clinics to collect the data for this thesis, many of these clinics had to see 
approximately 70 patients in a morning session. These clinics are clearly therefore 
extremely busy. 
 As a result of the patients feeling that they have not received enough medical care, 
many patients opted to seek services in the expensive private hospitals where 
physicians were more caring about their patients and well medically specialized in 
the treatment of diabetes. Some patients claimed that they would collect their 
medication from a MOH Clinic (free of charge) and then see a doctor at a private 
hospital where payment is required. So although empathy is needed in diabetes care, 
perhaps sometimes it can go too far. In this thesis examples were cited when a 
patient requested a change of medication, based on the recommendation of a fellow 
diabetic, it was agreed to, which may have been inappropriate for that particular 
patient but was done simply to accommodate the patient’s wishes. 
  
The other major patient concern was the lack of eye tests. This important and 
justifiable concern for regular eye screening should be mandatory in the management 
of diabetic condition since it helps in preventing eye complications (Obrosova et al., 
2010). On the contrary, the results of this research revealed that most of the patients 
had neither been screened for eye problems by their diabetic physicians nor referred 
to an ophthalmologist for an eye examination. This perhaps reflects the possibility 
that the majority of the diabetic clinic physicians lacked or knew little about using a 
fundus camera to examine the eye, this despite every clinic having such a camera for 
their use. Consequently, this tool should be available and used by the primary 
diabetic doctor for eye exam before referring the patient to an eye specialist for 
further evaluation. In the UK, NICE clinical guidelines for the management of type 2 
diabetes (NICE,2014) recommends eye screening at around or at the time of the first 
diagnosis. It further recommends for repeated structured eye surveillance annually 
depending on the findings of the first diagnosis as well as referral to an 
ophthalmologist. 
  
A third area of concern for many patients, perhaps not the same number as for 
empathy and eye monitoring, was the prescribing of drugs for their condition as 
 228 
 
improperly prescribed medication were common. In most cases, these included 
medicines that were either ineffective in controlling diabetes or had adverse effects. 
They also failed to inform the patients of the type and purpose of their medications, 
thus falling short of the required healthcare standards and principles. For example, in 
addition to receiving drugs associated with allergies, some patients were put on 
unnecessary hypolipidemic drugs. They only came to know about their drug 
regimens when told by the pharmacists which shows the value of patients’ 
understanding of their medications. Thus, the pharmacists could in the future play a 
critical educational role in diabetic management team because of their knowledge of 
the appropriate drugs. 
 A fourth area of concern, was although the patients knew that some blood tests were 
important  and necessary for management of diabetes, most patients admitted that 
their blood levels for HbA1c had not been monitored for a long time. HbA1c levels are 
not recommended for diagnosis of the diabetic state because it takes a long time to 
form, that is three months (Cohen et al., 2010), but it is useful in monitoring if blood 
glucose levels are controlled. It should be determined every two to six months until 
the blood glucose level is stable when it should be done at six-month intervals 
(NICE, 2014). In addition, rare or lack of blood analysis in diabetic patients’ results 
in the development of otherwise preventable complications such as renal failure due 
to hyperlipidemia. 
 
The final area of concern was about the correct diets of diabetics. Because of the role 
dietary control plays in diabetic management, a dietitian is an important member of 
the diabetes care team. However, some patients said they had not ever been referred 
to a dietitian which might be the cause of the poor eating habits in some patients as 
well as food and digestion problems. Other methods used by the patients for 
treatment of diabetes are use of a Chinese medicine costus and myrrh. Costus oil 
causes narrowing of the airways – an effect that lowers blood pressure, thus used in 
the management of hypertension in diabetic conditions. On the other hand,( Lotfy et 
al., 2006) observed that myrrh can be used in the treatment of infected wounds in 
diabetic patients when combined with honey and bee propolis. 
 
Clearly much remains to be done to satisfy patients concerns about their treatment. 
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7.2    Part B. Kidney Patients interviewed in Kuwait hospitals. 
 
As has previously been explained, this chapter was used as a marker in term of poor 
quality of care of diabetes in Kuwait which causes severe complication such as 
kidney disease and that could have been avoided through managing the patient’s 
condition better. The evidence of poor quality of care has been fully supported by the 
statements provided by the diabetic patients with final stage reveal disease and their 
physicians during the interviews. The interviews conducted have suggested that 
many of the diabetic patients reached the final stage renal disease because the 
patients’ diabetes is not well controlled by the primary care doctors. It was also 
observed that the patients’ notes, which provide details about a patient’s treatment, 
were incomplete and had little detail of patients’ treatments. 
 
As mentioned earlier , the treatment standards in the UK NHS are no different than 
Kuwait as only 14% of the patients in UK had HbA1c routine test and that will cause 
severe complications such kidney disease. About 7,400 people with end stage kidney 
disease in the UK due to diabetes (NAO, 2012). This requires dialysis and currently 
(2016) 20% of those receiving dialysis are diabetics (Kidney research.org.,2016)  
 
The  lack of a national kidney data records is a critical issue in the Gulf Cooperation 
Council (GCC). Available data does not provide accurate and updated estimates of 
the current situation. Additionally, given the growing burden of chronic kidney 
disease (CKD) confirmed in this thesis the importance of preventive strategies. 
Others have mentioned    there is a need for more studies to describe the 
epidemiology of ESRD and to assess the overall quality of care of the kidney 
(Hassanien et al., 2012). The prospective study by El-Reshaid et al., (2005), on 
chronic renal disease in Kuwait, stated that 24% of patients with chronic renal failure 
had as their main etiological factor, diabetes mellitus. 
 
This difference, between Kuwait and UK, may be due to the much higher prevalence 
of   obesity among the population of MENA Region, higher than in the population of 
other region such as European Region. The change of lifestyle such as poor diet, 
poor physical activity and the absence of routine screening in younger people, and a 
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reduced awareness in these younger people could lead to an increase in both diabetes 
and impaired glucose tolerance. The same source suggests that early diagnosis is the 
key for diabetes in the MENA Region (Majeed et al., 2014). The comparative 
prevalence in 2013 of diabetes mellitus according to the International Diabetes 
Federation (IDF) for Kuwait as compared with the UK was much higher 23.1 % and 
4.92 % respectively (IDF, 2013). Most Kuwait patients may do not comply with the 
treatment and most of the patients may come very late. For all these reasons they 
may lead to severe complication such as renal failure.  
So from the studies which have been conducted for this thesis the better use of 
HbA1c along with better glycaemic control and attempts to control hypertension and 
dyslipidemia plus greater empathy of the physicians and better education of the 
patients may help to overcome these problems.    
  
The results of the questionnaire for aspects of kidney disease related to diabetes for 
all 79 patients who took part is given in Appendix 3, in the Hamed Al Essa and 
Mubarak Al-Kaber Hospitals, Kuwait provided some interesting findings. The 
questionnaires reveal patterns in those who have kidney disease, kidney dialysis and 
transplants, as regards to their diabetes, in terms of its diagnosis, relevant symptoms, 
medication, healthcare processes and overall treatment. This research seeks support 
to the primary aim of the thesis to investigate whether further research to improve 
diabetic care within the nation is necessary.  
Body Mass Index calculations 
Body Mass Index (BMI) calculation enables an optimal body weight for an 
individual to be suggested ( Tchernof & Despres, 2005) And in this group 38% of the 
patients were overweight as their BMI was between 25 -30kg/m
2
 and 27.8% were 
moderately obese as their current BMI was between 30-35 kg/m
2
. The Kuwait 
diabetics had gained weight from their first diagnosis as their mean BMI rose from 
29.9 (first diagnosis) to 31.1(currently). In contrast, the non-Kuwait patients lost 
weight, their average BMI of 33.0 first diagnosis falling to 31.5. However the 
position is complicated, as females gained weight, mean BMI of 32 (first diagnosis) 
to 33.4 at the time of the study, whereas men lost weight. The study also found that 
the percentage of Kuwaiti patients of average weight was much greater than that for 
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non-Kuwaiti (25.5% versus 8.3%), while the percentage of non-Kuwaiti patients who 
were severely obese was higher than for Kuwaiti (41.7% versus 25.5%). 
Based on the population mean BMI (n=79), of 30.8(first diagnosis) and 
31.2(currently), we can confidently conclude that the patients gained weight. It is 
interesting to note that despite the side effects of gaining weight, some researchers 
argue that the mortality of patients on hemodialysis increases with an increased BMI 
However, according to my understanding it will depend on whether the increased 
BMI is due to again in adipose tissue or muscle mass. 
 However, weight gain among the patients can predisposed them to nephrolithiasis. 
Insulin resistance is common in obese patients, through feedback mechanism the 
body produces more insulin leading to hyperinsulinemia, (Mariappan et al., 2014) 
and this altered insulin sensitivity leads to mis- metabolism that finally leads to 
nephrolithiasis, formed especially from calcium oxalate. In addition to insulin 
resistance there is an altered ammonium ion production and this causes 
hypocitraturia which changes urinary pH linking in with an increase in body weight 
being inversely related to urinary pH. The total effect leads to defects in acid 
secretion by the kidney as hypocitraturia is directly linked to calcium nephrolithiasis. 
Weight gain may also lead to an increase in uric acid excretion and also oxalate due 
to a rise in endogenous oxalate metabolism. Kidney stones may cause painful 
micturition and haematuria(Shavit et al., 2015).According to Abona & Samhan 
(2006), patients are advised to record their daily weight and blood pressure, 
especially if they are taking antihypertensive medication and visits their physician if 
they have gained more than one kilogram in a week. Such practice did not appear 
common with these patients, as there was a general lack of communication between 
physicians and patients. This should be encouraged to improve patient care.  
 
Stage of kidney diseases. 
The kidneys play a vital role in many body systems including the regulation of acid-
base balance, excretion of urea, drugs, and fluid homeostasis. Additionally the 
kidneys also produce the hormone erythropoietin and actively participates in the 
metabolism of vitamin D, calcium and phosphorous. These functions are 
compromised when they are diseased and chronic kidney disease caused by structural 
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abnormalities leads to gradual failure to perform its vital roles. Complications 
developing from chronic kidney failure include; anemia, retinopathy, cardiovascular 
complications and bone disease. It is important for both the patient and physician to 
know the stage of their diseases to guide therapeutic interventions/supportive care. 
The finding that 87% of Kuwaiti patients, (24 males and 24 females) and 75% of 
non-Kuwaiti patients knew their stage of their kidney disease suggests 
communication between physician and patient is good. 
The implications of patients not understanding the rationale behind clinical tests are 
serious, but the implications for patients who do not know whether the nature of their 
illness is chronic or acute are even more serious.13 patients did not know the stage of 
their kidney disease and 14 patients they did not know what type of kidney disease 
they had. Such a lack of understanding makes it virtually impossible for patients to 
ensure they are taking the proper precautions and following the recommendations for 
diet, measurements, discussions with the physician, and clinical examinations from 
experts such as suggested by Abona & Samhan (2006) to understand the nature of 
disease progression. 
Staging of CKD has clinical significance, guiding therapeutic interventions so 
enabling the control of symptoms and complications. Of the Kuwaiti patients studied 
85.5% had chronic disease (23 males and 24 females) while 75% of non-Kuwaiti 
patients chronic renal illness (11 males and 7 females) and 14.5% and 25% of 
Kuwaiti and non-Kuwaiti patients simply did not know what type of kidney disease 
they had. 
In 2002, the US National Kidney Foundation Kidney Disease Outcomes Quality 
Initiative guidelines (NKF KDOQI) used the glomerular filtration rate and other 
markers of kidney failure like albuminuria to classify CKD into 5 stages. Since then, 
some changes have been made on this classification by the Kidney Disease 
Improving Global Outcomes (KDIGO) organization. In the United Kingdom a 
Consensus Conference further divided stage 3 of the classification into A and B, 
depending on the level of drop in GFR (see below). 
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Table 7.2B.1 Stages of chronic kidney disease (KDIGO). 
 
Stage Description GFR 
(ml/min/1.73 
m
2
) 
1 Kidney damage with normal or raised GFR ≥90 
2 Kidney damage with mild decrease in GFR 60-89 
3A 
 
3B 
 
Moderately lowered GFR, regardless of kidney damage 
45-59 
30-44 
4 Severely lowered GFR, regardless of kidney damage 15-29 
5 Kidney failure (end-stage renal disease), regardless of 
kidney damage or kidney failure treated by dialysis or 
transplantation 
<15 
 
For stage 1 and 2 the presence of proteins (<1 gram per day) in urine may be 
evident. If the protein is more than >100 mg/mmol, a suffix p is added. The 
United Kingdom Consensus conference suggested 3A and 3B because most 
patients with GFR of 46-59 ml/min/1.73 m
2
 were asymptomatic yet most of the 
patients with a GFR of below 45 had complications. Further, the conference also 
suggested it was necessary to find out what is causing CKD 
 
Symptoms and Medications 
The first phases of chronic kidney disease may be asymptomatic. Progressively, 
most patients begin feeling weak and tired, which can be attributed to the reduced 
erythropoietin production so reducing red cell formation causing anemia. In fact, 
95% of Kuwait patients (26 males and 26 females) and 92% of non-Kuwaiti 
patients (13 males and 9 females) reported that kidney disease affected their daily 
lives. Due to poor renal function waste metabolic products accumulate which can 
affect the CNS (Mayo clinic, 2016). Such patients may experience nausea, 
anorexia, vomiting, mental slowness, seizures, hyperreflexia, encephalopathy, 
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and insomnia. Fluid homeostasis may be compromised causing edema in sites 
such as the ankle, pleural effusion, and in the lung i.e. pulmonary edema. Extra 
fluid in the lung and anemia may lead to dyspnoea. Patients also develop 
abnormal urination patterns, polyuria and nocturia. The patients in this study said 
kidney disease affected their diet (12.2%), influenced their work (14.9%), their 
social life (9.5%). 
Hainsworth (2006) presented treatment guidelines for anaemia in kidney disease, 
stating that for erythropoietin:  
“diagnostic evaluation and assessment of anaemia…management of 
anaemia…assessment and optimisation of erythropoiesis…monitoring 
treatment…As with other NICE guidance there is a significant emphasis on 
patient-centred care. This particularly focuses on treatment with 
erythropoiesis-stimulating agents so that patients are fully informed about 
the benefits and side-effects of such treatment and the consequences of poor 
concordance” (Hainsworth, 2006). 
Management of CKD is critical in slowing down the progression of the condition, 
managing symptoms and complication (National Kidney Disease Education 
Program, 2014). Blood pressure should be regulated to <130/80 in case of 
proteinuria. In this thesis the patients admitted using tablets to manage their 
diabetes within the study 97.1% of patients reported that they were taking 
medication due to hypertension and 2.9% did not take any medication. Drugs 
such as angiotensin receptor blockers such as candesartan and angiotensin 
receptor antagonists such as captopril can be used. Beta blockers such as 
propranolol and calcium channel blockers such as verapamil can also be used. 
Management of hypertension not only slows disease progression but also reduces 
cardiovascular events associated with CKD. Diabetic patients should be 
monitored depending on the stage of CKD. Monitoring the hypoglycemic agents 
in stage 4 and 5 to ensure severe hypoglycemia does not occur. Drugs such as 
statins for example simvastatin can be used to lower cholesterol to reduce the 
cardiovascular risks (National Kidney Disease Education Program ,2014). 
Aspirin, an antiplatelet drug can as well be used. Non-pharmacological 
interventions such as diet and lifestyle modification can be helpful. Patients 
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should stop smoking, do frequent exercises to lose weight and to reduce the 
amount of salt they use per day. A renal transplant is the final ‘choice’ in case of 
end-stage kidney failure. 
Anti-Diabetic Medications in Chronic Renal Disease patients 
In this thesis the patients on the renal units had all taken oral hypoglycaemic 
medications for their type 2 diabetes but many were now receiving insulin as the 
primary treatment for their disease. In some cases they stopped both oral and 
insulin medications during renal dialysis. The majority of Kuwaiti males and 
females reported that they stopped taking tablet medication for their diabetes 
(89% and 83%) respectively, and for non- Kuwaiti patients 93% of males and 80 
% of females indicated that they were not taking any oral medications. The 
percentage of Kuwaitis males who were taking insulin for diabetes is greater 
than that for females (92% versus 80%). For non-Kuwaiti the percentage of 
males who were taking insulin for diabetes was less than that for females (91.7% 
versus 100%) respectively. 
The patients in this group reflect the clinical finding that one of the leading 
causes of chronic renal disease which might progress to end stage renal disease 
is diabetes. The regulation of insulin levels is different in patients with and 
without renal disease. Around 50% of the pancreatic secreted insulin into the 
portal circulation is subjected to first pass metabolism by the liver. The kidney 
also plays a role in the normal metabolism of insulin. Therefore, exogenously 
administered insulin which is not subjected to first pass metabolism by the liver 
is primarily metabolized by the kidney (Madhu, 2011). However, when there is 
impairment of kidney function, the half-life of insulin is prolonged because of 
lower levels of overall degradation (Cavanaugh, 2007). Normally, insulin is 
filtered in the glomeruli and then extensively reabsorbed in the proximal tubules 
to be degraded by the tubular cells into amino acids which are reabsorbed; 
leading to only 1% of the filtered insulin appearing in the urine. In patients with 
renal disease, the elevated levels of basal insulin vary according to the stage of 
the renal disease and where renal blood flow is reduced then in the early stages 
causes an elevation. In the more severe cases, the loss of renal functional tissues 
mass can hinder the metabolism of insulin. For example in the most severe cases 
when the GFR<20 ml/min a reduction of insulin clearance occurs in conjunction 
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with the decreased filtration. Such alteration in the degradation of exogenous 
insulin in renal- impaired diabetic patients leads to episodes of hypoglycemia 
(Madhu, 2011). 
Another aspect of insulin physiology which is affected in patients with renal 
disease is their sensitivity of insulin. Usually, insulin sensitivity is decreased in 
diabetic patients with renal disease which is improved with hemodialysis. Thus 
after hemodialysis, patients experience hypoglycemic episodes since their 
sensitivity is improved. The fluctuation in insulin level and the consequent 
hypoglycemic effect occurs due to biphasic insulin metabolism. In the initial 
stages of renal disease, the insulin need increases as a result of increased insulin 
resistance and reduced insulin secretion. While in advanced stages of renal 
disease, the insulin requirements become less as a result of decreased insulin 
metabolism and clearance, in addition to reduced food consumption as a result of 
decreased appetite (e.g; anorexia) (Madhu, 2011). 
Unfortunately, many hypoglycaemic agents have not been extensively studied in 
chronic kidney disease patients, so studies are awaited to conclude the safety and 
efficacy of oral hypoglycemic drugs in the presence of different degrees of renal 
impairment. Consequently, prescribing a hypoglycemic agent to renally 
impaired patient depends on the proper assessment of renal function, especially 
in fragile patients, as well as, renal function should be carefully and periodically 
followed during treatment to detect changes that may affect drug 
metabolism/excretion. Clearance of many drugs is decreased by kidney disease, 
and this results in prolonged exposure to higher levels of the drug or its 
metabolites and potentially leads to adverse side effects such as hypoglycemia 
(Cavanaugh, 2007). 
In patients with chronic renal disease, the preferred drugs are those which 
undergo hepatic metabolism to avoid the renal excretory problems. However, if 
a drug is needed which is subject to renal metabolism then dose adjustment has 
to practiced in a careful manner compatible with the patients glomerular 
filtration rate. This is complicated as such dosage adjustment is mostly based on 
the pharmacokinetic assessments in chronic kidney disease patients, which 
 237 
 
might be misleading, but they still offer as Bolignano has suggested, “a suitable, 
pragmatic solution in the absence of targeted studies”. (Bolignano et al, 2013).  
Consequently, the oral hypoglycemic agents, especially first-generation 
sulfonylureas, should be either avoided or used in reduced doses for patients 
with chronic kidney disease since they are affected by renal function. Of the 
second-generation sulfonylureas, glipizide is recommended because its 
metabolites are not active and do not cause hypoglycemia. For -glucosidase 
inhibitors and their metabolites, these may result in damage from a cumulative 
dose effect and result in possible hepatic damage, especially for patients with a 
serum creatinine > 2 mg/dl. (Cavanaugh,2007). Metformin is contraindicated 
with even mild to moderate kidney disease in order to avoid lactic acidosis. In 
contrast the thiozoladinediones do not require dose adjustments since they 
undergoes hepatic metabolism and may have an independent beneficial impact 
on the progression of diabetic kidney disease.  
Amylin is a neurohormone which is secreted along with insulin from the 
pancreatic β cells. Pramlintide is an amylin analog and although it is primarily 
excreted by the renal route, no dose adjustment is required in patients with 
moderate to severe renal disease (creatinine clearance 20-50 mL/min). There are 
no data available on the safety in patients on dialysis or with end-stage renal 
disease.  
The two DPP-4 inhibitors Sitagliptin and Saxagliptin have a predominant renal 
excretion. Hence dose adjustments have to be made in patients with moderate to 
severe renal insufficiency. Insulin secretagogues, Repaglinide is a non-
sulphonylurea insulin secretagogue which is extensively metabolized in the liver 
and excreted in the bile. Its half-life is around 0.6-1.8 hours. It is minimally 
excreted by the renal route; therefore, although the half-life of the drug is 
increased in patients with renal failure, there is no need for any dose 
modification in these patients (Cavanaugh, 2007). 
 
Eye disease 
Chronic kidney disease is an underlying cause of many organ complications 
including the eye. In this thesis 96% of Kuwaiti males 86% of Kuwaiti females 
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had their retinas examined, while for non-Kuwaitis, 93% for males and 100% for 
females respectively. However for their eye examination only 3.8% of Kuwaiti 
males and 0% of non-Kuwaiti males had their eyes examined by a specialist 
diabetic ophthalmologist. Similarly 0% of Kuwaiti females and 10% of non-
Kuwaiti females had their eye tested by a diabetes specialist. In the eye 
conjunctival calcification and cataract occurs due to chronic kidney failure 
(Mayo clinic, 2013). As mention earlier, CKD causes alters calcium metabolism 
in the body and this malfunctions affects the eye.  
Many of the patients in this study had had laser treatment for their eye disease. 
The findings that 78% and 68% of Kuwaiti males and females and 71% and 
60.0% of non-Kuwaiti males and females had received laser treatment  was 
perhaps surprising since specialist examination had not been performed. 
However ,retinal hemorrhage may occur in CKD as a result of microvascular, 
macular degeneration and diabetic retinopathy and some inherited kidney 
diseases lead to retinal abnormalities such as Alport syndrome, retinitis 
pigmentosa and hereditary angiopathy. (Savige et el, 2011) 
Similar to eye conditions renal problems can be familial and 27.3% and 16.7% of 
Kuwaiti and non- Kuwaiti patients said that they had a family history of kidney 
disease. The family member who suffered the condition were father (26.3%), 
mother (36.8%), brother (26.3%), father and mother and brother (5.3%), and 
uncle (5.3%) During development, the glomerular filtration barrier, and the inner 
retina share a developmental pathway, this means they share structural 
similarities like the epithelial cells and the basement membrane. Any inherited 
renal disease will thus have retinal features accompanying it (Savige et al, 2011). 
Kidney disease may cause cardiovascular disease, or it may be a consequence of 
heart disease. Most patients with kidney disease die because of cardiovascular 
complications. In CKD, there is anemia, fluid overload due to reduced 
glomerular filtration rate. Fluid overload may lead to pulmonary edema or pleural 
effusion leading to shortness of breath ( Sarnak et al. ,2003). 
 
Kidney disease and its relationship with heart disease. 
“Chronic kidney disease (CKD) is a major cause of cardiovascular morbidity 
and mortality all over the world … CKD remains a major health problem, 
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causing cardiovascular diseases such as congestive cardiac failure, myocardial 
infarction, hypertension, stroke, and sudden cardiac death in patients with 
chronic renal failure (CRF)” (Ulasi et al., 2006) 
When the kidney is diseased, fluid accumulates due to a disturbance of homeostasis. 
Blood volume increases which significantly increase cardiac preload - the amount of 
blood delivered to the heart through venous return, which influences the cardiac 
force during systole. An increase in preload causes an increase in the force of 
contraction, produced by greater heart contractility during ejection. To achieve this 
increased force overtime the heart may become hypertrophic adapting to its new 
‘conditions’. In patients with pre-existing heart conditions, this may be both painful 
and fatal ((Ulasi et al., 2006). In this thesis, 58.2% of the Kuwaiti sample had cardiac 
problems, 18 males and 14 females, including chest pain (28.1%) and 71.9% had had 
a heart attack (n=23). For non-Kuwaitis 37.5%, 6 males and 3 were females had heart 
problems, 44% had chest pain and 56% had suffered a heart attack. 
Hypertension is an immediate consequence of increased blood volume. When 
hypertension sets in as a result of kidney disease, it again worsens the not only 
kidney function but also the functioning of the heart and other organs. In some cases 
the heart cannot function normally leading to congestive heart failure (Sarnak et 
al.,2003). Erythropoietin is a hormone that controls erythropoiesis, produced by the 
kidney. Chronic kidney disease leads to reduced level of erythropoietin leading to 
anemia. In these patients, cardiac output increases because the tissues are not getting 
enough oxygen but in the process the heart itself may become ischemic leading to 
angina. Left ventricular hypertrophy is an indicator of an overworking heart. (Sarnak 
et al. ,2003) 
 
Diet and kidney disease 
Dietary measures are among the common non-pharmacological approaches used in 
managing chronic kidney disease since some foods worsen the condition. 73% and 
83% of Kuwaiti and non-Kuwaiti patients knew that if their kidneys were damaged 
they should avoid some foods. In this study, patients reports stopping using salt 
(13.3%) and potassium (18.3%). Those patients whom mentioned they avoided meals 
containing potassium as they had stopped eating bananas, oranges and tomatoes, but 
not other potassium containing foods like chocolate, lettuce, cucumber and nuts. 
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According to White (2012) patients should not eat a lot of fruits and vegetables since 
these foods contain a lot of potassium, accumulation of potassium in the body may 
lead to dysrhythmias. Most dairy products like milk and yogurt are a primary source 
of these electrolytes, so a limit on the use of dairy products to also control 
phosphorous levels can be useful. Two percent of patients reported they had stopped 
eating protein such as meat but not others food such as egg and milk, salt & 
potassium & protein (20%), salt & potassium (41.7%), the remaining 5% had 
different combination of these foods. 
Patients with kidney disease and those with a kidney transplant should avoid using 
more than 2.5 grams of sodium per day so ensuring that their blood pressure is 
controlled by avoiding any fluid buildup. Foods low in cholesterol and the avoidance 
of very fatty foods including mono-unsaturated fatty acids (White et al., 2012) are 
considered useful to reduce heart problems. 
According to Abona and Samhan (2006), patients should be more mindful of diet, 
and discuss diet in more detail with their physicians; for example, sausage, canned 
and frozen food, fast food, cheese, spices, certain condiments, and salt should only 
be consumed with extreme caution and avoided wherever possible. Patients should 
also take more action to discuss their diet with their physicians as they complete the 
table demonstrated in Appendix 14, take note of diet for potential relationships with 
changes in condition, and be especially mindful of the relationship between salt and 
blood pressure. 
As mentioned above, patients were surprisingly reluctant to follow the general 
recommendations for dietary adjustments, such as those provided by RenalInfo 
(2006) and Abona and Samhan (2006), while dietary measurements and testing were 
also surprisingly low. Although patients are recommended to take much greater 
action in adjusting their diets, their clinicians should play a greater helpful role in 
dietary communication, questioning, and organising a program for monitoring and 
measuring. According to EdRen (2011), the main sources of protein should be fish, 
cheese, eggs, milk, nuts, beans and soy products. It is also recommended that patients 
cut their salt intake to roughly half of the standard amount from 150-200 mmol per to 
only 80-100 mmol daily. EdRen (2011) clearly states that there is no specific ‘renal 
diet,’ while dietary advice may vary based on weight and other measurements 
(including the severity of complications). 
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More specific dietary recommendations, depending on the nature of complications, 
have been outlined by the sources discussed above, as well as a range of other 
experts including Stein & Wild (2002) and Suzuki & Kimmel (2007). Suzuki & 
Kimmel’s (2007) research suggested that 90% of dialysis patients did not meet the 
daily nutrition recommendations, although they do not state the specific level of 
deviation. Considering the volume of literature available, there is no excuse for 
Kuwaiti doctors to allow this topic to be such a minor part of treatment, and ensuring 
that patients are fully informed and actively encouraged to follow dietary 
recommendations. Thirteen years ago, Stein & Wild (2002) pointed out that patients 
having received a transplant can generally step away from the strict precautions 
taken beforehand. However, they should be aware of the potential for increased 
cholesterol levels and weight gain associated with kidney transplants. EdRen (2011) 
outline a range of dietary precautions for a range of renal conditions, including 
“excessive intake of protein must be avoided in CKD. Historically and on rare 
occasions a low protein diet has been advised for patients with renal failure … 
their protein intake should be moderate - not high, not too low … On 
haemodialysis a slightly higher protein intake is recommended …On peritoneal 
dialysis a higher protein intake is recommended due to a small loss of protein 
from the dialysate” EdRen (2011). 
 
Dietary recommendations for the failing kidney and CKD emphasises a precise 
amount of protein, with either too little or too much resulting in negative 
consequences for the patient. Low protein levels can result in general malnutrition, 
while high levels of protein can result in increased blood acid, muscle breakdown, 
excessive phosphate intake, nausea and kidney damage. Consequently, protein 
supplements are not recommended as they may not be effectively processed while 
harming the patient (EdRen, 2011b).  Hemodialysis patients are vulnerable to 
potassium and phosphate irregularities and higher rates of caloric utilization and so 
patients should slightly increase intake by up to 30-40 kcals/kilo of ideal body weight 
and take care not to consume too much potassium (levels can be examined via blood 
testing), and restrict (or take phosphate binders) phosphate intake or take phosphate 
binders (EdRen, 2011c). 
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Those patients that received a transplant must be mindful of the potential for 
increased weight gain and cholesterol both of which can lead to increased rates of 
heart disease, and generally only need to continue their restrictions for a short while 
after the transplant (Stein & Wild, 2002; Suzuki & Kimmel, 2007). After this, they 
should move to a healthy diet recommended for the average individual. However 
their antirejection medications can increase rates of infection, so whilst on these 
drugs, they should take great care to avoid raw foods and to wash hands prior to 
eating (EdRen, 2011d).  
 
Renal dialysis 
Renal dialysis, either hemodialysis or peritoneal dialysis, has associated risks. Of the 
dialysis patients, 46 were Kuwaiti (23 males, 23 females) and 18 were non-Kuwaiti 
(11 males, 7 females). These patients reported events such as hypotension (n=13, 20 
%), anemia (n=6, 10%), cramps, nausea and headaches (n=3, 5%), infections (n=1, 
2%), hypotension &other hypertension (n=1, 2%), while the remainder (n=40, 63%) 
were distributed in different groups of combinations of these types of renal dialysis. 
The problems may be caused by the drugs in dialysis or due to the altered 
pathophysiology during the process. Hemodialysis may cause sepsis, specifically 
bacteremia, which may occur if the equipment used or the dialysate fluid is 
contaminated. 
Hypotension may occur during hemodialysis due to excessive ultrafiltration, 
presence of emboli in the blood vessel (thrombus formation) or due to anaphylaxis. 
The reduced blood supply can cause ischemia of the affected body organs like the 
fingers. Hypersensitivity can occur when a change of dialysis membranes is made 
(Lindsay et al., 2004). Anticoagulants such as heparin are added to the dialysate, and 
this medication can cause bleeding. Older patients may experience dementia because 
of subsequent use of antacids containing aluminum or failure to remove aluminum 
from the dialysate water completely. 
 
Peritoneal dialysis, on the other hand, poses problems such as bladder perforation if 
the catheter is blindly inserted. Peritonitis often occurs over time, especially in 
continuous ambulatory peritoneal dialysis (CAPD). Peritonitis can be diagnosed by 
checking the opacity of the drained fluid, due to increased level of leukocytes in the 
fluid (Agarwal et al., 2013). Patients may also develop acquired cystic disease of the 
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kidney, those at increased risk develop hematuria two years after beginning dialysis, 
and the cysts may undergo malignant transformation. 
Discussion of the open question answered by diabetic patients. 
In this section a summary of the open question which was answered by the patients 
gives almost the same findings as in the previous section, so I will not discussed it 
in detail in this section. 
Overall conclusion 
This questionnaire survey revealed detailed information regarding the trends of 
kidney disease and transplants for patients in Kuwaiti clinics associated with 
diabetes. The results support the findings of the main study and literature, while 
facilities and employees need to improve to adequately meet patient needs in modern 
times. The failure to properly diagnose, explain, or treat the disease undoubtedly 
exacerbates the consequences of the challenges of this condition as it manifests 
within citizens. Although many elements show competence, the areas where it has 
not been shown particularly communication and diagnosis, do not meet the demands 
of the modern world, and therefore are in serious need of improvement. 
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7.3   Part C.  Discussion of the physicians structured interview 
Kuwaiti’s physicians  
It is well established that type 2 diabetes requires careful management to prevent its 
complications and ensure better treatment outcomes (American Diabetes 
Association, 2014). Due to numerous potential diabetic complications, its 
management requires a multi-disciplinary team of health professionals of different 
specializations. To optimize care, it should comprise a primary care doctor, 
ophthalmologist, podiatrist , doctor nephrologists, dentist, dietician, diabetes 
educator, pharmacist and a physiotherapist. By performing different roles, their 
combined efforts can achieve a single objective of improving treatment outcomes 
with the patient being the central focus. Since physicians play in a major role 
diabetes management, this part of thesis examined their opinions regarding the 
current standards of care in Kuwait.  
All seven consultants, four nephrologists and three ophthalmologists freely provided 
their experience in diabetic management as well as their interactions with the patients 
which can be compared to the international standards of treatment of type 2 diabetes .  
  
The Nephrologists’ responses and recommendations 
It is apparent from the results of the interviews, that diabetes management in Kuwait 
is problematic as all of them had met diabetic patients who had end-stage renal 
disease. They lamented that most of the cases were due to inadequately controlled 
blood sugar. They considered that the primary care doctors had failed to refer such 
patients to them for kidney examination, so ensuring early detection and treatment of 
kidney disease. The nephrologists attributed diabetes and hypertension as the leading 
causes of kidney disease and acknowledged that blood and urine tests should be done 
every six months if there are no problems and every three months in case of any 
renal abnormalities such as microalbuminuria. Additionally, they stated that the lack 
of symptoms in early kidney disease makes it very difficult for patients to know if 
they have poor renal function and only a limited number of their patients knew that 
kidney disease was a severe diabetic complication.  
According to Levey et al., (2011), the leading causes of kidney failure are type 2  
diabetes and hypertension. Though, kidney damage can result from high blood 
pressure, renal failure can also be the cause of hypertension due to reduced fluid 
excretion (Levey & Coresh, 2012). The estimated glomerular filtration rate (eFGR) is 
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critical in the diagnosis of kidney disease and should be determined by creatinine 
clearance rate where in chronic illness it is less than 60ml/min in a period of three 
months. Urine tests check for the presence of protein albumin in the urine and 
normally there should be little or no protein present with high levels of creatinine. 
However, if more than 30 milligrams of albumin per gram of creatinine with or 
without reduced eGFR is present it is an indication of kidney disease. 
The physicians’ comment about seeing patients too late has been documented 
elsewhere and because nephropathy progression occurs over time, diabetic patients 
should be screened regularly for kidney disease. According to Bakris (2011), the 
ADA and the NIH recommend screening diabetic patients at least once a year.  
 
For urinary excretion of albumin.  
As the physicians said in their interviews early kidney disease is asymptomatic and if 
any symptoms are present they might be vague and nonspecific such as fatigue and 
general weakness (Bakris, 2011). However, as the disease gets worse they become 
more marked such as weight loss, loss of appetite, impaired thinking, fluid retention 
and anemia. From their experiences, the nephrologists recommended that diabetic 
doctors should work hand in hand with other specialists and get patients referred as 
early as possible to help avert or slow the progression of renal disease. 
 
Ophthalmologists. 
Similarly, the ophthalmologists recognized the need for team work because in many 
cases of ocular complications they have encountered these were due to lack of early 
patient referral for an eye examination. They said that diabetic patients should be 
screened for retinopathy every six months in the presence of existing retinal changes, 
every three months in mild or moderate changes and monthly in severe conditions.  
According to Duckworth et al., (2009), individuals who are diagnosed for the first 
time with type 2 diabetes should be examined for eye complications by an 
ophthalmologist or optometrist. This determines whether the diabetes has been in 
progress for a very long time before diagnosis. In addition, the lack of symptoms 
during this period necessitates immediate examination after diagnosis. The results of 
the initial examination will determine the frequency of subsequent testing usually. 
every one to two years after the first review (American Diabetes  Association, 2014). 
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They also thought that all diabetic physicians should use a fundus camera, as 
provided in all the diabetes clinics in Kuwait, to examine the retina for microvascular 
complications of diabetes that requires regular eye examination (Vestergaard et al., 
2009). According to Feghhi et al., (2011), blindness in diabetes results from a severe 
proliferative retinopathy. It may require treatment with laser surgery if medications 
prove ineffective. However, it is important to note that screening guidelines differ 
from patient to patient with the determinants being type and duration of diabetes and 
other life style factors. 
If proliferative diabetic retinopathy is diagnosed then photocoagulation is usually 
effective in minimizing their growth. A very recent development to counter the effect 
of proliferative diabetic retinopathy has been to use vascular endothelial growth 
factor (VEGF) antagonists. The drugs are termed anti-vascular endothelial growth 
factor anti-VEGF and are asbevacizumab, ranibizumab and pegaptanib (Feghhi et 
al., 2011) because they antagonize VEGF protein which triggers the growth of blood 
vessels in diabetic retinopathy. Their results were claimed to be most beneficial, but 
need further testing to ensure their effectiveness in the clinic. 
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Chapter 8 
8. Conclusions  
From all the results obtained for this thesis it can be concluded that type 2 diabetes is 
not effectively managed in Kuwait. There are three major reasons to be able to make 
this ‘hard statement’. 
 
Firstly, the comments of the physicians in both Kuwait and Ascot (UK) illustrated 
clear deviations from the recommendations in the treatment guidelines of Kuwait 
which resulted in inadequate treatment outcomes among patients having type 2 
diabetes in Kuwait. This is illustrated by failing to provide the necessary patient 
education that would improve patient self-care and in some cases they make 
treatment errors such as prescribing insulin as the initial treatment for type 2 
diabetes. 
Secondly, the great majority of patients said they lacked an adequate understanding 
of their condition as well as their treatment. As a result, their disease develops into 
preventable diabetic complications, because they fail to seek proper management 
when it is appropriate. In addition, the great majority thought that the healthcare 
professionals in Kuwait were not doing enough to control their diabetes and its 
subsequent complications. 
Thirdly, from more severe cases of the disease or its complications of the patients 
and the physicians in Ascot, they felt that if their condition had been fully explained 
to them and this led to more intensive medical care that could have been avoided. 
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Chapter 9 
9.  Recommendations 
 
This study has found that the patients journey in Kuwait lacks the ‘seamless 
approach’ which is required to produce integrated patient centred care. To ensure that 
the personal focus of care is always maintained an enhanced continuity of care could 
be established and so the disease burden caused by type 2 diabetes will be reduced. 
Also, the use of integrated care, strengthened by enhanced professional activity, will 
ensure the attainment of personal focused care.  
Based on the data obtained for this thesis the following recommendations can be 
suggested to strengthen the role of primary care in Kuwait. Improve the care of type 
2 diabetes in Kuwait. 
 
Firstly, on behalf of the patients who were interviewed it is considered that the 
medical staff who treat type 2 diabetes should be encouraged to be more empathetic 
to their patients’ condition. This may require the training of existing family 
physicians and also looking to the future to produce more ‘indigenous’ medically 
qualified staff who could carry out this role. This should build in from the start of 
their careers the ethos of the continuity of care. 
This is not an impossible request as the medical profession is an honorable, noble 
and humanitarian profession based on the ‘message of mercy’ which doctors usually 
practice with extreme precision. Doctors are required to understand the suffering of 
the patients who may not be able to easily bear the pain or to help those patients who 
do not have adequate information about their illness. A doctor is required to listen 
patiently and to be calm in all conditions, as well as handling the angry or impatient 
patient or who may ask lots of questions regarding their condition. It is then 
necessary for the doctor to treat all cases with an open mind and full understanding, 
as well as being compassionate, merciful and fair while dealing with others. This is 
because the patient is in need of someone who takes care of them in order to ease 
their pain and any concerns associated with their disease. The doctor has to treat the 
patient using good manners and to listen to the patient with a great degree of 
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understanding so as to try and relieve the patients’ suffering and pain, so helping the 
patient to live with their condition. The Kuwait state, which provides very good 
facilities for the treatment of diabetes, should ensure their facilities are used to the 
full, so that no patient has to resort to private medical facilities to obtained adequate 
treatment. This will ensure a continuity of care is provided for all patients. 
 
Secondly, the patient is perhaps the most important member of the team because 
other team members will rely on information from him/her. They participate in 
monitoring their blood sugar and inform their physician who regularly sees them for 
checkups or whenever they get sick. The primary care doctors should be informed of 
any changes in the care plan including the diet, medicines, exercise and any 
emerging illness because of his direct contact with the patient for extended periods of 
time. In addition, the patient should notify him of any presenting symptoms of the 
eye, nerves, kidney or cardiovascular conditions so as to enable him make a referral 
to a specialist whenever necessary. 
Finally, the prevalence and increase of type 2 diabetes is posing a great challenge to 
the Health care system in Kuwait as is the case in many  other countries. Most 
patients with type 2 diabetes are obese and type 2 diabetes rapidly increases with a 
rising incidence of obesity. Structures and systems can only achieve so much and the 
one major problem found in this thesis, namely "unhealthy food" in Kuwait has to be 
seriously addressed. More vigorous and widespread educational programs are 
urgently needed to encourage healthy eating, as well as to increase exercise and 
smoking cessation. One aspects of this education should be to try and explain to 
patients that ‘jumping’ from one provider to another to obtain what they consider to 
be adequate treatment should be not be allowed as it greatly complicates their care.   
Next on behalf of the physicians who were interviewed: 
 
Firstly, the physicians should adhere to establishing and then using national and 
international treatment guidelines that are evidence-based. This practice would 
eliminate any poor practice and bias in diabetes management, thus making it easy to 
monitor and evaluate existing disease management programs or interventions and in 
the process making what is best termed ‘seamless care’. Emphasis should be given to 
this to reduce the disease burden which diabetes causes for Kuwait. 
 250 
 
Secondly, the NICE guidelines offer the best plan of care for the diabetic patient.  
They should have the opportunity to make decisions about their own treatment(s) and 
their care and working alongside integrated professionals to improve the clinical 
competence and patients’ outcome. This could be explained using the document 
entitled ‘ Integrated and person focus care’ which was released by the WHO in 2015. 
Physicians should take the ‘patients story’ as their baseline to improve the 
treatments. Physicians in Kuwaiti need to be far more diabetic patient centered who 
generally require a very high level of care to avoid the complications of their 
condition. In patient centered care, the patient has the right to information on the 
kind of treatment they receive and the various tests conducted on them the 
management of their type 2 diabetes. They should always be patient-centered with 
the individualization of therapies. This is necessary because of the numerous 
variations in factors for individual patients that may affect the treatment outcomes.  
Thirdly, a multi-disciplinary team of health care professionals is required and they 
should take the leading role in monitoring the patient, counseling and education as it 
will significantly improve the treatment outcomes. The primary care doctors should 
work hand in hand with other healthcare professionals in the careful management 
and treatment of diabetes. Referral of patients within the KMOH system, may help to 
avert or slow the progression of severe diabetes complications such as the end-stage 
renal disease. This requires competent, knowledgeable doctors in the diabetic clinics 
so as to avoid overloading the hospitals services. This should reduce the overall cost 
of the service.  The systems should involve the pharmacist in the diabetic clinics as 
one of the health care members of the team such as podiatrist, specialist nurses and 
other related professional groups. They could be very useful in assessing the 
effectiveness of the medication which is used for patients’ treatment. 
Fourthly, the cost of diabetes treatments in the world is, as compared with some 
other diseases, high including:  the costs of medications, inpatient care, and 
outpatient care. However some of the changes that need the greatest improvement of 
the treatment of diabetes in Kuwait are not those which are the most expensive 
including: blood pressure tests, cholesterol tests, and blood test and checks and test 
the early signs of limb, eye, and kidney damage, to prevent any complications that 
leads to an increased cost of treatment . In the UK the NHS Health Check in patients 
aged 40 to 74 is used to establish whether they suffer from any treatable disease. 
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These tests are repeated every 5 years. In Kuwait in some patients  type 2 diabetes 
starts in their 20’s so it would be very useful for  the MOH to insist on checking  
people from this age for early diagnosis and to prevent severe complications . 
Achievement of all these suggestions will decrease the total  budget provided by the 
government.   
 
Fifthly, there should also be provision of a comprehensive professional training and 
educational course for the physician and regular assessments by the peer physician 
and regular checks of the patients file by the Ministry of Health. There should be an 
educational program of human behavior for the physicians. For example, all 
prospective medical students should be interviewed before entering medicine school 
to examine his human behavior and potential care he would give to his patients. A 
simple fact to determine is how empathetic he is to his potential patients. 
 
Sixthly, the strength of any care system is about ability of that system to provide a 
continuity of care. Family physicians provide a range of acute and chronic and 
preventive medical care services. In addition to diagnosing and treating diseases, 
they also offer preventive care, including routine testing, and evaluation of health 
risks, immunization and screening tests, and provide personalized advice on 
maintaining a healthy lifestyle. 
 
Seventhly, In UK patients should not join to a private center without letter from the 
GP  but in Kuwait they have different procedures and regulations the Ministry Of 
Health watch the work of the private hospitals but they do not have the right  to 
prevent  the patients to go to private hospitals. If the MOH provide qualified doctors 
this will led patients to refuse to go to private hospitals and the reason for that their 
health mange by qualified  physician free of charge and they save their money. Also 
the MOH should enforce a rule like in the UK that the patients should not join to a 
private center without letter from the primary health center.  
 
Finally, The Ministry of Health should interview diabetic patients in their diabetic 
clinics and ask them about their satisfaction with physicians’ treatment. This would 
involve them discovering the true patients experience and this may help in 
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determining the actual physician competence in these clinics. Also more research 
should be done on the current methods of managing type 2 diabetes so as to validate 
their effectiveness. 
 
This study has not only confirmed the harsh realities of type 2 diabetes in Kuwait, 
but has provided data for its improvement. Hopefully, some action can be taken to 
improve the situation through awareness and improvements for the people in Kuwait 
who are currently suffering this disease and for those in the future who will, very 
unfortunately be the statistics of tomorrow. 
I also hope for a better health care in the future from the Ministry Of Health, 
especially because Kuwait is a rich country and can provide everything patients need. 
Physicians with better knowledge and better treatment will be a perfect support for 
these patients whom are fighting everyday just to survive and get ‘cured’.  
 
These changes could be implemented it will be to the benefit of all type 2 
diabetics in Kuwait. Surely a very desirable goal to achieve.  
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11.   Appendices 
Appendix 1 
Questionnaire  introductory comments to the patients  
Thank you for your participation, your comments are really appreciated. All your answers 
will be recorded in an anonymous way. 
Study number …..  Age …………. (years)  Sex   1) male □        2) female□ 
Height   ……… m       Body weight today…….kg  and at this time of first diagnosis ……. 
kg  
Patient Questionnaire 
1) Please state your age at the time of your original diabetes diagnosis: ………….. 
(years) 
2) What course of action was recommended when you were first diagnosed? (you can 
tick more than one box) 1) none □       2) tablets medication  □       3) dietary change  □        
4) exercise □          5) actively to lose weight □        6) other  □        (please specify) 
……………          
3) Were you ever able to control your diabetes through diet alone? 
  1) Yes  □ 2) No   □  3) I don’t know  □  If yes, please state the length of time  ….. (months) 
Also what types of dietary advice did you find useful to achieve this control? 
……………………………………………………………………………………………….. 
4) Were you ever able to control your diabetes with tablets medication?  
1) Yes     □     2) No  □      3) I don’t know □ 
If yes, are you currently taking any of the following medications for your diabetes    
1. Glucotrol (glipizide) □ 
2. Micronase, Glynase, or Diabeta (glyburide) □ 
3. Amaryl (glimepiride) □ 
4. Tolinase (tolazamide) □ 
5. Diabinese (chlorpropamide) □ 
6. Glucophage (metformin) □ 
7. Precose (acarbose) □ 
8. Rezulin (troglitazone) □ 
9. Prandin (repaglinide) □ 
10. Other (please specify below): 
      
□ 
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5) Have you ever used insulin to control your diabetes?  
1) Yes     □      2) No   □     3) I don’t know □ 
If yes, please write the length of time (months) you took Insulin- ……….. months  
Are you still taking insulin for your diabetes? 1) Yes   □   2) No  □  
6) What is your primary method for personally examining your blood-sugar level? 
(please mark just one box) 
1) blood or urine test (at the doctor’s office only) □     2) blood glucose test strips read by eye 
at home □      3) urine glucose test strips at home□      4) blood glucose read by strips and 
meter □          5) none    □                                                                
7) How often have you examined your blood sugar level in the past month? (please mark 
just one box) 
1) never  □      2) once a week or less  □       3) roughly 2-6 times per week  □                                
4) daily   □      5) twice a day or more  □      6) three times or more□ 
8) Have you undergone amputation of a toe, foot, part of a leg, or all of a leg for a 
poorly healing sore or poor circulation because of your diabetes?   (please mark just one 
box) 
a.) Yes   □      b.) No    □                                                                          
9) How often, approximately, do you routinely visit your doctor for diabetes? 
1) 5 or more times a year   □        2) 3 to 4 times a year □         3) 1 or 2 times a year   □                                                    
4)  once per 1-2 years  □       5) once per 3-5 years  □         6) never  □                                                                         
10) What specific category of doctor do you visit for your diabetes? 
1) general practitioner □      2) diabetes specialist  □     3) both (GP and specialist)    □                                      
4) none  □                                                                       
11) During the past year has your doctor examined your feet?   
1) Yes    □   2) No   □     3) I don’t know □ 
12)  Please tick the following for the amount of calories you should consume on a daily 
basis to maintain a healthy and safe body weight :a) 2000 or below □   b) 2500-3000 □ 
c) 2500-3000 □  d) 3000-4000 □  e) unsure of the actual total □ f) do not know □ g) other □ 
12a) Please state whether you are on a weight management program from a hospital 
dietitian 1) Yes   □              2) No□ 
13) Please fill in the appropriate box if you carry out any of the following type of 
exercise:a) walking for 10-30 minutes every day □      b)walking twice or three times a week 
for 10-30 minutes□        c) attending a gym for up to 30 minutes a day   □     d) attending a 
gym for a session of up to 30 minutes a week.  □       e) swimming twice or more a week for 
10-30 minutes □         f) any other form of exercise. □ please state 
…………………………… 
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14) Which of the following complications of diabetes are you aware of? (you may tick 
more than one)   
1) kidney problems □      2) feet problems  □     3) nerve problems  □      4) eye problems □      
5) digestive problems □   6) other □ (please specify)……………………..                                                   
Hypoglycemia 
15) Have you ever had a low blood sugar 1) Yes    □ 2) No  □      3) I don’t know □ 
 If yes how low does your blood sugar drop prior to noticing?  a) 60 mg/dL □ b) 54 
mg/dL □ c) 50 mg/dL  □     d) other □ ……………….  
16) Were there warning signals? Yes   □   No □  If yes, which of the following; 1) nausea  
□       2) numbness or tingling of the fingertips or lips  □      3) anxiety  □      4) dizziness □           
5) headache   □       6) other □ ……………………………………         
17)  For how many years you have been suffering any of these symptom? 
1) 1-2 years  □ 2) 2-3 years □ 3) 3-4 years □ 4) 4-5 years □ 5) 5 years or more □ 
18) Does hypoglycemia affect your lifestyle? 1) Yes   □      2) No  □    If  yes,  please  
describe in what way ………………………………………………………………….. 
19) Have you had severe hypoglycemic spells in the past 5 years? 
 1. Yes   □        2. No   □     3. I don’t know □  If Yes, which of the following 1) convulsions 
□        2)coma  □  3) heart problems   □   4)  low body temperature□       5) other □---
----------  
Please indicate number of events over the last five years: a) 1-2 times □  b) 2 -3 times □      
c) 3-4 times □ d) 4-5 times  □ e) 5 times or more □  
Hyperglycemia 
20) Do you test for urine for ketones? 1) Yes   □ 2) No □  3. Don’t know what ketones 
are□ 
 If Yes, please indicate how often you have been in ketoacidosis: 1) 1-2 times a year □         
2)2-3 times a year □ 3) 3-4 times a year   □  4) 4-5 times a year  □ 5) 5 times or more a year□    
21.) Were there warning signals due to hyperglycemia? 1) Yes   □       2) No □   If so, can 
you please write down what happened; …………………………………………… 
22) How many years has hyperglycemia been occurring? 
1)1-2 years □       2) 2-3 years □      3) 3-4 years □       4) 4-5 years  □     5) 5 years or more □ 
Kidney 
23) Have you ever been told by your doctor you have a kidney problem?  
 1) Yes □          2) No   □      3. I don’t know □if so, please indicate the time since diagnosis; 
1) 1 year  □    2) 2 years □     3) 3 years  □    4) 4 years □       5) other □ (please 
state)…………… 
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24) Have you been diagnosed as having protein in your urine? 1) Yes □  2) No  □    3) I 
don’t know   □ .         If yes did you transfer from diabetic physician to a nephrologists? 1) 
Yes  □         2) No □       3. I don’t know □ 
25) Do you require dialysis? 1) Yes □          2) No □       3) I don’t know □ 
26) If yes to 25 then what is your dialysis schedule? Number of visit(s) per week; a)1  □       
b) 2□        c) 3 □ 
27) Have you even had a kidney transplant? 1) Yes □       2)     No □ 
28)  Do you have high blood pressure? 1) Yes □   2) No □ 3) I don’t know □ 
 and if so, do you take medication for this reason? 1) Yes □   2) No □ 3) I don’t know □, if 
yes please specify the name(s) of blood pressure tablet medication you 
took…………………. 
Eye 
29.) Have you ever had the back of your eyes (the retina) examined? (not including 
examination by an option or optometrist just for glasses) 1) Yes □    2)   No □      3) I cannot 
recall □   If yes who conducted the eye examination? 
1) A general practitioner □        2) A diabetes specialist □       3) An eye specialist  □     4) I 
cannot recall □ 
30) How many times do you see eye doctor? 1) 1 per month  □      2) 1-2 per year □      3) 
2-3 per year □      4) 3-4 per year □     5) other □ ………….         6) never  □   
31) Do you have diabetic blurred vision as a result of you diabetes? 1) Yes □         2) No 
□   3) I don’t know □ 
32) Have you been diagnosed with a decreased in clearness of vision? 1) Yes □      2) No 
□       3. I don’t know □ 
Nerves 
33) Have you ever had foot problem? 1) Yes □          2) No □  
If yes, do you suffer from any of the following – (you can tick more than one) 
1) Numbness or tingling □   2) Burning or pain in feet □   3) Foot ulcer  □    4) Other □                                              
Circulation 
34) Have you ever had heart problems? 1) Yes □        2) No □     3) I don’t know □ 
If yes, is it 1) Chest pain □              2) Heart attack □          3) Other □                                                        
Lipids 
35) Do you take any medication for high cholesterol? 1) Yes □  2) No □  3) I don’t know 
□      if yes,  how long have you taken it? a) 1 year□      b) 2 years □   c) 3 years □    d) 4 
years □       e) other □ please state length of time ……………..  
Lifestyle 
36) Have you ever smoked cigarettes? (Check one box)1) Yes □        2)  No□       
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If yes, when did you start smoking?   1) 1 year □ 2) 2 years □ 3) 3 years □ 4) 4 years □ 5) 5 
years or more □ 
37) Do you drink alcohol? 1) Yes □   2) No □     If yes, for how long have you drunk it? 
1) 1 year □         2) 2 years □       3) 3 years □      4) 4 years □      5) 5 years or more □ 
Is the alcohol in the form of 1) beer  □  2) wine □  3) spirits □ 
Do you have any comments to make regarding you condition, so that it may be used in 
medical research?................................................................................................................... 
Thank you again for your participation, it is highly appreciated. For additional 
communication please contact: Eman Ahmed Buhajeeh Email: E.A.A.Bu-
Hajeeh@brad.ac.uk 
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Appendix 2 
Patient Questionnaire for the Ascot Rehabilitation - Introductory comments to the 
patients  
Thank you for your participation, your comments are really appreciated. All your answers 
will be recorded in an anonymous way. 
Study number ….  Age ………. (years) Sex   1) male □            2) female □ 
Height  ………m       Body weight today…….kg  and at this time of first diagnosis ……. kg  
1) Please state your age at the time of your original diabetes diagnosis: ……….. (Years)  
2) When did you first come to the UK for treatment?  Months …… or …… years. 
3) What is the primary reason you came to the UK for treatment?.................................. 
4) Who pay the expenses of the treatments?  1) You  □        2) Sponsor □ 
5) How would you rate your treatment so far in the UK? Excellent  □     Very good □   
Good  □    Average □       Poor  □      Very poor□ 
6) What aspects of your treatment did you find were carried out here in the UK that 
were not done in Kuwait? Please specify………………………………………………..  
7) In which clinic in Kuwait did you receive you treatment?.......................................... 
8) What course of action was recommended when you were first diagnosed? (You can 
tick more than one box) 1) None □      2) Tablets medication □         3) Dietary change □          
4) Exercise □                  5) Actively to lose weight □    6) Other (please specify) □ ………..        
9) Were you ever able to control your diabetes through diet alone? 
  1) Yes □   2) No □    3) I don’t know □ If yes, please state the length of time, ……. 
(months)  also what types of dietary advice did you find useful to achieve this control? 
……………… 
10) Before you came to the UK were you on weight management program from the 
hospital dietitian? 1) Yes □    2) No □ 
11) Please state whether you are on a weight management program from a hospital 
dietitian in UK?    1) Yes □    2) No □ 
12) Were you ever able to control your diabetes with tablets medication?  
1) Yes □          2) No □       3) I don’t know □ 
If yes, are you currently taking any of the following medications for your diabetes?    
1. Glucotrol (glipizide) □ 
2. Micronase, Glynase, or Diabeta (glyburide) □ 
3. Amaryl (glimepiride) □ 
4. Tolinase (tolazamide) □ 
5. Diabinese (chlorpropamide) □ 
 277 
 
6. Glucophage (metformin) □ 
7. Precose (acarbose) □ 
8. Rezulin (troglitazone) □ 
9. Prandin (repaglinide) □ 
11. Other (please specify below): 
 
□ 
 
13) Have you ever used insulin to control your diabetes?  
1) Yes □  2) No □   3) I don’t know □      If yes, please write the length of time (months) you 
took Insulin; …… months Are you still taking insulin for your diabetes? 1) Yes  □   2) No □
  
14) Have you had your medication changed by a doctor in the UK?   1)Yes □  2) No □ 
 If yes, do you now feel better due to the medication(s) change?          1)Yes □  2) No □ 
15) How would you rate the empathy shown by the physicians and nurses in the UK to 
your condition  
Excellent □  Very good □  Good □    Average □     Poor □     Very poor □ 
16) Is enough information about you day to day treatment provided for you in the UK? 
Excellent □  Very good □  Good □    Average □     Poor □     Very poor □ 
17) Which of the following complications of diabetes are you aware of? (You may tick 
more than one)   
1) kidney problems □       2) feet problems □       3) nerve problems □        4) eye problems □        
5) digestive problems □   6) other  □  (please specify)……………………..                                                   
Kidney 
18) Have you ever been told by your doctor in Kuwait you have a kidney problem?  
 1) Yes □           2) No □        3) I don’t know □ 
If so, please indicate the time since diagnosis; 1) 1 year □  2) 2 years □  3) 3 years □   4) 4 
years □       5) other □ please specify …………… 
19) Have you ever been told by your doctor in the UK you have a kidney problem?  
 1) Yes □   2) No □   3) I don’t know □     if yes, please indicate the time since diagnosis; 1) 1 
year □     2) 2 years □      3) 3 years □      4) 4 years □    5) other □ please specify……….  
20) If yes to either 18 or 19 was this diagnose by protein being found in your urine? 
1)Yes □     2) No □        3) I don’t know □ 
If yes, to question 20 were you transferred  from a physician to a nephrologists?  
1) Yes □          2) No □       3) I don’t know □ 
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21) Do you require dialysis? 1) Yes □          2) No □        3) I don’t know □ 
22) If yes to 21 then what is your dialysis schedule?  Number of visit(s) per week;  
a)1 □         b) 2 □        c) 3 □ 
23) Have you even had a kidney transplant? 1) Yes □ 2) No □ 
24)  Do you have high blood pressure?           1) Yes □           2) No □     3) I don’t know □ 
 And if so, do you take medication for this reason? 1) Yes         2) No        3) I don’t know □    
If yes, please specify the name(s) of blood pressure tablet medication you took? ………….. 
Nerves 
25) Have you ever had foot problems? 1) Yes  □         2) No □ 
If yes, do you suffer from any of the following – (you can tick more than one) 
1) Numbness or tingling □   2) Burning or pain in feet □  3) Foot ulcer □  4)Other □  ………                                              
Circulation 
26) Have you ever had heart problems? 1) Yes □    2) No □   3) I don’t know □ 
If yes, was it 1) Chest pain □   2) Heart attack □    3) Other □…………………                                                        
Lipids 
27) Do you take any medication for high cholesterol?  1) Yes □  2) No □  3) I don’t know 
□         if yes,  how long have you taken it? 
1)1year □       2) 2 years □      3) 3 years □        4) 4 years □        5)  other □……………..  
Lifestyle 
28) Have you ever smoked cigarettes? (Check one box) 1) Yes □   2) No □     
If yes, how long ago did you start smoking? 1)1year □   2) 2 years □  3) 3 years □    4) 4 
years □        5) 5 years or more  □ 
29) Do you drink alcohol? 1) Yes □        2) No □      If yes, how long have you drunk it? 
      1) 1 year □  2) 2 years □ 3) 3 years □  4) 4 years□      5) 5 years or more □  
In what form is the alcohol? 1) beer □   2) wine □   3) spirits □ 
Do you have any comments to make regarding you condition, so that it may be used in 
medical research?................................................................................................................... 
Thank you again for your participation, it is highly appreciated. For additional 
communication please contact:  
Eman Ahmed Buhajeeh  Email: E.A.A.Bu-Hajeeh@brad.ac.uk 
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Appendix 2A 
Summary of the findings in Ascot Rehab center: 
 
 Represents the current age distribution of the patients who took part in the 
study in Ascot. 14.3% of the sample had an age are less than 40 years, while 
21.4% of them were between 40 - 49 years, 35.7% of them were between 50 - 
59 years, and the remaining four patients were above the age of 60 years 
(28.6%). 
 The mean of body weight at first diagnosis for males was greater than that of 
body weight at the time of the study, 88.3 and 79.1Kg, respectively, while the 
mean of body weight at first diagnosis for females was less than that of body 
weight at the time of the study, 75.4 and 73.4 Kg, respectively. The means of 
body weight for males were greater than the means of body weight for 
females in the two scales. 
 The BMI values were calculated and compared for the patients, using the 
paired Student’s t test, they were 29.5 kg/m2 (S.D. ± 4.6 kg/m2) at first 
diagnosis and at the time of the study were 28.1 kg/m
2 
(S.D. ± 4.1) .Using the 
t-test results, we have no evidence against the null hypothesis, therefore, there 
is no significant difference was found (p>0.05) between BMI at their first 
diagnosis and at the time of the study. 
 When descriptive statistics for this group of patients were calculated for age 
at the time of their original diabetes diagnosis it was found the mean of the 
ages was 38.5 years with standard deviation of ±12.6 years. In terms of range, 
the minimum age was 23 years while the maximum was 65 years. 
 That 64.4% of the sample members came to the UK for treatment in the year 
2014, while 35.6% came in the year 2015. Moreover, all patients of the 
sample study (n=14) reported that the expenses of the treatments were paid 
by their sponsor. 
 The majority of them considered that stroke was the primary reason, while 
14.3% of the sample members reported that cancer was the reason, and 7.1% 
of them said that the gangrene was the reason. 
 85.7% of patients considered their treatment in the UK was ‘Excellent’, while 
14.3% considered it as ‘Very good’ 
 Frequency distribution of clinics in Kuwait which provided treatment for 
the patients in the study. 
Clinic in Kuwait Number Percent 
Al-Farwaniah 1 7% 
Al-Jahra 2 14% 
Al-Qadisa 1 7% 
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Bayan 1 7% 
Al-Fardose 1 7% 
Al-Jaberriah 1 7% 
Kefan 1 7% 
Meshref 1 7% 
Sabah al Salim 1 7% 
Salmeia 1 7% 
Salwa 2 14% 
Total 14 100% 
 
 In this table the clinics in bold letters are those which were used in the first 
part of the thesis, which included clinics chosen at random from Kuwait. The 
above distribution of patients and their clinics attended shows that 14% of the 
patients said that they receive their treatment in Al-Jahra Clinic and  14% in 
the Salwa Clinic. For the remainder respectively, 7% of them reported that 
they receive their treatment in the clinics which appear in the table above. It 
can be stated that the comments made by patients from clinics not included in 
the random sample studied in the first part of the thesis provides very similar 
experiences to those shown in the bigger study in Kuwait. 
 In terms of percentages, 78.6% of patients said that the course of action 
which was recommended when they were first diagnosed was tablets 
medication, while for the remaining 21.4% the course recommended was to 
administer insulin. It was surprising to find that modifications to their diet, 
and increasing their levels of exercise, were never suggested. 
 All of the sample patients in Ascot (n=14) reported that they were never able 
to control their diabetes through diet alone in Kuwait. 
 All of the sample members (n=14) [100%] reported that before they came to 
the UK they were not on a weight management program from a hospital 
dietitian. 
 All of the sample members (n=14) [100%] reported that were on weight 
management program from a hospital dietitian in the UK. 
 All of males and females (n=14) reported that they had their medication 
changed by a doctor in the UK. When patients (males and females) were 
asked whether they feel better due to the medication(s) change, all of them 
answered positively. Additionally, all the males and females patients highly 
rated the empathy shown by both the physicians and nurses in the UK in 
regard to their condition as  being ‘Excellent’, and also they gave ‘Excellent’ 
to the level of information about their day to day treatment provided for them 
in the UK. 
 It is appropriate to mention that all the males and females studied reported 
that none of them had ever been told by their doctors in Kuwait that they had 
kidney problems.  
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 In contrast, when they came to the UK two males (22.2%) indicated that they 
were told by their doctors that they had a kidney problem; the other seven 
males did not have a problem. The diagnosis of the problem of two of the 
males since diagnosis was 4 months and 8 months. For the females, 3 were 
told in the UK had a problem with their kidneys, the times after diagnosis 
were one month, 4 months, and 8 months respectively. The two others did not 
have a problem. 
 On further analysis, two males out of the 9 reported that their diagnose 
showed the presence of protein in their urine, while 77.8% of them (n=7) 
answered negatively. Among the group of females, 60% of them (n=3) 
indicated that diagnose showed the presence of protein in their urine, while 
40% of them (n=2) answered negatively. In addition, both males and females 
who had been told by their doctors in the UK that they had a kidney problem 
pointed out that they were transferred from their UK physician to a UK 
nephrologist. 
 We can mention in this regard, that for those patients with a renal problem 
none was severe enough to require dialysis, and none required a kidney 
transplant. For one man who came to the UK and then was assessed for renal 
function he had a value of 23%. On referral to a UK nephrologist the value 
progressively rose to 50%. 
 64.3% of patients said that they had high blood pressure, while 35.7% of 
them reported negatively. Among the patients who had high blood pressure 
(n=9), all of them pointed out that they took anti-hypertensive medication and 
22% (n=2) of the patients took amlodipine tablets and three took lisinopril ( 
Zestril). It is worth mentioning that four patients (44%) did not know the 
name of the tablet medication they took for hypertension. 
 In a question about smoking, 50% of patients (n=7) reported that they had 
smoked cigarettes, while the rest answered in the negative. Among the 
patients who had smoked it was cigarettes for all of them (n=7) and they 
pointed out that they smoked cigarettes for a period of 5 years or more. 
Moreover, only one patient out of 14 (7%) indicated that he drinks alcohol; 
the remaining 93% did not. It is worth mentioning here, the patient who drank 
alcohol; it was in the form of spirits for 5 years or more. 
 The majority area for concern of all Kuwaiti patients that the majority of the 
clinical workers did not have sufficiently developed skills or empathy in 
Kuwait. Doctors and Nurses were commonly wanting of not providing 
sufficient attention to patient problems, but the doctors and nurses in UK 
provide sufficient attention to patient’s problems.  
 The second area of concern of all Kuwaiti patients was that  the effectiveness 
of treatment was considered to be  either inadequate in terms of meeting 
patient desires, or even inadequate in terms of healthcare standards and 
principles  
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 The third area for concern of 7 Kuwaiti patients was that the primary care 
doctors in Kuwait did not measure the HbA1C, and the HbA1C was not done 
as a routine requirement of their treatment. However in UK they routinely 
measure the HbA1c and some of them mention that they learnt what the 
HbA1c is and why it is important for the diabetic patients, from their UK 
physician. 
 the fourth area of concern of 6 patients was that the medication(s)  which 
was prescribed by the physician in Kuwait may even be unsuitable for 
administration and did not  actually work 
 the fifth area of concern of 5 patients was that they have kidney complication 
due to diabetes and their physician did not mention that for them before they 
arrived in UK. They only found out about their condition on their admission 
to the hospital in the UK and for some patients their renal function was 
seriously low. For example one patients reported that his kidney ‘work only 
23% ‘and that dialysis was a likely treatment in the future. Some patients 
with their UK treatment knew their kidney function would be monitored.   
 
Results from a pilot study in a UK hospital. 
In any study collecting useful data to make the study more reliable is considered 
good practice. During the time this study was undertaken it was discovered that in a 
UK hospital, in Ascot, Berkshire, there was a rehabilitation centre (Rehab) to which 
the Kuwaiti government sent patients for care of their medical conditions.  Amongst 
these patients were those suffering from the severe consequences of type 2 diabetes 
such a stroke or gangrene.  
Every month Kuwait sends patients to UK for specialist medical care who are 
selected by a number of different Ministries, including: the Ministry of Health, the 
Ministry of Defence and the ‘Cabinet’ which oversees all the other ministries. Each 
of these organisation could send between 350-700 patients to the UK.   
Consequently, the total minimum number which can be sent is 1050 (i.e. 350 x3) and 
as a maximum 2100 (700 x3). Not all these patients are diabetics with their 
complications, as some come for cancer treatment. In 2012 the Kuwaiti Ministry of 
Health sent 689 patients abroad per year for orthopedic and neurosurgery alone. All 
of these patients will have required rehabilitation, as Inpatients or Outpatients (Ascot 
Rehabilitation centre, 2015) 
 
It is appreciated that this group is relatively small and suffering severe disease and 
could be thought of as a biased group on which to do analysis. Consequently it has 
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been included as an Appendix to the main study as being of scientific interest rather 
than being representative of the majority of patients in Kuwait.  
On the encouragement of their medical staff and with full ethical approval 14 of their 
patients volunteered to be questioned using the same technique as was done in 
Kuwait.  The aim was determine in a group of Kuwaiti subjects what had been their 
experiences of the treatment of their type 2 diabetes. This group had had the disease 
for an median 13.5years. Whilst it is true this group is very different from the study 
group in Kuwait, they had all been treated in the Kuwaiti system and so can give 
their perspective of their treatment over a longer time – to see if their treatment had 
changed over the years.  
Background to the Ascot Rehabilitation Centre (Ascot Rehab).For readers not 
familiar with this centre the following description is provided.  
 
A description of Ascot Rehab may be useful for the reader to understand the nature 
of the work of this unit. According to their published information material - 
 Ascot Rehab services are focused on reducing the negative effects of disability - 
specifically rehabilitating patients  
(a)after musculoskeletal injury or surgery , (b)with traumatic brain injury 
(transport injuries) , (c) with neurological conditions , (d) post 
cerebrovascular accident , (e) post-spinal injuries and surgery , (f) with 
peripheral neuropathy.  
Through improving the physical functionality and wellbeing of patients, Ascot Rehab 
clinical intervention post injury or event will improve their quality of life. The 20 bed 
Ascot Rehab Inpatient unit, with gym, therapy rooms and hydro pool will cater to 
inpatients and outpatients requiring specialised intensive rehabilitation. The average 
length of stay for inpatients is 10 weeks; therefore the total number of patients the 
unit could accommodate per year at an average fill of 90% capacity is 94 patients. 
Patients would receive an intensive rehab package consisting of an average of twenty 
sessions per week. 
 
Outpatient therapy consists of individual sessions or intensive therapy packages 
(average ten therapy sessions per week) and accommodates (per year), approximately 
 208 physiotherapy patients having 6 sessions per week, for 6 weeks  
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 191 occupational therapist patients having 3 sessions per week, for 6 weeks  
 104 speech and language therapist - patients having 1 session per week, for 6 
weeks  
 26 psychology patients having 1 session per week, for 6 weeks  
Physiotherapy sessions form the bulk of Outpatient provision as e.g.: 
musculoskeletal injuries tend not to require speech and language therapy or 
psychology input to the extent inpatient injuries do.    
 
Discussion for the Kuwaiti diabetic patients’ questionnaires in Ascot 
From the research conducted, the majority of the patients (n=14) who sought medical 
attention in Ascot Rehabilitation, United Kingdom were between the ages of 50-59 
years with very few being below 40 years. This reflects the age at which problems 
with diabetes are most commonly found perhaps complicated by their ability to carry 
out normal physical activities which as a result of less physical activities makes it 
difficult for the receptors to respond to insulin when it is produced (Bowman, 2008).  
Additionally, the age at the time of their first diagnosis varied, for the age ranges:  
40-49 years, 30-39 years and 20-29 years, were represented by 28.6% each. The 
individuals who were diagnosed as having type 2 diabetes over 49 years of age was 
14.2%. This indicates that the patents in Ascot were representative of those found in 
the part of the thesis concerned with the diabetic clinics in Kuwait 
Rating of the patient experience of their treatment in the United Kingdom 
Most patients who participated in this study considered the experience in the United 
Kingdom as “more excellent” as compared to their experience in Kuwait.  Most of 
the patients thought that majority of the health practitioners in Kuwait “lacked 
sufficient empathy” or their skills to tackle diabetes and other related conditions were 
inadequate. The patients stressed that the nurses and the doctors in their home 
country failed to provide the attention needed to the challenges faced by them, their 
patients. This data confirms the findings made in the first part of this thesis when 109 
patients were interviewed at diabetic clinics in Kuwait. In contrast, the medical staff 
– both their physicians and nurses in the United Kingdom had provided them with 
sufficient care and attention that they felt they needed ." a positive relationship 
between physicians' empathy and patients' clinical outcomes was confirmed, 
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suggesting that physicians' empathy is an important factor associated with 
clinical competence and patient outcomes".(Hojat et al.,2011). 
As a result of this better communication between them and the physicians and nurses 
the patients felt they were able to have a greater understanding about their 
condition(s) in the United Kingdom than was possible in Kuwait. Most of the 
patients who took part in the study believed that doctors in the United Kingdom 
showed sufficient empathy and developed skills in dealing with the diabetic 
conditions and complications in patients of all ages and severities. A large majority 
of the participants (72%) in the study stated that their experience of the medical care 
in the United Kingdom showed that medical staff had high level of empathy to them 
and their medical conditions as compared to their counterparts in Kuwait. This 
finding has also been made in 21% of the participants indicated that physicians’ 
education and empathy in the United Kingdom was much better as compared to the 
education of the physicians in Kuwait when dealing with patients with diabetic cases.  
This lack of empathy and attention to detail was described in the following way by 
40 year old patient.  
He raised concerns that the spread of cancer in his body was as a result of the 
carelessness of diabetic doctors. In Kuwait he was frequently prescribed creams for 
topical applications by his diabetes doctor for a back condition which progressively 
became worse and developed into him feeling continuous pain in the thigh.  The pain 
continued and only after visiting a private clinic was he made aware that the source 
of his pain was due to a tumor that had developed in his back.  
Most of the patients that participated in the study thought that Kuwait was a rich 
country with adequate medical facilities which are unfortunately being misused or 
mismanaged.  Some patients quoted poor management of their medical conditions by 
the physician as resulting in paralysis. Diabetes is a major risk factor for the 
development of stroke, yet this risk is not understand or realized by diabetic patients.  
This is because, physicians, nurses and diabetes educators, are less equipped to 
educate diabetic patients. (Air et al., 2007) 
 ‘Ninety percent of physicians report discussing the risk of cardiovascular 
disease and the importance of prevention, although only one-half of patients 
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report their physician had discussed risk factor modification... Frequent and 
repeated patient advising regarding cardiovascular and cerebrovascular 
complications of diabetes and warning signs is necessary to improve utilization 
of primary and secondary prevention measures’. Air et al., (2007) 
 Most of the patients who took part in the study believed that physician education and 
monitoring by the Ministry of Health would help to improve the quality of medical 
services in the country. Most of the patients travelled to the United Kingdom as a 
result of complications associated with diabetes such as gangrene, cancer and stroke.  
Complications of diabetes can occur when the disease is not properly diagnosed as 
quickly as it should be, so allowing the complications of the condition to progress 
untreated (Robab, 2011). Medical practitioners in Kuwait have therefore to improve 
their ability to achieve earlier diagnosis of diabetic conditions as well as management 
of the disease. Some 7% of the patients said that gangrene was one of the reasons  
they travelled to United Kingdom to seek medical attention, 79% of the research 
sample cited stroke while the remainder,14% quoted cancer as the primary reason for 
them to travel to the United Kingdom to seek medical attention. In addition, 14% of 
the participants considered their treatment at the Ascot Rehabilitation Centre as very 
good with the remaining, 86% of the participants quoting their treatment as being 
excellent. 
Aspect of treatment that is carried out in Ascot Rehabilitation Centre relative to 
diabetes. 
When these Kuwaiti patients were admitted to Ascot all females and males (n=14) 
stated that their medications were changed by the clinicians in the UK. The medical 
practitioners were empathetic to the patient and provided information about the 
disease to their patients. Some patients applauded the practitioners in the UK for 
paying attention to most of their symptoms related to diabetes. Additionally, the 
physicians in Ascot Rehabilitation Centre suggested diet and weight management 
programs in the overall treatment of type 2 diabetes mellitus, something that was less 
likely to be suggested by the medical practitioners in Kuwait. The large majority of 
the patients (78.6%) had been prescribed in Kuwait, tablet medication as a remedy 
for dealing with diabetes with the remaining 21.4% being recommended for insulin 
 287 
 
intake on their first diagnosis of the disease. Insulin was rarely used by the medical 
practitioners at the Ascot Rehabilitation Centre in the UK. 
Consequently, due to the changes in medications of all the patients would suggests 
that the course of action that is taken by most of the health practitioners in Kuwait 
while dealing with the patients is against the NICE  guidelines which does not 
recommend the use of insulin by the patient when they are first diagnosed with type 
2 diabetes condition. The NICE guideline recommends clinicians to provide 
information about the disease to the patient before providing them with ongoing and 
individualized nutritional advice. These findings are very similar to those made in the 
first part of the study where insulin was recommended for the first line treatment. 
The guidelines recommend the provision of the advice in a form that respects the 
needs of an individual’s beliefs, culture and needs by being sensitive to the effects 
and willingness to change on their quality of life. In addition, the practitioners in 
Kuwait are not following the NICE guidelines as they have failed to emphasize 
advice on eating of balanced meals. A clinician should encourage eating of feeds 
with high-fiber content with sources of carbohydrates that have low-glycaemic index 
such as vegetables, fruits and whole grains (Jenkins, 2014). The clinicians are 
expected to possess competencies and expertise in nutrition (Lorentsen & Bergstad, 
2005). Instead, the clinicians have opted to give tablets and insulin to the patients 
when they are first diagnosed with insulin which is against the NICE guidelines 
(NICE, 2010).  
A major finding was that all the patients (n=14) reported that in the UK they were 
able to control their diabetic condition through utilization of the diet alone. 
Moreover, 100% of the participants indicated that they were now on weight 
management programme as a remedy of dealing with their medical condition. 
Weight management was never considered as an alternative treatment by the 
clinicians in Kuwait. One of the most effective methods that individuals can utilize in 
the management type 2 diabetes is through paying attention to personal lifestyle. 
Unhealthy eating and lack of exercise have been reported as among the major causes 
of this type of diabetes. Lifestyle intervention is beneficial both before and after the 
development of diabetes. Many studies have demonstrated the importance of healthy 
diet, weight loss and regular exercise in people who have already been diagnosed 
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with such type of diabetes mellitus (Robab, 2011). Physical exercise is one of the 
main components of lifestyle modification that can assist an individual in controlling 
and preventing type 2 diabetes. Even dietary regimen may be significant in the initial 
phases of losing weight, exercise incorporation as part of weight loss programme to 
assist in the prevention of weight gain as well as maintaining weight loss (Jenkins 
2014). The dietary program entails choosing foods that are low in fat, increasing 
consumption of high-fiber feeds as well as choosing of semi-skimmed and skimmed 
milk and low fat yoghurt (Allawi, 1997)   
Weight management is vital in the control of type 2 diabetes as obesity is one of the 
diseases contributory factors. Physical activities such as muscle strengthening 
activities and moderate intensity aerobic activities such as walking and cycling are 
vital strategies for the management and control of diabetes (Okada, 2011). 
Continuous physical activities can favorably affect the sensitivity of the receptors to 
insulin hence improving the symptoms of diabetes.  
Awareness of the complications associated with type 2 diabetes  
On the awareness of the complications associated with type 2 diabetes, 21% of the 
patients or participants were only aware of the feet problem as a complication, 36% 
of the participants were aware of the kidney, feet and eye as a complication with the 
remaining 43% considering the eye and the feet as one of the complications.  
Awareness about the kidney problems by the patients 
It is appropriate to mention that all females and males who took part in the study 
reported that they had never been informed that kidney problems are a long term 
complication of type 2 diabetes. However, 22% of the male participants had been 
told by their physicians in the UK that they had kidney problems that were related to 
their diabetes. The diagnosis of their problem was rapid in the UK as a result of 
frequent checkups conducted by the medical staff.  The majority of the male 
participants (78%) had no protein in their urine the remainder had protein in their 
urine. In addition, those individuals with renal changes were transferred to 
nephrologists in the UK, something that was not done with the medical practitioners 
in Kuwait. Fortunately, according to the nephrologists’ report, all the patients with 
renal problems were not severe enough to require kidney transplant or dialysis.  
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The clinicians in the United Kingdom are specialized for effective medical care to 
their patients, unlike in Kuwait where clinicians are less specialized in their roles. 
The concerns of five of the patients were that their physicians in Kuwait failed to 
mention that they had developed kidney problems as a complication of diabetes. 
However, they were informed about it once they were admitted in the UK hospitals. 
Some of the patients realized that their kidney function had deteriorated and that their 
renal function was quite low. Two of the participants in the study noted that their 
kidneys “worked only for 23% and that dialysis was the only regimen in the future.  
Discussion of the open question answered by diabetic patients in Ascot. 
The Kuwaiti patients were concerned with the skills of the clinical workers in 
Kuwait, as they had not provided the quality services they expected for them as a 
diabetic patient. The manner in which complications, such as stroke and kidney had 
been addressed did not meet the required NICE guidelines.  
Stroke that occurs due to cell death because of inadequate blood flow to the brain 
affects many diabetic patients. Stroke occurs in individuals with glucose intolerance, 
in both diagnosed and undiagnosed diabetes. Hyperglycemia leads to cerebral 
acidosis thus increasing the chances of stroke occurring in diabetic patients which 
may cause intracerebral and subarachnoid hemorrhage. Ischemic stroke mainly 
occurs due to oxygen starvation of the brain. (Cade, 2008)  
Kidney complications are also common in diabetic patients, but the manner in which 
they were managed in Kuwaiti does not meet the required standards as physicians 
should carry out kidney function tests in order to curb such complications at an early 
age as early reduces the risk of developing cardiovascular diseases. (Allawi, 1997) 
The UK physicians were stated by the patients to have more empathy and clinical 
skills. One of the patients reported they considered they had suffered more as a result 
of the Kuwaiti system which almost amounted to neglect. Another patient suggested 
that cancer had spread in his body due to poor care as she had often complained to 
the doctor about feeling some numbness and burning in the foot while the doctor 
continued issuing medication without conducting any checkups. He prescribed 
topical creams to be applied on the legs. His condition became worse, and he sought 
advice  from a private hospital which found that the cause of the pain in the leg was 
due to tumors he had on her back." A positive patient-physician relationship is a 
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critical element in the practice of medicine and in the art of healing." Hojat et 
al.,2002). Some Studies have shown that diabetes increased the risk for different 
forms of cancer. Insulin resistance is common in obese patients, through feedback 
mechanism the body produces more insulin leading to hyperinsulinemia 
.Hyperinsulinemia can encourage the growth of tumors. Obesity is associated with 
increased risks of different types of cancer such as kidney and breast cancer. The 
risks of presence cancers are doubled by the type 2 diabetes patients such as liver 
cancer, pancreatic cancer and breast cancer (Diabetes UK, 2016). 
The Kuwaiti patients were concerned that treatment did not meeting their 
expectations. For example, physiotherapy treatments in Kuwaiti are used but and 
most patients considered that this did not allow them to overcome some of their 
difficulties arising due to diabetes in the microvasculature. In the UK they found that 
physiotherapy was more actively used which enabled patients to move and walk, 
even after their short-term treatment.  
"Physical therapists will play an important role in the care of people with 
diabetes because numerous interventions provided by physical therapists (such 
as therapeutic exercise) can assist in alleviating symptoms, slow the metabolic 
progression to overt type 2 DM, and reduce morbidity and mortality associated 
with these complications" (Cade, 2008) 
One point mentioned by the majority of the patients was that in Kuwait the 
physicians never measured their HbA1C, which elsewhere in the world is a routine 
requirement for diabetic patients (Day, 2001). Their treatment in UK required 
physicians to frequently measure patients HbA1C and also to give an explanation to 
their patients as to why they were conducting such tests on them and the significance 
of performing the test. 
The patients from Kuwait also raised concerns about the kinds of medications they 
were prescribed in Kuwait. Some they thought were inappropriate as they were not 
helpful to their condition. For example, one hypertensive patient was given an 
injection to lower their blood pressure which had been checked using a blood 
pressure meter. The effects were a profound hypotension. The patient’s brother 
commented to the physician that the manometer was not working well. The physician 
checked and found that the manometer was not working well, so he considered 
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giving the patient another medication to restore his blood pressure but instead the 
patient was taken to ICU in order to counter the effect the first drug had on him.  
The issue of diabetic kidney complications was also a concern for the patients. In 
Kuwaiti doctors never mentioned to them their kidney complication and some of 
only realized their condition after coming to the UK. In some patients their renal 
function was such that they ought to have been receiving medication but whilst in the 
UK they perceived that their treatment was much better and knew their kidney 
function would be checked. Physicians play an important role in managing patients 
with chronic kidney disease by regular assessment and providing them with medical 
care and support during all stages of kidney disease.  Communication between 
patients, pharmacists, dietitians and physicians provides the best care for patients 
with chronic kidney disease (Weber et al., 2008). 
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Appendix 3 
 Questionnaire  introductory comments to the patients with Kidney disease 
Thank you for your participation, your comments are really appreciated. All your 
answers will be recorded in an anonymous way. 
Nationality   Kuwaiti □        non Kuwaiti  □   Study number…….  Age ………….. (years)  
Sex   1) Male □  2)Female □     Height ………m       Body weight today…….kg  
Questionnaire Diabetes 
 
1.Do you have diabetes? 1)Yes □            2) No    
 
2. What your body weight at the time of first diagnosis ……. kg 
3. Please state your age at the time of your original diabetes diagnosis: ……… (years) 
4. Were you ever able to control your diabetes with tablets medication? 1)Yes □              
2) No □           3) I don't know □        if yes please specify the name(s) of tablet medication 
you took? .......................................... 
5. How many years did you take it? a)less than 1 year  b) 1-3 years □ c)3-5 years □ d) 
more than 5 years □ e) other □ ……………… 
 
6. Are you still taking tablet medication for your diabetes?1) Yes □    2) No □ 
 
7. Have you ever used insulin to control your diabetes?        1) Yes □   2) No □   3) I don’t 
know □   If yes, please write the length of time you took Insulin ………………days/weeks  
8. Are you still taking insulin for your diabetes? 1) Yes □     2) No □ 
9. Please state whether you are on program from a hospital dietitian? 1)Yes □  2) No □ 
10. How often have you examined your blood sugar level in the past month? (please 
mark just one box) 1) never □    2) once a week or less □   3) roughly 2-6 times per week □                                      
4) daily □       5) twice a day or more □          6) three times or more □ 
11. Have you ever had a low blood sugar? 1) Yes □        2) No □        3) I don’t know □ 
12. Have you ever had a high  blood sugar? 1) Yes □     2) No □        3) I don’t know □ 
13.Do you test for urine for ketones? 1) Yes □   2) No □  3) I don’t know what ketones are 
□.  If Yes, please indicate how often you have been in ketoacidosis 1) 1-2 times a year □        
2) 2-3 times a year □  3) 3-4 times a year □   4) 4-5 times a year □  5) 5 times or more a year 
□     
Blood pressure 
14. Do you have high blood pressure? 
1) Yes □              2) No □         3) I don't know □       and if so, do you take medication for 
this reason? 1) Yes □           2) No □        3) I don’t know □, if yes please specify the 
name(s) of blood pressure tablet medication you take…………………………….. 
 15. How often you check your blood pressure checked ? 
1) Daily □       2) Weekly □       3) Monthly □       4) Annually □            5) Other □      
Eye 
16. Have you ever had the back of your eyes (the retina) examined? (not including 
examination by an option or optometrist just for glasses) 1)Yes □  2) No □  3) cannot recall □   
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If yes who conducted the eye examination? 1) A general practitioner □  2) A diabetes 
specialist □       3) An eye specialist  □        4) Cannot recall □  
17. Have you had laser treatment for your eyes? 1) Yes □       2) No □ 
18. Have you ever had a foot problem? 1) Yes □   2) No □ If yes, do you suffer from any 
of the following – (you can tick more than one) 1) Numbness or tingling □    2) Burning or 
pain in feet □    3) Foot ulcer  □   4) Swelling of the legs, ankles, feet □   5) Other □                                                          
19. Please fill in the appropriate box if you carry out any of the following type of 
exercise :a) walking for 10-30 minutes every day □  b) walking twice or three times a week 
for 10-30 minutes  □ c) attending a gym for up to 30 minutes a day □ d) attending a gym for 
a session of up to 30 minutes a week □  e) swimming twice or more a week for 10-30 
minutes □      f) other form of exercise  □  please state …………………… 
Circulation 
20. Have you ever had heart problems? 1) Yes □        2) No □           3) I don’t know □ 
If yes, is it 1) Chest pain □   2)Heart attack □   3) Other  □                                                       
Kidney 
 
21. Have you ever been told by the diabetic physician you have kidney disease?  
1) Yes □   2) No □ 
 
22. Have you been diagnosed by a diabetic clinic as having protein in your urine?          
1) Yes □   2) No □    3) I don’t know □ 
23. If yes did you transfer from diabetic physician to nephrologists?                                 
1) Yes □   2) No □    3) I don’t know □ 
24. Have you been told what caused your kidney disease? 1)Yes □  2) No □  3) I don’t 
know □    If yes, is it due to a) diabetes □ b) high blood pressure □ c) kidney stone □ d ) 
medications □  e) others □ …………………………………… 
 
25. What tests does the clinic carry out to diagnose that you have kidney disease on you 
whilst you were there? a) Blood test □  b) Protein in urine □  c) Nothing □  d) I don’t know 
□ e) other □……………….  
 
26. How long has it been since you were first diagnosed with kidney disease? (Circle 
one) a) 1  year □  b) 1-3 years □  c) 3-5 years □  d) 5-10 years □  e) other □ ……………… 
 
 27. What type of kidney disease do you have ?a) Acute □  b) Chronic □ c) I don’t know □   
 
 28. Do you know what is the stage of your kidney disease? 1)Yes □   2) No □If  yes is it : 
a. Stage 1- slight kidney damage with normal or increased filtration □     b. Stage 2- mild 
decrease in kidney function □         c. Stage 3- moderate decrease in kidney function □ d. 
Stage 4- severe decrease in kidney function □   e. Stage 5-kidney failure □   
 
 29. Do you have any symptoms due to kidney disease ?a) Change in urination patterns □     
b) swelling □      c) skin rash / itching □       d) coma □       e) nausea and vomiting □  
f) shortness of breath □        g) fatigue □       h) Other  □  
………………………………………….                                              
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30. Does kidney disease affect your daily life? 1) Yes □  2) No □. If yes, can you give an 
example : a) does it affect your diet? □ b) does it affect your work? □ c) does it affect your 
social life? □ d. other □ …………………………………….    
 
31. Do you have a family history of kidney disease? 1) Yes □   2) No  □ . If yes please give 
the family member who suffered the condition ……………………………. 
 
32. Do you know what food you should avoid if your kidneys are not behaving in a 
normal way ? 1) Yes □  2)  No □   and  if yes is it  a) Salt □ b) Potassium □- you can tick 
more than one - is it (bananas□, oranges□, tomatoes□, dried fruits□ and vegetables□, milk□, 
chocolate□, nuts and seeds□ and dairy products□. Low potassium foods include apples□, 
berries□, watermelon□, fresh beans□, lettuce□, cucumbers□, onions□ and vanilla-flavored 
desserts□ c) phosphorus- you can tick more than one- is it  (Cola□, peanut butter □and 
nuts□, liver□, broccoli □ and dairy□ are all high in phosphorus. d) Protein -you can tick 
more than one- is it  ( Egg□, meat□, milk□  e) any other-food you should avoid? ………. 
 
Dialysis 
33. If you are having renal dialysis what are the risks from this type of treatment? a) 
bleeding from access point □ b) hypotension □  c) infections □  d) anemia □  e) cramps, 
nausea and headaches □   f)infectious disease □   g) others  □ 
34. Where do you receive the dialysis?  a) home □            b) hospital □ 
35. How long does each dialysis take? a)1 -3hr □  b) 4-6 hr □  c)7-10 hr  □ d. other □ ……. 
36. How often you must go for the dialysis? a. every day b. twice a week c. three times a 
week  d. Other   
  
Kidney transplant 
 
37. Have you had a kidney transplant? a) Yes □  b) No □ If yes, what was the date of the 
transplant? ……………………………………………….. 
 
38. Do you know what was the source of the transplant kidney?  1) Yes □  2) No □  
If yes,  is it  a) living related donors like  parents, children or siblings □ b) living unrelated 
donor like friend or spouses □  c) altruistic donor □ 
 
39. Have you had get any of the following problems following the transplant; 1)Yes□                   
2) No □   if yes:       a) High blood pressure □   b) Cardiovascular disease □  c) Presence of 
blood in the urine □  d) Hernia □   e) Kidney stones □    f) Other □  
 
40.  Do you know what treatment(s) are currently prescribed for you? 1)Yes □  2) No □           
If yes Is it (you can tick more than one)  a.  Cyclosporins (Neoral, Sandimmune, SangCya) 
□.  b.  Azathioprines (Imuran) □ c.   Corticosteroids such as prednisolone (Deltasone, 
Orasone) □.      
 
41. Are there any side effect(s)due to the medication(s)? 1)Yes □  2) No □   
If yes is it (you can tick more than one) a) puffiness of face □  b) increase in weight  □ c) 
high blood sugar and blood pressure □  d) bone disease □  e) cataracts □ f) stomach acidity 
□  g) skin changes □  h) acne □  i) facial hair □  j)other □ …………. 
 
Anemia 
42. Have you ever been told you were anemic? 1)Yes □  2) No □. If yes, how long ago 
were you first diagnosed? a) Less than 1 year □  b) 1-3 years □   c) 3-5 years □  d) more 
than 5 years □  f) other □ …………………………………….       
43. Have you taken medication to prevent anemia? 1)Yes □  2) No □  3) I don’t know □  
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If yes, is it a) Folic acid □  b)Iron □   c) other   □………………………………           
Bone disease 
44. Have you ever been told you had weak bones? 1)Yes □   2) No □. If yes, when were 
you had weak bones? a) Less than 1 year □ b)1-3  years  □ c) 3-5  years □   d) more than 5 
years □  f) other □ ……………………… 
 
45.  Do you take medication for your bones? 1)Yes □         2) No □. If yes ,is it a) calcium 
□ b)vitamin D  □ c) combination of vitamin D and calcium   □  
Please provide use with comments or other feedback regarding you condition, so that it 
may be used in medical research……………………………………………………….. 
Thank you again for your participation, it is highly appreciated.  
For additional communication please contact:  
Eman Ahmed Buhajeeh   Email: E.A.A.Bu-Hajeeh@brad.ac.uk 
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Appendix 4 
Physicians Questionnaires 
Questions which were designed as points of discussion with ophthalmologist. 
1. How often do you think that the diabetic patients’ eyes should be checked? 
2. What do you think is the best strategy to ensure that the treatment reduce the 
value of proliferative retinopathy 
3. How long does it take for the first diagnosis of retinopathy to progress to 
blindness? 
 
4. Have you ever seen a diabetic patient with a severe eye problem due to not 
being referred at the onset of the ocular problems.  
 
Questions which were designed as points of discussion with nephrologists 
1. What in your clinical experience are the major causes of kidney disease ? 
2. What are the most common kidney tests which should be done? 
3. How often the patient should be tested? 
4. How does the patient know if they have poor renal function? 
5. Have you ever seen a diabetic patient with a final stage of a kidney disease due to 
not being referred at the onset of the renal problems?  
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Appendix 5 
Physicians interview for the UK 
1) What is the most common diabetic complication(s)   that Kuwaiti patients 
present -with ,  in your unit?  
2) Do you think that diabetic patients treatment in Kuwait could be enhanced?  
Yes/ No If yes, what enhancements do you think could have been made. 
3) Did you change the medication (s) of the diabetic patients after admission? 
Yes No 
If yes, was the most common reason for such a change  
4) In your opinion what is the major reason(s) Kuwaiti patients come to the UK 
for treatment. 
5) Do you have any comments to make regarding the treatment of Kuwaiti 
patients in the UK, so that it may be used in medical research? 
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Appendix 5 A 
Interview Results for UK physicians. 
UK physicians at Ascot. - Introductory comments. 
Five structured interviews were conducted with consultant physicians in the Ascot 
Rehabilitation Centre, regarding topics relevant to diabetes and renal, providing 
evidence regarding the interactions between patients and physicians. This thereby 
served to establish any links between the findings from the Ascot Kuwaiti patients 
and their physicians. The questionnaire contained only five questions, open and 
closed questions were used and the study was carried out by face-to-face sessions. 
 
What is the most common diabetic complication(s)   that Kuwaiti patients 
present with, in your unit? 
 
consultant Consultant comments 
1 Here, the respondent was provided with a variety of answers: a) kidney 
problem, b) heart problem, c) stroke, and d) impaired sensation (nerve 
complications). 
 
2 Here, the respondent answered macro vascular disease.  
 
3 Here, the respondent answered - chronic kidney disease. 
 
4 Here, the respondent answered -stroke and eye problems.  
 
5 Here, the respondent provided two answers: a) stroke due to diabetes, 
and b) neuropathy). 
 
 
Do you think that diabetic patients’ treatment in Kuwait could be enhanced?  
Yes/ No If yes, what enhancements do you think could have been made?” 
consultant Consultant comments 
1 ”She responded “yes” – the lack of empathy of the primary car doctors 
in Kuwait was noted and they should listen to the patient issue(s) and 
the physician should be carrying out suitable tests such as HbA1c, 
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kidney function test, cholesterol test and eye test to prevent any 
complication. She stressed that a very important enhancement could be 
to transfer the patients to a dietician as soon as possible after diagnosis. 
She found that in the patients she saw this had not occurred. 
 
2 ” He responded “yes” by screening their patients in systematic way, the 
physician should be carrying out suitable tests such as HbA1c, kidney 
function test and eye test to prevent any complications 
3 ” he responded “yes”  by transferring patients to a dietician ,the 
physician should be carrying out suitable tests such as HbA1c, kidney 
function test and  by patient education to be aware about diabetic 
complications and monitor their blood glucose level. 
4 ” he responded “yes” the physician should be carrying out suitable tests 
such as HbA1c, and monitors the blood glucose level. 
5 ”he responded “yes”  by primary care doctors  education ,better 
diagnosis and patient education    
 
Did you change the medication (s) of the diabetic patients after admission? Yes/ 
No. If yes, was the most common reason for such a change? 
consultant Consultant comments 
1 “Yes because it is not the most suitable medicine and by this medicine 
which was prescribed in Kuwait the blood sugar will not be controlled 
“. 
2 “Yes to improve glycemic control.” 
3 “Yes to control blood glucose for example; change the short acting 
insulin to long acting insulin for a patient who was recumbent” 
4 “Yes to improve and control diabetes and blood pressure.”  
5 “Yes because it is not the suitable medicine and by this medicine which 
prescribed in Kuwait the blood sugar will not be controlled.”  
 
 
 
 300 
 
In your opinion what are the major reason(s) Kuwaiti patients come to the UK 
for treatment? 
consultant Consultant comments 
1 The response was “They don’t have the best treatment in 
Kuwait.” 
2 The response was “there is no quality of care in Kuwait and they 
need more specialization and physicians need more education.”  
3 The response was “there is no quality of care in Kuwait, the 
physicians need more education and there is no expertise.”  
4 The response was “there is no quality of care in Kuwait.”  
5 “They don’t have the best treatment in Kuwait.” They have severe 
complication due to diabetes which if it is treated from the beginning 
they will not have this complication 
 
Do you have any comments to make regarding the treatment of Kuwaiti 
patients in the UK, so that it may be used in medical research? 
 
consultant Consultant comments 
1 She responded that Patients should be properly checked as  if the 
physician controls the glucose and the blood pressure, and carrying out 
all the proper test   that will reduce the  risk of complication(s) and he 
should treat each patient as one of  his family . All the physicians know 
the Guidelines for the treatment of diabetes even if he is not consultant 
which they had studied in the medical school.  So the physician should 
be encouraged to keep their education up to date and their work should 
be monitored by the MOH to ensure it is suitable. . In UK if the 
physicians  did not do their  work properly they can face the risk of 
removal of their license to practice  so, the MOH in Kuwait could use a 
similar system  and should remove the license from each physician who 
did not do his work well.  The MOH should ask the patients if they are 
happy with their treatment(s).     
2 He responded the physicians need more education and they should due 
the proper test such as HbA1c and they should follow the NICE 
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guideline.  They should have empathy and listen to patient health 
problems. Patient should be educated about diabetic complications and 
how they monitor the blood glucose.  They should be transferred to 
dietician. Patient association group that one of the patient spoke directly 
to MOH about the bad treatment(s) in Kuwait. If the patients are not 
treated well from the beginning that can lead to severe complication 
and the government will spend more money to treat their patients .The 
government should be aware that the citizens’ health is their 
responsibility and if they treated correctly from the beginning the 
budget of treatment will be less. Any physician not doing his job 
properly should have his license removed.   
3 He responded the physicians need more education and they should do 
the proper tests such as HbA1c and they should follow the NICE 
guidelines.  For example the Kuwait Government employ of UK 
physician to train the physicians in Kuwait. There should be stricter 
laws, for example in the UK there are rules that for example if the 
physician caused a minor mistake he should more educate. If he caused 
a major problem he could have his license removed. The MOH should 
be responsible for monitoring their physicians working practices which 
the UK does after the findings of the   Harold Frederick Shipman 
Inquiry. 
4 He responded the physician need more education and they should due 
the proper test such as HbA1c and they should be aware that a medicine 
which is good for one patient may not good for the another  so they 
should change the medicine if it is not suitable for the patient . There 
should be team of physicians to exchange the information about 
diabetes treatments. If the diabetes is treated well from the beginning   
it may lead to no/fewer diabetic complications. The MOH should 
monitor the physician working practices. 
5 He responded “A patient should get proper checks, such as a physician 
should control the glucose and the blood pressure, and carry out all the 
proper tests   that will reduce the risk of complications.  A Patient 
should get education from the beginning of their disease by their  
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physician  who should give the patient  enough time so that he can 
explain to the patient the complications of the disease and how the 
patient  should monitor his blood glucose level. In UK the physician 
submits his CV which mentions how may courses he has taken    and 
how many conferences he has attended in the current year and that 
should be happening in Kuwait. 
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Summary of the analysis of comments by physicians in UK. 
Comments of consultants about their current experiences in treatments of 
diabetic patients with severe complications due to diabetes. Each physician 
made a number of comments which have been listed below. 
Table 1 Comments of consultants. 
 
 
 
 
 
 
 
 
Key: 1*Primary care doctors skill/education/empathy 2*HbA1c /kidney function test 
/eye test/cholesterol test 3* dietician 4*Change the medication 5*treatment 6* 
Diabetic guideline.7* patients education 8* Kuwaiti government/MOH.  
From table 1major areas of concern were found for consultants, namely. 
From Table 1 column 1.Primary care doctors  need more education and the lack of 
empathy of the primary care doctors in Kuwait was noted and they should listen to 
the patient issue(s)- was highlighted by all consultants .Comment: This is sport 
which physicians in Kuwait said. 
From Table 1 column 2. The primary care doctors should be carrying out suitable 
tests such as HbA1c, kidney function test, cholesterol test and eye test to prevent any 
complication.Comment: This is sport which physicians in Kuwait said. 
From Table1column3, 4&5.The medication of the patients was change in UK 
because it is not the suitable medicine and by this medicine which prescribed in 
Kuwait the blood sugar will not be controlled -was highlighted by all consultants. 
Physicians 
number 
1* 2* 3* 4* 5*  
6* 
7*  
8* 
1 + + + + + +  + 
2 + + + + + + + + 
3 + +  + + + + + 
4 + +  + +   + 
5 + +  + +  + + 
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Kuwaiti patients came to the UK for treatment because they don’t have the best 
treatment in Kuwait and there is no quality of care in Kuwait. Very important 
enhancement could be to transfer the patients to a dietician as soon as possible after 
diagnosis-- was highlighted by 2consultants .Comment: This is sport which some 
patients said that there medication which prescribed by the primary doctor not 
suitable and they are not in weight managements also the evidence from their 
files shows that referral to dietician was not carried out. The physicians in 
Kuwait said that the treatment was inadequate which lead to severe 
complication . 
From Table 1 column6.Primary care doctors in Kuwait should follow the NICE 
guidelines -was highlighted by 3consultants. Comment: This is sport which 
physicians in Kuwait said. 
From Table 1 column7. Patient should get education from the beginning  of their 
disease by their  physician  who should give the patient  enough time so that he can 
explain to the patient the complications of the disease- was highlighted by 
3consultants . Comment: This is sport which physicians in Kuwait and the 
majority of the patients said that the primary doctors do not have empathy and 
do not listen to patients issue. 
From Table 1column8. If the patients are not treated well from the beginning that can 
led to severe complication and the government/MOH will spend more money to treat 
their patients .The government should be aware that the citizens’ health is their 
responsibility and if they treated correctly from the beginning the budget of treatment 
will be less. Any physician not doing his job properly should have his license 
removed. One physician said in UK the physician submits his CV which mentions 
how may courses he has taken and how many conferences he has attended in the 
current year and that should be happening in Kuwait. 
UK physicians 
UK practitioners associated with the Ascot Rehabilitation clinic view diabetic 
treatment in Kuwait as having a few problems based on the manner in which the 
patients were treated. Based on these concerns of the UK doctors, the primary care 
doctor in Kuwaiti should be encouraged to both know and follow the guidelines for 
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diabetes treatment even if they are not of consultant status. Kuwaiti physicians 
providing non-optimal care may reflect on the lack of a formal system requiring them 
to keep their diabetic knowledge up to date   as happens in the UK. 
"Good doctors make the care of their patients their first concern :they are 
competent, keep their knowledge and skills up to date ,establish and maintain 
good relationships with patients and colleagues, are honest and trustworthy, 
and act with integrity and within the law"( General Medical Council, 2009). 
 Many dietitians have limited knowledge about cultural food in the terms of religion 
and habitual choice. Dietitians and physicians should be aware of the traditional food 
choice and not only of the medical aspects of their patients’ condition. So treatment 
with healthy diet should take into account patients culture of  food and habitual 
choice as happens in UK (Thaker & Barton, 2012).In the  Ascot centre the dieticians 
have a very  good knowledge about traditional patient food which is a very important  
medical aspect which can led to positive  improvements in a  patient health. 
 
The UK physicians, were worried that the overall quality of care in Kuwait diabetes 
is lower than they considered optimal. This may reflect the suggestion that some 
physicians were not specialized to treat diabetes. Also they seemed to carry out 
treatments without strict adherence to guidelines which perhaps is best summarized 
by one patient describing them as “reckless”. In this study, two examples of this were 
found. One patient had to have toes on both feet leg amputated and in another due to 
a wrong diagnosis a patients had a cancer spread to all parts of the body. 
 A greater awareness of the physicians of the potential severity of the diabetic state 
may have saved the patients toes because in this case the patient’s feet were initially 
treated by topical application of creams rather than considering the numbness and 
burning sensations were potentially more serious. The situation was made even more 
problematic because even after constant complaints by the patient that his condition 
was not improving the doctor never did any check-up but only gave the patient some 
more cream to apply. In the case of the tumor, topical application for the patient’s 
pain and aching in his thigh was unsuccessful as it was later discovered that the thigh 
pain was in fact due to a tumor in his lower back and this was indicated by the pain 
in his leg. 
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In contrast to the UK based physicians, Kuwaiti diabetes treatment is not focused on 
patient centred care. Physicians in Kuwaiti needs to be far more diabetic patient 
centred who generally require a very high level of care to avoid the complications of 
their condition. This could be easily addressed by them providing more information 
to their patients, which patients in this study said were never given to them during 
their treatment. Not unsurprisingly, patients lacked basic information to try and help 
them in their treatment of their condition. In patient centred care, the patient has the 
right to information on the kind of treatment they receive and the various tests 
conducted on them (Health.org,2014) One finding is of special concern in that the 
patients were not tested for their levels of HbA1c, which are essential for all diabetic 
patients (Diabetes UK, 2015). Late diabetic diagnosis and uncontrolled blood sugar 
levels lead to more severe and more costly complications which could be prevented 
by regular management .The most common test the physician should carry out urine 
and blood test to prevent kidney complications due to type 2 diabetes .The 
management of diabetes and it is complications causes greater expense affecting  the 
budget of the individual and health service (Bilous & Donnelly, 2010).  Further, the 
necessary tests such as those used to monitor kidney function so as to avoid 
progression to kidney failure should also be carried out for all patients.  It should not 
be the case that  some of the patients only heard about some of these tests in the 
private hospitals of Kuwait or other countries to which they had been sent to receive 
their treatments 
These comments are also supported by the comments made by the nephrologists and 
ophthalmologists in Kuwait. 
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Appendix 6 
Consent form verbal statements  given to each patient  
Please tick each box to agree with the statements 
 To explain the nature of the study  
To provide the chance to ask question about the study.                   
I hope you understand that all information collected will be treated confidentially.                                                                                                                       
I confirm that I am taking part in this study of my own free will            
I am free to withdraw from the study at any time and for any reason.  
If I withdraw from the study, then I may ask for my data to be removed.  
I agree to take part in this study. 
Participant code---------------   Date--------------- 
  803
 
 7 xidneppA
 )evoba dna sraey 12( stneitap tludA rof stnatsnoc demrofnI
 
 سنة فأكثر) 12اقرار مستنير للمرض للبالغين (
يهدف هذا البحث الي التعرف على معلوماتك ونمط حياتك وطريقة تعاملك مع مرض السكر وخبراتك بخصوص  
التشخيص والمتابعة والعلاج ونمط حياتك اليومية ومعرفتك بتأثيرات السكر على حالتك الصحية وبصفة خاصة 
ة وذلك بهدف تطوير سياسات احتمالات تأثير السكر على الكلي والعين وعلى الاعصاب وعلى الدورة الدموي
 المقدمة للمريض  والإرشاداتوبرتوكولات التوعية الصحية 
ان المشاركة في هذا البحث اختيارية أو ليست اجبارية وفي حالة موافقتك على المشاركة في هذا البحث فإنه لا  
الاجابة على أي يتضمن اعطاء اي ادوية أو اجراء فحوصات طبية او سحب عينات دم ومن حقك التحفظ على 
 سؤال دون ابداء الاسباب ولن يتم كتابة اسمك أو ما قد يدل على شخصيتك في نتائج هذا البحث.
في حالة الموافقة يتعهد الباحث بالمحافظة على الخصوصية وسرية المعلومات وعدم تداولها خارج اطار البحث  
 ن ناحيتك.وكذلك فإن مشاركتك بالبحث لن يترتب عليها اي تكاليف مالية م
 في حالة عدم الموافقة لن يؤثر ذلك على حقك الكامل في تلقي الرعاية الصحية المقررة لك  
 يرحب الباحث بالإجابة على اي اساله طوال فترة اجراء هذا البحث وقبل اعطاء الموافقة. 
في حالة موافقتك فإنه يحق لك الانسحاب من الدراسة في اي وقت دون ابداء الاسباب دون ان يؤثر على حقك  
 الكامل يتلقى الرعاية الصحية المقررة لك 
 البحث  وأثناءيرحب الباحث على اجابة او استفسار قبل اعطاء الموافقة  
 
 
       ------------------ اسم     اوفق
      ------------------اسم     لا اوافق
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Appendix 8 
 
Participant information sheet .An investigation into the treatment of diabetes in 
Kuwait. 
This project is envisaged as being structures as an informal structural interview. This 
will informing the potential participants of the following information. 
To the patient the following comments would be made. 
 My name is Eman Buhajeeh  and I am a PhD research student at the University of Bradford 
in the UK.  I would like you to take part in a research project I am undertaking about the 
treatment of diabetes in Kuwait. I will explain what the purpose of the project is and if you 
do not understand anything then please ask me for clarification. 
Why have you been chosen? 
This is a pilot project and you have been selected at random from those patients who are 
attending a regular diabetes clinic. This means you all have firsthand experience of the 
treatment of diabetes in Kuwait. It does not require you to do anything except give your 
views and experiences and requires no special training. 
 
What is purpose of the project? 
The purpose of this research is to determine what experiences patients have of their 
treatment of diabetes and this method is the best method to use as it asks people who are 
currently undergoing treatment here in Kuwait. Assessing your experience will provide us 
with information about the professional standard of care. 
Do I have to participate?  
 You are free to decide whether or not to participate. 
 If you agree, I will give you this information sheet for you to keep, and if you agree to 
this suggestion your agreement will be taken as an agreement to take part in this study.   
 If you do not agree, you are still free to change your mind at any time and without giving 
a reason. 
 If you do withdraw at any time, then you may also ask for any data already collected to be 
destroyed, and we will do this for you. 
 Who is conducting the investigation 
The investigation will be carried out by me (Eman Buhajeeh  ), under the supervision of Prof 
Rattray  and Dr I Naylor of the |University of Bradford. Please contact me supervisors if you 
have any questionsE.A.A.Bu-Hajeeh@brad.ac.uk;  This study has been reviewed by the  
University of Bradford ethics panel. 
What will you have to do? 
 You will be asked a series of question about your diabetes  
 The questions will determine factors such as your age and the duration of your diabetes.  
 You are expected to give the best answers you can to the questions asked 
 During the interview notes may be made but no tape recording or other form of recording 
such as video will be used. 
 The notes will be anonymous as you will be simply allocated a number.  
 The whole process should take no more than 1 hour to complete. 
What are the probable benefits? 
 You will be helping us to develop this way diabetes is treated in Kuwait.  
Are there any risks? 
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 No – it is a matter of only answering a number of questions.  
 If you find the process to your dissatisfaction - you may stop at any point and withdraw 
from the study. 
 No in terms of people reading specific answers from specific people - since all data is 
anonymous and so none of your answers can ever be traced back to you as an individual. 
Will my response be kept confidential? 
All responses will be strictly confidential. Your personal data will be destroyed when the 
final study has been completed and any papers published, which may be in about 3 years 
time. Anonymous questionnaires and interview transcripts may be kept indefinitely, but this 
will be reviewed after 5 years. 
Can I withdraw from the investigation? 
You may withdraw at any time and ask for your data to be destroyed. Please just ask me to 
do this .Contact for further informationEman Buhajeeh  PhD student, E.A.A.Bu-
Hajeeh@brad.ac.uk The patient would at the end of the interview be sincerely thanked 
for their participation. 
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Appendix 10 
Cross tabulation of the antihypertensive medications taken by male and female Kuwaiti 
subjects who took part in this study. 
     Drug Group      Male  Female   
Calcium channel blockers 
          
Norvasc (amlodipine)     1  2  3 
Usually Twynsta but if not available takes 
Valsartan and Norvasc (amlodipine)   1  0  1
  
Total       2  2  4 
Beta blockers 
Tenormin (atenolol)     0  1  1 
Total       0  1  1 
Angiotensin II receptor antagonists 
Co- Diovan (valsartan)     0  4  4 
Micardis (telmisarten)     0  0  0 
Total       0  4  4 
ACE inhibitors 
Coversyl (perindopril)     1  1  2 
Capoten (captopril)     0  0  0 
Zestril (lisinopril)     3  3  6 
Total       4  4  8 
Combined preparations 
Tenormin (atenolol) +Norvasc (amlodipine)  0  1  1 
Capoten (captopril) + Zestorectic (Lisinopril)  0  1  1 
Capoten (captopril) + Norvasc (amlodipine)  1  0  1 
Co-Diovan (valsartan/hydrocholorthiazide)   0  1  1 
+ Isoptin ( verapamil) 
Diovan (valsartan) + Norvasc (amlodipine)  0  1  1 
Tenorectic ( atenolol and chlorthalidone)  0  3  3 
Tenorectic(atenolol+chlorthalidone) and   0  1  1 
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Zestril (lisinopril) 
Tenorectic(atenolol+chlorthalidone)   0  1  1 
and Lasix (Furosemide) 
Tenormin (Atenolol) and Co-Diovan (valsartan  0  1  1 
+ hydrocholorthiazide) 
Tenormin (atenolol) and Zestril (lisinopril)  0  1  1 
Zestoretic (lisinopril) and Isoptin(verapamil)  1  0  1 
Zestril (lisinopril) and Concor                1  0  1 
Total       3  11  14 
Total 9 22 31 
Did not know which drug they were taking  3  9  12 
No drugs being taken     12  7  19 
  
For the non-Kuwaiti patients the results were: 
     Drug Group     Male  Female   
Calcium channel blockers 
Norvasc (amlodipine)     0  2  2 
Adalat (nifedipine)     1  0  1 
Total       1  2  3 
Beta blockers 
Tenormin (atenolol)     1  1  2 
Total       1  1  2 
Angiotensin II receptor antagonists 
Co-Diovan (valsartan)     0  1  1 
ACE inhibitors 
Capoten (captopril)     2  1  3 
Zestril (lisinopril)     4  3  7 
Total       6  4  10 
Combined preparations 
Tenorectic (atenolol + chlorthalidone)   0  2  2 
Zestoretic (lisinopril) + nifedipine)   0  3  3 
 315 
 
Zestril (lisinopril) + Tenormin (atenolol)  0  1  1 
Lasix (furosemide) + Zestorectic (lisinopril)  0  1  1 
Total        0  7  7 
Diuretic drug –Lasix ( furosemide)   1  0  1
   Total                                                        9                          14                     
23 
Did not know which drug they were taking  5  1  6 
No drugs being taken     9  9  18 
Total       23  24  47 
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Appendix 11 
Symptoms of Hyperglycemia 
For Kuwaiti nationals 
Symptoms     Male (n=22) Female (n=36)   
          
Pain in the body and blurred vision  0  2   2 
Cold/ sweating     8  3   11 
Sweating and fatigue    2  4   6 
Fatigue, shakiness and blurred vision  1  5   6 
Fatigue, shakiness, blurred vision and        4  4                                     8 
Increase in appetite 
Fatigue, shakiness and sleepiness  1  4   5 
Fatigue, cold, shakiness and sweating  1  4   5 
Heart palpitations and shakiness              2                 2 
Blurred vision and heart palpitations  0  2   2 
Fatigue and abdominal itching   0  2   2 
Unconsciousness    1               2              3
    
Shakiness, heart palpitations and poor   0  2   2 
Concentration 
The blood glucose becomes 300mg/dl          2                                                          2 
Drowsiness and dry mouth                           0                         2                                2 
 
For non-Kuwaitis 
Symptoms     Male (n=22) Female (n=22)  
   
       
Pain in the body and blurred vision  2  1   3 
Cold/ sweating     7  1   8 
Sweating and fatigue    2  1   3 
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Fatigue, shakiness and blurred vision  -  4   4 
Fatigue, shakiness, blurred vision and an 1 0  2                           2 
increase in appetite 
Fatigue, shakiness and sleepiness  2  2   4 
Fatigue, cold, shakiness and sweating  2  1   3 
Heart palpitations and shakiness                 1   1 
Blurred vision and heart palpitations  2  1   3 
Fatigue and abdominal itching   0  1   1 
Unconsciousness    1                1                       2
                     
Shakiness, heart palpitations and poor   2  1   3 
Concentration 
Poor concentration     1  0   1 
Fatigue      0  2   2 
Sweating, coldness and blurred vision  0  2   2 
Hunger, shakiness  
Coldness and heart palpitations              1  1                                     2 
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Appendix 12 
Poster from Desman Diabetes Institute 
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Appendix 13 
Table 1: Types of Diet and their Replacements 
Food Group Stay Away From Replacements 
1- Drinks  Pepsi, Coke,  
 Canned Juices 
 Alcohol 
 Non Alcoholic 
Beer 
 Diet Pepsi, Diet Coke, 
 Natural juices,  
 Drinks that contains  
 Chemical sugars such 
as Aspartame or 
Saccharin 
 Tea and coffee at 
moderate amounts, 
replacement of 
traditional sugar with 
Aspartame or 
Saccharin. 
2- Fruits, 
Vegeta
bles 
and 
snacks  
 Jam,  
 Cakes.  
 Chocolates. 
 Potato chips.  
 Avocado.  
 Salted olives. 
 Fried 
vegetables. 
 Boiled potatoes. 
 Lentils,  
 Peas   
 Legumes  
 Fresh canned fruits 
Bakery 
and 
Grains.   
 All bakery 
made from 
white flour 
such white 
bread and 
pastries 
  Different 
types of  
 Pasta  
 Whole Meal bread 
 Whole Meal pastries 
 Oats  
 Brown Rice  
3- Soup  Soup made 
with animal fat  
 Readymade 
soup 
 Soup in a 
cup(high 
sodium and 
preservatives) 
 Homemade soup 
 Lentil soup 
 Legumes Soup 
4- Eggs, 
Milk 
and 
dairy 
product
s 
 Full Cream 
Milk 
 Full cream 
dairy products 
such as cheese 
and yoghurt  
 Low fat milk 
 Skimmed milk 
 3 egg yolks per week 
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 Salted Butter  
 Egg Whites 
5- Fish  Shrimps 
 Craps 
 Sea Shells 
 All other fish types 
 None fried 
 Tuna 
6- Meat  Fried meat  
 Corned beef 
 Chicken skin  
 Sausages  
 Chicken without skin 
 Rabbits meat 
7- Fats  All plant and 
animal fats 
(Poly-saturated 
fatty acids) 
 Sun flower and corn 
oil 
 Polyunsaturated Fatty 
Acids 
 
 
Table 2: The Amount of Calories present in Arabic Appetizer- Kubbah and 
Stuffed vegetables- (per 100 grams serving)  
# Food Type Calories 
1 Dulmah – stuffed vine leaves with rice and minced meat  108 
2 Stuffed eggplant or squash with rice and minced meat 215 
3 Halabi Kubbah- Rice dough stuffed  with minced meat 358 
4 Potatoes Kubbah – potatoes stuffed with minced meat 230 
5 Jerish Kubbah – Groats  stuffed with minced meat 236 
6 Lemon Kubbah- (Halabi Kubbah with rice, tomato and 
lemon sauce  
298 
7 Bulgur  Kubbah- Bulgur stuffed with minced meat  234 
8 Fried Kebab – Minced meat mixed with vegetables and 
covered with eggs  
480 
9 Meat loaf 253 
       
Table 3: The Amount of Calories present in Arabic Cooked Rice  
 (per 100 grams serving)  
# Food Type Calories 
1 Boiled Rice 102 
2 Rice with Lentils  234 
3 Rice with Bulgur 222 
4 Rice with Carrots  147 
5 Rice with Kidney Beans 236 
6 Rice with Tomatoes  196 
7 Rice Dessert  288 
8 Rice Mash 76 
 
 
 321 
 
 
Table 4: The Amount of Calories present in Arabic Cooked vegetables 
 with meat broth or sauce   (per 100 grams serving)  
# Food Type Calories 
1 Okra Broth 74 
2 Beans Broth 102 
3 Tomato Broth 198 
4 Eggplant Broth 78 
5 Cabbage Broth 83 
6 Zucchini Broth 108 
7 Pumpkin Broth 246 
8 Chickpeas Meat Broth 139 
9 Spinach Broth 106 
10 Potatoes Broth 250 
11 Cheese Pasta Broth 287 
12 Lentils Broth 99 
13 Cabbage Broth 83 
14 Turnips Broth 26 
15 Boiled Kidney Beans 40 
 
Table 5: The Amount of Calories present in Arabic Fried  
Vegetables with plant fats (per 100 grams serving)  
# Food Type Calories 
1 Fried eggplant 256 
2 Fried potatoes  471 
3 Fried tomatoes  173 
4 Fried meat balls  554 
5 Fried sheep kidneys and liver  322 
 
Table 6: The Amount of Calories present in Arabic Soups Meat and 
 Chicken (per 100 grams serving)  
# Food Type Calories 
1 Turnips Lemon Soup (Without Meat) 64 
2 Rice Tomato Soup (without Meat) 123 
3 Tomato Soup (without Meat) 95 
4 Chicken Broth Soup 190 
5 Meat Broth Soup 208 
6 Vegetables Chicken Soup 264 
7 Lentil Meat Soup 280 
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Table7: The Amount of Calories present in Arabic Desserts 
 (per 100 grams serving)  
# Food Type Calories 
1 Milk Pudding (Milk with Corn Flour) 221 
2 Baked dates  234 
3 Dates dessert  263 
4 Baklava 435 
5 Sweet Rice with Milk 65 
6 Dumplings  458 
7 Biscuits  342 
8 Chocolates with Nuts 532 
 
 Green Salads:   50-70 Calories  
 
Table 8: Sample Weekly Diet for a Diabetes Patient that Provides 800-1000 
Calories Per Day 
Day Breakfast Lunch Dinner 
Saturday  1 cup 
of 
Milk 
 Tea or 
coffee 
witho
ut 
sugar 
 1 
Boile
d Egg 
 ¼  
loaf 
of 
bread  
 Lamp ribs Broth 
cooked freely  
 Meat Soup 
or any 
type of 
Soup 
 Salad 
 Fruits as 
indicated 
in the fruit 
section  
Sunday  Squash or eggplant 
broth  
 10 table spoons of 
rice 
 Salad 
 Small 
piece of 
bread  
 1 piece of 
cold meat 
or cheese 
 Fruits as 
indicated 
in the fruit 
section 
Monday  100-150 grams of 
Tuna  
 1 piece of whole 
meal bread 
 Salad with lemon 
and vinegar 
 Vegetable 
or lentil 
soup 
 50 grams 
of boiled 
potatoes 
 Fruits as 
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indicated 
in the fruit 
section  
Tuesday  Chicken without 
Skin 
 Salads  
 Fruits as indicated in 
the fruit section 
 Vegetable 
or lentil 
soup 
 Salads 
 Whole 
Meal 
Bread 
 
Wednesda
y 
 1 piece of grilled 
fish 
 100 grams of Tuna 
 Mashed potatoes  
 Salad 
 Pasta 
cooked 
with 
tomato 
sauce 
 10-15 
table 
spoons 
Thursday  Vegetable cooked 
with meat broth with 
rice 
 Fruits as indicated in 
the fruit section 
 Bakla 
Meat 
Broth  
 Whole 
Meal 
Bread 
 
Friday  Grilled meat 
 Salad 
 Low fat 
Cheese 
 Fruits as 
indicated 
in the fruit 
section 
 
Fruits Section: 
Fruits are considered very important to human body as they contain vitamins and 
fiber that helps in both the digestion and the secretion of food. The list of fruits that 
can be consumed safely by a diabetic are 1-2 oranges, 1-lemons, 2-figs, 1 piece of 
water melons. 
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Cooking Tips: 
 All meats should be grilled and cannot be fried  
  Use Whole Meal bread 
 Use low fat or Skimmed Milk 
 Use Saccharin or Aspartame 
 
Food Type % of Glucose increase in 
Blood Level  
Sugar (Glucose)  100% 
Honey-dates-mashed Potatoes  80-90 % 
White Bread-White Rice-Turnips 70-79% 
Whole Meal Bread-Bananas- raisins  60-69% 
Pasta-oats-sucrose  50-59% 
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Appendix 14 
Data sheet as suggested by Abona and Samhan (2006) 
             
Date 
 
            8.00 am 
B
o
d
y
 
te
m
p
er
a
tu
r e
 
            12.00 pm  
            16.00 pm 
            21.00 pm 
            8.00 am 
B
lo
o
d
 
p
re
ss
u
re
 
            12.00 pm 
            16.00 pm 
            21.00 pm 
            weight 
            Volume of drinks 
            Volume of urine  
            Creatinine 
            BUN 
            White blood cells  
            Hemoglobin 
            potassium 
            calcium 
            phosphate 
            Sugar level 
            Level of 
Cyclosporine in 
blood 
 
 
 
 
 
 
 
 
 
 
 
